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SUMMARY 
Aspects of carbohydrate quality and their relevance for risk markers of type 2 diabetes 
mellitus and related health outcomes 
Concern has been raised that the commonly advocated low-fat, high-carbohydrate diet might 
be actually detrimental for the growing number of people with impaired IR since it favors 
postprandial rises in glucose and insulin, which are associated with an increased risk of type 
2 diabetes mellitus (T2D). Successful prevention strategies to fight the increasing prevalence 
rates of obesity, T2D and related chronic diseases are urgently needed. Since insulin-
resistant individuals are particularly prone to glycemic excursions, this might also extend to 
puberty, a period characterized by physiological IR. A further age group, which to date has 
not been addressed, are elderly people, who represent a growing proportion of our 
population and for whom specialized prevention strategies might be necessary. 
Therefore, the overall aim of the present thesis was to investigate the relevance of different 
aspects of carbohydrate quality for selected risk markers of T2D. In this regard, prospective 
associations between puberty and young adulthood as well as 5-year longitudinal relations in 
older age were examined. 
Major data source was the DOrtmund Nutritional and Anthropometric Longitudinally 
Designed (DONALD) Study, which includes data on dietary intake, anthropometry, and 
health from birth until adulthood. Moreover, data from the Blue Mountains Eye Study (BMES) 
was used, where information on nutritional status and markers of liver function was 
repeatedly collected from an older Australian cohort. Additionally, a systematic literature 
search was conducted on the association between carbohydrate quality and chronic low-
grade inflammation in adults. 
Four analyses (Study I, II, III, and V) and one systematic review (Study IV) were performed. 
Study I, including 262 participants of the DONALD Study, showed that a higher habitual 
dietary insulin index, but not a higher glycemic index (GI), during puberty was related to a 
higher percentage body fat in young adulthood. Study II revealed that a habitually higher 
dietary GI during puberty was the only aspect of carbohydrate nutrition which was 
consistently related to the analyzed T2D risk markers i.e. homeostasis model assessment IR 
(HOMA-IR), alanine-aminotransferase (ALT), and gamma-glutamyltransferase (GGT) in a 
subsample of the DONALD Study (n=226 and n=214, respectively). In Study III, again based 
on data from the DONALD Study (n=205), a higher habitual pubertal intake of carbohydrates 
from higher GI food sources and a lower intake of whole grains was associated with higher 
levels of the pro-inflammatory cytokine interleukin-6 in younger adulthood. In this regard, 
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Study IV showed that the observational evidence in adults is less consistent for a beneficial 
role of a lower GI or GL compared to dietary fiber/whole grain. However, there is less 
consistent evidence from intervention studies for anti-inflammatory benefits of higher fiber or 
whole grain diets than there is for low-GI/GL diets (60 studies were included in the 
systematic review). Benefits of higher fiber and whole grain intakes suggested by 
observational studies may hence reflect confounding. Finally, in Study V, including 866 older 
people from the BMES, no longitudinal relation was observed between the different aspects 
of carbohydrate quality and liver enzymes and serum lipids. 
In conclusion, our results suggest a particular relevance of postprandial glycemic – and also 
insulinemic – excursions during puberty for risk markers of T2D during adulthood. Overall, 
efforts to improve carbohydrate quality should not focus solely on a high whole grain intake, 
but needs to be complemented by an advice for a preferred selection of low-GI foods. 
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ZUSAMMENFASSUNG 
Aspekte der Kohlenhydratqualität und ihre Relevanz in Bezug auf Risikomarker für 
Typ 2 Diabetes und assoziierte Erkrankungen 
Zunehmend werden Bedenken laut, dass die derzeitige Empfehlung, sich fettarm und 
kohlenhydratreich zu ernähren, ungünstig für die steigende Zahl an Menschen mit gestörter 
Insulinresistenz ist, da sie zu postprandialen Blutglukose- und Insulinanstiegen führt, welche 
wiederum mit einem erhöhtem Risiko für Typ 2 Diabetes mellitus (T2D) verbunden sind. 
Daher sind vor dem Hintergrund der steigenden Prävalenz von Übergewicht, T2D und 
weiteren chronischen Erkrankungen erfolgreiche Präventionskonzepte dringend notwendig. 
Da insbesondere insulinresistente Personen sehr empfindlich auf Blutzuckeranstiege 
reagieren, könnte dies auch auf die Phase der Pubertät zutreffen, die durch eine 
physiologische Insulinresistenz gekennzeichnet ist. Eine weitere, bisher kaum 
berücksichtigte Altersgruppe sind ältere Menschen, die einen immer größeren Anteil in 
unserer Gesellschaft ausmachen, und für die möglicherweise speziell zugeschnittene 
Präventionskonzepte erforderlich sind.  
Das übergeordnete Ziel dieser Arbeit war, die Relevanz verschiedener Aspekte der 
Kohlenhydratzufuhr für Risikomarker von T2D zu untersuchen. Von Interesse waren hierbei 
prospektive Assoziationen zwischen der Pubertät und dem Erwachsenenalter sowie 5-
Jahres-Veränderungen bei älteren Personen. 
Daten für diese Untersuchungen lieferte die DOrtmund Nutritional and Anthropometric 
Longitudinally Designed (DONALD) Study, in der Informationen zur Ernährung, 
Anthropometrie und dem Gesundheitsstatus von der Geburt bis ins Erwachsenenalter 
erhoben werden. Außerdem wurden Daten aus der Blue Mountains Eye Study (BMES) 
herangezogen, in der wiederholt Informationen zur Ernährung und zu Markern der 
Leberfunktion in einer älteren australischen Kohorte erfasst wurden. Zusätzlich wurde eine 
systematische Literaturrecherche zum Zusammenhang zwischen der Kohlenhydratqualität 
und chronisch geringgradiger Entzündungsneigung im Erwachsenenalter durchgeführt. 
Vier Auswertungen (Studie I, II, III, V) und eine systematische Literaturrecherche wurden 
durchgeführt (Studie IV). Studie I, in der 262 Probanden aus der DONALD Studie 
eingeschlossen wurden, zeigte, dass ein gewohnheitsmäßig höherer Insulin Index, jedoch 
nicht ein höherer glykämischer Index (GI), in der Pubertät mit einem höheren Körperfettanteil 
im jungen Erwachsenenalter assoziiert war. In Studie II war ein habituell höherer GI in der 
Pubertät der einzige Aspekt der Kohlenhydratqualität, der in einer Untergruppe der DONALD 
Studie (n=226 bzw. n=214) konsistent mit den untersuchten T2D Risikomarkern 
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(Homeostasis model assessment IR (HOMA-IR), Alanin-Aminotransferase (ALT) und 
Gamma-Glutamyltransferase (GGT)) zusammenhing. Studie III basierte ebenfalls auf Daten 
der DONALD Studie (n=205) und konnte zeigen, dass eine gewohnheitsmäßig hohe Zufuhr 
von Kohlenhydraten aus Lebensmitteln mit einem höheren GI sowie eine niedrigere 
Aufnahme von Vollkorn während der Pubertät mit höheren Werten des proinflammatorischen 
Cytokins Interleukin 6 assoziiert war. In diesem Zusammenhang wurde aus Studie IV 
ersichtlich, dass die vorhandene Evidenz aus Beobachtungsstudien weniger eindeutig für 
den günstigen Einfluss eines niedrigen GI ist als für die Ballaststoff- und Vollkornzufuhr. Im 
Gegensatz dazu ist die Evidenz aus Interventionstudien weniger konsistent, dass eine 
ballaststoff- und vollkornreichen Kost verglichen mit einer Kost mit niedrigem GI/GL anti-
inflammatorische Effekte hat (60 Studien wurden im systhematischen Review 
eingeschlossen). Günstige Effekte eines hohen Ballaststoff- und Vollkornverzehrs aus 
Beobachtungsstudien lassen Confounding vermuten. Schließlich deutete Studie V, 
basierend auf Daten von 866 Probanden aus der BMES, darauf hin, dass kein longitudinaler 
Zusammenhang zwischen den verschiedenen Aspekten der Kohlenhydratqualität und den 
Leberenzymen oder Serumlipiden besteht.  
Zusammenfassend lässt sich festhalten, dass unsere Ergebnisse auf eine besondere 
Relevanz von postprandialen Blutglukose-, sowie Insulinanstiegen während der Pubertät für 
verschiedene Risikomarker von T2D im jungen Erwachsenenalter hinweisen. Insgesamt 
sollten Bemühungen, die Kohlenhydratqualität zu steigern, sich nicht ausschließlich auf 
Vollkornprodukte fokussieren, sondern um den Hinweis für eine bevorzugte Auswahl von 
Lebensmitteln mit einem niedrigen GI erweitert werden.  
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1. INTRODUCTION 
Obesity and type 2 diabetes mellitus (T2D) can be considered today‘s main public health 
burdens worldwide – and their prevalence rates are expected to increase even further in the 
upcoming years [1, 2]. Thus, successful prevention strategies to fight these increasing rates 
are urgently needed. Besides physical activity, dietary approaches are considered to be an 
important part in obesity and diabetes prevention. However, despite the plethora of available 
studies investigating the effect of different diets on the risk of obesity, T2D, and related 
health outcomes, an agreement has not yet been reached.  
Not least due to the findings of two large intervention studies at the beginning of this century, 
showing that a high-fiber, low-fat diet as part of a lifestyle modification including physical 
activity can prevent the progression to manifest T2D in individuals with impaired glucose 
tolerance [3, 4], this diet composition is generally advocated. However, one decade later, 
concern has emerged that a low-fat high-carbohydrate diet might be actually harmful for the 
increasing number of persons with insulin resistance (IR), since it induces postprandial 
glucose and insulin excursions, thereby increasing the risk to develop T2D [5-7].  
Furthermore, the focus has changed from solely looking at the carbohydrate proportion to 
also taking into account its quality. Indeed, most nutritional recommendations entail the 
advice to consume a diet characterized by a high fiber and whole grain intake [8-11]. 
Moreover, it has been suggested that all successful dietary approaches for T2D prevention 
alternatively proposed to the common low-fat diet share a unifying mechanism: They induce 
less glycemic and insulinemic excursions, and hence reduce the strain on beta cells [5]. In 
this regard, interest in the concepts of the dietary glycemic index (GI) and dietary glycemic 
load (GL) has increased. These concepts estimate the relative and absolute glycemic 
responses to consumed carbohydrates, respectively [12, 13]. Recently, changes in glucose 
and insulin homeostasis, while being closely associated with T2D pathogenesis, have also 
been linked to obesity, low-grade inflammation and hepatic steatosis [14]. These conditions 
are tightly linked: While obesity is considered to be an initial factor in disease development, 
chronic low-grade inflammation is a shared condition both in obesity and diabetes [15]. 
Moreover, hepatic IR often parallels systemic IR and results in hepatic fat accumulation [16]. 
This coexistence and more importantly linkage of these diseases, i.e. T2D, obesity, low-
grade inflammation and hepatic steatosis, makes it evident to address them together and 
gives the chance to reveal potential underlying mechanisms by which dietary aspects impact 
on these health outcomes. 
Although being relevant for all age groups, associations between carbohydrate nutrition and 
diabetes risk markers have been extensively investigated especially in middle-aged 
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populations. However, other periods in life might also be relevant: As insulin resistant 
individuals are particularly prone to postprandial rises in glucose and insulin [17, 18], this 
might also extend to puberty, a period characterized by physiological IR [19]. The rising 
awareness that prevention should start early in life underlines the importance of investigating 
the role of carbohydrate nutrition during this phase. Finally, progress in health care systems 
implies that people are getting older [2]. Hence, preventive strategies tailored to the special 
needs and adapted to metabolic alterations related to aging are becoming indispensable.  
Taken together, prospective data on the relevance of carbohydrate quality on the risk of T2D 
and related health outcomes can be regarded insufficient – particularly in pediatric and 
elderly populations. Moreover, attention should also be paid to the potential importance of 
nutrition during critical periods such as puberty. Hence, one main aim of this thesis was to 
investigate the relevance of carbohydrate quality during puberty for different risk markers 
related to T2D and related health outcomes in younger adulthood: First, the association with 
adult body composition will be examined, as obesity frequently precedes T2D (Aim 1). 
Second, the relevance for different risk markers of T2D will be assessed (IR and hepatic 
steatosis markers) (Aim 2), to then look at the association with inflammatory markers, the 
main mechanism discussed linking carbohydrate intake to T2D risk (Aim 3, 1st research 
question). The DOrtmund Nutritional and Anthropometric Longitudinally Designed (DONALD) 
Study represents an ideal data basis to investigate these prospective associations between 
dietary factors and later risk markers. Additional to these analyses in sub-samples of the 
DONALD Study, two further research questions will be addressed: In a more systematic 
approach, evidence on the relatively new research field of low-grade inflammation will be 
assembled for different aspects of carbohydrate quality in both observational and intervention 
studies (Aim 3, 2nd research question). Finally, to also consider carbohydrate quality in an 
elderly population, data from the Australian Blue Mountains Eye Study (BMES) will be used, 
offering the possibility to examine the longitudinal association between carbohydrate nutrition 
and hepatic steatosis markers – a further condition closely linked to T2D and highly prevalent 
in older age groups (Aim 4).  
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Outline of this thesis 
This thesis builds on data from two observational studies and additionally comprises a 
systematic review. In the Background section (Chapter 2), the different aspects of 
carbohydrate quality will be defined and the epidemiology of T2D will be summarized along 
with its related disease outcomes, namely obesity, low-grade inflammation and hepatic 
steatosis. Moreover, available evidence linking carbohydrate quality and these health 
outcomes will be presented – both from a mechanistic and an epidemiological point of view. 
Based on this overview, four Research Aims (Chapter 3) will be formulated and addressed 
subsequently. In Chapter 4, the General Methodology of the DONALD Study, BMES, and the 
conducted systematic review on which this thesis is based will be described. The research 
aims will be addressed in five Original Articles, which will be summarized in Chapter 5. The 
result of these publications will be brought into a wider context in the General Discussion 
section (Chapter 6) and will be finally summarized in Chapter 7 (Summary and 
Perspectives). In this chapter, ideas for future research will also be suggested. This thesis is 
cumulative and does not include detailed descriptions of the performed statistical analyses or 
the obtained results. The information on the analytical approaches, detailed presentations of 
the results and discussions of specific findings can be found in the original articles (OA) 
(Appendices 1-5). 
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2. THEORETICAL BACKGROUND 
2.1 Aspects of carbohydrate quality 
Carbohydrates represent a diverse group with different chemical structures and physiological 
properties [20]. According to the Joint Food and Agriculture Organization (FAO)/World Health 
Organization (WHO) Expert Consultation on carbohydrates in human nutrition, which took 
place in Rome 1997, the primary classification of carbohydrates should be based on 
chemistry; that is, by molecular size, degree of polymerization, the type of linkage and 
character of individual monomers. This classification results in three main groups: (1) sugars, 
which comprise mono- and disaccharides as well as polyols, (2) oligosaccharides, the so 
called short chain carbohydrates like malto-oligosaccharides, and (3) polysaccharides, which 
can be further divided into starch and non-starch polysaccharides [21]. However, within the 
2006 scientific update the FAO/WHO acknowledged that, when classifying carbohydrates 
solely on chemical characteristics, nutritional implications cannot be drawn directly, since 
each of the three main groups has various and overlapping physiological effects. Moreover, 
during this update the recommended intake of 55% to 75% of total daily energy from 
carbohydrates was questioned and it was emphasized that the nature of dietary 
carbohydrates appears to be more important than the total intake [22]. Likewise, the German 
Nutrition Society (DGE) concluded in the evidence based dietary guidelines for 
―Carbohydrate Intake and Prevention of Nutrition-Related Disease‖ published in 2011, that 
for primary prevention purposes the quality of carbohydrate nutrition is more important than 
its quantity [23].  
To date, numerous classifications based on different physiological properties exist, including 
terms such as available and unavailable carbohydrates, simple and complex carbohydrates 
or glycemic and non-glycemic carbohydrates, which are more or less suitable for translation 
into health benefits [20, 24]. This thesis focuses on the terms dietary fiber, whole grain, 
added sugar, dietary glycemic index (GI), glycemic load (GL), and dietary insulin index, 
insulin load to describe different aspects of carbohydrate quality, which are subsequently 
explained in detail. 
2.1.1 Dietary fiber and whole grain 
In 2006, the FAO/WHO scientific update on carbohydrates proposed to define dietary fiber 
as intrinsic plant cell wall polysaccharides reflecting the naturally occurring polysaccharides 
in vegetables, fruits and whole grains, for which health benefits are clearly established [22]. 
However, according to the FAO/WHO Codex Alimentarius definition from 2008, three 
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different categories of dietary fiber exist, all of which cannot be hydrolyzed by endogenous 
enzymes in the small human intestine: Besides naturally occurring fiber in the plant cell wall, 
according to this definition, also extracted and synthetic carbohydrate polymers, for which 
physiological health benefits can be verified by scientific evidence, are considered as dietary 
fiber [25]. This definition was further specified in the Ninth Vahouny Fiber Symposium, 
organized by the International Life Sciences Institutes from Europe and America, where it 
was agreed upon that non-digestible carbohydrates with a degree of polymerization of more 
than three are also considered as dietary fiber [26]. These two approaches to define dietary 
fiber – the so-called plant-rich diet and the indigestibility approach – are still subject to 
debate. An argument against the extension of the term dietary fiber to include extracted and 
synthetic carbohydrate polymers, as proposed by the indigestibility approach, is the 
insufficient evidence for these polymers, whose effects are diverse and often not directly 
associated with health benefits [24]. Furthermore, concern has been raised that this would 
lead to the misinterpretation that an insufficient fiber intake can be compensated with 
extracted and synthetic carbohydrate polymers. By contrast, the plant-rich diet approach is in 
accordance with dietary recommendations to increase dietary fiber consumption in the form 
of fruits, vegetables and whole grains. Furthermore, the plant cell walls are nutrient dense 
with respect to vitamins, minerals, and phytochemicals, all of which are associated with 
beneficial health outcomes [24]. 
As mentioned above, besides fruits and vegetables, whole grains are a main source of 
dietary fiber and a high consumption is commonly recommended. However, the existing 
definitions and meanings of the term ‗whole grain‘ are as diverse as those existing for dietary 
fiber [20]. The Whole Grain Label Statement of the United States (US) Food and Drug 
Administration (FDA) defined whole grains as: ―Cereal Grains that consist of the intact, 
ground, cracked or flaked caryopsis, whose principal anatomical components – the starchy 
endosperm, germ and bran – are present in the same relative proportions as they exist in the 
intact caryopsis.‖[27]. In scientific studies though, a less strict definition is often applied [28], 
e.g. considering foods with added bran but no endosperm or germ as whole grains [29]. In 
2008, the Whole Grain Task Force stated that it ―supports the use of the term whole grain for 
products of milling operations that divide the grain into germ, bran, and endosperm, but then 
recombine the party into their original proportions before the flour leaves the mill‖ [30]. 
However, recombined whole grain flours rarely comprise the single ingredients in the same 
proportion as in the intact caryopsis [31]. Hence the Whole Grain Task Force proposed a 
less strict addition to the US FDA term such as ―… as they exist in the intact caryopsis to the 
extent feasible by the best modern milling technology‖ [30]. With regards to possible health 
benefits, it would furthermore be useful to distinguish between intact whole grains (e.g. 
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kernels) and those physically disrupted (e.g.  whole grain flour), as the latter one exerts a 
completely different postprandial glycemic response compared to intact kernels [31]. Further 
discordance exists regarding the definition of a whole grain food. According to the US FDA it 
is defined as ―a product containing >51% whole grain by weight per reference amount 
customarily consumed per day‖ [32]. Other suggested cut-offs for whole grain foods are 
>10% or >25% of the content as whole grain, allowing a wider range of foods to be 
considered and hence reducing the possibility of underestimating the overall whole grain 
intake [20].  
2.1.2 Added sugar  
Total sugar comprises all mono- and disaccharides present in foods except polyols. 
However, as several foods, like fruits, vegetables or milk, are naturally high in sugars and 
their consumption is not related to adverse health outcomes, the need for a further 
differentiation became evident [24]. That led to suggestions of numerous different terms to 
describe sugar intake, among them free sugars, added sugars, extrinsic and intrinsic sugars 
and non-milk extrinsic sugars. One common problem of these terms is that they are lacking a 
coherent definition and may hence cause confusion for the consumer. Moreover, these terms 
relate to food attributes not associated with the sugars per se but the food matrix [20]. 
According to the Institute of Medicine in the US, added sugars are defined as sugars and 
syrups added to the food or beverage during processing or preparation [33]. While the 
voluminous texture of fruits and vegetables normally prevents against an overconsumption of 
sugars from these sources, added sugars are more likely to be consumed in high proportions 
and are therefore more closely related to a high energy intake [24]. Hence, under a public 
health perspective, the differentiation between naturally occurring and added sugars could be 
useful. Moreover, a common approach in epidemiological studies is to further differentiate 
between different sources in the diet. Particularly, sugars from sugar-sweetened beverages 
are often investigated separately, since the consumption of these beverages has been linked 
to T2D risk [34]. 
2.1.3 Dietary Glycemic Index and Glycemic Load 
The concept of the GI was introduced by Jenkins et al. because it became evident that the 
chemical composition of carbohydrate containing foods cannot predict their postprandial 
blood glucose responses [35]. Before that, the overall assumption persisted that mono- and 
disaccharides – the so-called simple sugars – induce high blood glucose increases, whereas 
polysaccharides – the complex carbohydrates – were related to comparably lower increases 
[36].  
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The GI of a food is defined as the 2-hour incremental area under the curve (AUC) of glucose 
response following the intake of 50 g of available carbohydrates from a test food as 
compared to the 2-hour AUC of glucose response induced by the same amount of 
carbohydrates from ingested glucose (reference food) [35]. In their initial studies, Jenkins et 
al. could also show that there was no association between the GI and the sugar or fiber 
content of a food [35]. Hence, many products rich in dietary fiber have a high GI [37]. 
Glycemic responses of common foods are illustrated in Figure 1. However, it has to be 
noted, that most European potato varieties and preparation methods are associated with 
lower glycemic responses compared to those common in the US and Australia [38]. 
 
Figure 1: The glycemic response to 50g carbohydrate portions of common foods in relation to the 
reference food glucose (GI=100), from [39]. 
As there are numerous factors influencing the glycemic response of a food, the dietary GI 
cannot be predicted and thus needs to be measured. Factors affecting the postprandial blood 
glucose curve are for instance the degree of processing (the glycemic response is higher 
when the gross matrix structure is homogenized) or the amylase and amilopectin content 
(amylopectin has a greater effect on glucose rises) [40]. The measurement of the GI follows 
a standardized procedure where the capillary blood glucose levels are observed in at least 
10 healthy subjects up to two hours after ingestion of 25g or 50g available carbohydrates 
from the test food (depending on the carbohydrate content of the food, since the amount 
should be edible in 5 to 15 minutes with the addition of 250 ml water) as well as the 
reference food glucose [40]. The mean of the individual ratios of the two measured AUC are 
then multiplied by 100 to derive the foods GI value. Over the years, GI values for a wide 
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range of carbohydrate containing foods have been compiled [37, 41], which can be grouped 
into low-GI (GI ≤ 55), moderate-GI (GI  55 to ≤ 70) and high-GI foods (GI > 70) [37]. 
To also take the carbohydrate content of a food into account, which affects the absolute 
glucose response together with the GI, the concept of the GL was introduced by Salmeron et 
al. [42, 43]. The GL represents the amount of carbohydrates adjusted for its glycemic 
potency and is defined as the amount of available carbohydrates multiplied by their 
respective GI.  
In epidemiological studies, not the GI or GL values of a single food are of interest but the 
dietary GI and GL to estimate the overall glycemic effect of the diet. For this purpose, GI 
assignments need to be made for every carbohydrate containing food recorded by the study 
participants. However, dietary assessment methods vary in their precision: Mean GI values 
are assigned to food groups in food frequency questionnaires (FFQ), while in the case of 
weighed dietary records a more precise assignment can be made. The carbohydrate content 
(in grams) of each food consumed is then multiplied by the food‘s GI to obtain its GL. The 
sum of these GL values for each subject divided by 100 corresponds to the total daily GL. 
The overall dietary GI is obtained by dividing the total daily GL by the total daily carbohydrate 
intake multiplied by 100. 
2.1.4 Dietary Insulin Index and Insulin Load  
The blood glucose response after consumption of a food or meal is not always proportional 
to the insulin response. Yet, the insulinogenic effect of foods is commonly estimated by its 
GL which takes both carbohydrate content and GI into account [44]. Indeed, according to a 
recent Australian study, the dietary GL was shown to be the best predictor of postprandial 
insulin response in 121 test foods and 13 meals [45], but it only yields an indirect estimate. 
However, protein – especially when consumed together with carbohydrates, also leads to 
increases in insulin responses while at the same time reducing glycemia [46]. Furthermore, 
fat consumed with carbohydrates decreases postprandial glycemia but not insulinemia [47, 
48]. As GI measurement cannot be conducted in foods with little or no carbohydrate content, 
the GI and thus the GL are not available as indicators for insulin responses to these foods.  
In contrast, the concept of the food insulin index (FII) provides a classification of all foods 
according to their postprandial insulin response [44] and is defined as the 2-hour insulinemic 
response (AUC) following the intake of 1000 kJ of a food (2000 kJ for meals) relative to the 
2-hour insulinemic response to glucose i.e. the reference food (FII = 100). Since the measure 
of comparison for the FII is energy as opposed to carbohydrate for the GI, also foods with no 
or only little carbohydrate content can be considered [49]. To date, 121 FII values, measured 
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at the Human Nutrition Unit School of Molecular and Microbial Bioscience at the University of 
Sydney, Australia in groups of 10 individuals, are published [45].  
Similar to the dietary GI and GL, the overall dietary insulin index and dietary insulin load of 
the diet can be estimated based on the FII, which needs to be assigned to all foods primarily. 
For this assignment, the principal consideration is the dietary GL when matching a 
carbohydrate-rich food with a published FII, as it best predicts the FII [45, 49]. For foods low 
in carbohydrates, the protein content is additionally considered. The average dietary insulin 
load can be calculated by summing the product of FII, energy content and consumption 
frequency over all recorded food items [50]. The average dietary insulin index can then be 
calculated by dividing the insulin load by total energy intake [50]. While both insulin index and 
insulin load resemble the dietary insulin demand they still have slightly different 
interpretation: The dietary insulin index is more a qualitative measure, which ranks foods 
according to their postprandial insulin response, whereas the dietary insulin load gives an 
insight of the quantity of the insulin demand of the diet. 
2.2 Risk markers of type 2 diabetes mellitus and related health outcomes 
T2D represents a growing public health problem with both incidence and prevalence rates as 
well as related comorbidities increasing rapidly – also in younger age groups [2, 51]. 
Knowledge on different risk markers, indicating an increased risk before a disease manifests, 
and moreover, insight into the interaction between IR or T2D and closely linked conditions 
such as obesity, chronic low-grade inflammation and hepatic steatosis is pivotal to better 
elaborate preventive approaches. Furthermore, it might be necessary to consider special 
circumstances in different stages of life such as physiological occurring IR during puberty or 
age related metabolical changes in older age groups [19, 52]. 
2.2.1 Type 2 diabetes mellitus 
Definition and diagnosis  
The term diabetes mellitus comprises heterogenic metabolic disturbances, all resulting in an 
hyperglycemic condition and sharing the underlying cause of either an impaired insulin 
secretion due to malfunction of the pancreatic beta cells, an impaired insulin effect on target 
cells or both [53]. There are three main types of diabetes: T1D, T2D, and gestational 
diabetes mellitus (GDM). Other specific types of diabetes mellitus also exist, such as 
maturity-onset diabetes of the young. However, their proportion is very small. The focus of 
this thesis is on T2D, formerly also known as non-insulin dependent diabetes or adult-onset 
diabetes, which accounts for 90-95% of all diabetes cases. While an absolute deficiency of 
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insulin secretion exists in T1D, T2D is caused by a resistance to insulin action accompanied 
by an inadequate compensatory insulin secretion [54].  
Diagnosis of diabetes is traditionally based on fasting plasma blood glucose values either 
from single measurements or from the results of a 75g oral glucose tolerance test (OGTT) 
(see Box 1). HbA1c (glycosylated haemoglobin), while being already frequently used to 
monitor blood glucose control, was introduced as a further diagnostic criterion firstly in 2009, 
when an International expert committee came to the conclusion to recommend the use of 
HbA1c in diabetes diagnosis. The reasons for this were on the one hand the international 
standardized method for measuring HbA1c and on the other hand the growing evidence from 
epidemiological studies that the specifity of a diabetes diagnosis is sufficient for HbA1c 
values ≥ 6.5% [54]. 
Further criteria exist to define those patients who do not yet have a manifest diabetes but 
neither glucose levels considered normal and healthy – summarized under the term 
―intermediate hyperglycemia‖ (see Box 1). 
 
However, a large number of individuals suffering from T2D or intermediate hyperglycemia 
remain undiagnosed and are themselves unaware of their health condition as hyperglycemia 
develops gradually with the absence of classical symptoms at earlier stages [54].  
Several direct, indirect and surrogate measures exist to assess insulin sensitivity/resistance 
and beta cell function in humans: While the ―hyperinsulinemic euglycemic glucose clamp 
technique,‖ a direct measure of insulin sensitivity developed in 1979 [55] is still considered 
Box 1: Diagnosic criteria for diabetes mellitus/intermediate hyperglycemia 
according to IDF/WHO [1]: 
Diagnostic test: oral glucose tolerance test (OGTT) 
Diabetes mellitus: 
 Fasting plasma glucose ≥ 126 mg/dl (≥ 7.0 mmol/L) or 
 2-h plasma glucose* ≥ 200 mg/dl (≥11.1 mmol/L) 
Impaired fasting glucose (IFG): 
 Fasting plasma glucose 110 mg/dl to 125 mg/dl (6.1 - 6.9 mmol/L) and (if 
measured) 
 2-h plasma glucose* <140 mg/dl (<7.8 mmol/L) 
Impaired glucose tolerance (IGT): 
 Fasting glucose <126 mg/dl (<7.0 mmol/L) and 
 2-h plasma glucose* ≥140 mg/dl to <200 mg/dl (≥7.8 - <11.1 mmol/L) 
 
* if 2-h plasma glucose is not measured, status is uncertain as diabetes or IGT cannot be 
excluded 
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the gold standard [56], this method can be regarded time-consuming, labor intensive, and 
expensive. A widely used indirect test to assess glucose tolerance in clinical practice is the 
oral glucose tolerance test (OGTT), which however does not provide information on insulin 
sensitivity/resistance per se [57]. Homeostasis model assessment (HOMA), introduced by 
Matthews et al. in 1985 [58], is a simple surrogate index derived from fasting steady-state 
glucose and insulin concentrations, which has been widely used especially in large-scale 
epidemiological studies to estimate both IR (HOMA-IR) and beta cell secretion (HOMA-β) 
[56, 57]. Other indices and risk markers exist displaying different advantages and limitations 
and therefore the decision which marker to use needs to be based on the underlying study 
conditions [57]. The fact that T2D is often paralleled by hepatic steatosis, led to the 
recognition of the liver enzymes alanine aminotransferase (ALT) and gamma 
glutamyltransferase (GGT) – commonly used as surrogate parameters for hepatic fat content 
– as risk markers for T2D [59-63]. The link between systemic and hepatic IR will be 
described in more detail in Chapter 2.2.4. 
Epidemiology  
According to the 2013 update of the 6th edition of the International Diabetes Federation (IDF) 
Diabetes Atlas, worldwide 382 million people between 20 and 79 years of age live with 
diabetes, which implies a prevalence of 8.3% [64]. Of interest, the IDF estimates that globally 
half of those who have diabetes are unaware of their health status – 85% of these live in low- 
and middle-income countries. The proportion of undiagnosed diabetes cases is estimated by 
using representative population-based studies which report the percentage of these cases 
[2]. Furthermore, worldwide, 6.9% of the adult population (316 million people), are estimated 
to have IGT [64]. In Europe, 56.3 million people are estimated to have diabetes, of which 
20.1 million are undiagnosed, and further 60.6 million adults are estimated to have IGT. The 
diabetes prevalence in Europe amounts to 6.8%. Worldwide, this is the second lowest 
prevalence following Africa – however, over one-quarter of the global diabetes health care 
costs are spent in this continent [64]. For Germany, data from the "German Health Interview 
and Examination Survey for Adults" (DEGS1) conducted between 2008 and 2011 indicated a 
prevalence of 7.2% among adults aged between 18 and 79 years with an additional 2.1% of 
undiagnosed cases [65]. Compared to data from the German National Health Interview and 
Examination Survey 1998 the diabetes prevalence increased by 38% [65]. According to IDF 
data, 1.6 million people suffer from diabetes in Australia – besides Germany another country 
under study in this thesis – implying a prevalence of 7.8% [64]. Of note, Australia has one of 
the highest prevalence of abnormal glucose tolerance among developed countries [66]. IDF 
figures furthermore show that the global number of diabetes cases is expected to rise up to 
552 million – implying a prevalence of 9.9% – by 2030. In Europe and Australia, the 
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prognostic prevalence for 2030 is 7.1% and 9.3%, respectively [2]. Notably, this global 
increase in diabetes cases is inversely related to income status and is expected to parallel 
the increasing adult population [2]. Besides giving estimates for diabetes prevalence, the 
Global Burden of Disease project additionally published estimates of mean glucose levels. 
Using a complex, multi-level approach, they came up with a global age-standardized mean 
fasting plasma glucose of 5.50 mmol/L for men and 5.42 mmol/L for women, implicating a 
rise of 0.07 mmol/L and 0.09 mmol/L per decade, respectively [67]. 
Compared to adults, it is more difficult to give overall T2D prevalence numbers for children 
and adolescents. A recent systematic review, which aimed to summarize available global 
incidence and prevalence rates for children and adolescents, came to the conclusion that 
there is a substantial variation among countries, age categories and ethnic groups. This 
variation in incidence and prevalence data is largely caused by population characteristics 
and methodical dissimilarities. According to this review, worldwide diabetes incidence rates 
in children and adolescents ranged from 0 to 330 per 100,000 person years and the 
observed prevalence ranged from 0% to 5.3% among included studies [51]. A recent 
publication based on data from the National Health and Nutrition Examination Survey 
(NHANES) (1999 to 2010) showed a prevalence of 0.48% for T1D and of 0.36% for T2D 
among 12 to 19 year old US adolescents. Undiagnosed T2D accounted for 34% of the T2D 
cases [68]. With a total diabetes prevalence of 0.84% (T1D and T2D together) this data 
suggests an increase compared to data from NHANES III (1988 to 1994), when a total 
prevalence of 0.41% was estimated. Even if the data has to be evaluated with caution 
because of the low precision of diabetes estimates [68], the proportion of T2D cases of the 
combined diabetes prevalence appeared to increase from 31% to 43% comparing data from 
NHANES III with the recent survey [68, 69]. Furthermore, the consideration of early 
disturbances in carbohydrate metabolism is equally important, as this increases the risk for 
later T2D: Alarmingly, a population based US study identified 15.7% of the adolescents to 
have IR as being defined by fasting insulin levels [70]. For Germany, a prevalence of 0.14% 
for T1D and T2D was observed in the German Health Interview and Examination Survey for 
Children and Adolescents (KiGGS), analyzing data from 2003 to 2006 of children and 
adolescents up to the age of 17 [71]. In a cross-sectional German survey it was noted that 
2.5% of the included 721 school-leaving students (mean age: 15.5 years) had impaired 
fasting glucose and impaired glucose tolerance or T2D [72]. Similarly, data from the diabetes 
registry of Baden-Württemberg indicated a prevalence of 2.3 per 100.000 among children 
and adolescents aged 0 to 20 years [73]. Hence, compared to the US, T2D prevalence rates 
are much lower in Germany, but nonetheless need to be taken serious in terms of public 
health interventions.    
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Risk factors 
There are several risk factors which are associated with T2D, including family history of 
diabetes, overweight, unhealthy diet, physical inactivity, increasing age, high blood pressure, 
ethnicity, IGT, or the previous development of GDM. According to IDF and the Global Burden 
of Disease project, the increase in diabetes prevalence is mostly caused by a rising 
incidence due to demographic changes like aging of the population, by increases in risk 
factors such as obesity and sedentary lifestyle being observed more frequently, and by a 
rising lifespan of patients with diabetes due to better health care options [2]. According to the 
Robert-Koch Institute which conducted the German surveys, aging of the population 
accounts for 14% of the increase seen in Germany over the last 13 years. With data from the 
DEGS1, it could also be shown that the diabetes prevalence is increasing with age, body 
mass index (BMI) group, and a lower socioeconomic status [65]. 
Consequences 
If not treated at an early stage, long-term damage, dysfunction, and failure of different organs 
due to chronic hyperglycemia may occur in patients with diabetes. These complications 
include retinopathy with potential loss of vision, nephropathy causing renal failure, peripheral 
neuropathy being associated with foot ulcers or amputations, and autonomic neuropathy 
leading to gastrointestinal, genitourinary, and cardiovascular symptoms and sexual 
dysfunction. Moreover, diabetes is associated with an increased risk for development of 
hypertension or abnormalities in the lipid metabolism as well as cardiovascular disease 
(CVD). Of note, recent reports suggest, that T2D among adolescents – the so-called early 
onset T2D – requires particular attention, as it is more difficult to control compared to the 
later-onset form and also displays a more aggressive disease phenotype, i.e. a more rapid 
decrease in beta cell function [74-76].  
Data from the IDF Diabetes Atlas, stating that 5.1 million people died (accounting for 8.4% of 
the global all-cause mortality among adults) and health care costs of 548 billion USD arose in 
2013 due to diabetes, underlines the great public health impact of diabetes and its 
associated comorbidities [64]. 
Insulin resistance 
An impaired insulin secretion and/or IR represent the underlying pathology of T2D. Both 
conditions are closely linked. However, to fully understand the linkage between T2D and 
pathophysiological relevant phenotypes such as obesity, chronic low-grade inflammation and 
hepatic fat accumulation, an understanding of the metabolic effects of IR, also on a 
molecular level, is essential.  
Insulin is an anabolic hormone, secreted by the beta cells of the Langerhans islets in the 
pancreas, which is essential for tissue development, growth, and glucose homeostasis. 
THEORETICAL BACKGROUND 
14 
 
Insulin secretion is increased in response to enhanced circulating levels of glucose, amino 
acids, and to a small degree also of free fatty acids. The main targets of insulin can be 
considered adipose tissue, muscle cells and central organs such as the liver. For 
maintenance of normoglycemia, insulin stimulates glucose uptake in the skeletal muscle and 
adipose tissue, glycogen storage in the muscle and liver, and inhibits gluconeogenesis in the 
liver and kidney as well as glycogenolysis in the liver. Furthermore, insulin enhances 
triglyceride (TG) synthesis in the liver and adipose tissue and inhibits lipolysis. Regarding 
protein metabolism, protein synthesis is promoted and its degradation suppressed in muscle 
and liver cells [77, 78] (Figure 2).  
 
 
Figure 2: Physiological and impaired insulin actions and their main metabolic consequences (adapted 
from [79, 80]). 
Blue arrows/font refer to the healthy state and red arrows/font to the insulin resistant. 
Abbreviations: FFA, free fatty acids; HDL, high density lipoprotein; LDL, low density lipoprotein; VLDL, 
very low density lipoprotein 
Under conditions of IR, these diverse signaling pathways are disturbed, leading to systemic 
hyperglycemia, which in turn increases the strain on beta cells [78]. The insulin resistant 
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state is moreover closely linked to further metabolic perturbations such as hyperlipidemia 
[79] (Figure 2).  
On a molecular level, insulin affects responsive cells by binding to its receptor on the cell 
surface, which leads to downstream signaling events. The insulin receptor is a 
transmembrane α2β2heterodimer, whose α subunits are extracellular and entail insulin 
binding elements, while the linked β units interfuse the plasma membrane. The receptor 
belongs to the tyrosine kinase receptors. Under physiological, insulin-sensitive conditions, 
insulin binding to α subunits causes the β subunits to phosphorylate themselves, which 
activates the catalytic activity of the receptor. The activated intrinsic kinase then 
phosphorylates several proximal substrates such as members of the insulin receptor 
substrate family, leading to the activation of two major signaling pathways: First, the Ras-
mitogen-activated Protein Kinase (MAP-Kinase) pathway, leading to the completion of 
functions related to cell growth and gene expression and second, the Phosphatidylinositol-3-
Kinase (PI3K)-AKT/protein kinase B (PKB) pathway, which modulates most metabolic 
functions of insulin such as glucose transport and synthesis of glycogen, proteins, and lipids 
[78, 81, 82].   
These physiological insulin signaling pathways can be disturbed through e.g. alterations in 
insulin receptor expression, ligand binding, phosphorylation, kinase activity, or impaired 
proximal signaling, hence causing IR [78]. A variety of counter-regulatory pathways exists 
which inhibit insulin-signaling, leading to diminished insulin action in target tissues. There are 
two main pathways for inhibition of insulin-signaling, involving the cJun N-termial kinase 
(JNK) and the inhibitor of nuclear factor κB (NFκB) kinase β (IKKβ) [15]. These two kinases 
induce IR through different mechanisms: JNK phosphorylates serine residues on IRS-1, 
being thereby counter-regularly to the physiological tyrosin kinase cascade. IKKβ induces IR 
through transcriptional activation of NFκB, which in turn promotes the expression of 
numerous target genes whose products, among them are different cytokines, transcription 
factors and surface proteins, induce IR [14].  
The described disturbances, leading to counter-regulatory molecular pathways, can be 
induced in different conditions and by various signals such as inflammation, excess 
circulating saturated fatty acids, necrotic residues (cell-extrinsic), as well as mitochondrial 
dysfunction, oxidative stress, or membrane/endoplasmatic reticulum (ER) stress (cell-
intrinsic) caused by either hyperglycemia or hyperlipidemia [15]. The particular role of fatty 
acids and inflammatory markers in IR will be described in chapters 2.2.2 and 2.2.3, 
respectively.  
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2.2.2 Obesity 
Obesity is considered a major risk factor for IR and T2D – according to WHO estimates, 44% 
of the diabetes burden is attributable to overweight and obesity [83]. Epidemiological 
evidence suggests a strong association between obesity, particularly abdominal adiposity, 
and an elevated risk for T2D as well as CVD [84-87]. Overweight and obesity are defined as 
abnormal or excessive body fat accumulation that may have detrimental health effects [83]. 
Different indices exist to assess overweight and obesity: the body mass index (BMI) can be 
considered the most common, although crude indicator among adults and is defined as 
weight/height2 (kg/m2). It classifies an individual as overweight if having a BMI >25 kg/m2 and 
as obese if the BMI is >30kg/m2 [83]. However, it has been criticized that the BMI does not 
distinguish between weight associated with muscle or fat mass [88-90] nor does it allow a 
relation between BMI and body fat, as this varies according to build and proportion [83]. 
Thus, additional consideration of age, sex, ethnicity, physical activity, and body fat 
distribution is necessary for a correct use and interpretation of BMI values. Compared to the 
gold-standard method of computer tomography as well as the equally accurate method 
magnetic resonance imaging (MRI), both waist circumference or the waist-to-hip 
circumference ratio provide reasonable validity to assess abdominal adiposity [91, 92]. 
Besides BMI as a surrogate marker of body fatness, a distinction between fat mass and fat-
free mass is often suggested – either using percentage body fat (%BF), fat mass index (FMI) 
(%BF / height2), or fat-free mass index (FFMI) ([weight - weight · %BF] / height2) [90, 93-95]. 
It is not clear what the gold standard method for measurement of %BF is, as even the best 
methods used are indirect [92]. Historically, densitometry has served as a standard, but due 
to its impracticability in epidemiological studies, it has often been replaced by dual energy x-
ray absorptiometry (DEXA). DEXA can be considered a practicable method, providing 
reproducible measurements of the different body components, i.e. fat mass, fat-free mass, 
and bone-mineral mass. However, the x-ray and scanning unit is expensive and both trained 
radiology personnel as well as software is needed for proper usage [92]. In contrast, skinfold 
measurements are low in costs, which is one reason why this technique is probably the most 
widely used method in epidemiological studies. However, it is essential to have good trained 
personnel to achieve valid measurements. While it provides a direct measure of body fat, it 
has to be noted that not all fat is accessible to the calipers, e.g. intraabdominal fat [92]. To 
define excess body fat, %BF reference values have been published [96, 97].  
According to the WHO, since 1980, obesity prevalence has nearly doubled worldwide [83]. 
Global estimates from the International Association for the Study of Obesity (IASO) and the 
International Obesity Task Force (IOTF) state that 2010 approximately one billion people 
were overweight and 475 million people were obese [98]. For Europe, IASO/IOTF estimate 
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that 60% of the adult population (260 million) were overweight or obese in 2010 [98]. 
According to DEGS1, 53.0% of women and 67.1% of men over the age of 18 years are 
overweight and 23.9%, and 23.3%, respectively, are obese. Thereby, prevalence increases 
with age group [99]. For Australia, the Australian Health Survey 2011-2012 revealed that 
63.4% of Australians aged 18 years and older were overweight or obese, with a prevalence 
of 75% among those aged 65 to 74 years [100].  
For children and adolescents, classification of overweight and obesity is done by using sex- 
and age-specific BMI percentiles as the BMI varies during childhood growth [101]. These 
percentiles are available on a national and international basis. In Germany, reference curves 
from Kromeyer-Hauschild, which are based on data from 17 regional studies conducted 
between 1985 and 1999 [102], and the newer percentiles from the KiGGS study conducted 
between 2003 and 2006 [103], exist. Compared to Kromeyer-Hauschild, the KiGGS data 
already includes 50% more overweight children, reflecting the more recent BMI distribution 
[104]. Hence, the Kromeyer-Hauschild percentiles should be used for classification of 
overweight and obesity, which is defined as a BMI above the 90th and 97th percentile, 
respectively [102]. For an international comparison, the IOTF has developed an international 
standard, which provides age- and sex-specific cut-offs corresponding to an adult BMI of 25 
and 30 kg/m2 at 18 years of age and is based on six nationally representative surveys from 
Brazil, Great Britain, Hong Kong, the Netherlands, Singapore, and the US [105]. To adjust for 
changes occurring with normal growth, BMI z-scores, also called standard deviation scores 
(SDS), are often calculated using population based BMI reference data. These scores 
express in units of standard deviations (SD) how far away a child‘s BMI lies from the mean 
BMI value for sex and age [106]. For definition of excess body fat in children and 
adolescents, reference percentile curves were developed with data from 1985 British 
Caucasian children aged 5 to 18 years, where a %BF above the 85th and 95th percentile is 
defined as overfat and obese, respectively [107].  
Regarding prevalence data for children, IASO/IOFT estimate that worldwide up to 200 million 
school aged children are overweight with 40-50 million of them being obese, and that in 
Europe 20% of all school aged children (12 million) are overweight or obese  [98]. For 
Germany, data from the KiGGS study, using the definition for overweight and obesity by 
Kromeyer-Hauschild [102], revealed that 15% and 6% of all children aged three to 17 years 
were overweight or obese, respectively. Regarding adolescents, 15.4%, 18.4%, and 17.1% 
of the seven to ten, eleven to 13, and 14 to 17 year olds, respectively, were overweight or 
obese. Comparing this prevalence to the reference population from the 1980ies and 1990ies, 
overweight and obesity in the youth has risen by 50% in Germany, with the highest increases 
among the 14 to 17 year olds [104]. 
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The underlying pathology of obesity is either an enlargement of fat cells or an increase in 
their number [108]. However, the former condition is associated with metabolic dysregulation 
[109]: Large adipocytes secrete more fatty acids and additionally different types of cytokines, 
chemokines and hormone-like factors – the so-called adipokines – which are able  to 
modulate IR as well as inflammatory, thrombotic, and coagulation systems [84, 108]. 
Elevated levels of free fatty acids contribute essentially to IR by affecting the primary targets 
of insulin: In the liver, production of glucose and triglycerides and secretion of very low 
density lipoproteins (VLDL) is increased. In the muscle, excess free fatty acids reduce insulin 
sensitivity through the inhibition of insulin-stimulated glucose uptake. The resulting increase 
in circulating levels of glucose and to some extent free fatty acids induces an elevated insulin 
secretion from the pancreatic beta cells, which in turn leads to hyperinsulinemia. (see Figure 
2 in Chapter 2.2.1). Regarding the role of insulin in lipid metabolism, it is of interest that 
adipose tissue lipolysis is the most sensitive pathway with regard to its action. This implies 
that under the condition of IR, more free fatty acids are produced through increased lipolysis 
of stored TG in adipose tissue, which in turn further inhibit the antilipolytic effect of insulin 
[79, 84]. 
On a molecular level, exposure of cells to increased levels of saturated fatty acids can impair 
proximal signaling of the insulin receptor through activation of JNK and IKKβ [78, 110, 111].   
Besides free fatty acids, some of the adipokines secreted by the adipose tissue also affect 
insulin action: Pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and 
interleukin 6 (Il-6) constitute a major role in this process [79]. These adipokines will be 
discussed in the following section. 
2.2.3 Chronic low-grade Inflammation 
Chronic low-grade inflammation is considered to play a crucial role in the pathogenesis of 
T2D [112] and CVD [113] (see Table 1 for an overview of the role of selected immune 
mediators in T2D/CVD). Additionally, other diseases such as dementia [114], depressive 
disorders [115], certain types of cancer [116] and finally, an overall higher risk of all-cause 
mortality in old age [117] have been linked to a subclinical inflammatory state. Both obesity 
[118] and T2D [112] are now considered inflammatory diseases.  
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Table 1: Selected pro- and anti-inflammatory immune mediators and their potential role in 
type 2 diabetes mellitus and cardiovascular disease (adapted from [118-120]). 
Immune mediator Possible role in T2D/CVD 
Primary pro-inflammatory 
cytokines (e.g. IL-1, TNF-α) 
 mediate the attraction and migration of inflammatory cells into 
vascular tissue 
 induce expression of cellular adhesion molecules 
 induce ―messenger cytokines‖  
 TNF-α promotes IR, IL-1 regulates insulin secretion 
―Messenger‖ cytokine IL-6  principal procoagulant cytokine 
 can increase plasma concentrations of fibrinogen, PAI-1 and 
CRP 
 promotes IR 
CRP  amplifies inflammatory and procoagulant responses 
 predisposes to a state of hypercoagulability 
 downregulates nitric oxide, a vasoactive peptide that helps 
maintain vascular tone 
 PAI-1  reduces plasma fibrinolysis 
 promotes atherothrombosis 
Adiponectin 
 anti-inflammatory adipose tissue hormone 
 promotes insulin sensitivity 
 stimulates fatty acid oxidation 
Abbreviations: CRP, c-reactive protein; IL, interleukin; PAI-1, Plasmingen activator inhibitor type 1; TNF, tumor 
necrosis factor  
Particularly the recognition of adipose tissue as an endocrine organ, secreting adipokines 
such as cytokines, has given further insight into the relation between obesity and IR [121]. 
The first clear link between obesity, diabetes, and chronic low-grade inflammation was 
provided by scientific findings related to the pro-inflammatory cytokine TNF-α: It was shown 
that this cytokine is overexpressed in the adipose tissue of obese mice, and furthermore, that 
the neutralization of TNF-α led to a decrease in IR [122, 123]. From then on, several other 
pro-inflammatory cytokines and mediators such as IL-6 have also been found to be 
overexpressed in adipose tissue in obese mice and humans [118] and their elevated 
circulating levels have been linked to obesity and incident T2D [124, 125]. In contrast, 
decreased circulating levels of the anti-inflammatory adipokine adiponectin have also been 
shown to correlate with greater adipocyte size [126]. Furthermore, it has been observed that 
macrophages accumulate in adipose tissue in excess [127, 128], probably driven by necrosis 
of hypertrophic adipocytes [129]. These macrophages are characterized by expression of 
pro-inflammatory cytokines such as TNF-α and IL-6, and reactive nitrogen species such as 
nitric oxide [15] and are thought to play an important role in influencing adipocyte biology and 
systemic IR [15, 130].  
In addition to the induction through pro-inflammatory cytokines and macrophages, 
inflammatory signaling pathways can also be activated intracellularly through metabolic 
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stress [118]: the functional capacity of the ER can be overburdened in obesity causing ER 
stress. Particular in beta cells, an increased flux of proteins through the ER caused by 
elevated insulin production can lead to ER stress [131]. Moreover, several cell stressors, 
especially increased glucose metabolism, are associated with an increase in mitochondrial 
production of reactive oxygen species [132]. Besides activation of increased inflammatory 
pathways, oxidative stress can also impair insulin secretion, as beta cells are particularly 
vulnerable to oxidative stress because of their low levels of antioxidative enzymes [18, 112]. 
Of note, insulin displays anti-inflammatory actions in insulin-sensitive humans. However, a 
possible compensation of oxidative stress by insulin is lost in insulin-resistant individuals due 
to prolonged pro-inflammatory conditions [133]. This pro-inflammatory state is considered a 
primary cause of obesity-linked IR [118] and adipose tissue inflammation might furthermore 
be the main distinction between metabolically unhealthy and metabolically healthy obese 
individuals [134], perhaps explaining the increased CVD risk among some obese individuals 
[135]. 
Pro-inflammatory cytokines are able to inhibit insulin action in adipocytes via autocrine and 
paracrine signaling and are furthermore able to induce systemic IR via endocrine signals. 
Hence, supplementary to excess levels of free fatty acids, the circulating cytokines add 
further to the insulin resistant state [79, 118]. Thereby, as described for the other influencing 
factors, the inhibition of downstream signaling of the insulin receptor is the primary 
mechanism leading to inflammation induced IR [14, 130, 136].  
2.2.4 Hepatic insulin resistance and nonalcoholic fatty liver disease 
Besides adipose tissue, muscle cells, and pancreas, the liver is a major target of insulin 
action and particularly affected by obesity [14].  
Nonalcoholic fatty liver disease (NAFLD) – a term used to describe a spectrum of hepatic 
diseases ranging from hepatic steatosis to cirrhosis, has received rising scientific attention as 
the hepatic manifestation of the metabolic syndrome [137]. In fact, NAFLD often 
accompanies abdominal adiposity [14] and hepatic fat accumulation is frequently observed in 
patients with IR or T2D [16].  
The prevalence of NAFLD is increasing worldwide and is estimated to be 30% in adults and 
up to 10% in children and adolescents in developed countries [138-140]. Of particular 
concern is the rising prevalence of hepatic steatosis observed in children, which entails long-
term detrimental health consequences [141]. Clinical diagnosis refers to the total liver fat 
content: If levels between 5 and 10% are exceeded or, alternatively, if cytoplasmatic TG 
droplets are present in more than 5% of hepatocytes and significant alcohol consumption can 
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be precluded, a NAFLD is diagnosed. If, additionally to fat accumulation, hepatocyte injury, 
infiltration of pro-inflammatory markers or fibrosis exists, this condition is termed nonalcoholic 
steatohepatitis (NASH) [142]. Hence, inflammatory processes are tightly linked to 
progression of fatty liver disease [14]. The gold standard for diagnosis of NAFLD is a liver 
biopsy. However, because of its invasive character, it is only conducted if clinical indications 
are present and thus inapplicable in epidemiological studies. Non-invasively, liver fat content 
can be estimated through different medical imaging techniques, e.g. sonography or magnetic 
resonance spectroscopy [142]. Furthermore, elevated liver enzymes can be used to assess 
liver health: If hepatocyte injury occurs, e.g. through impaired mitochondrial function due to 
oxidative stress, ALT and GGT are subsequently increasingly released [143]. Generally, it 
has to be noted that liver steatosis is often an asymptomatic disease and the majority of 
patients do not show any abnormalities during laboratory investigations [142].  
The association between obesity, IR and hepatic steatosis can be largely explained by 
insulin actions and inflammatory processes: Hepatic steatosis arises if an imbalance exists 
between TG synthesis and removal. The fatty acids required for TG synthesis are thereby 
derived from three different sources: from the diet, de-novo lipogenesis, and adipose tissue 
[138]. In the condition of IR and obesity, increased levels of free fatty acids are delivered 
from adipose tissue, which are taken up by the liver and stored as TG. With the development 
of hepatic IR, insulin is no longer able to inhibit gluconeogenesis, leading to increased 
glucose levels, being stored as TG. However, due to a higher insulin sensitivity of the 
signaling molecule for β-oxidation (Foxa2), the inhibiting effect of insulin is retained 
intrahepatically during IR [144], leading to both hyperglycemia and hypertriglyceridemia 
[145]. Additionally, increased inflammatory gene expression has been observed in the liver 
with increasing adiposity [146], having two possible causes: First, lipid accumulation in the 
hepatocytes might be associated with a subacute inflammatory response similar to adipose 
tissue inflammation. Second, pro-inflammatory substances might reach the liver through the 
portal vein, where they initiate hepatic inflammation, activate Kupffer cells – the resident 
hepatic macrophages – and participate further in the development of IR [14, 146]. The fact 
that adipokines produced by visceral fat are – in contrast to peripheral fat cells – directly 
transported to the liver through portal circulation, highlights again the special role of visceral 
adipose tissue in metabolic disease development. Indeed, NAFLD often accompanies 
abdominal obesity [14]. 
2.2.5 Relevance in different stages of life 
A persons‘ health status is traditionally thought to be the result of a complex interaction 
between genetical and environmental factors. The latter ones include a wide range of 
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influences, including diet, activity status as well as the socioeconomic and ecological 
environment. In the 1990ies, Barker et al. added an additional feature to this interaction: The 
concept of programming, which has been particularly extensively described for the perinatal 
period. Barkers concept originates from the observation that low birth weight was associated 
with later occurrence of T2D or CVD [147]. This simple epidemiological comparison was later 
extended to the whole period of early life, including both the perinatal phase as well as the 
time until the age of two years and onwards [148]. The concept of programming is based on 
the idea that lifetime consequences can result from stimuli or insights occurring during critical 
or sensitive periods early in life [149]. Subsequently, the characterization of specific critical 
periods for a later development of obesity or its complications, including T2D, have been 
extended to the period of adiposity rebound and adolescence [150].  
However, not only in terms of potential programming effects it is of interest to consider e.g. 
diet and health outcome interactions during specific stages in life. This thesis builds on the 
assumption that during a lifetime, dietary habits and also activity levels may change: They 
are possibly firstly shaped during childhood and adolescence, adhered to during adulthood, 
but then maybe need to be modified again during the process of aging to adapt to changes in 
everyday life e.g. caused by retirement or impaired health status.  
Adolescence 
Puberty can be regarded a time frame which is of particular interest for carbohydrate 
metabolism. Besides pregnancy [151], puberty is the only period in life where a physiological 
IR occurs [19]. This decrease in insulin sensitivity, occurring during mid-puberty, is not 
related to body fat content, but leads to increased levels of fasting glucose and insulin. 
However, compared to the ―pathological‖ IR, beta cell function is conserved, since the cells 
do not increase insulin secretion in the same proportion, leading to disproportionally low 
acute insulin responses. At the end of puberty, insulin sensitivity recovers again to pre-
pubertal levels [19].  
Additionally to changes in insulin sensitivity, puberty is also characterized by changes in 
levels of Insulin-like growth factor 1, growth hormones and sex steroids [152]. The occurring 
hormonal changes impact, among others, on appetite, satiety, and fat distribution and may 
predispose adolescents to later overweight and other related health outcomes. For instance, 
also adiponectin levels decrease and as this cytokine is involved in insulin metabolism and 
disposes anti-inflammatory effects, deviations in these changes might nevertheless have an 
impact on later health [153, 154].  
Furthermore, puberty is characterized by behavioral changes in diet and activity levels: It has 
been frequently reported that on average adolescents decrease their physical activity and 
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prefer inactive pastimes such as watching TV [153]. Also, dietary quality is often reduced in 
puberty, particularly in regard to carbohydrates: generally, adolescents consume more added 
sugars, particularly as soft drinks, fast foods, and less fiber-rich products compared to 
younger children [155-157]. Importantly, these changes cannot be dismissed as short-term 
behavioral exceptions but instead may persist in the long-term [158, 159], underlining the 
importance to address this period and regard it as pivotal for public health approaches. 
Moreover, even if healthy normal-weight adolescents are able to adapt to these physiological 
and behavioral changes, this might not apply to those who enter puberty with excess body 
weight or emerging IR, exposing them to a higher risk for later development of T2D and CVD 
[160]. 
Older age 
As stated by the IDF and Global Burden of Disease project, two of the factors leading to an 
increase in diabetes prevalence are the rising incidence due to demographic changes such 
as aging and the rising lifespan of patients with T2D due to better health care options [2]. 
Therefore, improved health care not only impacts on diabetes, but also prognosis of 
numerous other diseases, hence accounting for exactly these observed demographic 
changes [161].  
An increased age is among the risk factors for several diseases, including T2D and NAFLD 
[2, 162]. It was shown that a state of chronic low-grade inflammation is involved in several 
processes of aging [52]. Hence, investigation of diet disease associations is not only of 
interest in older age groups because of higher disease prevalence, but also because 
metabolic adaptations might occur, which need to be specifically addressed. Finally, primary 
and secondary prevention approaches fitted for older age groups are essential to develop, 
since these age groups constitute a growing proportion of our population. 
2.3 Evidence linking carbohydrate quality to risk markers of type 2 diabetes mellitus 
and related health outcomes 
Carbohydrate quality plays a crucial role in the development of T2D and related diseases [5]. 
In this chapter, the evidence for the relation between dietary GI/GL, dietary fiber and whole 
grain intake and risk markers of T2D, obesity, low-grade inflammation, and hepatic steatosis 
will be discussed. For this purpose, each part will start with a short overview of the 
mechanisms proposed for the presented association.  
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2.3.1 Carbohydrate quality and risk markers for type 2 diabetes mellitus 
Postprandial hyperglycemia and -insulinemia are tightly linked to diabetes pathogenesis. 
Particularly different aspects of carbohydrate quality have been shown to impact on glucose 
homeostasis [5]. While a lower blood glucose response is commonly attributed to a fiber- and 
whole grain-rich diet, the dietary GI is a somewhat newer and more precise parameter for 
estimating postprandial glucose excursions (see Chapter 2.1.3). For both aspects, relevant 
mechanisms and available evidence for adults as well as children/adolescents, will be 
presented – the latter in more detail, as this thesis focuses on the relevance in puberty. 
Dietary glycemic index and glycemic load 
Rapid increases in postprandial blood glucose levels in response to consumption of high-GI 
meals stimulate insulin release from beta cells, while the release of counter-regulatory 
hormones such as glucagon is suppressed. Of note, the incremental area under the blood 
glucose curve following a high-GI meal can be at least twice as high compared to a low-GI 
meal although containing the same nutrients and energy [13]. Hyperinsulinemia, caused by 
postprandial hyperglycemia, may in turn induce downregulation of the insulin-receptor which 
results in IR [163, 164]. This is considered to eventually lead to a cycle of compensatory 
hyperinsulinemia and IR, enhancing the strain on beta cells. Additionally, IR can be caused 
by counter-regulatory hormone secretion as well as increased levels of free fatty acids in the 
late postprandial phase. Elevations in blood glucose and free fatty acid levels can 
furthermore impair beta cell function – conditions which have been termed ―glucotoxicity‖ and 
―lipotoxicity‖ [13]. It could be shown that healthy non-obese children are capable to increase 
insulin sensitivity of their peripheral tissues and thus adapt to postprandial glycemia [165]. 
However, obese adolescents, who are often less insulin sensitive and not able to increase 
their insulin sensitivity, have to increase their insulin secretion to achieve a comparable 
decrease in glucose levels [166]. While beta cell mass is able to compensate changes in 
metabolic load in most healthy individuals, regular consumption of a high-GI meal can 
worsen IR and contribute to an overwhelming metabolic load in susceptible individuals. The 
beta cell mass may eventually fail to compensate for IR caused by a possible increased beta 
cell apoptosis and T2D develops [5, 17, 18] (Figure 3). Another point to be mentioned in 
relation to dietary GI and diabetes risk is the ―second meal effect,‖ which describes an 
improved carbohydrate tolerance approximately four to five or ten to twelve hours after a 
previous meal. This beneficial effect could be shown for low-GI carbohydrates such as lentils, 
barley and oats, and is mainly described for low-GI whole grain foods [167-169]. Thereby, 
the low-GI feature appears to particularly impact on the shorter term period, for example a 
low-GI breakfast impacts on the glucose response at lunch [31, 170]. 
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Figure 3: Effect of a high-GI meal on the development of type 2 diabetes mellitus, from [5]. 
There exist five meta-analyses of prospective cohort studies conducted on adults on the 
relevance of dietary GI/GL for T2D development [171-175]. All of them consistently show a 
protective effect of a low dietary GI/GL on later diabetes risk. Additionally, meta-analyses 
demonstrated a link between higher dietary GI/GL and an increased CVD risk, a common 
consequence of T2D [171, 176-179]. Furthermore, two recently published meta-analyses 
showed for the first time a dose-response relationship between dietary GI/GL and T2D risk: 
For a 100-g increment in dietary GL, the risk for T2D increased by 45% in the meta-analysis 
by Livesey et al.[175]. In the meta-analysis by Greenwood et al., a 5-unit increase in GI and 
a 20-unit increase in GL was associated with an 8% and 3% increased T2D risk, respectively 
[173]. However, the evidence-based dietary guideline ―carbohydrate intake and prevention of 
nutrition-related diseases,‖ published by the DGE, only rated the evidence for the association 
between dietary GI/GL and T2D as possible (evidence grades: inconclusive, possible, 
probable, and convincing) [23]. This decision was explained by the heterogeneity observed 
among published studies. However, three of the meta-analyses were published [172, 173, 
175] after the guideline publication, and one of them explained the sources of heterogeneity 
among the included studies [175]. This indicates that the conclusion on evidence rating may 
need to be revised in an updated version. 
Regarding evidence for children or adolescents, there do not exist studies with ―hard 
endpoints‖ such as manifest T2D and there is only one observational study assessing the 
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relevance of dietary GI/GL for HOMA-IR as a marker of IR [180] and thus a risk marker for 
disease development. For the present literature overview, HOMA-IR as well as liver enzymes 
(ALT and GGT) were chosen as endpoints since the analyses included in this thesis also 
focused on these parameters as risk markers for T2D (see Chapter 3 and OA2, Appendix 2). 
In the Danish part of the European Youth Heart Studies, no prospective association was 
found between the dietary GI at 8 to 10 years of age, assessed by a single 24h recall, and 
HOMA-IR values six years later in 233 girls and boys [180] (Table 2). 
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Table 2: Observational study in children and adolescents examining the relation between dietary GI and GL and IR (measured by 
HOMA-IR)1 
//3 
~ 
Abbreviations: Ø average value, mean or median as provided in the original publication; GI, glycemic index; GL, glycemic load; SD, standard deviation 
1
 Only relevant exposures and outcomes are presented 
2
 n number refers to those in final analysis
 
3 : direct association with GI or GL, (): trend for association with GI or GL, : no association with GI or GL,: inverse association with GI or GL 
4 
original values based on white bread reference and were converted to glucose reference by dividing by 1.4286 [37] 
Results 
 no association between 
dietary GI at baseline and 
HOMA z-scores at follow-up 
(p for trend≥0.4) 
 cross-sectional analysis 
(including 651 adolescents) 
showed also no association 
(p for trend≥0.7) 
Covariates 
considered in 
analysis 
age, sexual maturity (at 
baseline and follow-up), 
BMI, physical activity, 
mother`s education, 
school location, 
baseline HOMA z-
scores 
Outcomes: 
average 
(baseline) 
level 
Mean (SD) 
HOMA-IR:  
girls: 1.8 (1.0), 
boys: 1.7 (0.9) 
Exposure: 
assessment method, 
average baseline 
values 
24h recall interview 
supplemented with a 
qualitative food record 
from the same day 
 
mean (SD) dietary GI: 
girls: 60
4
 (5), boys: 58 
(5)
4
 
Follow-
up 
6 years 
Population, 
recruitment, name of 
study
2
 
233 participants 
 
Danish part of the 
European Youth Heart 
Studies 
 
% female: 59% 
Ø age: 9.7 years 
Ø BMI: 17.1 
First 
author, 
Year, 
Country 
Kynde 
2010 
[180] 
Denmark 
THEORETICAL BACKGROUND 
28 
 
Intervention studies examining the effect of dietary GI or GL on IR markers show 
inconsistent results: Ebbeling et al. [181] compared the effect of an ad libitum reduced-GL 
diet with an energy restricted low-fat diet on body composition (see Chapter 2.3.2) and IR 
after 6 months of intervention and further 6 months of follow-up. In the low-GL diet, lower 
HOMA-IR values were observed as compared to the low-fat diet independently of the BMI of 
the 14 participating obese adolescents. Another study showing a beneficial effect of dietary 
GI was conducted in Italy and included 26 obese girls and boys aged 7 to 13 years. In this 
randomized intervention trial, a low-GI hypocaloric and a high-GI hypocaloric diet were 
compared in relation to different cardiometabolic parameters. HOMA-IR values were 
significantly reduced after 6 months in the low-GI group only. However, no between-group 
differences were provided [182]. In a pediatric weight management center in the US, a 
portion controlled diet was retrospectively compared to a healthy eating plan with and without 
assistance of a dietitian. According to the healthy eating plan, less than 10% of energy 
should be consumed from saturated fat and the GI should be below 50. ALT levels 
decreased significantly in the group with the healthy eating plan supported by a dietitian. 
However, again differences between groups were not provided. Furthermore, compliance or 
dietary intake was not assessed; hence the conclusions rely only on the advices given. In 
addition, it was not mentioned whether potential confounding factors were considered, further 
impairing the study results, particularly as the participants‘ families could elect their diet of 
choice by themselves rather than being randomized to one of the groups [183]. The two 
interventional trials from Mirza et al. [184] and Ramon-Krauel et al. [185] did not find effects 
of dietary GI or GL: In the first study, 64 obese Hispanic US children and adolescents took 
part, who were randomized to either a low-GL or a low-fat diet for two years. Dietary 
counseling was conducted in the first 12 weeks only. After two years, and also after in-
between measurements every three months, no difference in HOMA-IR was observed 
between the two intervention groups [184]. Ramon-Krauel et al. conducted their study in girls 
and boys, who were obese similar to the participants in the presented intervention studies 
but were also diagnosed to have fatty liver. In this study, both a high-GL and a low-fat diet 
led to reductions in ALT concentrations and hepatic lipid content after six months, with no 
difference between the two groups. HOMA-IR reductions tended to be greater after the low-
fat diet. However, baseline levels in this group were almost twice as high compared to the 
low-GL group [185] (Table 3). 
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Table 3: Intervention studies in children and adolescents examining the effect of dietary GI and GL on IR (measured by HOMA-IR and  
ALT)1 
+/-
3
 
+ 
(+) 
- 
Results 
 at 12 months, HOMA-IR had 
increased significantly less in the 
RGL compared to the RFD group 
(p for difference=0.02)  
 results remained unchanged 
after additional adjustment for 
BMI (p for difference=0.03) 
 HOMA-IR significantly 
reduced only in the LGI-group 
(p=0.04, for HGI: p=1.0) 
 no differences between 
groups assessed 
 no differences between 
groups for changes in HOMA-IR 
(p for difference>0.1)  
 
Outcome: 
baseline levels 
and primary 
endpoints 
mean (SEM) 
HOMA-IR:  
RGL: 3.5 (0.7) 
RFD: 4.3 (0.7) 
mean (SD) 
HOMA-IR:  
LGI: 3.1(1.5) 
HGI: 3.2 (1.6)  
mean (SE) 
HOMA-IR:  
LGD: 3.35 (0.4) 
LFD: 3.35 (0.3) 
(values derived 
from total study 
sample; 
completers and 
non-completers)  
Dietary Intervention 
reduced GL diet (RGL) (n=7): ad 
libitum, mean (SEM) GI: 53 (3), 
mean (SEM) GL (g/1000kcal): 69 
(6)  
reduced fat diet (RFD) (n=7): 
energy restricted (-250 to 500 
kcal/d), mean GI: 56 (2), mean GL: 
79 (7)  
 
dietary counseling 
 
low-GI diet (LGI) (n=13): mean 
estimated GI: 60 
high-GI diet (HGI) (n=13): mean 
estimated GI: 90 
both diets hypocaloric (30% less 
energy) 
 
dietary counseling, meal plan 
provided, recording of consumed 
foods 
low-GL diet (LGD) (n=33): 
mean (SE) GI after 3 months: 51 
(1), after 24 months: 56 (1), mean 
(SE) GL after 3 months: 64 (3), 
after 24 months: 77 (4)  
low-fat diet (LFD) ( n=31): 
mean GI after 3 months: 55 (1), 
after 24 months: 54 (2), mean GL 
after 3 months: 74 (3), after 24 
months: 74 (3)  
 
dietary counseling first 12 weeks 
 
Study design 
randomized 
controlled trial, 
6 months 
intervention, 6 
months follow-up 
randomized 
intervention trial,  
6 months duration 
randomized 
controlled trial, 
24 months 
intervention 
Participant 
characteristics
2
 
14 obese 
participants 
 
% female: 69% 
Ø age: 16.1 years 
Ø BMI: 36 
26 obese 
participants 
 
% female: 54% 
age: 7-13 years 
Ø BMI: 28.3 
64 obese Hispanic 
participants 
 
% female: 44% 
Ø age: 11.7 years 
Ø BMI: 30.6 (BMI-
z score: 2.24) 
First 
author, 
Year, 
Country 
Ebbeling 
2003 [181] 
USA 
Iannuzzi 
2009 [182] 
Italy 
Mirza 2013 
[184] 
USA 
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Table 3: continued. 
+/-
3
 
- 
(+) 
Abbreviations: Ø average value, mean or median as provided in the original publication; ALT, alanine aminotransferase; GI, glycemic index, GL, Glycemic load; SD, standard 
deviation; SE, standard error; SEM, standard error of the mean 
1
 Only relevant exposures and outcomes are presented 
2
 n number refers to those who completed the study
 
3
 +: effect of dietary intervention on body fat measures, -: no effect of dietary intervention on body fat measure 
Results 
 trend for greater decrease in 
HOMA-IR in LFD-group (p for 
difference=0.08), but this group had 
higher baseline values 
 decrease in ALT-concentrations 
in both groups, with no difference 
between them (p for difference=0.4) 
 ALT levels decreased 
significantly in the HEP plus dietitian 
group (p<0.005) 
 no differences between groups 
assessed 
Outcome: baseline 
levels and primary 
endpoints 
mean (SD) HOMA-IR:  
LGD: 4.5 (1.6) 
LFD: 9.3 (8.1) 
 
mean (SD) ALT (IU/l): 
LGD: 63.3 (36.0) 
LFD: 75.9 (50.9) 
mean ALT (U/l):  
PC: 50.0 
HEP plus dietitian: 
30.6 
HEP : 23.8 
Dietary Intervention 
low-GL diet (LGD) (n=8): mean 
(SD) GI after 6 months: 55 (7), 
mean (SD) GL (g/1000kcal): 56 
(13)  
low-fat diet (LFD) (n=9): mean GI 
after 6 months: 60 (7), mean GL: 
70 (8)  
 
dietary counseling 
portion controlled diet (PC)  
(n=28) 
healthy eating plan 
(HEP) (n=21) 
HEP without seeing a dietician  
(n=15) 
HEP recommends <10%  
of  calories from 
saturated fat and low GI (≤  
50) 
Study design 
randomized pilot 
intervention trial, 
6 months 
duration 
retrospective 
study,  
4.5 months 
Participant 
characteristics
2
 
17 obese 
participants with 
fatty liver 
 
% female: 18% 
Ø age: 11.9 years 
Ø BMI: 32.7 (BMI-z 
score: 2.39) 
64 participants 
 
% female: 64% 
Ø age: 11.3 years 
Ø BMI: 32.8 
First 
author, 
Year, 
Country 
Ramon-
Krauel 2013 
[185]  
USA 
Siegel 2011 
[183] 
USA 
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Dietary fiber / whole grain 
Regarding the association between dietary fiber and its effect on postprandial glycemic 
excursions, it is crucial to consider the food structure. As described in Chapter 2.1.1, intact 
kernels and milled flour – although both whole grain foods by definition and high in dietary 
fiber – have completely different postprandial glycemic responses [31]. In fact, an Australian 
analysis demonstrated that the fiber content of 121 tested foods and 13 mixed meals could 
not predict postprandial glycemia or insulinemia. In turn, dietary GI and GL were the best 
predictors for blood glucose responses [45].  Nonetheless, viscous fibers, like those in oats 
or barley, have gel-like properties, and are able to delay gastric emptying, leading to slower 
rates of glucose appearance in the blood with subsequently decreased insulin secretion. 
These beneficial effects are of relevance particularly for diabetic patients, for whom they are 
best described [186]. According to a relatively new investigation, dietary fiber from cereals 
might influence protein absorption and digestion in the small bowel. As presented in Chapter 
2.1.4, protein intake induces increases in insulin concentration. Hence, the concomitant 
consumption of fiber- and protein-rich foods could possibly counteract these insulin rises 
[187].  
Regarding beneficial effects of whole grain foods on diabetes risk, the high magnesium 
content is also relevant: Magnesium enhances insulin secretion and could thus improve 
glucose clearance from the blood [188].  
Finally, the second meal effect, which has already been mentioned in the section referring to 
the GI, is discussed for most low-GI whole grains such as intact barley or rye kernels. In 
contrast to the low-GI feature, the fermentation of indigestible carbohydrates in the colon 
might be responsible for an improved carbohydrate tolerance after the longer interval 
between meals (ten to twelve hours), i.e. between breakfast and dinner [31]. 
Results from meta-analyses on prospective cohort studies in adults support a beneficial role 
of a high fiber and whole grain intake: Particularly a high intake of cereal fiber [189, 190] and 
whole grains [191-193] is consistently related to a decreased risk of T2D [190, 191, 193] and 
CVD [189, 192, 193]. The evidence-based dietary guideline from the DGE concluded that 
fiber from cereals and whole grains reduce the risk for T2D and scored the evidence for this 
association as probable. For total fiber consumption it was however stated that there is 
possibly no association to diabetes risk. Likewise, no relationship seems to exist with soluble 
fiber (possible evidence) as well as fiber from fruit and vegetables (probable evidence). 
Evidence on the relevance of insoluble fiber is considered inconclusive [23].  
There are only four studies among children and adolescents regarding the role of dietary 
fiber and whole grain intake on diabetes risk factors and they are all observational: The 
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study from Denmark mentioned above also investigated fiber intake and its association with 
HOMA-IR levels after six years. However, as for dietary GI, no prospective association was 
observed. In the cross-sectional analysis, baseline fiber intake was inversely related to 
baseline HOMA-IR levels in girls only [180]. A similar observation has been made in a Finish 
study, which aimed to assess the effect of a lifelong dietary counseling to meet the Nordic 
Nutrition Recommendations on insulin sensitivity. It was observed that girls, who had a high 
fiber intake at the age of 15, had lower HOMA-IR levels at the age of 20 years. For boys, no 
such association was observed [194]. However, a US study including 16 overweight Latina 
adolescents did not support a role of dietary fiber for IR among girls: In this study, 12-week 
changes in fiber intake were not related to changes in HOMA-IR [195]. Also, a British study 
including adolescent girls only, found no clear association between dietary fiber intake and 
later IR: In this study, fiber intake was divided into soluble and insoluble fiber. Neither 
insoluble fiber intake at 16/17 years of age, nor changes in intake between 16/17 and 18/19 
years were related to 3-year changes in HOMA-IR levels, whereas an increase in soluble 
fiber intake between 16/17 and 18/19 years of age was related to a decrease in HOMA-IR 
levels. Nonetheless, soluble fiber intake at the age 16/17 was not related to changes in 
HOMA-IR levels [196] (Table 4).  
There are two other studies, which did not study HOMA-IR or liver enzymes but HbA1c and 
insulin sensitivity measured by euglycemic insulin clamp: In a Dutch study, fiber intake during 
adolescence was not prospectively related to HbA1c levels at age 36, which were measured 
as part of different metabolic syndrome components [197]. Furthermore, a higher whole grain 
intake was cross-sectionally related to greater insulin sensitivity among US adolescents 
[198]. 
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Table 4: Observational studies in children and adolescents examining the relation between dietary fiber and whole grain intake and IR 
(measured by HOMA-IR)1 
//3 
~ 
 
girlscs 
() 
boys  
girls  
Results 
 changes in fiber intake 
were not related to changes 
in HOMA-IR 
 no association between 
dietary fiber intake at 
baseline and HOMA z-
scores at follow-up (p for 
trend ≥0.2) 
 among girls but not 
boys, baseline fiber intake 
was inversely associated 
with baseline HOMA z-
score (p for trend=0.03 and 
0.5, respectively); non-
significant after Bonferroni 
correction 
 in girls but not in boys, 
fiber intake (g/1000kcal) 
was inversely associated 
with HOMA-IR (p for 
trend<0.0001, and 0.8. 
respectively); also after 
adjustment for BMI 
 
Covariates 
considered in 
analysis 
age, baseline 
HOMA-IR, baseline 
fiber 
age, sexual maturity 
(at baseline and 
follow-up), BMI, 
physical activity, 
mother`s education, 
school location, 
baseline HOMA z-
scores 
study group, age, 
sex, BMI 
Outcomes: 
average 
(baseline) level 
mean (SD) 
HOMA-IR: 3.8 
(2.5) 
mean (SD) 
HOMA-IR:  
girls: 1.8 (1.0),  
boys: 1.7 (0.9) 
mean HOMA-IR:  
girls: 1.69,  
boys: 1.72 
Exposure: 
assessment method, 
average baseline 
values 
3-day diet records 
 
mean (SD) dietary fiber: 
15.4g (10.0), 
8.1g/1000kcal (3.0) 
mean (SD) whole-wheat 
grains (servings/d): 1.1 
(1.3) 
24h recall interview 
supplemented with a 
qualitative food record 
from the same day 
 
mean (SD) dietary fiber 
(g/MJ): girls: 2.1 (0.7), 
boys: 2.1 (0.7) 
4-day food record 
 
mean fiber intake: girls: 
15.7g, 2.1g/1000kcal; 
boys: 17.7g, 
2.0g/1000kcal 
Follow-
up 
12 
weeks 
6 years 
5 years 
Population, 
recruitment, name of 
study
2
 
16 overweight girls 
 
re-analysis of Adolescent 
Latinas Adjusting Sugars  
(ALAS) Study 
 
Ø age: 14.5 years 
Ø BMI Z-score: 2.0 
233 participants 
 
Danish part of the 
European Youth Heart 
Studies (EYHS) 
 
% female: 59% 
Ø age: 9.7 years 
Ø BMI: 17.1 
518 participants 
 
re-analysis from the 
Special Turku Coronary 
Risk Factor Intervention 
Project (STRIP) Study 
 
% female: 47% 
Ø age: 15 years 
Ø BMI: 20.5 
First 
author, 
Year, 
Country 
Davis 
2007 
[195] 
USA 
Kynde 
2010 
[180] 
Denmark 
Oranta 
2013 
[194] 
Finland 
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Table 4: continued. 
//3 
 
soluble 
fibercc  
Abbreviations: Ø average value, mean or median as provided in the original publication; cc, concurrent; cs, cross-sectional;  SD, standard deviation 
1
 Only relevant exposures and outcomes are presented 
2
 n number refers to those in final analysis
 
3 : direct association with dietary fiber/whole grain intake, (): trend for association with dietary fiber/whole grain intake, : no association with dietary fiber/whole grain 
intake,: inverse association with dietary fiber/whole grain intake 
Results 
 no prospective association 
between intake of soluble or 
insoluble fiber at age 16/17 
years and changes in HOMA-
IR (p for trend>0.05) 
 increases in grams of 
soluble fiber between ages 
16/17 and 18/19 years were 
associated with a decrease in 
HOMA-IR (p for trend<0.05) 
 no cc association for 
insoluble fiber (p for 
trend>0.05) 
Covariates 
considered in 
analysis 
age at entry, race, 
change between 
the ages of 16/17 
and 18/19 years in 
height and 
menstrual status, 
parental education 
Outcomes: 
average 
(baseline) 
level 
mean (SD) 
HOMA-IR: 2.62 
(3.38) 
Exposure: 
assessment method, 
average baseline 
values 
food diary on three days 
 
mean (SD) soluble fiber 
(g) at age 16/17 years: 
4.00 (1.80), at age 18/19 
years: 4.39 (2.03) 
mean (SD) insoluble 
fiber (g) at age 16/17 
years: 7.34 (3.34), at age 
18/19 years: 7.69 (3.80) 
Follow-
up 
3 years 
Population, 
recruitment, name of 
study
2
 
774 girls 
 
National Heart, Lung, 
and Blood Institute 
Growth and Health Study 
 
Ø age: 16.0 years 
Ø BMI: 23.8 
First 
author, 
Year, 
Country 
White 
2012 
[196]  
UK 
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2.3.2 Carbohydrate quality and obesity 
Different aspects of carbohydrate nutrition have been related to an unfavourable 
development of body composition. This chapter will describe the relevance of the dietary GI 
on body fat, as this will be one focus of the present thesis. So far, mechanisms and evidence 
for these associations have been debated controversially. Comparable to Chapter 2.3.1, 
emphasis lies on evidence regarding children and adolescents. 
Dietary glycemic index and glycemic load 
After consumption of a high-GI meal, blood glucose levels increase rapidly, but decrease 
equally steep, often below baseline levels, two to four hours afterwards – a condition termed 
―reactive hypoglycemia.‖ This hypoglycemic state is characterized by the coexistence of high 
insulin and low glucagon levels inducing uptake of glucose – and also fatty acids – in muscle, 
fat, and liver cells while reducing fat oxidation. Hence, two of the main circulating metabolic 
fuels are decreased, leading to enhanced levels of counter-regulatory hormones which 
stimulate hunger and food intake to restore energy homeostasis [13, 199, 200]. Decreased 
fat and increased carbohydrate oxidation has been related to weight gain, while the counter-
regulatory hormone-response is associated with loss of lean body mass through its 
proteolytic effects [200-202]. Conversely, low-GI meals have been associated with increased 
satiety, delayed return of hunger, as well as reduced ad libitum food consumption [203]. It 
could be shown that these meals lead to lower 10-hour blood glucose and insulin levels as 
well as higher concentrations of the satiety hormone cholecystokinin compared to high-GI 
meals [204]. Compared to fully gelantized starches, which are present in the majority of high-
GI foods such as breads and breakfast cereals, low-GI foods are digested more slowly and 
reach lower parts of the ileum where they stimulate satiety signals [200, 205-207]. Studies 
assessing the effect of low- versus high-GI breakfast and/or lunch on subsequent energy 
intake in children and adolescents observed a significantly greater energy intake after 
consumption of a high-GI meal [199, 208]: In obese boys, a high-GI breakfast and lunch was 
associated with a higher voluntary energy intake as compared to moderate- or low-GI meals. 
In accordance with this result, hormonal and metabolic changes that promote greater food 
intake were observed [199]. Likewise, the consumption of a high-GI breakfast was related to 
higher lunch intake as compared to low-GI as well as low-GI with added sucrose breakfasts 
in normal and overweight children. Furthermore, in this study, children consuming a high-GI 
breakfast reported greater hunger ratings at lunchtime compared to a low-GI breakfast, 
although immediate satiety following breakfast was comparable [208]. It has moreover been 
proposed that the occurrence of both hyperinsulinemia and hypoglycemia might favor the 
consumption of high-GI foods, which would subsequently induce another hypoglycemic 
condition [199, 209].  
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One meta-analysis of intervention studies compared the effects of high- and low-GI/GL diets 
on parameters of obesity and obesity-related risks in overweight and obese adults. In total, 
14 studies were included. No difference was observed comparing the effects of these two 
diets on change in body weight (14 studies) or waist circumference (10 studies). Only three 
studies assessed the effect on fat free mass: Unexpectedly, low-GI/GL diets induced a 
significantly greater decrease in fat free mass compared to high-GI/GL diets.  [210]. The 
DGE came to the conclusion that in women a higher dietary GI is related to higher risk of 
adiposity with a possible evidence – for men, the evidence for such a relation was 
considered inconclusive. Regarding dietary GL it was concluded that there is possibly no 
relationship with adiposity risk [23].  
In the evidence-based dietary guidelines the available data on adiposity risk is presented for 
children/adolescents and adults separately, as there are more studies available for this 
disease outcome for both age groups compared to the other diseases presented. However, 
regarding the role of dietary GI/GL on childhood and adolescent adiposity development, the 
available evidence until 2010 was termed inconclusive [23]. Four prospective observational 
studies addressed the relevance of dietary GI/GL on later body fat development, but not all 
support a strong role for GI or GL. Two of these identified studies were conducted in the 
DONALD Study, examining a prospective relevance both in childhood [211] and adolescence 
[212]. The first included 380 young children and analysed the prospective association 
between dietary GI and GL at an age of two and percentage body fat at an age of seven as 
well as the impact of the change of dietary GI and GL during the five years on changes in 
body fat. Neither a prospective nor a concurrent relevance could be shown for dietary GL. 
Baseline dietary GI tended to be prospectively related to percentage body fat at an age of 
seven. However, because multiple comparisons were done and the concurrent analysis 
showed no association, the authors concluded that overall there appeared to be no 
association [211]. Likewise, Cheng et al. [212] did not find a cross-sectional or 4-year  
concurrent relationship in an analysis including 215 adolescents from the DONALD Study. 
However, a stratified analysis revealed that overweight adolescents with a higher dietary GI 
at baseline tended to have higher %BF and BMI-SDS at baseline, whereas no association 
was observed for normal weight adolescents. In contrast, a US study including 85 overweight 
Latino adolescents observed no correlation between dietary GI or GL and adiposity variables 
including total fat mass [213]. An Australian study, assessing the association between 
carbohydrate nutrition and development of adiposity in 856 participants from the Sydney 
Childhood Eye Study, indicated – similar to adult cohort studies – a relevance for girls only. 
However, only a statistical trend was observed for a relation between baseline GL and 5 year 
changes in body fat, while the concurrent analyses also showed no relevance of dietary GL 
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in girls. Dietary GI was not related to later body fat, neither in girls nor in boys [214] (Table 
5). 
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Table 5: Observational studies in children and adolescents examining the relation between dietary GI and GL and body fat measures1 
//3 
 
GIpros () 
 
overweight: 
GIcs () 
Results 
 trend for prospective 
associations between GI and 
%BF (p for trend=0.07) 
 no prospective 
associations between GL 
and %BF (p for trend=0.4) 
 no concurrent 
associations between GI/GL 
and %BF (p for trend≥0.4) 
 no cs or cc associations 
between GI/GL and %BF (p 
for trend≥0.4) 
 interaction for %BF with 
overweight status (p for 
interaction: cs: 0.04, cc: 
0.03); statistical trend only for 
overweight adolescents at 
baseline: a higher dietary GI 
at baseline tended to be 
related to a higher %BF at 
baseline (p for trend=0.05) 
Covariates 
considered in 
analysis 
age, age
2
, age
3
, sex, 
maternal 
overweight, year of 
birth, birth weight, 
rapid weight gain 
between birth and 
age 2, intakes of 
energy, protein, 
fiber, and added 
sugar 
age, age
2
, age
3
, sex, 
maternal 
overweight, 
breastfeeding, 
energy, and fiber 
intake 
Outcomes: 
average 
(baseline) level 
mean (SD) %BF 
(estimated using 
skinfold 
measurements): at 
age 2 years: 18.9 
(3.1); at age 7 
years: 17.5 (4.6) 
median (IQR) %BF 
(estimated using 
skinfold 
measurements): at 
baseline: 16.3 (12.6, 
22.6); at endpoint: 
17.5 (13.7-23.7) 
Exposure: 
assessment method, 
average baseline 
values 
3-day weighed dietary 
records 
 
mean (SD) dietary GI at 
age 2 years: 51.7 (3.5); 
at age 7 years: 55.8 (3.0) 
mean (SD) dietary GL 
(g/d) at age 2 years: 62.8 
(14.6); at age 7 years: 
112.8 (24.4) 
3-day weighed dietary 
records 
 
mean (SD) dietary GI at 
baseline: 55.7 (3.4); at 
endpoint: 56.5 (3.7) 
mean (SD) dietary GL 
(g/d) at baseline: 120.1 
(29.7); at endpoint: 151.8 
(42.8) 
Follow-
up 
5 years 
mean: 4 
years 
Population, 
recruitment, 
name of study
2
 
380 participants 
 
DONALD Study 
 
% female: 47% 
Ø age: 2 years 
215 participants 
 
DONALD Study 
 
% female: 54% 
Ø age: 9.4 years 
First 
author, 
Year, 
Country 
Buyken 
2008 
[211] 
Germany 
Cheng 
2009 
[212] 
Germany 
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Table 5: continued. 
//3 
~ 
 
girls: 
GLpros() 
Abbreviations: Ø average value, mean or median as provided in the original publication; %BF, percentage body fat; BIA, bioelectrical impedance analysis; cc, 
concurrent; cs, cross-sectional; DEXA, dual-energy X-ray absorptiometry; FFQ, food frequency questionnaire; GI, glycemic index, GL. Glycemic load;  IQR, interquartile 
range; SD, standard deviation
 
1
 Only relevant exposures and outcomes are presented 
2
 n number refers to those in final analysis
 
3: direct association with GI or GL, (): trend for association with GI or GL, : no association with GI or GL,: inverse association with GI or GL 

Results 
 GI/GL were not 
significantly correlated to 
changes in adiposity 
variables 
 trend for prospective 
associations between GL at 
baseline and change in %BF 
(p for trend=0.07) in girls 
 no prospective relation 
between GI and %BF in girls 
(p for trend=0.17) 
 change in GI/GL not 
related to cc change in %BF 
in girls (p for trend≥0.15) 
 among boys, no 
association between GI/GL 
and change in %BF 
(prospective and cc 
analyses) 
Covariates 
considered in 
analysis 
sex, Tanner stage, 
time between 
visits, baseline 
visceral adipose 
tissue, energy and 
fiber intake, and 
baseline 
subcutaneous 
abdominal adipose 
tissue 
age, sex, ethnicity, 
parental 
education, 
exposure to 
passive smoking, 
change in height, 
screen viewing 
time, time spent in 
physical activity, 
and energy intake 
Outcomes: 
average 
(baseline) level 
mean (SD) total 
fat mass (DEXA: 
kg): 28.7 (9.6) 
mean (SD) %BF 
(BIA): at baseline: 
girls: 23.9 (9.0), 
boys: 15.8 (7.4) 
Exposure: 
assessment method, 
average baseline 
values 
multiple pass 24h dietary 
recalls 
 
mean (SD) dietary GI at 
baseline: 59 (6) 
mean (SD) dietary GL 
(g/d) at baseline: 133 
(51) 
120-item self-
administered FFQ 
Mean (SD) dietary GI at 
baseline: girls: 54.3 (3.4), 
boys: 54.3 (3.2) 
Mean (SD) dietary GL 
(g/d) at baseline: girls: 
138.0 (53.3), boys: 145.1 
(54.2) 
Follow-
up 
mean: 
1.5 
years 
5 years 
Population, 
recruitment, 
name of study
2
 
85 overweight 
participants 
 
Study of Latino 
Adolescents at Risk 
for Diabetes cohort 
 
% female: 44% 
Ø age: 14.2 years 
856 participants 
 
Sydney Childhood 
Eye Study 
 
% female: 49% 
Ø age: 12 years 
First 
author, 
Year, 
Country 
Davis 2009 
[213] 
USA 
Gopinath 
2013 [214] 
Australia 
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The four identified intervention studies also showed inconsistent results for an effect of 
dietary GI/GL on body fat in children or adolescents: Two of the studies were already 
mentioned in Chapter 2.3.1, as they addressed both measures of IR and adiposity [181, 
184]. Besides beneficial effects on HOMA-IR, the reduced-GL diet in the study by Ebbeling et 
al. [181] also led to greater reductions in fat mass over the duration of 12 months compared 
to the reduced-fat diet. Moreover, the authors conducted a post-hoc analysis of the study, 
pooling the data from both groups: These results showed that the change in dietary GL was 
a strong predictor of change in %BF among both groups. Likewise, the results of the study 
from Mirza et al. [184] on the outcomes IR and BMI were similar (results for body fat were not 
presented): Both the low-GL and the low-fat diet prescribed to obese Hispanic children and 
adolescents did not differ in their effect on BMI reductions. Another US study on 85 obese 
girls and boys compared the effect of a low-carbohydrate, and a low-GL diet (both ad libitum) 
to an energy-restricted portion controlled diet. Percentage body fat decreased in all three 
groups over the three months intervention period and remained low after nine months of 
follow-up. However, like in the aforementioned study, no significant group differences were 
observed [215]. In turn, in 465 European children from the Diet, Obesity and Genes 
(DiOGenes) family-based study, a low protein diet accompanied by a high-GI was associated 
with the greatest increases in %BF and the counterpart, a high-protein, low-GI diet was 
protective against the development of obesity. However, no isolated effect of dietary GI was 
observed, which might be due to the little difference achieved in GI (2.3 instead of the aimed 
15 points difference between the groups). It should furthermore be noted that the DiOGenes 
study is a family intervention study which primarily focussed on the obese/overweight 
parents. Among the included children the baseline prevalence of obesity/overweight was 
48% - hence these children represent an at-risk population [216] (Table 6). 
In addition, two retrospective studies including obese US children do not investigate the 
effect on body fat mass (one main focus of this thesis) but on body weight or BMI: The study 
by Siegel et al. [183] was already mentioned in Chapter 2.3.1: Their results showed that 
those children following a low-GI healthy eating plan for three months, additionally supported 
by a dietician, decreased their BMI compared to participants on a healthy eating plan without 
support by a dietician or on a portion controlled diet [183]. The second study included ten 
year old children who were either assigned to an ad libitum low-GI/GL (n=64) or an energy-
restricted low-fat diet (n=43). Participants following the former diet had greater decreases in 
their BMI and weight compared to participants in the low-fat group. However, these results 
cannot be attributed to GI only, as the macronutrient composition of the diets was not 
matched [217]. 
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Table 6: Intervention studies in children and adolescents examining the effect of dietary GI and GL on body fat measures1 
+/-
3
 
+ 
+ 
Results 
 at 12 months, fat mass had 
decreased significantly more in 
the RGL compared to the RFD 
group (p for difference=0.01, ITT 
analysis) 
 pooled post-hoc analysis: GL 
was a significant predictor  of 
change in %BF (0-6 months) 
among both groups (p for 
trend=0.006) 
 %BF increased significantly 
more in the LP/HGI group than 
in the other groups (p for 
difference=0.04) 
 percentage of 
overweight/obese children 
decreased significantly in the 
HP/LGI group (p for 
difference=0.03) 
Outcomes: 
baseline levels 
and primary 
endpoints 
mean (SEM) total 
fat mass ((kg):  
RGL: 38.8 (2.6) 
RFD: 48.5 (3.0) 
mean (SD) %BF 
(DEXA: kg):  
girls: 30.0 (8.9) 
boys: 25.8 (11.8) 
Dietary Intervention 
reduced GL diet (RGL) (n=7): ad 
libitum, mean (SEM) GI: 53 (3), 
mean (SEM) GL (g/1000kcal): 69 
(6)  
reduced fat diet (RFD) (n=7): 
energy restricted (-250 to 500 
kcal/d), mean GI: 56 (2), mean 
GL: 79 (7)  
 
dietary counseling 
low-protein/low-GI (LP/LGI) 
(n=102),  
LP/high-GI (LP/HGI) (n=87), 
high-protein /LGI (HP/LGI) 
(n=92),  
HP/HGI (n=96), 
control diet (n=88) 
target difference: 15 GI points, 
achieved difference: 2.3 GI points 
 
dietary counseling 
Study design 
randomized 
controlled trial, 
6 months 
intervention, 6 
months follow-up 
randomized 
intervention trial, 
6 months 
intervention 
Participant 
characteristics
2
 
14 obese 
participants 
 
% female: 69% 
Ø age: 16.1 years 
465 participants 
  
DiOGenes 
 
% female: 57% 
Ø age: 12.4 years 
First 
author, 
Year, 
Country 
Ebbeling 
2003 [181] 
USA 
Papadaki 
2010 [216] 
Netherlands, 
Denmark, 
UK, Greece, 
Germany, 
Spain, 
Bulgaria, 
and Czech 
Republic 
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Table 6: continued. 
+/-
3
 
- 
- 
Abbreviations: Ø average value, mean or median as provided in the original publication; %BF, percentage body fat; DEXA, dual-energy X-ray absorptiometry; GI, glycemic 
index; GL, glycemic load; ITT, intention to treat; SD, standard deviation; SE, standard error; SEM, standard error of the mean 
1
 Only relevant exposures and outcomes are presented 
2
 n number refers to those who completed the study
 
3
 +: effect of dietary intervention on body fat measures, -: no effect of dietary intervention on body fat measure 
 
Results 
 no differences in %BF between the 
diet groups 
 in all diet groups, %BF decreased 
after 3 months of intervention (all p 
for difference ≤0.0002), remained 
reduced through to 12 months (all 
comparisons with baseline p for 
difference≤0.0002) 
 results for %BF not presented 
 no differences between groups in 
averaged mean BMI z-score at any 
of the measured time points or the 
overall decrease in BMI z-score (p 
for difference>0.1)   
 both dietary groups decreased 
their BMI z-scores at 3, 12, and 24 
months post-intervention (p for 
difference to baseline<0.0001, 
0.003, and 0.002, respectively) 
Outcomes: 
baseline levels 
and primary 
endpoints 
mean (SD) %BF 
(DEXA):  
40.7 (3.7) 
mean (SE) %BF 
(air-displacement 
plethysmography):  
LGD: 42.3 (0.8) 
LFD: 43.3 (0.7) 
 
mean (SE) BMI z-
score :   
LGD: 2.25 (0.05) 
LFD: 2.24 (0.03)  
(values derived from 
total study sample; 
completers and non-
completers) 
Dietary Intervention 
low-carbohydrate diet (LC) 
(n=35): ad libitum, mean (SD) GL 
(g/1000kcal) at baseline: 73.2 
(11.4) 
reduced GL diet (RGL) ( n=36): 
ad libitum, mean GL (g/1000kcal) 
at baseline: 76.5 (11.2) 
portion controlled diet (PC) 
(n=31): energy restricted (-500 
kcal/d), mean GL (g/1000kcal) at 
baseline: 74.0 (12.6) 
 
dietary counseling 
low-GL diet (LGD) (n=33): 
ad libitum; mean (SE) GI after 3 
months: 51.3 (1.3), after 24 
months: 55.5 (1.0), mean (SE) GL 
after 3 months: 63.8 (2.6), after 24 
months: 77.2 (3.5)  
low-fat diet (LFD) ( n=31): 
mean GI after 3 months: 55.0 (1.0), 
after 24 months: 54.4 (1.5), mean 
GL after 3 months: 73.8 (2.5), after 
24 months: 73.6 (3.4)  
 
dietary counseling first 12 weeks 
Study design 
randomized clinical 
trial, 
3 months 
intervention, 9 
months follow-up 
randomized 
controlled trial, 
24 months 
intervention 
Participant 
characteristics
2
 
85 obese 
participants 
 
% female: 58% 
Ø age: 9.8 years 
64 obese Hispanic 
participants 
 
% female: 44% 
Ø age: 11.7 years 
First 
author, 
Year, 
Country 
Kirk 2012 
[215] 
USA 
Mirza 2013 
[184] 
USA 
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2.3.3 Carbohydrate quality and chronic low-grade inflammation  
As described in Chapter 2.2, chronic low-grade inflammation is involved in the 
pathophysiology of obesity, T2D and hepatic steatosis and furthermore discussed as a main 
mechanism linking carbohydrate intake to the development of these diseases [52]. In the 
following section, the potential underlying mechanisms for the association between dietary 
GI/GL, fiber and whole grain intake and inflammatory markers will be outlined. Since the 
presentation and comparison of the evidence is part of the third research aim (see Chapter 
3) the literature overview will not be presented here (for details see OA4, Appendix 4). 
Dietary glycemic index and glycemic load 
Rapid increases in blood glucose levels have been associated with generation of reactive 
oxygen species and superoxide radicals even in healthy individuals [133, 218]. On an 
intracellular level, hyperglycemia leads to overproduction of superoxide within mitochondria, 
while nitric oxide is increasingly generated under the influence of insulin. Their combinatory 
product, peroxynitrite, is associated with DNA damage and impairment of mitochondrial and 
cellular function [218]. Due to the anti-inflammatory effects of insulin, these effects are only of 
short duration in healthy, insulin sensitive individuals, but – as described in Chapter 2.2.3 – 
effects last longer in insulin resistant or obese people [133, 219]. This implies, that oxidative 
stress induced by high-GI meals is of particular relevance in persons with impaired glucose 
tolerance [5]. Of interest, it could be shown in individuals with T2D that acute glucose 
fluctuations are more closely linked to activation of oxidative stress compared to sustained 
hyperglycemia [220]. Furthermore, reactive hypoglycemia, already described in Chapter 
2.3.2, leads to increased secretion of counter-regulatory hormones such as catecholamines 
as well as free fatty acids, which are thought to further intensify the pro-inflammatory state 
[133, 221]. NFκB is an important mediator of pro-inflammatory gene transcription, and its 
activation is closely linked to IR (see Chapter 2.2.1). It could be shown in healthy lean adults, 
that the consumption of 50g available carbohydrates as glucose or white bread lead to a 
three times higher NFκB activation compared to the consumption of pasta – a classical low-
GI food. Interestingly, activation of NFκB paralleled glycemic but not insulinemic excursions, 
indicating that even in insulin sensitive subjects the pro-inflammatory effects of glucose are 
able to overwhelm the anti-inflammatory insulin actions (Figure 4) [222]. Moreover, the 
dietary GI also impacts on total antioxidant capacity, as could be shown in a feeding study 
with overweight men [223]: In those men following a high-GI diet over one week, an acute 
decline in antioxidant concentrations was observed as compared to those following a low-GI 
diet. 
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Figure 4: Proposed mechanisms linking high-GI and high-fiber foods to inflammation thereby 
contributing to type 2 diabetes mellitus and cardiovascular disease, from [224] 
Abbreviations: CVD, cardiovascular disease; FFA, free fatty acid; Glu, glucose; SCFA, short chain 
fatty acid 
Dietray fiber and whole grains 
It has been proposed that dietary fiber interacts beneficially with gut microbiota and thereby 
influences inflammatory responses on a molecular level. Evidence from animal studies 
indicates that short chain fatty acids produced from fermentable fiber bind to receptors which 
are involved in inflammatory responses (Figure 4) [225]. Additionally, the inhibitory effect on 
nitric oxide synthase induction during fiber supplementation has been attributed to increased 
butyrate levels – one of the metabolic fiber products [226]. Another link between fiber-rich 
and whole grain products and inflammation are their high levels of bioactive compounds 
displaying anti-inflammatory effects: There are various antioxidants in cereal fibers with 
different mode of action. The main properties can be summarized as cofactors of antioxidant 
enzymes (e.g. zinc or selenium), radical scavengers (e.g. polyphenols or carotenoids), 
modification of the redox-status of tissues and cells, and protection of intestinal epithelium 
cells from oxygen-derived free radicals. The latter property also refers to the role of cereal 
antioxidants in thrombogenesis and platelet aggregation [31]. 
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2.3.4 Carbohydrate quality and hepatic steatosis 
The close link between liver fat accumulation and obesity as well as IR suggests a relevance 
of dietary factors associated with disturbances in glucose and insulin metabolism in NAFLD 
pathophysiology and prevention. To date, there are very few studies in humans assessing 
the direct effects of dietary modifications on markers of hepatic steatosis and of those who 
do, the inhibition of a further disease progression is often the primary aim. Hence, nutritional 
recommendations for NAFLD are mainly derived from approaches related to the closely 
associated conditions obesity and T2D, since weight loss and regain of glucose homeostasis 
are the major therapy aims for NAFLD [227]. Related mechanisms and evidence have been 
already described under Chapter 2.3.1 and 2.3.2. Noteworthy, Chapter 2.3.1 already 
includes intervention studies in children and adolescents with the liver enzymes ALT and 
GGT among the outcomes, as these are newly recognized markers for T2D risk [59-63]. 
Thus, these studies will only be briefly summarized in this chapter. This section will focus on 
mechanisms and evidence for the relevance of carbohydrate quality on different markers of 
hepatic steatosis in studies including adults. Also note that studies on GI/GL and dietary 
fiber/whole grain will be presented in one table, as there are only few of them and some 
investigate both aspects. 
Dietary glycemic index and glycemic load 
It has been observed that a hypercaloric intake of carbohydrate-rich foods inducing 
increased postprandial glucose elevations leads to enhanced hepatic lipogenesis [228-230]. 
Hyperglycemia in response to consumption of a high-GI meal is associated with increased 
glucose uptake in the liver, where it is subsequently stored as TG after conversion through 
de novo lipogenesis [142]. Furthermore, hyperglycemia induced oxidative stress might also 
be relevant, since a pro-inflammatory state is also thought to be of importance in NAFLD 
pathophysiology, particularly in regard to the progression to NASH [143]. Considering the 
liver as a main tissue of lipid metabolism, dietary effects on serum lipids are also relevant: A 
high intake of carbohydrates is associated with increased levels of TG [231]. Moreover, 
increasing the proportion of carbohydrates in the diet for the expense of fat is related to 
reduced levels of high density lipoprotein (HDL) [232]. While not affecting TG and HDL-
cholesterol, low-GI diets are in turn associated with reduced total and low density lipoprotein 
(LDL)-cholesterol [233, 234]. Thus, in terms of lipid metabolism, both carbohydrate content 
and its glycemic potency might be relevant – suggesting a potential role of dietary GL.  
Regarding observational evidence on the association between dietary GI/GL and NAFLD, 
Fraser et al. [235] showed in a post-hoc analysis of an intervention trial, that a Mediterranean 
diet approach was associated with a greater reduction of ALT after six and twelve months 
compared to the traditional American Diabetes Association diet as well as a low-GI diet. The 
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study included 201 obese participants with diabetes and both the Mediterranean and the low-
GI diet included the recommendation to consume low-GI carbohydrates with differing 
amounts of carbohydrates advised: While 50-55% of energy stemmed from carbohydrates in 
the low-GI diet, the Mediterranean diet included only 35% of energy from carbohydrates, 
implying a lower GL in this diet, which was however not stated. A cross-sectional study from 
Valtuena et al. [236] related the grade of steatosis from 241 apparently healthy Italians to 
different aspects of carbohydrate nutrition. They observed an increasing steatosis grade with 
an increasing dietary GI, whereas no association could be shown for dietary GL. Of interest, 
an additional stratified analysis revealed a relevance of the dietary GI particularly for insulin-
resistant participants: Whereas no significant difference in steatosis grade could be observed 
between insulin-sensitive persons with a low/medium or a high dietary GI, those who were 
insulin-resistant and consumed a diet characterized by a high-GI had a prevalence of high-
grade liver steatosis twice as high compared to a low/medium-GI diet (Table 7). 
Two recent intervention studies also examined the effect of diets differing in GI on liver fat: 
A German study, including 32 young men, examined the effect of carbohydrate intake and 
dietary GI during a refeeding phase after preceding weight loss. For this purpose, one week 
of overfeeding was followed by three weeks of caloric restriction (halved energy intake) with 
a subsequent refeeding period. During the phase of caloric restriction, liver fat and TG-levels 
improved under both diets, suggesting that any potential effect of carbohydrate modification 
was overridden by the effect of weight loss. In the subsequent 2-week period of refeeding, 
carbohydrate intake but not dietary GI was positively associated with liver fat and TG-levels 
[237]. The other intervention trial included 35 older US-adults and compared a low-fat, low-
saturated fat, low-GI diet with a high-fat, high-saturated fat, high-GI diet. No significant 
difference was observed between the two groups with respect to liver fat and ALT-levels. 
However, the absolute percentage of liver fat decreased significantly only in the diet 
characterized by a low-GI. In this regard, a higher baseline liver fat percentage was 
predictive of a greater decrease. Conversely, the diet characterized by a high-GI, but also a 
high-fat content (43 percentage of total energy intake (En%) compared to 23En%) led to 
improved TG- and HDL-cholesterol concentrations, supporting the detrimental effect of a 
high carbohydrate intake on these markers [238] (Table 8). 
In children and adolescents, two intervention studies were identified that examined the 
effect of a low-GI diet on ALT concentrations: In a randomized pilot intervention trial including 
17 obese adolescents, both a low-GL and a low-fat diet were associated with decreased ALT 
levels after six months, with no significant difference between the intervention groups [185]. 
In the retrospective study by Siegel et al. [183], ALT concentrations decreased significantly in 
the group following a low-GI healthy eating plan with assistance of a dietitian compared to 
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those following the plan without a dietitian or a portion controlled diet (see Table 3 in Chapter 
2.3.1).   
Dietary fiber and whole grain 
The role of dietary fiber and whole grain products for liver fat accumulation is thought to be 
attributed to beneficial effects on blood lipids and/or oxidative stress. Regarding the former 
mechanism, particularly a high intake of viscous fiber is related to lower levels of total and 
LDL cholesterol [239-241]. It could be shown that soluble fibers such as ß-glucans reduce 
bile acids and cholesterol re-absorption from the ileum, thereby inhibiting cholesterol 
synthesis in the liver [234, 242, 243]. The regulating effect on bile acid metabolism might also 
be associated with a reduction in hepatic fat accumulation [142]. Fiber and whole grain 
products are furthermore rich in antioxidants (see Chapter 2.3.3), which may exert beneficial 
effects in the pathogenesis of steatohepatitis and fibrosis [142, 244].  
In observational studies on the relation between dietary fiber or whole grain intake and 
markers of liver fat accumulation, a common approach is to compare the diets of patients 
with and without NAFLD, as done by Zelber-Sagi et al. [245]. In this cross-sectional study, 
including 340 Israelis (30% of them diagnosed with NAFLD) fiber intake did not differ 
between the healthy participants and those with fatty liver [245]. In a Japanese study, 
NAFLD-patients were compared to those with diagnosed NASH instead of healthy persons, 
in order to find potential dietary strategies to inhibit disease progression. Although fiber 
intake was lower in NASH-patients, the difference between these two patient groups was not 
statistically significant [246]. Additionally, in the study by Valtuena et al. [236] no association 
between grade of steatosis among quartiles of fiber intake was observed (Table 7).  
Even if the intervention study by Utzschneider et al. [238] was not designed to create a 
difference in dietary fiber, significant differences were observed in fiber intake which resulted 
from the difference in carbohydrate intake. Therefore, the beneficial effect on absolute 
percentage of liver fat after the low-fat/low-saturated fat/low-GI diet might possibly also be 
attributed to the higher fiber content (Table 8).   
No studies in children or adolescents were identified reporting on the relevance of fiber or 
whole grain intake for liver enzyme concentrations.  
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Table 7: Observational studies in adults examining the relation between dietary GI/GL, dietary fiber and whole grain intake and markers of 
hepatic steatosis1 
//3 
() 
~ 
Results 
 ALT-concentrations 
decreased in all diet 
groups (p for difference 
to baseline<0.001) 
 MMD diet was 
associated with the 
lowest ALT-
concentrations after 6 
and 12 months (p for 
difference <0.001) 
 no significant difference 
between NASH- and FL-
patients in fiber intake 
Covariates 
considered in 
analysis 
baseline 
measurements 
- 
Outcomes: 
average 
(baseline) level 
mean (SD) ALT 
(U/l): 
ADA: 25.0 (1.5) 
LGI: 22.8 (1.4) 
MMD: 24.5 (1.6) 
mean (SD) steatosis 
(%): 
NASH: 55 (21) 
FL: 43 (19) 
 
mean (SD) ALT 
(IU/l): 
NASH: 119 (88) 
FL: 75 (53) 
 
mean (SD) TG 
(mg/dl): 
NASH: 162 (100) 
FL: 168 (95) 
 
mean (SD) HDL-
cholesterol (mg/dl): 
NASH: 54 (34) 
FL: 48 (14) 
Exposure: 
assessment method, 
average baseline 
values 
dietary counseling, FFQ, 
24-h recall  
 
American Diabetes 
Association Diet (ADA) 
(n=64): 
low-GI diet (LGI) (n=73): 
modified Mediterranean 
diet (MMD) (n=64): also 
low-GI carbohydrates 
(no GI values provided) 
3-day dietary records 
 
mean fiber (g): 
NASH: 12.9 
FL: 15.1 
 
Follow-
up 
12 
months 
- 
Population, 
recruitment, 
name of study
2
 
201 obese 
participants with 
diabetes 
 
post-hoc analysis 
of a quasi-
randomized 
controlled trial 
 
% female: 49% 
Ø age: 56.0 years 
Ø BMI: 31.5 
46 partcicpants (28 
with NASH, 18 with 
simple fatty liver 
(FL)) 
 
% female: 37% 
Ø age: 47.9 years 
Ø BMI: 27.6 
First 
author, 
Year, 
Country 
Fraser 2008 
[235]  
Israel 
Toshimitsu 
2007 [246]  
Japan 
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Table 7: continued. 
//3 
ALT:  
GI: 
GL, fiber: 
 
~ 
 
 
 
 
 
 
 
Results 
 ALT concentrations were 
higher in the 4. GI-quartile, 
but not TG- or HDL-
cholesterol concentrations 
 prevalence of high-grade 
liver steatosis (measured by 
ultra-sonography) increased 
with GI-quartiles (p for 
trend=0.03), but not with GL-
, or fiber-quartiles (p for 
trend>0.2) 
 stratification by IR-status: IR-
individuals: prevalence of 
high-grade liver steatosis 
twice as high in high-GI (Q4) 
as compared to 
low/moderate-GI (Q1-Q3) 
group; insulin-sensitive 
individuals: no significant 
difference  
 fiber intake was not related 
to significant differences in ALT- 
and TG-concentrations between 
participants with and without 
NAFLD 
Covariates 
considered 
in analysis 
sex, waist 
circumferenc
e, IR, energy 
intake, and 
other 
nutritional 
factors 
age, gender, 
BMI and total 
calorie intake, 
other 
nutritional 
factors 
Outcomes: average 
(baseline) level 
mean (SD) ALT (U/l): 
GI Q1-Q3: 21 (9) 
GI Q4: 24 (12) 
 
mean (SD) TG 
(mmol/l): 
GI Q1-Q3: 0.86 (0.60)  
GI Q4: 0.94 (0.79)  
 
mean (SD) HDL-
cholesterol (mmol/l): 
GI Q1-Q3: 1.54 (0.44)  
GI Q4: 1.52 (0.61) 
mean (SD) ALT (U/l): 
22.0 (10.0) 
 
mean (SD) TG 
(mg/dl): 
117.0 (61) 
 
Exposure: assessment 
method, average 
baseline values 
3-day dietary records 
 
quartile ranges GI: 
Q1: 49.2-53.6 
Q2: 53.7–55.6  
Q3: 55.7–57.9  
Q4: 58.1–68.5  
 
quartile ranges GL (g/d): 
Q1: 75–147  
Q2: 147–181  
Q3: 181–211  
Q4: 212–352  
 
quartile ranges fiber(g/d): 
Q1: 7.3–15.2  
Q2: 15.3–19.5  
Q3: 19.5–23.2  
Q4: 23.3–40.3 
semi-quantitative FFQ 
 
mean (SD) fiber (g): 
NAFLD: 27.0 (12.1) 
healthy: 26.4 (12.7) 
Follow
-up 
- 
- 
Population, 
recruitment, 
name of study
2
 
241 participants 
 
% female: 43% 
Ø age: 59.8 
years 
Ø BMI: 27.1 
349 partcipants 
(30% NAFLD 
prevalence) 
 
% female: 47% 
Ø age: 50.7 
years 
Ø BMI: 27.2 
First 
author, 
Year, 
Country 
Valtuena 
2006  [236] 
Italy 
Zelber-Sagi 
2007 [245] 
Israel 
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Table 7: continued. 
 
Abbreviations: Ø average value, mean or median as provided in the original publication; ALT, alanine-aminotransferase; FFQ, food frequency questionnaire; FL, fatty 
liver; GI, glycemic index, GL, glycemic load; HDL, high density lipoprotein; NAFLD, Nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; Q, quartile; SD, 
standard deviation; TG, triglyceride 
1
 Only relevant exposures and outcomes are presented 
2
 n number refers to those who completed the study
 
3
 : direct association with GI,GL, dietary fiber or whole grain intake, (): trend for association with GI,GL, dietary fiber or whole grain intake, : no association with 
GI,GL, dietary fiber or whole grain intake, : inverse association with GI,GL, dietary fiber or whole grain intake 
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Table 8: Intervention studies in adults examining the effect of dietary GI/GL, dietary fiber and whole grain intake on markers of hepatic 
steatosis1 
+/-
3
 
- 
(-) 
 
Results 
 no effect of dietary GI was   
observed on liver fat or TG 
levels, neither in the caloric 
restriction nor in the refeeding 
phase 
 no effect on diet group on 
liver fat or ALT-levels (p for 
difference≥0.1) 
 significant decrease in 
absolute percentage of liver 
fat only after LSAT diet (p for 
difference<0.05), higher liver 
fat at baseline was thereby 
predictive of a greater 
absolute decrease  
 HSAT-diet lead to 
significantly improved TG- 
and HDL-cholesterol 
concentrations compared to 
LSAT (p for difference≤0.01) 
Outcome: baseline levels 
and primary endpoints 
mean liver fat (%):  
6.21 
 
mean TG (mg/dl): 
93.9 
median (IQR) liver fat (% by 
weight):  
LSAT: 2.2 (3.1) 
HSAT: 1.2 (4.1) 
 
mean (SEM) ALT (IU/l): 
LSAT: 20.5 (1.4) 
HSAT: 19.8 (1.0) 
 
mean  (SEM) TG (mmol/l): 
LSAT: 1,29 (0.16) 
HSAT: 1,26 (0.10) 
 
mean (SEM) HDL-
cholesterol (mmol/l): 
LSAT: 1.56 (0.11) 
HSAT: 1.55 (0.10) 
Dietary Intervention 
low-GI diet (LGI) (n=16): 
mean GI=41 
high-GI diet (HGI) (n=16): 
mean GI=74  
 
all foods/beverages provided, 
intake supervised by 
nutritionists 
low-fat/low-saturated 
fat/low-GI diet (LSAT) 
(n=20): average (SEM) daily 
GI <55, mean fiber (g/d): 40.0 
(1.9) 
high-fat/high-saturated 
fat/high-GI diet (HSAT) 
(n=15): average daily GI >70, 
mean fiber (g/d): 13.3 (0.7) 
 
all foods provided, dietary 
records to monitor compliance 
Study design 
controlled, 
parallel-group 
intervention trial, 
6 weeks 
duration; 
study protocol: 
1week 
overfeeding (50 
or 65% CHO), 3 
weeks caloric 
restriction, 2 
weeks refeeding 
(50 or 65% CHO 
with either high 
or low GI) 
randomized, 
double-blind, 
parallel design 
intervention 
study, 4 weeks 
duration 
Participant 
characteristics
2
 
32 men 
 
Ø age: 25.5 years 
Ø BMI: 23.5 
35 participants 
 
% female: 63% 
Ø age: 69 years 
Ø BMI: 29.0 
First author, 
Year, 
Country 
Lagerpusch 
2013 [237]  
Germany 
Utzschneider 
2013 [238] 
USA 
T
H
E
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E
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5
2
 
  
Table 8: continued. 
 
Abbreviations: Ø average value, mean or median as provided in the original publication; ALT, alanine-aminotransferase; GI, glycemic index, GL, glycemic load; HDL, 
high density lipoprotein; IQR, interquartile range;  SEM, standard error of the mean; TG, triglyceride 
1
 Only relevant exposures and outcomes are presented 
2
 n number refers to those who completed the study
 
3
 +: effect of dietary intervention on liver fat measures, -: no effect of dietary intervention on liver fat measures 
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2.4 Conclusive Considerations 
In adults, evidence from prospective cohort studies supports a beneficial role of both a high 
cereal fiber and whole grain intake and a low dietary GI/GL for T2D risk (see Chapter 2.3.1). 
However, proposed mechanisms differ and the relevance in childhood and adolescence has 
to be regarded as inconclusive. Particularly the relevance of puberty as a potentially critical 
period for later disease development with the physiologically occurring IR has yet to be 
addressed: carbohydrate nutrition during this period might be of specific relevance and the 
detection of associations with later T2D risk markers would be pivotal for dietary preventive 
approaches, which should start early in life. Moreover, it is of great relevance to also 
consider newly emerging risk factors for T2D such as liver enzymes, so that investigations 
cover both systemic and hepatic IR (Aim 2). As obesity is the major risk factor for T2D 
development (see Chapter 2.2.2), clarification of the question whether postprandial rises in 
glucose or insulin during puberty are related to later development of an unfavorable body 
composition is of importance (Aim 1). One of the main discussed mechanisms linking 
carbohydrate quality to T2D and CVD is chronic low-grade inflammation (see Chapter 2.3.1-
2.3.3). Given a potential role for risk markers of T2D, it would be interesting from a 
mechanistic point of view, whether this role also extends to inflammation. Thus, the long term 
relevance of adolescent carbohydrate nutrition also needs to be determined for inflammatory 
markers (Aim 3, 1st research question). In adults, numerous observational and interventional 
studies have recently been conducted in the emerging research field of chronic low-grade 
inflammation. A systematic review of these studies, comparing both the relevance of dietary 
GI and GL as well as fiber and whole grain and the results from observation and intervention 
studies, needs yet to be done (Aim 3, 2nd research question). Scientific evidence on the role 
of carbohydrate quality for chronic disease risk focuses mainly on studies in middle-aged 
adults, implying the outlined need for long-term studies, starting e.g. in puberty. On the other 
hand, older adults represent a growing proportion of our population with a higher prevalence 
of most chronic diseases. Additionally, metabolic alterations may occur as part of the aging 
process, including a higher pro-inflammatory state (see Chapter 2.2.5). Hence, investigating 
the role of carbohydrate nutrition in an older population is crucial for dietary 
recommendations adapted to special age groups. The accumulation of liver fat seems to 
coexist with IR and obesity (see Chapter 2.2.4). However, the role of carbohydrate nutrition 
and liver function has not been fully elucidated yet (Aim 4). 
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3. AIMS AND RESEARCH QUESTIONS 
As outlined in the previous chapters, carbohydrate quality plays a crucial role in the 
development of T2D and related health outcomes. However, prospective evidence in certain 
periods of life such as puberty or older age is lacking. Furthermore, a systematic compilation 
of the available literature on the relevance of carbohydrate quality on chronic low-grade 
inflammation has not been done yet. To fill in these gaps, the following four aims were 
formulated for this thesis: 
Research aim 1: To examine carbohydrate nutrition and body composition 
Is a diet inducing higher levels of postprandial glycemia or insulinemia during puberty 
prospectively related to body composition in young adulthood? 
Postprandial excursions in blood glucose or insulin levels during critical periods of 
physiological IR such as puberty could impact on later overweight development. As 
overweight is one proposed mechanism linking dietary GI to T2D risk, investigating the 
prospective association between dietary GI and insulin index during puberty and body 
composition in young adulthood is of great interest. Applying the new concept of the FII to 
dietary data from the DONALD Study furthermore allows to distinguish between postprandial 
glycemia and insulinemia and their potentially different relevance for later overweight 
development. 
 
Research aim 2: To examine carbohydrate nutrition and type 2 diabetes mellitus risk 
markers 
Is the quantity and/or the quality of carbohydrate intake during puberty prospectively related 
to risk markers of type 2 diabetes mellitus in younger adulthood? 
Carbohydrate nutrition during the critical phase of puberty may be of particular relevance for 
later risk of T2D. Using data from the DONALD Study, the habitual carbohydrate intake – 
both in its quantity and quality – during puberty will be related to different risk markers for 
T2D in younger adulthood. 
 
Research aim 3: To examine carbohydrate nutrition and chronic low-grade 
inflammation 
Is the quantity and/or the quality of carbohydrate intake during puberty prospectively related 
to inflammatory markers in younger adulthood? 
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Chronic low-grade inflammation contributes to the development of many chronic diseases 
and represents a likely intermediary in the relationship between carbohydrate nutrition and 
both T2D and CVD. Therefore, analyzing the prospective associations between carbohydrate 
nutrition during puberty and inflammatory markers in younger adulthood will give further 
mechanistic insights into the overall relevance of carbohydrate quality for T2D risk. 
Is carbohydrate quality of relevance for low-grade inflammation in adults? Evidence from 
observational and interventional studies 
The potential effects of carbohydrate nutrition on chronic inflammation have been 
investigated in a number of observational and interventional studies. A comparative 
assessment of the evidence from these two types of studies may be particularly insightful 
since evidence appraisal on the relevance of carbohydrate nutrition for chronic diseases (i.e 
T2D, CVD, cancer etc.) almost exclusively draws on observational studies. Hence, the 
evidence from published observational and interventional studies conducted in adults on the 
relevance of fiber intake, whole grain consumption and dietary GI/GL for markers of chronic 
low-grade inflammation (hsCRP and IL-6) will be systematically evaluated. 
 
Research aim 4: To examine carbohydrate nutrition and liver function 
Is carbohydrate quality longitudinally associated with markers of liver function in an older 
Australian population? 
Alterations in liver function such as hepatic fat accumulation are thought to play a causal role 
in the development of T2D and the metabolic syndrome. Indeed, the liver enzymes ALT and 
GGT are newly recognized risk markers for T2D. The close relationship with IR and obesity 
suggests a link to carbohydrate induced disturbances in glucose and insulin metabolism. 
Therefore, the cross-sectional and longitudinal associations between carbohydrate quality 
and markers of liver function will be examined using data from the BMES, as these 
comorbidities become more frequent in older age groups. 
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4. GENERAL METHODOLOGY 
The proposed research questions will be investigated on the basis of data from two 
observational studies: The DONALD Study, providing longitudinal data from young Germans, 
and the BMES, which includes data on an older Australian population. Furthermore, to give 
an overview on the current evidence for the relevance of carbohydrate quality on chronic low-
grade inflammation, a systematic review was conducted. This chapter provides a brief 
overview on the study designs of the DONALD Study and BMES and describes the 
procedure of the systematic literature search. 
4.1 The DONALD Study 
The DONALD Study is an ongoing open cohort study conducted at the Research Institute of 
Child Nutrition in Dortmund, Germany [247, 248]. The study focuses on nutritional behavior, 
food consumption, growth, development, metabolism and health from infancy to adulthood. 
Since 1985, participants are recruited in the city of Dortmund and surrounding communities 
via personal contacts, maternity wards or pediatric practices. Eligible are healthy babies of 
Caucasian decent whose mothers and/or fathers are willing to participate in a long-term 
study and of whom at least one parent has sufficient knowledge of the German language. 35 
to 40 infants are newly recruited every year and first examined at the age of 3 months. Each 
child returns for 3 more visits during the first year, 2 in the second and then annually until 
adulthood. Since 2005, participants from the age of 18 years are invited for subsequent 
examinations with fasting blood withdrawal – until then the study is purely observational and 
non-invasive. Furthermore, data on parental socio-demographic characteristics, lifestyle, 
health status and anthropometry are obtained every four years up to study participants‘ age 
of 18 years in a personal examination and by questionnaire. The study was approved by the 
Ethics Committee of the University of Bonn, and all examinations are performed with written 
parental and participants‘ consent.  
At each visit the assessments always include a medical examination, anthropometric 
measurements, questionnaires, and detailed 3-day weighed dietary records [247] (Figure 5). 
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Figure 5: Examination schedule of the DONALD Study, from [248]. 
For the dietary records, all foods and beverages consumed as well as leftovers are weighed 
and recorded on three days by the participants themselves (or by the parents of the younger 
participants) to the nearest 1g using electronic food scales (initially Soehnle Digita 8000; 
Leifheit SG, Nassau; Germany; now WEDO digi 2000; Werner Dorsch GmbH, 
Münster/Dieburg, Germany). Recording household measures, such as number of spoons or 
scoops, is allowed when weighing is not possible. All foods consumed by the participants are 
listed in the in-house food and nutrient database LEBTAB (Lebensmitteltabelle). LEBTAB is 
based on the German standard food tables [249], contains data obtained from commercial 
food products, and is continuously updated to include all recorded food items [250]. It allows 
examining intake of both macronutrients and different parameters of carbohydrate quality 
such as added sugar, dietary fiber and whole grain. To further allow the examination of 
dietary GI, GL and insulin demand, the database was extended to include the dietary GI 
according to existing standard procedures [251] and FII, for which a standardized 
assignment procedure was developed and implemented (see OA1, Appendix 1)1.  
Anthropometric measurements are performed according to standardized procedures: At each 
visit, body weight and height is recorded to the nearest 100g and 0.1cm, respectively, and 
from the age of 6 months onward skinfold thickness is measured twice at four different sites 
(supra-iliacal, subscapular, biceps, triceps) on the right side of the body for estimation of 
body fat. 
                                               
1
 Contribution of Janina Goletzke: Complementation of assignment of GI values (approximately 500) 
and complete revision of the existing GI database, assignment of all FII values to the 3-day weighed 
dietary records (together with Gesa Joslowski) 
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Venous blood samples are drawn after an overnight fast, centrifuged within 15 minutes and 
frozen at –80°C in the Research Institute. Noteworthy, work presented in this thesis was part 
of two projects funded by the Federal Office for Agriculture and Food and the World Cancer 
Research Fund. Within the first project, examining the long-term relevance of carbohydrate 
nutrition during puberty for IR and inflammation in younger adulthood, serum and plasma 
samples were transported to the technical laboratory of the German Diabetes Center to 
determine serum activities of the liver enzymes ALT and GGT as well as concentrations of 
inflammatory markers. Serum insulin concentrations were measured in the Laboratory for 
Translational Hormone Analytics in Paediatric Endocrinology at the University of Giessen 
within the WCRF funded project. 
Notably, puberty was defined according to chronological age. Chronological age might be 
confounded because children of the same age may differ substantially in their pubertal stage. 
However, the chronological age range we used starts at the same time point at which 
DONALD participants on average are undergoing puberty according to the age at take-off 
(onset of pubertal growth spurt). Furthermore, the chronological age range ends where most 
girls and boys included in the DONALD study have already experienced their first menarche 
and their voice break, respectively [252, 253]. Therefore, we supposed that chronological 
age as defined, adequately covers the period of puberty. In addition, preliminary analyses 
using age at take-off and peak height velocity to define puberty were run and yielded similar 
results for the relationships of the dietary GI, GL, and insulin demand with %BF. Thus, 
chronological age was used uniformly to define puberty in order to not reduce the sample 
sizes too much. 
4.2 The Blue Mountains Eye Study 
The BMES is a population-based cohort-study of vision, common eye diseases, and other 
health outcomes in an urban, predominantly Caucasian Australian population aged 49 years 
and older, which was initiated in 1992 with three 5-year follow-up examinations. In the 
baseline examination participated 3654 eligible residents of two postcodes of the Blue 
Mountains region, west of Sydney, Australia (1992-1994; BMES-1). Of these, 2335 took part 
in the second examination (1997-99; BMES-2) and 1952 in the third (2002-04; BMES-3). The 
study was conducted in accordance with the recommendations of the Helsinki Declaration 
and was approved by the University of Sydney and the Sydney West Area Health Service 
Human Research Ethics Committees. Written informed consent was obtained from all 
participants. BMES data could be used for the present thesis because of a collaboration 
between the Research Institute of Child Nutrition in Dortmund (Dr. Buyken) and the 
University of Sydney (Prof. Brand-Miller, Prof. Mitchell). 
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In the BMES, liver enzymes – which are relevant for this thesis – were initially analyzed in 
the first follow-up (BMES-2). Hence, baseline examination data could not be used and thus, 
BMES-2 data were termed baseline and BMES-3 data (second re-examination) as the 
respective 5-year follow-up.  
Dietary data was collected using a 145-item FFQ modified for the Australian diet and 
vernacular from an early Willett questionnaire [254]. This FFQ was validated against 4-day 
weighed food records collected on three occasions during one year (n=79) and showed 
moderate-to-good agreement for ranking individuals according to their dietary GI, dietary 
fiber, and total carbohydrate intake [255]. Nutrient intakes were estimated using the 
Australian Tables of Food Composition (NUTTAB95) and published GI values with the 
glucose=100 scale [256]. Additional GI data was obtained from the Sydney University 
Glycemic Index Research Service online database (www.glycemicindex.com). 
Fasting blood specimens were drawn, centrifuged on site and then sent within the same day 
to the Westmead Hospital, Sydney, for analysis of – among others – the liver enzymes ALT 
and GGT as well as fasting triglycerides and HDL cholesterol, which were of interest for the 
fourth research aim. 
4.3 Systematic literature search 
As part of the third research aim, a systematic review was conducted according to the 
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement 
[257]: For this purpose, the databases MEDLINE, EMBASE and Cochrane Library (Cochrane 
Central Register of Controlled Trials (CENTRAL)) were systematically searched for 
observational and interventional studies assessing the relevance of dietary GI/GL, fiber or 
whole grain intake for concentrations of the inflammatory markers hsCRP or IL-6. To be 
included in the review, different pre-specified inclusion criteria had to be met, e.g. only 
studies conducted in adults who were either healthy, overweight, had features of the 
metabolic syndrome or T2D were considered 2 (for details see OA4, Appendix 4).  
                                               
2
 Contribution of Janina Goletzke:  Formulation of inclusion and exclusion criteria (together with Anette 
Buyken), completion of the literature search (together with Gesa Joslowski and Anna Felbick), 
conduction of the updated search, data extraction (together with Anna Felbick), contacting the authors 
to request additional information 
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5. ORIGINAL ARTICLES 
Aim 1: To examine carbohydrate nutrition and body composition 
The research question of Aim 1 assessed whether a diet inducing higher levels of 
postprandial glycemia or insulinemia during puberty is prospectively related to body 
composition in young adulthood. This aim was addressed using DONALD data: All 
participants having at least two 3-day weighed dietary records available during puberty and 
anthropometric measurements taken in young adulthood were included in this analysis. 
Addressing the question whether postprandial glycemia or insulinemia is more relevant for 
later unfavorable body composition development, the dietary GI and GL as well as the 
dietary insulin index and insulin load – novel measures of insulin demand – were examined. 
While dietary GI values were available for the majority of carbohydrate containing foods 
recorded from the participants, the dietary insulin index had to be newly assigned to all 
carbohydrate- protein-, or fat-providing foods.  
In this group of 262 DONALD participants, the dietary insulin index during puberty was 
prospectively related to higher levels of percentage body fat during young adulthood. No 
association with later BMI was observed. Neither the dietary GI nor the dietary GL were 
related to body composition in young adulthood.  
The abstract of this analysis is presented below (see Appendix 1 for the full publication). 
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OA1 Prospective associations of dietary insulin index, glycemic index, and glycemic 
load during puberty with body composition in young adulthood. 
Joslowski G, Goletzke J3, Cheng G, Günther ALB, Bao J, Brand-Miller JC, Buyken 
AE.  IJO 2012, 36, 1463-1471 
 
Background: Puberty is a so-called critical period for overweight development and 
characterized by physiological IR during mid-puberty. This study addressed the hypothesis 
that habitual consumption of a diet inducing higher levels of postprandial glycemia or 
insulinemia during puberty may have an unfavorable effect on body composition in young 
adulthood. 
Methods: Multivariate regression analysis were performed on 262 DONALD participants with 
at least two 3-day weighed dietary records during puberty (baseline: girls 9-14years; boys 
10-15years) and anthropometric measurements in young adulthood (18-25years). A 
published dietary glycemic index was assigned to each carbohydrate containing food. 
Similarly, each food was assigned a food insulin index (insulinemic response to a 1MJ 
portion of food relative to 1MJ of glucose) using 121 values measured at Sydney University. 
Results: Dietary glycemic index or glycemic load during puberty were not related to body 
composition in young adulthood. In contrast, a higher dietary insulin index (II) during puberty 
was associated with higher levels of percentage of body fat (%BF) in young adulthood, even 
after adjustment for early life, socioeconomic and nutritional factors; %BF in energy-adjusted 
tertiles of dietary II were 23.1 (95%CI: 21.9, 24.4), 24.4 (23.2, 25.7), 24.8 (23.6, 26.0) %, 
ptrend =0.02. Adjustment for baseline %BF attenuated this relationship (ptrend=0.1). Dietary II 
was not related to BMI. 
Conclusion: This study suggests a prospective adverse influence of dietary II during puberty 
on %BF in young adulthood. Postprandial increases in insulinemia rather than increases in 
glycemia appear to be implicated in an unfavorable development of body composition. 
                                               
3
 Contribution of JG:  assignment of all FII values to the 3-day weighed dietary records (together with 
GJ), interpretation of the data (together with all co-authors) 
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Aim 2: To examine carbohydrate nutrition and risk of type 2 diabetes mellitus 
To answer the research question of Aim 2, whether the quantity and/or the quality of 
carbohydrate intake during puberty is prospectively related to risk markers of type 2 diabetes 
mellitus in younger adulthood, data from 226 DONALD participants was used. Compared to 
the first research aim, a smaller number of adult participants was considered for this 
investigation – even if the age group was extended to include adults beteen18 and 36 years. 
The reason for this was that in contrast to fasting blood samples, which were only added to 
the DONALD protocol in 2005, anthropometric measurements were already part of the 
DONALD examination schedule prior to that and hence more frequently available. Evaluating 
nutritional data from at least two 3-day weighed dietary records, different parameters of 
carbohydrate nutrition (total carbohydrate intake, dietary GI, GL, added sugar, fiber and 
whole grain intake) were studied. Analyses of the fasting blood samples taken in younger 
adulthood from the DONALD participants provided measures of insulin sensitivity (HOMA-IR 
was calculated on the basis of fasting insulin and glucose values) and concentrations of the 
liver enzymes ALT and GGT. It was hypothesized that recurring postprandial glycemic 
excursions during a phase of physiological IR might be particularly relevant for later risk to 
develop T2D. As the dietary GI is a valid predictor of postprandial blood glucose excursions, 
it was postulated that associations are more pronounced for this aspect of carbohydrate 
quality compared to the other aspects investigated. 
Indeed, the analysis revealed a consistent association between a higher dietary GI during 
puberty and increased levels of HOMA-IR, ALT and GGT in younger adulthood. Furthermore, 
a higher intake of added sugars from drinks was related to higher GGT levels during 
adulthood. No other examined parameter of carbohydrate nutrition was prospectively related 
to the risk markers of T2D in young adulthood.  
Below, the abstract of the respective publication is presented (see Appendix 2 for the full 
publication). 
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OA2 A habitually higher dietary glycemic index during puberty is prospectively 
related to increased risk markers of type 2 diabetes in young adulthood.  
Goletzke J4, Herder C, Joslowski G, Bolzenius K, Remer T, Wudy SA, Rathmann SA, 
Roden M, Buyken AE. Diab.Care 2013, Jul; 36(7):1870-6 
 
Background: Carbohydrate nutrition during periods of physiological IR such as puberty may 
impact on future risk of type 2 diabetes. This study examined whether the amount or the 
quality (dietary glycemic index, GI; glycemic load, GL; added sugar, fiber and whole grain 
intake) of carbohydrates during puberty is associated with risk markers of type 2 diabetes in 
younger adulthood. 
Methods: The analysis was based on 226 participants (121 girls and 105 boys) from the 
DONALD Study with an average of five 3-day weighed dietary records (range 2-6) during 
puberty (girls: 9-14 years, boys: 10-15 years) and fasting blood samples in younger 
adulthood (18-36 years) (average duration of follow-up: 12.6 years). Multivariable linear 
regression was used to analyze the associations between carbohydrate nutrition and 
homeostasis model assessment IR (HOMA-IR) as well as the liver enzymes alanine-
aminotransferase (ALT), and gamma-glutamyltransferase (GGT) (n=214).  
Results: A higher dietary GI was prospectively related to greater values of HOMA-IR (ptrend 
=0.03), ALT (ptrend =0.02), and GGT (ptrend =0.04). After adjustment for sex, adult age, 
baseline BMI, early life and socioeconomic factors as well as protein and fiber intake, 
predicted mean HOMA-IR values in energy-adjusted tertiles of GI were 2.37 (95% 
confidence intervals: 2.16, 2.60), 2.47 (2.26, 2.71), and 2.59 (2.35, 2.85). The amount of 
carbohydrates, GL, added sugar, fiber and whole grain intake were not related to the 
analyzed markers.  
Conclusion: Our data indicate that a habitually higher dietary GI during puberty may 
adversely affect risk markers of type 2 diabetes in younger adulthood. 
                                               
4
 Contribution of JG:  Complementation of assignment of GI values to the 3-day weighed dietary 
records (together with GJ), conduction of statistical analysis (together with KB), interpretation of the 
data (together with all co-authors), and drafting of the manuscript 
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Aim 3: To examine carbohydrate nutrition and chronic low-grade inflammation 
In order to describe the association between carbohydrate nutrition and markers of low-grade 
inflammation, a two-step approach was used: An additional analysis was run with data from 
the DONALD Study to answer the first research question of Aim 3: Is the quantity or the 
quality of carbohydrate intake during puberty prospectively related to inflammatory markers 
in younger adulthood? For this purpose, 3-day weighed dietary records during puberty and 
blood samples in younger adulthood were used from 205 participants. Examined aspects of 
carbohydrate nutrition were total carbohydrate intake as well as dietary GI, dietary GL, added 
sugar, fiber, and whole grain intake and inflammatory markers were hsCRP, IL-6, IL-18 and 
adiponectin. 
The results showed a relevance of a high total carbohydrate intake for later concentrations of 
IL-6. Separate analyses of carbohydrates from low and higher GI food sources did however 
reveal that only a high intake of the latter was related to higher IL-6 levels. Furthermore, a 
higher GL and a lower intake of whole grains during puberty were prospectively related to 
unfavorable levels of the pro-inflammatory cytokine IL-6. None of the other inflammatory 
markers was associated with carbohydrate nutrition. 
A systematic literature search was conducted to answer the second question of Aim 3: Is 
carbohydrate quality of relevance for low-grade inflammation in adults? For this purpose, 
evidence from both observational and interventional studies was considered. Comparative 
assessment of studies relating dietary GI/GL, fiber or whole grain intake to markers of low-
grade inflammation may be particularly insightful since chronic low-grade inflammation is 
related to the development of many chronic diseases such as T2D. Hence, dietary 
approaches to lower inflammatory markers could also be suitable in regard to preventive 
recommendations for T2D. 
A total of 60 studies could be included assessing either the effect of carbohydrate quality on 
the inflammatory markers hsCRP or IL-6 – two commonly used markers in epidemiological 
and clinical studies. Regarding dietary GI, observational evidence is less consistent for a 
beneficial role on low-grade inflammation compared to a high dietary fiber and whole grain 
intake. However, several intervention studies do support a potential role of dietary GI or GL 
for low-grade inflammation, while the majority of intervention studies does not report a benefit 
of increasing fiber or whole grain intake. Anti-inflammatory benefits of higher dietary fiber and 
whole grain intakes suggested by observational studies are hence not supported by 
intervention studies, indicating that confounding is likely.  
In the following, the abstracts of both publications are presented (see Appendices 3 and 4 for 
the full publications). 
ORIGINAL ARTICLES 
65 
 
OA3 Prospective association between carbohydrate nutrition during puberty and 
markers of chronic low-grade inflammation in younger adulthood 
Goletzke J5, Buyken AE, Joslowski G, Bolzenius K, Remer T, Carstensen M, Egert S, 
Nöthlings U, Rathmann W, Roden M, Herder C (under review) 
 
Background: Chronic low-grade inflammation represents a likely intermediary in the 
relationship between carbohydrate nutrition and both type 2 diabetes mellitus and 
cardiovascular disease. This study assessed the prospective association between 
carbohydrate quantity and quality (dietary glycaemic index, GI; glycaemic load, GL; added 
sugar; fibre and whole grain intake) during puberty, a potentially critical period for later 
disease, and low-grade inflammation in younger adulthood.  
Design: The analysis was based on 205 participants (113 girls and 92 boys) from the 
DONALD study with at least two 3-day weighed dietary records during puberty (girls: 9-14 
years, boys: 10-15 years) and blood samples in adulthood (18-36 years). Multivariable linear 
regression models were used to analyse the associations between carbohydrate nutrition 
and different pro- and anti-inflammatory immune mediators (high-sensitivity C-reactive 
protein, hs-CRP; IL-6; IL-18; adiponectin).  
Results: A higher intake of carbohydrates during puberty (ptrend=0.005), particularly from 
higher GI food sources (ptrend=0.01), was prospectively related to higher levels of IL-6 in 
younger adulthood, independently of baseline BMI, early life, socioeconomic and other 
nutritional factors. Furthermore, a higher dietary GL (ptrend=0.002) and a lower intake of whole 
grains (ptrend=0.01) were independently associated with higher adult IL-6 levels. Dietary GI, 
added sugar and fibre intakes were not independently associated with IL-6 (ptrend≥0.09). 
Carbohydrate nutrition during puberty was not independently related to hs-CRP, IL-18 and 
adiponectin levels (all ptrend>0.1).  
Conclusion: During puberty, a high intake of carbohydrates from higher GI food sources and 
a low whole grain consumption prospectively predict greater IL-6 concentrations in younger 
adulthood. 
                                               
5
 Contribution of JG:  Complementation of assignment of GI values to the 3-day weighed dietary 
records (together with GJ), conduction of statistical analysis (together with KB), interpretation of the 
data (together with all co-authors), and drafting of the manuscript 
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OA4 The role of carbohydrate quality in chronic low-grade inflammation – a 
systematic review on observational and intervention studies 
Buyken AE, Goletzke J6, Joslowski G, Felbick A, Cheng G, Herder C, Brand-Miller J. 
AJCN (in press) 
 
Background: Chronic low-grade inflammation is a likely intermediary between quality of 
carbohydrate and chronic disease risk. We conducted a systematic literature search to 
evaluate the relevance of carbohydrate quality on inflammatory markers in observational and 
intervention studies.  
Methods: MEDLINE, EMBASE and the Cochrane Library were searched for studies on 
associations between glycemic index (GI), glycemic load (GL), dietary fiber or fiber 
supplements or whole grain intake and high-sensitivity C-reactive protein (hsCRP) or 
interleukin-6 (IL-6). Included studies had to be conducted on adults (healthy, overweight, with 
type 2 diabetes or metabolic syndrome features, but without inflammatory disease) with at 
least 20 participants and 3 weeks duration.  
Results: In total, 22 of the 60 studies meeting our inclusion criteria examined GI/GL: 5 of 9 
observational studies reported lower levels of hsCRP or IL-6 among persons with a lower 
dietary GI/GL; 3 of 13 intervention studies demonstrated significant anti-inflammatory effects 
of a low-GI/GL diet and 4 further studies were suggestive of beneficial effects (trends or 
effects in a subgroup). For fiber intake, 13 of 16 observational studies reported an inverse 
relationship with hsCRP or IL-6, but only 1 of 11 intervention studies demonstrated a 
significant anti-inflammatory effect of fiber intake and a further trial reported a beneficial 
trend. For whole grain intake, 6 of 7 observational studies observed an inverse association 
with inflammatory markers, but only 1 of 7 intervention studies reported significant anti-
inflammatory effects, one further study was suggestive (in a subgroup) and another study 
found an adverse effect (trend only).  
Conclusion: In summary, evidence from intervention studies for anti-inflammatory benefits is 
less consistent for higher fiber or whole grain diets than for low-GI/GL diets. Benefits of 
higher fiber and whole grain intakes suggested by observational studies may reflect 
confounding. 
                                               
6
 Contribution of JG:  Completion of the literature search (together with GJ and AF) (including the 
updated search) and data extraction (together with AF), contacting of the authors to request additional 
information,  interpretation of the results (together with all co-authors), and drafting of the manuscript 
(together with AEB) 
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Aim 4: To examine carbohydrate nutrition and liver function 
In the fourth research aim, the following research question was addressed: Is carbohydrate 
quality longitudinally associated with markers of liver function in an older Australian 
population? For this purpose, data from the BMES was used. The possibility to use this study 
sample offered the advantage to investigate the stated associations in an age group where 
chronic disease incidence is more pronounced. Hence, preventive dietary approaches should 
be designed to especially target those groups. Recently, hepatic fat accumulation has been 
given much attention as a new mechanistic target regarding the pathophysiology of T2D and 
other chronic diseases. The current analyses were based on data from 866 BMES 
participants, for whom dietary data and information on ALT, GGT, TG, and HDL were 
available both on BMES2 and 3. ALT and GGT were used as non-invasive markers of liver 
fat and TG and HDL as measures of disturbances in lipid metabolism.  
A high dietary fiber intake, especially from fruit sources, was cross-sectionally related to 
lower GGT- and TG-levels. Moreover, a higher dietary GI was associated with lower HDL-
cholesterol levels in the cross-sectional analysis. In the 5-year change on change analyses, 
no associations were observed between aspects of carbohydrate quality and markers of liver 
function. 
The abstract on these analyses is outlined on the next page (see Appendix 5 for the full 
publication). 
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OA5 Carbohydrate quality is not associated with markers of hepatic fat 
accumulation over 5 years in an older population.  
Goletzke J7, Buyken AE, Gopinath B, Rochtchina E, Barclay AW, Cheng G, Brand-
Miller JC, Mitchell P. Br.J.Nutr 2013, Jan 23:1-8 
 
Background: Nonalcoholic fatty liver disease (NAFLD) is closely associated with IR and 
obesity. Hence, carbohydrate quality could be of relevance to risk of NAFLD, but prospective 
data are lacking. The aim of this study was to investigate longitudinal associations between 
carbohydrate quality (including dietary glycemic index (GI), and intakes of sugar, starch, 
fiber) and markers of liver function in an older Australian population.  
Methods: 
Eye Study with fasting blood specimen and dietary intake data at baseline and 5-year follow-
up. Multilevel mixed regression analysis was used to relate dietary GI and sugar, starch and 
fiber intake to the liver enzymes alanine-aminotransferase (ALT) and gamma-
glutamyltransferase (GGT) as well as fasting TAG and HDL-cholesterol (HDL-C).  
Results: After adjustment for potential confounding factors, a lower fiber intake was cross-
sectionally related to higher GGT (ptrend =0.02) and fasting TAG (ptrend =0.002) levels, with 
fruit fiber being the most relevant fiber source (ptrend =0.095 for GGT; ptrend =0.003 for TAG). A 
higher dietary GI was associated with lower HDL-C (ptrend =0.046). Changes in carbohydrate 
quality during 5 years were not related to changes in ALT, GGT, TAG or HDL-C (ptrend ≥0.08).  
Conclusion: The absence of longitudinal associations between carbohydrate quality and 
liver enzymes and serum lipids in this older population does not support a major role of 
carbohydrate nutrition in liver function among elderly. 
 
                                               
7
 Contribution of JG:  conduction of statistical analysis (together with GC), interpretation of the data 
(together with all co-authors), and drafting of the manuscript 
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6. GENERAL DISCUSSION 
The overall aim of this thesis was to investigate the relevance of different aspects of 
carbohydrate quality during selected periods of life for risk markers of T2D and related health 
outcomes i.e. obesity, chronic low-grade inflammation and hepatic fat accumulation. 
Regarding the period of puberty, the results indicated that a habitual higher dietary GI during 
adolescence was prospectively associated with lower risk markers of T2D (Study II) but not 
with body composition in young adulthood (Study I). Furthermore, both a high intake of 
carbohydrates from higher GI food sources and a lower whole grain intake during puberty 
appeared to be detrimental for chronic low-grade inflammation in younger adulthood (Study 
III). For adults, the systematic literature search in observational and interventional studies 
showed that there is less consistent evidence from intervention studies for anti-inflammatory 
benefits of higher fiber or whole grain diets than there is for low-GI/GL diets. This indicates 
that benefits of higher fiber and whole grain intakes suggested by observational studies may 
reflect confounding (Study IV). Moreover, carbohydrate quality was not prospectively related 
to markers of liver function among elderly (Study V). 
Below, the central findings of the Studies I-V will be related to the current scientific 
discussion. Also, general methodological issues regarding exposure and outcome 
assessment as well as concerning the two study populations from the DONALD Study and 
BMES will be discussed. Finally, the public health relevance of the present findings and 
possible practical implications will be presented.  
6.1 Research Aims 
In the following chapters, the findings related to the four research aims will be discussed in 
the context of the current nutritional recommendations. For a detailed discussion of the 
respective results, please see the corresponding publications (Appendices 1 to 5). 
6.1.1 Research Aim 1: To examine carbohydrate nutrition and body composition 
With regard to the first research question, a novel link was found between postprandial 
insulinemia, but not glycemia, during puberty, and %BF in young adulthood. The dietary 
insulin index and insulin load represent a relatively new concept for estimating the dietary 
insulin demand, which considers not only carbohydrate rich foods, but in contrast to the 
dietary GI also those high in protein or fat. However, it should be noted that the dietary 
insulin index might be particularly useful to disentangle diet-disease related mechanisms 
while its practicability might be limited: Dietary GI values are similar in healthy and insulin 
resistant subjects and are hence unaffected by a person‘s metabolic status. In contrast, Lan-
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Pidhainy and co-authors showed that the dietary insulin index is more dependent on insulin 
sensitivity and glycemic control. As the insulin index is hence subject dependent and not a 
food‘s property, this observation suggests, according to the authors, a limited clinical utility 
[258]. However, as the DONALD population consists of healthy young Germans and hence a 
very homogeneous sample, comparing the dietary insulin index/insulin load to the dietary 
GI/GL represent useful concepts to examine the different effects of dietary postprandial 
glycemia and insulinemia. 
While dietary insulin demand has not yet been related to body composition, one human [259] 
and one animal study [259, 260] suggest a special relevance of early rises in postprandial 
insulin levels for later obesity risk. From a mechanistic point of view, high postprandial insulin 
levels may lead to a preferred direction of nutrients away from oxidation in muscle towards 
storage in fat [203], to a suppression of lipolysis [199], and to reduction in insulin sensitivity, 
leading in turn to increased insulin secretion [13]. This implies that long-term exposure of the 
beta cells to an increased postprandial demand may promote IR and the development of 
higher %BF [261, 262].  
Overall, the role of insulin for body weight is controversially discussed: Gary Taubes, one 
popular advocate in this discussion, recently published an essay claiming that ―lipophilia‖ but 
not the ―energy balance hypothesis‖ explains overnutrition and obesity [263]. According to 
this theory, an increased insulin response due to a high intake of carbohydrate rich foods is 
causal for overweight development by triggering fat accumulation. Particularly because he 
completely refuses a causal impact of overeating in obesity development, Taube‘s essay has 
been debated controversially. Taubes opponents mainly highlight the interaction of both 
hypotheses as well as the impact of other factors such as physical activity [263-268]. 
According to the lipophila hypothesis, hyperinsulinemia is causal for overweight 
development. Other researchers – among them Robert Lustig – declare IR as a defence 
mechanism to prevent further weight gain, although obesity, hyperinsulinemia, and hence IR 
are closely linked conditions [269-272]. According to this theory, the explanation for this 
paradox is that not all tissues are equally insulin-resistant in obesity: while the adipose tissue 
remains largely insulin sensitive, the liver as the primary target of insulin becomes resistant 
which has substantial consequences (Lustig 2008): This was shown in animal studies where 
isolated hepatic IR promoted adipogenesis and peripheral IR (Cai, Yuan et al. 2005). Of 
interest, a recent animal study [273] shed further light on the role of insulin in overweight 
development: By taking advantage of the fact that mice have two insulin genes, the 
researchers created a line that was genetically limited in the amount of insulin they could 
produce. After being fed a high-fat diet, these mice did not gain weight, and had less liver fat 
and inflammation compared to those mice with higher insulin levels. The authors found that 
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the low insulin levels in the former haploid mice contributed to a greater energy expenditure 
due to changes occurring in white adipose tissue: it took on energy burning attributes which 
are normally associated with brown adipose tissue. This study thus indicates that 
hyperinsulinemia leads to obesity not by causing fat accumulation directly but by decreasing 
energy expenditure and thus allowing energy storage [273, 274]. 
If, as the present results suggests, dietary insulinemia is indeed more important than 
glycemia regarding body composition, this might explain why studies relating dietary GI/GL to 
body composition are reporting such inconsistent results: dietary GI/GL would then only be 
crude estimates, as they do not consider protein and fat which are other important 
contributors to insulin demand [49]. Indeed, a lower FII can be achieved by choosing foods 
with a lower GL – which in turn can be obtained by lowering the GI or the carbohydrate 
content – but also by substituting carbohydrate rich foods for those rich in protein and/or fat. 
Of interest, a low-GI, high-protein diet as employed in the DiOGenes study is characterized 
by a lower insulin demand as insulin demanding carbohydrates are substituted for less 
insulin-demanding protein (particularly non-dairy protein). Findings from this study revealed 
that adherence to this diet was associated with the most successful 2-year weight loss 
maintenance among overweight adults [275] and the prevention of overweight and obesity 
over a 6 month period in children and adolescents at risk for overweight development [216] 
(see Chapter 2.3.2). Based on these results, a new large multicenter intervention study – the 
PREVIEW (PREVention of diabetes through lifestyle Intervention and population studies in 
Europe and around the World) study – will examine whether this diet is also successful in 
preventing the manifestation of T2D in pre-diabetic participants.  
As a high dietary insulin demand might be particularly detrimental for adolescents entering 
puberty with excess body fat, a subsequent analysis was done using data from the RESIST 
study: the results indicated that in obese adolescents at risk for T2D, adherence to an energy 
restricted low-GL and insulin load diet might assist in weight loss [276].  
Overall, the present findings revealed that postprandial insulinemia is associated with an 
unfavorable development of body composition. While being important from a mechanistic 
point of view, more evidence is needed to draw final conclusions regarding the relevance of 
the FII concept and its possible inclusion into dietary recommendations.  
6.1.2 Research Aim 2: To examine carbohydrate nutrition and type 2 diabetes mellitus 
risk markers 
The analysis regarding the relevance of carbohydrate nutrition during puberty for risk 
markers of T2D in younger adulthood provides new epidemiological evidence of a 
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detrimental role of recurring postprandial glycemic excursions during puberty for later levels 
of HOMA-IR, ALT, and GGT. These results are in accordance with observational evidence in 
adults showing an association between a higher dietary GI and an increased diabetes risk, 
but are the first to suggest that this association emerges already during puberty. While it has 
already been proposed that the dietary GI might be particularly important for insulin-resistant 
persons [5], our data indicates that this may extend to physiologically occurring IR 
experienced during puberty. Of note, the observed relation was partly attributable to adult 
body composition (the significant associations were attenuated towards a trend after 
additional inclusion of adult waist circumference in the final models; for further detail see 
OA2, Appendix 2); however, a trend remained, suggesting an additional mechanism such as 
oxidative stress, which is addressed in the third research aim. In Study I (see previous 
chapter), no independent association has been observed between dietary GI and adult body 
composition. A possible explanation for this slight inconsistency could be the different study 
sample.  
In the present analysis, the dietary GI was the only aspect of carbohydrate nutrition that was 
consistently related to the different risk markers for T2D, pointing to a specific role of 
postprandial glycemia during puberty on later T2D risk. Intervention studies assessing the 
effect of a low-GI/GL diet in children and adolescents on T2D risk markers however provide 
only some support (see Chapter 2.3.1). Particularly further long term evidence, e.g. from 
large-scale prospective studies preferably in at-risk populations such as overweight or 
insulin-resistant adolescents, is still lacking and would be of great relevance to further 
support the present results.  
Health authorities consistently judge the evidence for an impact of the dietary GI or GL on 
different health outcomes as inconclusive, although they do acknowledge a potential relation 
particularly for the risk of T2D. In the 2003 report of a joint WHO/FAO expert consultation on 
―Diet, nutrition and the prevention of chronic diseases,― the evidence for an association 
between dietary GI and weight gain and T2D was ranked as possible [10]. The US Dietary 
Guidelines Advisory Committee (DGAC) concludes that strong and consistent evidence 
shows that GI and GL are not related to body weight. Regarding T2D, the evidence for an 
association between dietary GI and T2D is rated moderate, while convincing evidence 
shows, according to the DGAC, that there is no relation to dietary GL [8]. The European 
Food and Safety Authority (EFSA) acknowledges that there is some support for a role of a 
lower GI and GL for the development and treatment of T2D and also for possible favorable 
effects on some metabolic risk factors. However, the available evidence until 2009 was still 
regarded inconclusive [9]. Likewise, the DGE concluded that a higher dietary GI is possibly 
associated with the development of obesity in women, and T2D in both men and women (see 
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Chapter 2.3.2 and 2.3.1). Evidence exists furthermore for a possible role of a higher dietary 
GI and GL in the development of coronary heart disease (CHD) in women only [23]. 
Interestingly, contrary to the national and international health agencies, the different diabetes 
associations are more supportive of the GI concept: They do acknowledge an additional 
benefit of considering the GI besides carbohydrate counting in dietary diabetes management 
[277-279].  
The underlying reason for why the different health authorities judged the evidence regarding 
the GI as inconclusive and thus do not include the GI concept in dietary recommendations is 
the heterogeneity among the studies. However, as already mentioned, a meta-analysis from 
Livesey et al. [175] showed that heterogeneity among the included studies was almost 
exclusively attributable to differences in the studies regarding sex, ethnicity and dietary 
instrument validity. After accounting for these sources of heterogeneity, the authors showed 
a robust and consistent dose-response relation between a higher dietary GL and T2D risk.  
To conclude, the present results are in accordance with observational evidence relating a 
higher dietary GI to an increased T2D risk in adults and extend this to puberty. Even if further 
large-scale studies in children and adolescents are needed to support the present findings, 
the inclusion of low-GI food choice advices in dietary recommendations might need to be 
considered.   
6.1.3 Research Aim 3: To examine carbohydrate nutrition and chronic low-grade 
inflammation 
Addressing the first research question of the third aim, again using data from the DONALD 
Study, it was shown that during puberty, a high intake of carbohydrates from higher GI food 
sources and low whole grain consumption appears to be detrimental for later low-grade 
inflammation. These results add to the accumulating evidence that a high carbohydrate 
intake may be detrimental if the carbohydrates stem from higher GI food sources [280-284]: 
In the EPICOR study (EPICOR is performed on Italian cohorts recruited as part of the 
European Prospective Investigation into Cancer and Nutrition (EPIC)), a high dietary GL and 
a high carbohydrate intake from high- but not low-GI foods was related to an increased risk 
of CHD in women but not in men [281]. Another study by Jacobsen et al. [280] reported that 
the replacement of saturated fat with carbohydrates with low-GI values was associated with a 
lower risk of myocardial infarction, while replacing saturated fat with carbohydrates with high-
GI values was associated with a higher risk. Furthermore, results of a Finish cohort showed 
that the replacement of high-GI carbohydrates with medium-GI carbohydrates was 
associated with a reduced T2D risk among men, while there was no association observed 
when medium- or high-GI carbohydrates were replaced with low-GI carbohydrates [282]. Our 
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data extends these observations to chronic low-grade inflammation, a condition closely 
linked to chronic disease development. 
While these results further indicate a relevance of the dietary GI during puberty (see previous 
Chapter 6.1.2), they also suggest a beneficial role of whole grain intake. Regarding the risk 
of obesity [23], T2D [190, 191, 193], and CVD [189, 192, 193] – as already mentioned in 
Chapter 2.3.1 – the majority of observational studies conducted in adults points to a 
beneficial role of a high fiber – particular cereal fiber – and whole grain intake. In contrast, 
only few studies exist in children and adolescents. Further, the results are not as supportive 
for a beneficial effect on obesity or T2D risk, and indicate that relevance might depend on 
baseline weight [23]. Regarding low-grade inflammation, there is only one observational 
study among US-adolescents which found an inverse association between fiber intake and 
CRP concentration [285].  
In contrast to the dietary GI, which is, as explained above, not part of most of the current 
dietary recommendations, the recommendation for a high intake of dietary fiber and whole 
grain is part of most nutritional recommendations [1, 8, 9, 11, 286]. The WHO/FAO expert 
panel judged the evidence of dietary fiber being protective against obesity as convincing and 
against T2D and CVD as ―probable‖ [10]. According to the DGAC, moderate evidence 
suggests that a higher intake of dietary fiber from whole grain foods is associated with 
reduced risk of obesity, T2D, and CVD. Regarding whole grain intake, the evidence is also 
judged as moderate for a beneficial effect on obesity and CVD, but only limited for T2D [8]. 
The EFSA concludes that a higher fiber intake is related to a decreased risk for T2D and 
CVD as well as improved weight maintenance and sustained weight loss in overweight 
subjects. However, they do acknowledge, that the contribution of dietary fiber per se to this 
beneficial effect remains to be established [9].  The DGE concluded that a higher dietary fiber 
intake reduces the risk for obesity and CVD with probable evidence. Furthermore, the 
beneficial effects of cereal fiber on T2D risk were rated probable. With regard to whole grain 
intake, according to the evidence appraisal of the committee, a higher intake reduces the 
risks of adiposity (possible), T2D (probable), and CHD (probable) [23].  
The presented conclusions from the different health authorities on the relevance of dietary 
fiber and whole grain intake mainly build on evidence from observational studies. Notably, 
the WHO expert panel concluded that some discrepancy exists between observational and 
interventional studies in regard to relevant fiber sources for T2D prevention [10]. The 
systematic review conducted to address the second research question also revealed 
considerable discrepancies: While observational studies almost consistently suggested 
benefits of a high intake of fiber and whole grains for chronic low-grade inflammation, this 
was not verified by intervention studies. In turn, some but not all observational and 
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interventional studies are supportive of a protective role of a low dietary GI for inflammatory 
status. Thus, the discrepancies observed for dietary fiber and whole grain are not applicable 
to dietary GI and GL. Considering these results, the above presented conclusions and 
dietary recommendations may need to be revised: Fiber and whole grain notably correlate 
with other aspects of a healthier lifestyle [287], which cannot be completely adjusted for in 
observational studies. Hence, although observational studies on chronic low-grade 
inflammation (and also on T2D and CVD, see Chapter 2.3.1) indicate an inverse association, 
the beneficial effect of fiber or whole grain per se remains to be established – as concluded 
by the EFSA [9] – and might be rather overestimated.  
Taken together, the present results extend the discussion that a high carbohydrate intake 
might actually be detrimental for chronic low-grade inflammation if the carbohydrates stem 
from high-GI food sources. Likewise, the beneficial effect of a high pubertal whole grain 
intake on later low-grade inflammation is in accordance with observational evidence in 
adults. However, in contrast to studies on dietary GI/GL, an inconsistency between 
observational and intervention studies reporting on fiber and whole grain intake was 
observed in adults, suggesting residual confounding and questioning current 
recommendations on high fiber and whole grain intakes which are almost solely based on 
observational evidence.  
6.1.4 Research Aim 4: To examine carbohydrate nutrition and liver function 
In the last research aim, the relevance of changes in carbohydrate nutrition on markers of 
liver function was examined in a population of older Australians. The lack of longitudinal 
associations and only small effect sizes suggest that carbohydrate nutrition is not of major 
relevance for liver function in this elderly population. In accordance, an intervention trial in 
older US-adults found no effect of a low-fat, low-saturated fat, low-GI diet over four weeks on 
ALT levels, but on the absolute percentage of liver fat when compared to its high-fat, high-GI 
counterpart. Of note, higher liver fat at baseline was predictive of a greater decrease in 
percentage of liver fat. [238]. However, regarding the present results, different aspects need 
to be kept in mind: The cohort of the BMES can be regarded comparably healthy (see also 
Chapter 6.2.3) and their diet is characterized by a high intake of fruits and low intake of sugar 
and soft drinks – thus by a good carbohydrate quality. This could indeed be one explanation 
for the fact that an association between dietary GI and the liver enzymes ALT and GGT was 
observed in the young DONALD cohort (see OA2, Appendix 2): The carbohydrate quality in 
younger age groups is less ideal now [155-157], indicating that this problem might not have 
reached older age groups yet. Furthermore, the healthy constitution of the BMES sample 
might also have precluded the detection of a strong association: Valtuena et al. [236] 
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suggested that the dietary GI was relevant for the risk of high-grade steatosis only in those 
who were insulin resistant. However, as only few participants in BMES had T2D or IFG, there 
was limited power to detect possible interactions with health status. Furthermore, the ALT 
values in the present sample were in the upper normal range at both examinations. Of 
interest, a recent publication showed an inverse relationship between ALT values in the 
normal range with total mortality, cardiovascular and non-cardiovascular events in middle-to-
older aged participants from three large prospective cohort studies. These results suggest 
that associations between ALT levels and clinical outcomes are complex and that higher but 
still normal ALT levels might have a different predictive value compared to clinically elevated 
ALT levels [288]. Hence, although the present results are not indicative of an association, 
carbohydrate nutrition might still be of relevance for persons exhibiting clinically elevated liver 
enzyme levels.  
Overall, this study does not suggest a role of carbohydrate nutrition in the studied elderly 
population. However, carbohydrate nutrition might be relevant for individuals with a diet 
characterized by an unfavorable carbohydrate quality and/or in those with clinically increased 
liver enzyme levels, which needs to be investigated in further studies. 
6.2 Methodology and study population 
This thesis builds on the data of two observational studies and one systematic review. 
Hence, there are different methodological issues to be considered regarding the aspects and 
markers chosen as exposure and outcome variables. These issues will be addressed in the 
following chapters.  
6.2.1 Assessment of dietary predictors 
Dietary assessment 
Dietary intake in the DONALD Study is assessed with 3-day weighed dietary records, the 
quasi-gold standard of dietary assessment methods [289]. This direct and prospective 
method does not rely on memory and portion sizes are assessed very precisely as they are 
not estimated but weighed. Additionally, for all foods, information on type and brand name 
are collected. In the DONALD Study, recipes as well as packages and labels are provided by 
the participants and their families for further information on the foods consumed, which are 
then added to the dietary record data [247]. The fact that all foods consumed need to be 
weighed and recorded implies that a high motivation is essential, and also exerts a 
substantial burden on the participants and their families and may thus inadvertently affect 
their usual food intake. Moreover, foods which are only rarely consumed such as fish, lentils 
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or seasonal fruits might not be captured by a 3-day dietary record. Hence, for estimation of 
the habitual dietary intake, records have to be collected repeatedly [92, 290]. In the DONALD 
Study, 3-day dietary records are collected annually during puberty, allowing thus a better 
estimation of the habitual diet.  
By contrast, a FFQ was applied repeatedly to estimate dietary intake in the BMES. FFQs are 
commonly used in epidemiological studies as they are relatively inexpensive and easy to 
administer, particularly in large cohorts. However, as FFQs commonly capture periods of the 
previous 3 to 12 months, this method, while being able to estimate the habitual diet, relies on 
the participants‘ long-term memory and their ability to estimate and describe their usual food 
intake [92]. Furthermore, the list of foods enquired is relatively restricted, e.g. in the BMES, 
the FFQ comprises 145 items [255] and frequencies and average serving sizes need to be 
interpreted [92].  
Overall, using a FFQ is applicable in this larger study sample, which was almost four-times 
bigger than the DONALD Study sample (comparing the subsamples used for this thesis). In 
addition, a FFQ was frequently applied in the studies assessing the association between 
carbohydrate quality and inflammatory markers included in the systematic review. 
Dietary predictors 
Regarding the different aspects of carbohydrate quality, the estimation of the diet‘s GI from 
individual foods is discussed controversially: Some authors argue that the glycemic response 
of a mixed meal cannot be accurately estimated by the GI values of its single components 
since other aspects such as the macronutrient composition influence blood glucose 
responses [291, 292]. In contrast, others have shown that the sum of GI values of individual 
foods can actually be used to estimate the GI of a whole diet or mixed meal [293-295]. 
Limitations of GI assignment comprise the fact that it is often based on GI values for similar 
foods only when no direct match is available and that it may vary between researchers. 
Furthermore, whereas weighed dietary records allow a direct assignment of GI values to all 
recorded foods, the GI assignment needs to be based on food groups if dietary intake is 
assessed by FFQ. This implies the additional risk of summarizing low- and high-GI foods in 
the same food group, e.g. whole kernel and wholemeal breads are both assigned the GI of 
wholemeal bread even though their glycemic response is different [31, 37]. To reduce the 
outlined shortcomings, a standardized assignment procedure, as used for the present 
studies (see OA 1, 2, 3 in Appendices 1, 2, 3) is of great importance. Furthermore, regarding 
FFQ data, a validation and provision of correlation coefficients is crucial for a correct 
interpretation of the results. This was done for the BMES where the FFQ showed moderate 
to good agreement for ranking individuals according to their GI as well as their total 
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carbohydrate, sugar, starch, and fiber intake, but not their GL [255]. Barkley et al. also 
showed that the majority of prospective studies investigating associations between total 
carbohydrates, GI, GL and chronic disease risk do not assess whether their FFQ is able to 
adequately rank individuals according to their GI and GL but rely on correlations with total 
carbohydrate intake only. However, the authors demonstrated that correlations for 
carbohydrates cannot be simply transferred to GI and GL but need to be assessed 
independently. Additionally, it has to be noted that in contrast to other FFQs, the FFQ used in 
BMES contained some additional questions on the type of breakfast cereals, which 
increased the accuracy of GI estimates [255]. Nonetheless, the FFQ was not designed to 
specifically assess dietary GI, which would be even more desirable and should, for instance, 
also include questions about the type of bread.  
Livesey et al. [175] showed in their meta-analysis that the heterogeneity among the included 
studies was to a large extent attributable to the ability of the FFQ to correctly measure 
carbohydrate consumption. They concluded that a meta-analysis without appropriate 
covariates such as dietary instrument validity would thus underestimate the importance of GL 
in the contribution to risk of T2D. As mentioned before, only very few studies used dietary 
instruments specifically validated for GI/GL. Thus, for the assessment of dietary instrument 
validity, the surrogate measure total carbohydrate intake had to be used [175]. It is of note 
that also in the systematic review conducted as part of this thesis, two of the four studies 
reporting no associations for dietary GI/GL had employed an FFQ for which correlation 
coefficients with dietary records were comparably low for total carbohydrate intake.  
An alternative and more exact approach to measure the glycemic impact of the diet would be 
to continuously monitor blood glucose concentrations [296]. However, this expensive 
approach would not be ethical in a young cohort like the DONALD Study, and moreover not 
feasible – especially in a large cohort like the BMES. Furthermore, as the sensors are only 
worn for a few days, habitual dietary intake cannot be estimated from these data, unless they 
would be applied repeatedly.  
Regarding the FII, the same limitations apply as debated for GI estimation. Additionally, the 
FII assignment was based on 121 published values only, as compared to about 2800 values 
available for GI. 
Comparing dietary GI and dietary fiber and whole grain intake as aspects of carbohydrate 
quality, there exist some differences which should be noted: Epidemiological studies on 
dietary GI/GL are not as amenable to residual confounding, since dietary GI/GL do not 
strongly correlate with healthy lifestyle behaviors as most populations are still largely 
unaware of what constitutes a low dietary GI [5]. In turn, it is well known that a higher fiber or 
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whole grain intake correlates notably with other aspects characterizing a healthier lifestyle 
and dietary recommendations to increase fiber intake are quite established [287] (see also 
Chapter 6.1.3). Hence, compared to dietary GI/GL, assessment of the fiber and whole grain 
intake might be more accurate but entails a higher possibility to reflect unmeasured 
confounding.  
6.2.2 Outcome measurements 
Regarding the different risk markers referred to in this thesis, some methodological 
considerations are warranted. Overall, it has to be noted, that the different outcome 
measures were only taken once in younger adulthood in the DONALD Study, compared to 
the repeated dietary assessment during puberty (two to six times). In BMES, dietary intake 
as well as liver enzymes and serum lipids were repeatedly measured (two times). 
Anthropometry 
In the DONALD Study, %BF is assessed by skinfold measurement, which is regarded a 
method susceptible to measurement error. Hydrostatic weighing would be more precise but 
is, however, not feasible in epidemiological studies. Another option would be the DEXA 
method, which has been regarded as a gold standard due to its practicability and high 
precision regarding measurements of body components [297]. However, in the DONALD 
Study, the method of choice has to be applicable on an annual measurement basis, 
precluding this option. A further alternative for the measurement of body fat would be the 
bioelectrical impedance method (BIA), which would be feasible in a cohort study due to its 
practicability and quick and safe handling [92]. Nevertheless, according to findings from 
Willett et al., BIA is not superior to BMI in predicting overall adiposity in the general 
population [298]. Overall, the skinfold technique is the most widely used technique in 
epidemiological studies [92] and equations of Durnin and Womersly [299], which were used 
in this thesis, on average agree very well with results from hydrostatic weighing [300]. An 
advantage of skinfold measurement is the low costs, but trained personnel is needed. In the 
DONALD Study, standardized procedures are applied by trained staff and an annual quality 
control is run to affirm quality standards. 
Risk markers for type 2 diabetes mellitus 
Diagnosis of diabetes is commonly based on 2-hour postprandial glucose values determined 
during an OGTT or, more recently, also on HbA1c values. The gold standard for measuring 
insulin sensitivity is the hyperinsulinemic euglycemic glucose clamp technique. However, this 
method is regarded time-consuming, labor intensive, and expensive [55, 56, 92]. In analyses 
of DONALD data, HOMA-IR and the liver enzymes ALT and GGT were used as T2D risk 
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markers. An OGTT has been newly introduced in the study since 2011, but data is not yet 
available for enough participants to be considered in the present analyses. Furthermore, for 
HbA1c measurement full blood samples are required, which are not obtained in the DONALD 
Study. The HOMA index is a simple surrogate index derived from fasting steady-state 
conditions, which has been widely used especially in large-scale epidemiological studies [56, 
57]. Besides the quantitative insulin sensitivity check index (QUCKI), the HOMA index can be 
regarded the best and most extensively validated simple surrogate index [56, 57]. It may not 
give appropriate results in subjects with absent/severely impaired beta cell function [57], 
which does however not apply to the DONALD participants. Moreover, using the same 
metabolic parameters, i.e. fasting glucose and insulin levels, both HOMA-IR, estimating IR, 
and HOMA-ß, an estimate on insulin secretion, can be calculated, with the former index 
being more frequently used [56]. Besides these common indices, the liver enzymes ALT and 
GGT are recently recognized as risk markers for T2D because of the close link between 
hepatic and systemic IR [59-63] (see chapter 2.2.4). 
Inflammatory markers 
To examine the impact of carbohydrate nutrition on chronic low-grade inflammation in the 
DONALD Study, the pro-inflammatory markers IL-6, hsCRP, IL-18, and the anti-inflammatory 
adipose tissue hormone adiponectin were considered. The systematic review focused on 
studies reporting results for IL-6 and hsCRP, as these two inflammatory markers represent 
the most commonly measured immune mediators in clinical and epidemiological studies. 
Both CRP and IL-6 have been related to increased T2D [301, 302] and CVD risk [303-305] in 
cohort studies. However, while being frequently used, Mendelian randomization studies 
indicated that the association between CRP and risk of CVD is not causal [306, 307], but 
may have been biased by confounding or reverse causation. In contrast, evidence for a 
causal role in CVD development exists for IL-6 [308, 309]. These findings from Mendelian 
randomization analyses might be transferable to the inflammatory markers‘ role in T2D 
development. Regarding the relevance of adiponectin as a prognostic marker, meta-analyses 
showed a prospective association between decreased adiponectin levels and an elevated 
T2D risk [310], but no consistent relation with CHD and CVD risk [311-313]. Compared to 
these three markers, IL-18 is less frequently studied. However, results from the 
MONICA/KORA Augsburg Study showed a positive association between IL-18 
concentrations and T2D risk [314], but not coronary events [304]. Hence, to better evaluate 
the usefulness of the different inflammatory markers in predicting T2D and CVD risk, further 
research is needed to assess their specific role in chronic disease development.  
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Markers of liver function 
The gold standard for a diagnosis of NAFLD is liver biopsy [142]. To non-invasively estimate 
hepatic fat accumulation, the enzymes ALT and GGT are commonly used. Of note, GGT also 
serves as a marker for alcoholic fatty liver, which was the reason for excluding those BMES 
participants with a higher alcohol intake [137, 142, 315, 316] (for details see OA5, Appendix 
5). Regarding the use in epidemiological studies, it has to be noted that raised liver enzymes 
can only reveal an increased risk, yet no quantitative conclusions about the extent of hepatic 
fat accumulation can be drawn. Indeed, NAFLD can be present without any elevations in liver 
enzymes. However, liver enzymes are commonly used as minimally invasive parameters to 
estimate fat accumulation and NAFLD risk [142, 315]. Additionally, serum lipids can be used 
as risk markers, since NAFLD is closely related to dyslipidaemia and the metabolic syndrome 
[137, 317, 318].  
6.2.3 Study characteristics 
Both the DONALD Study and the BMES are characterized by a prospective study design. 
Even if purely observational, this study design allows following a group of individuals over 
time and it is possible to study different exposures in order to determine how these factors 
are related to the development of specific outcomes. Hence, in contrast to cross-sectional 
approaches, prospective cohort studies are able to identify occurrences of diseases or their 
development. Regarding the particular examinations done in the context of this thesis, 
DONALD analyses focused on dietary intake during the critical period of puberty, while in 
BMES analyses, five year changes during older age were examined. Noteworthy, only 
subsamples of both cohorts were used for the present analyses. 
Longitudinal cohort studies such as the present ones generally face the problem that only 
very interested participants will participate over the long-term, which in turn is often 
associated with a higher education and socioeconomic status. This may indeed introduce 
selection bias and hampers generalizability. However, it should be noted that the latter 
limitation is of minor importance when examining associations between exposure and 
outcome within a cohort, since it is unlikely to affect internal validity [247]. Unquestionably, 
the results presented cannot be generalized and thus require confirmation in other 
populations. 
In the systematic review, the relevance of different aspects of carbohydrate quality from both 
observational and intervention studies was compared. The inclusion of both study designs 
served as an opportunity to compare their results and also revealed some discrepancies (see 
Chapter 6.1.3 and OA4, Appendix 4). As explained above, results from observational studies 
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can only give an indication for a causal relation which then needs to be further verified by 
intervention studies. However, it has to be noted that not all research questions can be 
answered by intervention studies, i.e., particularly in children and adolescents, the 
conduction of clinical trials is notoriously difficult, and often not ethically feasible.  
DONALD Study 
The prospective open cohort nature of the DONALD Study entails the rare and valuable 
possibility to cover the time from birth until adulthood. Moreover, the repeated, 
comprehensive measurements, taken in close intervals, allow to examine different 
associations between diet, anthropometrical characteristics, and risk markers for different 
health outcomes over the course of growth.  
Even though the DONALD sample is very homogenous and can be regarded non-
representative, comparison of the anthropometric characteristics with the German reference 
population shows only slight differences: Indeed, DONALD participants included in the 
different analyses of this thesis (Studies I, II, III) had slightly lower to comparable BMI values 
during puberty compared to the German reference population [102]. Participants included in 
the DONALD sub-sample for the body composition analyses (Study I) had a median %BF of 
17% for men and 29% for women in young adulthood. However, since DEGS1 used BMI to 
identify overweight and obesity, no data on %BF were available for comparison. Regarding 
overweight and obesity prevalence in adulthood, on average 17.8% of the women were 
overweight and 5.4% of these were obese in Studies I, II, and III; among men, on average 
30.7% were overweight and of these, 6.4% obese (average age: 21 years). Comparing this 
data to overweight and obesity prevalence in the DEGS1, the DONALD values are lower, 
especially for women: In DEGS1, 30.0% of the 18 to 29 years old women were overweight, 
and 9.6% obese. For men, the survey showed an overweight prevalence of 35.5% in 18 to 
29 years old men, and an obesity prevalence of 8.6% [99]. This comparison further highlights 
the good health condition of the DONALD cohort, but also indicates the difficulty to apply the 
current findings to the growing proportion of overweight adolescents and young adults. 
With regards to the daily macronutrient intakes, data from EsKiMo (Ernährungsstudie als 
KiGGS Modul), a nutrition module included in the KiGGS study, can be used as a reference. 
In this survey, information of the adolescents‘ diet was assessed with a personally conducted 
interview from twelve years onwards covering dietary intake of the last four weeks. The 
median energy intake during puberty was approximately 7MJ for female and 9MJ for male 
DONALD participants (in all three subsamples of Studies I, II, III) and hence around 1MJ 
lower as compared to girls and boys aged twelve years in EsKiMo. With a median intake of 
36En% fat, 13En% protein, and 51En% carbohydrates of the DONALD participants during 
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puberty (in all three subsamples of Studies I, II, III)), the macronutrient proportions are 
comparable to twelve year old girls and boys in EsKiMO: These boys and girls had with 
13En% a comparable median protein intake, but a lower fat intake (33En%), and a slightly 
higher carbohydrate intake (52.5En% for girls, and 51.8En% for boys in EsKiMo) [319]. 
BMES 
In contrast to the DONALD Study, the BMES is a population-based cohort study including a 
representative older Australian community sample. Those 3654 participants, who started at 
baseline, where invited to three follow-up visits every five years. As participants died or were 
lost to follow-up, the sample size was reduced subsequently, introducing the possibility of 
selective survival and also affecting the representativeness (see above).  
In the BMES subsample used in Study V, 68% of the 543 women and 70% of the 323 men 
were overweight or obese (median age 67 years; range: 54 to 94). Of note, data for 
overweight and obesity is only reported combined for a better comparability with the 
Australian Bureau of Statistics data. This prevalence data indicates that 70% of the women 
and 80% of the men aged 65 to 74 years were classified as overweight or obese. Hence, 
while prevalence rates were comparable for women, the male participants in the BMES are 
characterized by a lower overweight and obesity prevalence compared to the general 
Australian population in this age group [100].  
Regarding dietary intake in the present BMES subsample, women and men consumed both 
48En% carbohydrates, 31En% and 32En% fat, and 18En% and 17En% protein with a 
median energy intake of 8.0 and 8.9MJ, respectively. These intake values can only be 
compared to data from the National Nutrition Survey conducted in 1995 by the Australian 
Bureau of Statistics, as results from the 2011/13 Australian Health Survey are not yet 
available. Dietary intake was assessed by 24-h recalls and the results for the age group 55 to 
64 years – the oldest group included in the survey – were as follows: With a median energy 
intake of 6.6MJ, women consumed 37En% fat, 45En% carbohydrates, and 17.3En% protein 
and men consumed 34En% fat, 45En% carbohydrates, and 17En% protein with a median 
energy intake of 9.4MJ (percentage of energy values calculated on the basis of gram and 
energy data)  [320]. Hence, women in the BMES had a higher and men a slightly lower 
energy intake compared to the general Australian population. Furthermore, the BMES 
participants consumed less fat and more carbohydrates, while protein intake was 
comparable with the survey results. 
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6.3 Public Health relevance and possible practical implications 
This thesis builds on the assumption that a high carbohydrate intake might be particularly 
detrimental not only for the growing number of overweight and insulin resistant individuals [5, 
6], but also – as shown in this thesis – for adolescents facing a physiological IR. Even if not 
the amount of carbohydrates but their quality was the focus of the present thesis, some 
comments can be made: The present findings do not provide an indication for a beneficial 
effect of a carbohydrate-rich diet on risk markers of T2D. Furthermore, possible detrimental 
effects of a high carbohydrate intake from high-GI food sources on later low-grade 
inflammation are indicated. Hence, these results do not support the current 
recommendations to consume between 45 and 70% of energy as carbohydrates [8-10, 23] 
but are in accordance with the conclusion of the evidence-based dietary guideline of the 
German Nutrition society, stating that the total carbohydrate intake is not of relevance for the 
risk of T2D [23].  
So far, while agreement exists on the importance to highlight carbohydrate quality in 
nutritional recommendations, the single aspects of carbohydrate quality have been included 
to a different extent:  
As already summarized in Chapter 6.1.3, most health agencies recommend a high intake of 
dietary fiber. These recommendations are largely based on observational evidence. In the 
systematic review (Study IV), it has been observed that the strong observational evidence for 
a beneficial effect of a high fiber and whole grain intake on chronic low-grade inflammation 
was not supported by intervention studies, indicating potential residual confounding (see 
Chapter 6.1.3 and OA4, Appendix 4). This finding might also be applicable to the closely 
related health outcomes T2D and CVD, for which comparable strong observational evidence 
exists (see chapter 2.3.1). It should hence be considered that the current recommendations 
to increase the intake of dietary fiber and whole grain products, although contributing to a 
balanced diet, might probably not yield the expected health benefits. Indeed, the DGAC 
concluded that there was limited evidence showing an association between whole grain 
consumption and reduced incidence of T2D in large prospective cohort studies [8]. 
Furthermore, the FDA declared in a recent statement, that there is ―very limited credible 
scientific evidence‖ for a health claim stating a relation between whole grain consumption 
and reduced risk of T2D. This statement was part of a letter sent to a food supplier 
(ConAgra) in response to his health claim petition. The FDA refused the suggested claims 
(stating a more consistent association between whole grains and T2D) after reviewing the 
petition, as well as the available literature on whole grain intake and T2D risk, and notes 
made during a public comment period. Confusingly enough, the FDA instead announced to 
consider exercising enforcement discretion for the following health claim to not mislead 
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consumers: ―Whole grains may reduce the risk for T2D, although the FDA has concluded 
that there is very limited scientific evidence for this claim.‖ While the comprehensibility of this 
claim might be questioned, food manufacturers seem to be pleased to still be able to link 
whole grains to a reduced disease risk [321]. In this context, a recent study from Harvard 
revealed that grain products with the ―Whole Grain Stamp,‖ one of the most commonly used 
front-of-package labels, were indeed higher in fiber and lower in trans-fats, but also higher in 
sugar and calories compared to products without the stamp. The other labels examined also 
had mixed performances for identifying healthier grain products. These results underline the 
need for a consistent, evidence-based standard for labeling whole grain foods [322]. 
Particularly, a common definition of what is regarded a whole grain food is desired in light of 
the diverse definitions currently existing (see Chapter 2.1.1), which would also simplify 
consumers‘ food choices. 
Concomitant with the recommendation to increase dietary fiber and whole grain intake, 
health agencies often advise a reduction in sugar intake, particularly from sugar-sweetened 
beverages [23, 323]. The observation that total sugar intake was not of relevance for T2D 
risk markers is in agreement with the evidence-based guideline from the German Nutrition 
Society [23]. Observational evidence however points to an unfavorable role of sugar intake 
from soft drinks [23] for which the present analyses show only a relevance for the liver 
enzyme GGT, one of the examined risk markers for T2D (see OA2, Appendix 2). However, 
comparable to dietary fiber and whole grain intake, soft drink consumption might be more a 
marker for an overall unhealthier nutrition and lifestyle, as large effects have only been 
shown in observational studies comparing extremes of dietary intake. A focus solely on soft 
drinks, which is observed in some of the recent health campaigns, e.g. the ban of all soft 
drinks above 473ml (16oz) in New York restaurants, might not relate to the desired 
decreases in disease prevalence rates. However, in light of an increase in sugar 
consumption, partly due to a higher availability in processed foods, and taking into account 
the fact that sugar does not possess any nutritional value, the recommendation for a reduced 
consumption is indeed reasonable [324-327].  
In contrast to dietary fiber and sugar, the dietary GI is currently not included in most of the 
nutritional recommendations (see Chapter 6.1.2). However, the present results indicate a 
special role of postprandial glycemia during puberty for later low grade inflammation and T2D 
risk. For obesity, postprandial insulinemia was of greater relevance in our analyses. As the 
concept of the dietary insulin index is however very new, more studies are needed to confirm 
this. Regarding dietary GI, a consistent relevance for the different risk markers for T2D was 
shown in the present analyses. Even if available intervention studies in children and 
adolescents show inconsistent results for a relevance of dietary GI (see Chapter 2.3.1), no 
DISCUSSION 
86 
 
unfavorable effects have been reported when following a low-GI diet. Therefore, the GI 
concept may need to be incorporated into dietary recommendations given to adolescents. So 
far, the main argument against its inclusion in dietary recommendations is the heterogeneity 
among the studies [9, 23, 328], which may however be based to a large extent on 
methodological problems [175] (see Chapter 6.1.2 and 6.2.1). Considering the GI in 
nutritional recommendations, a GI label on food products could promote a successful 
implementation as most people are largely unaware of the GI concept. However, so far GI 
claims on food labels are only authorized in Australia, New Zealand, and South Africa. 
Particularly in the EU, strict requirements might hamper the introduction of a low-GI label or 
health claim: For a qualified health claim, a single nutrient, substance, food or food category 
needs to be defined. As this is contrary to the whole GI concept, a permission of a GI health 
claim is very unlikely in the EU unless the regulations change. So far, the EFSA concluded in 
2010 that low-GI carbohydrates were ―not sufficiently characterized‖ and that their health 
benefits had not been established [329]. In this context, Aziz et al. [330] recently published 
an evaluation of the use of GI claims on food labels on behalf of Health Canada, which was 
also not supportive of an inclusion of the GI value on the product label. This evaluation has 
been criticized by the International Carbohydrate Quality Consortium (ICQC) committee 
[331]: In the response letter, the committee particularly highlighted the fact that the GI claim, 
as any other dietary claim, should not be used in isolation. A procedure similar to the 
Australian GI symbol was proposed, where the low-GI symbol requires the fulfillment of strict 
nutritional criteria. The Australian example furthermore shows that the GI concept is not too 
difficult to understand for consumers if communicated sufficiently: While the prediction of the 
dietary GI is rather sophisticated, the implementation can be done by using simple 
substitution tables (see Table 9), which can be used regardless of the implementation of a GI 
symbol. Indeed, one in four Australians choose low-GI products and substitute them for 
regular high-GI variants within a food group. Finally, the committee emphasized the need to 
distinguish high-GI whole grains from low-GI counterparts [331]. Indeed, analyses in the 
DONALD cohort also revealed that 76% of the whole grain foods consumed from the 
participants were of moderate- to high-GI (see OA3, Appendix 3), even though several low-
GI options exist on the German food marked (e.g. wholemeal bread with intact kernels and 
unprocessed muesli with nuts etc.). It is thus pivotal to not only recommend the consumption 
of whole grain foods but also give specific dietary advice – preferably supported and 
facilitated by substitution tables or GI labels – which encourage a preferred selection of low-
GI foods.  
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Table 9: Substitution of low-GI carbohydrate food sources for high-GI counterparts within the 
context of a prudent diet (modified from [38, 332]) 
High-GI Food Low-GI Alternative 
Bread—white or wholemeal 
Breads containing intact whole grains; sourdough and pumpernickel 
breads 
Processed breakfast cereals 
(i.e. cornflakes) 
Unrefined cereals such as rolled oats or natural muesli, i.e. with nuts 
and dried fruits 
Plain biscuits or crackers Biscuits made with dried fruit, oats, and whole grains, nuts 
Cakes and muffins Make them with fruit, oats, oat bran, rice bran, and psyllium husks 
Potato: mashed potatoes, 
oven potatoes 
Pasta, lentils or low-GI potato varieties/preparations (i.e. baby new 
potatoes (small size), waxy potatoes, sweet potatoes, potato salad) 
Rice: sticky white rice Longer grain varieties such as Basmati, parboiled or brown rice 
 
Overall, relating the results of this thesis to the current nutritional recommendation to 
consume a high-carbohydrate, high-fiber diet, the following modifications appear to be 
required: Since the present analyses indicate that it can be actually detrimental to have a 
high carbohydrate intake if the carbohydrates stem from higher GI food sources, the health 
agencies should either move away from recommending a minimum intake level or 
accompany their recommendation by detailed advice to consume not only fiber/whole grain-
rich but also low-GI carbohydrate foods. 
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7. CONCLUSION AND PERSPECTIVES 
To conclude, the results presented in this thesis indicate a particular relevance of the diets‘ 
blood glucose rising effect during the critical period of puberty for later risk markers of T2D. 
Since both obesity and diabetes prevalence are increasing also in younger age groups, 
preventive strategies starting early in life are urgently needed. As the present analyses 
indicate a special relevance of the diets‘ glycemic potency, efforts to improve carbohydrate 
quality – particularly in adolescents – should not focus solely on a high whole grain intake, 
but need to be complemented by an advice for a preferred selection of low-GI foods.  
Future intervention studies should aim to disentangle the effect of fiber and whole grain 
intake per se on different health outcomes, leading either to a confirmation or revision of the 
current recommendations. Also, more well-conducted studies using dietary assessment 
methods being able to estimate the GI correctly, which assess the long-term effect of low-GI 
diets, are urgently needed to overcome the current methodological problems hampering the 
formulation of conclusive remarks regarding the relevance of the GI concept.  
The inclusion of OGTT measurements in the DONALD protocol will furthermore lead to a 
more precise evaluation of T2D risk in this cohort. Overall, the present results need to be 
verified by other prospective studies, ideally encompassing a longer time span, i.e. until 
middle adulthood. Moreover, further studies are needed to examine the impact of 
carbohydrate quality in the elderly, preferably in cohorts characterized by less favorable 
nutritional habits or a higher prevalence of IR or T2D.   
Importantly, any public health strategy to improve carbohydrate quality during adolescence 
should be accompanied by advice on the overall diet quality and regular physical activity. 
Successful prevention strategies to reduce later risk for obesity and diabetes should 
furthermore not focus on adolescents only but involve all age groups including, for example, 
a family based approach. 
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ORIGINAL ARTICLE
Prospective associations of dietary insulin demand, glycemic
index, and glycemic load during puberty with body composition
in young adulthood
G Joslowski1, J Goletzke1, G Cheng1, ALB Gu¨nther2, J Bao3, JC Brand-Miller3 and AE Buyken1
BACKGROUND: Puberty is a so-called critical period for overweight development and is characterized by physiological insulin
resistance during mid-puberty. This study addressed the hypothesis that habitual consumption of a diet inducing higher levels
of postprandial glycemia or insulinemia during puberty may have an unfavorable effect on the body composition in young
adulthood.
METHODS: Multivariate regression analysis was performed on 262 participants of the Dortmund Nutritional and
Anthropometric Longitudinally Designed Study with at least two 3-day weighed dietary records during puberty (baseline: girls
9 --14 years; boys 10--15 years) and anthropometric measurements in young adulthood (18--25 years). A published dietary
glycemic index was assigned to each carbohydrate-containing food. Similarly, each food was assigned a food insulin index
(insulinemic response to a 1 MJ portion of food relative to 1 MJ of glucose) using 121 values measured at Sydney University.
RESULTS: Dietary glycemic index or glycemic load during puberty was not related to body composition in young adulthood. In
contrast, a higher dietary insulin index and a higher dietary insulin load during puberty were associated with higher levels of
percentage of body fat (%BF) in young adulthood, even after adjustment for early life, socioeconomic and nutritional factors;
%BF in energy-adjusted tertiles of dietary insulin index were 22.9 (95% confidence intervals (CI): 21.6, 24.1), 24.5 (23.2, 25.7),
24.7 (23.5, 25.9) %, Pfor trend¼ 0.01; %BF in energy-adjusted tertiles of dietary insulin load were 22.8 (95% CI: 21.5, 24.0), 24.5
(23.2, 25.7), 24.8 (23.6, 26.0) %, Pfor trend¼ 0.01. Adjustment for baseline %BF attenuated these relationships (Pfor trend¼ 0.1
and¼ 0.08, respectively). Dietary insulin demand was not related to body mass index.
CONCLUSION: This study suggests a prospective adverse influence of dietary insulin demand during puberty on %BF in young
adulthood. Postprandial increases in insulinemia rather than increases in glycemia appear to be implicated in an unfavorable
development of body composition.
International Journal of Obesity (2012) 36, 1463--1471; doi:10.1038/ijo.2011.241; published online 17 January 2012
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INTRODUCTION
Over the previous years, the relevance of the dietary glycemic
index (GI) for the development of obesity has been controversially
debated. Among adults, prospective cohort studies suggest a
role of the dietary GI for body composition.1 - 4 However, similar
associations have not been observed among healthy children and
adolescents5,6 or overweight Latino adolescents.7
Intervention studies in overweight and obese adults suggest a
specific efficacy of low-GI weight-loss diets8,9 for persons with
already increased insulin secretion levels.9 Puberty is a so-called
‘critical period’ for overweight development, which is character-
ized by physiological insulin resistance and changes in levels of
various hormones, including insulin-like growth factor (IGF)-1,
growth hormones as well as sex steroids.10 In fact, IGF-1 levels rise
steeply during puberty and peak before the end of puberty,
whereas the development of the insulin sensitivity follows the
reverse course.11,12
It is possible that postprandial glycemia and insulinemia are
relevant targets during puberty so as to prevent the development
of an unfavorable body composition. Mechanisms linking the
habitual consumption of high-GI foods to body composition
include reduced satiety signaling, as fully gelatinized starches in
high-GI foods do not reach the lower parts of the ileum, and
enhanced carbohydrate oxidation and decreased fat oxidation in
response to habitual postprandial glycemia and insulinemia.13 In
addition, reactive hypoglycemia in the late postprandial phase has
been proposed to induce hunger and higher voluntary energy
intakes.14 Counter-regulatory hormone responses following this
reactive hypoglycemia may have proteolytic effects, favoring the
loss of lean body mass and a reduction of resting energy
expenditure.13 Finally, elevated IGF-1 levels may predispose to
obesity later in life,15 and the GI of a meal has been found to
acutely affect the IGF-1 axis.16
As high-GI foods influence both blood glucose and insulin
levels, it is not clear which of these postprandial changes is
potentially more relevant for an unfavorable development of body
composition. Insulin secretion is also stimulated by dietary protein
and, moreover, dietary protein and fat may both act synergistically
with carbohydrates, raising insulin levels and reducing post-
prandial glycemia.17 - 19 The food insulin index (FII) compares the
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postprandial insulin response to any food relative to a reference
food (glucose) and also, unlike the GI, considers foods with no or
low amounts of carbohydrates.20
This study addressed the hypothesis that habitual consumption
of a diet inducing higher levels of postprandial glycemia or
insulinemia during puberty may have an unfavorable effect on
body composition in young adulthood.
METHODS
Study population
The present study was ancillary to the Dortmund Nutritional and
Anthropometric Longitudinally Designed Study (DONALD Study), an
ongoing, open cohort study conducted at the Research Institute of
Child Nutrition in Dortmund, Germany. Details on this study have been
described elsewhere.21
Briefly, as the recruitment began in 1985, detailed data on diet, growth,
development, and metabolism between infancy and adulthood have been
collected from 41300 healthy children. Every year, an average of 50
infants are newly recruited and first examined at the age of 3 months. Each
child returns for three more visits in the first year, two in the second and
then once annually until adulthood. The study was approved by the Ethics
Committee of the University of Bonn, and all examinations are performed
with parental consent.
The children who were initially recruited for the DONALD Study differed
considerably in age. Because of the open cohort design, many children
have not yet reached young adulthood. In total, 394 subjects were aged 18
years or older by the time of this analysis. They were term (37 - 42 week
gestation) singletons with a birth weight X2500g and had at least one
anthropometric measurement in young adulthood. As we were interested
in the long term-relevance of dietary parameters during adolescence for
adult body composition, we regressed dietary intake on the last
anthropometric measurement available during young adulthood (X18
and p25 years of age, mean age¼ 20.3 years). Of these, 308 participants
had provided at least two 3-day weighed dietary records at baseline
(puberty was defined by chronological age: girls 9 --14 years, boys 10 - 15
years), allowing the estimation of habitual dietary intake during puberty.
Participants who were identified to consistently underreport their energy
intake (that is, all food records were implausible or they had provided more
implausible than plausible food records) were excluded from the study
(n¼ 23). A 3-day weighed dietary record was considered plausible when
the total recorded energy intake was adequate in relation to the basal
metabolic rate (estimated from the Schofield equations22) using modified
cut-offs from Goldberg et al.22,23 Overall, 1379 records were included (2 - 7
records per participant). Furthermore, participants had to have anthropo-
metric data available at baseline and information on relevant covariates
such as early life (for example, breast feeding) and socioeconomic factors
(for example, maternal overweight). This resulted in a final sample of
262 participants (53.6% female, 46.4% male).
Anthropometric measurements
Participants are measured at each visit according to standard procedures,24
dressed in underwear only and barefoot. From the age of 2 years onward,
standing height is measured to the nearest 0.1 cm using a digital
stadiometer (Harpenden Ltd., Crymych, UK). Body weight is measured to
the nearest 100 g using an electronic scale (Seca 753E; Seca Weighing and
Measuring Systems, Hamburg, Germany). Skinfold thicknesses are mea-
sured from the age of 6 months onward at four different sites (supra-iliacal,
subscapular, biceps, triceps) on the right side of the body to the nearest
0.1mm using a Holtain caliper (Holtain Ltd., Crosswell, United Kingdom).
Since 2005, waist circumference is also routinely measured according to
World Health Organization recommendations at the midpoint between
the lower rib margin and the iliac crest.25 The three trained nurses who
perform the measurements undergo an annual quality control, conducted
in six to eight healthy young adult volunteers. Average inter- and intra-
individual variation coefficients obtained in the last 6 years (2005--2010)
were 0.7 and 1.8% for waist circumference, 7.9 and 12.7% for biceps,
5.4 and 6.2% for triceps, 5.2 and 7.8% for subscapular, and 7.5 and 9.1%
for supra-iliacal skinfolds.
Anthropometric calculations
Regarding body mass index (BMI, kgm2) in puberty, sex- and age-
independent standard deviation scores were calculated using the German
reference curves for BMI.26 Percentage body fat (%BF) was derived using
equations of Slaughter et al.27 for pubescent children, which consider
triceps and subscapular skinfolds. Overweight during puberty was defined
according to values proposed by the International Obesity Task Force,
which correspond to an adult BMI of 25 kgm2.28 The reference values for
%BF published by McCarthy et al.29 were used to determine pubertal
participants with excess body fatness, that is, %BF above the 85th
percentile.29
Regarding anthropometric data in young adulthood, BMI was calculated
and %BF was estimated from skinfolds using Durnin and Womersley
equations,30 which are based on triceps, biceps, scapular and iliacal
skinfolds.
Nutritional assessment
Food consumption in the DONALD Study is assessed annually using 3-day
weighed dietary records. All foods and beverages consumed are weighed
and recorded, as well as leftovers, to the nearest 1 g over 3 days using
electronic food scales (initially Soehnle Digita 8000; Leifheit SG, Nassau;
Germany; now WEDO digi 2000; Werner Dorsch Gmbh, Muenster/Dieburg,
Germany). For this analysis, dietary variables were calculated as individual
means of the 3-day weighed dietary records using LEBTAB,31 the in-house
database, which is continuously updated to include all recorded food
items. LEBTAB is based on the German standard food tables32 and data
obtained from commercial food products. Currently, LEBTAB contains more
than 13 100 entries, including additives, supplements and medicine, that is,
1207 basic food items and 10 832 composite foods.
To better describe the habitual dietary intake during puberty, an
individual average intake was calculated from at least two records during
puberty.
Dietary GI and insulin index
Dietary GI is defined as the incremental area under the curve of glucose
response following the intake of 50 g of carbohydrate from a test food as
compared with area under the curve of glucose response induced by the
same amount of carbohydrate ingested as glucose in 5 - 10 separate
individuals.33 A published GI value34 was assigned to each carbohydrate-
containing food recorded in the dietary records (based on glucose as the
reference food) according to a standardized procedure.35 The carbo-
hydrate content (in grams) of each consumed food was then multiplied by
the food’s GI to obtain its glycemic load (GL). The sum of these GL values
for each subject corresponds to the total daily GL. The overall GI is
obtained by dividing the total daily GL by the total daily carbohydrate
intake.
The FII is defined as the insulinemic response (area under the curve)
following the intake of 1000 kJ of a food relative to the insulinemic
response to glucose that is, the reference food (FII¼ 100).20 Foods
originally tested against a white-bread standard were converted to the
glucose standard by a conversion factor of 0.73. For the present analysis,
121 FII values measured at Human Nutrition Unit School of Molecular and
Microbial Biosciences University of Sydney, Australia in groups of 10
individuals36 were available to assign a FII value to each food recorded in
the dietary records according to a standardized procedure similar to that
established for GI assignment (Figure 1). The dietary GL was the principal
consideration when matching foods rich in carbohydrates with an
available FII, as it is the best predictor of FII.20,36 The protein content
was used as a guide to find the best match when carbohydrate content
was low. A published FII or a close match was available for 36% of the
foods (steps 1 and 2), a weighted mean was calculated for another 33%
(step 4) and 18% of the foods were assigned the mean FII of the respective
food group (step 3). For 11% of the foods the FII value was assigned
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zero (step 6) and the GL ratio was used to calculate the FII of 3% foods
(for example, FIIsucrose¼GLsucrose/GLglucose FIIglucose; step 5). The average
dietary insulin load was calculated by summing the product of FII, energy
content and consumption frequency over all recorded food items in the 3-
day dietary records. The average dietary insulin index was calculated by
dividing the insulin load by total energy intake.37
Potentially confounding factors
On their child’s admission to the study, parents are interviewed by the
study pediatrician, and weighed and measured by the study nurses using
the same equipment as for children from 2 years onward. Information on
the child’s birth characteristics are abstracted from the ‘Mutterpass’, a
standardized document given to all pregnant women in Germany. The
duration of full breastfeeding (no solid foods and no liquids other than
breast milk, tea or water) is inquired by the pediatricians at the first visits
until complementary feeding is initiated. For this analysis the following
characteristics were considered: breastfeeding status (ever fully breastfed
(yes/no) was defined as fully breastfed 42 weeks), maternal overweight
status (BMI X25 kgm2), high maternal educational status (X12 years of
schooling) and smoking in the household (yes/no).
Statistical analysis
To analyze the potential relation of dietary insulin index, insulin load, GI
and GL during puberty with body composition in young adulthood, the
distribution of these dietary variables was grouped into tertiles (T1 - T3).
Tests for differences were performed among the tertiles of dietary insulin
index, insulin load, GI and GL using ANOVA for normally distributed
continuous variables, Kruskal - Wallis test for non-normally distributed
continuous variables and w2-test for categorical variables. Analysis of the
association between diet during puberty and body composition in young
adulthood was performed by multiple linear regression analysis. As BMI
was not normally distributed it was log-transformed before the analysis.
Each potential confounder was initially considered separately and included
if it modified the respective association substantially. Thus, sex was
retained in the basic model (model A). In a further step, we also adjusted
for early life (breastfeeding) and socioeconomic factors (maternal over-
weight) as well as other nutritional factors (model B). In a final model, we
controlled for confounding by body composition at baseline (model C). All
dietary variables except dietary insulin index and GI were energy adjusted
using the residual method.38 To account for age-dependent changes in
intake levels all variables were standardized by age group and sex
(mean¼ 0, s.d.¼ 1).6
The adjusted means (that is, least-squares means predicted by the
model when the other variables were held at their mean values) are
presented with their 95% confidence interval by tertiles. P-value o0.05
was considered as statistically significant. All statistical analyses were
carried out using SAS procedures (version 9.1.3, SAS Institute, Cary,
NC, USA).
RESULTS
Subjects who were excluded from the study sample (n¼ 132) did
not differ in sex, birth weight or length, gestational age, BMI and
%BF in young adulthood from those who were included (n¼ 262)
(data not shown).
Baseline characteristics of the 262 healthy participants did not
differ across tertiles of GI and GL. However, subjects with a diet in
the lowest tertile of insulin index and insulin load were less likely
to be overweight at baseline and those in the lowest tertile of
insulin load tended to have lower levels of %BF at baseline.
Furthermore, participants in the lowest tertile of the dietary insulin
load were less likely to have had mothers with a high level of
education (Table 1). Mean BMI--standard deviation scores during
puberty were close to zero, indicating that the BMI values at
baseline were comparable to the German reference population.
Participants in the highest dietary insulin index and insulin load
tertile had lower of total and saturated fat, total and animal
protein, but higher intakes of vegetable protein, carbohydrate,
and added sugar (% of total energy, %E) as well as higher dietary
GI and GL compared with participants in the lowest dietary insulin
index and insulin load tertile (Table 2). Comparable differences
were seen across tertiles of GL. A higher dietary GI was related to
lower intakes of total and animal protein as well as fiber, and
higher added sugar intake (%E), a higher dietary insulin index and
a higher GL.
Overall, dietary insulin index, insulin load, GI and GL during
puberty were not related to BMI in young adulthood, (Table 3) and
dietary GI and GL during puberty were not related to %BF in
young adulthood (Table 4). However, a higher dietary insulin index
Figure 1. Flowchart for the assignment of FII values to food items recorded in the 3-day weighed dietary records (FII values measured at
Human Nutrition Unit School of Molecular and Microbial Biosciences University of Sydney, Australia).
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Table 1. Demographic, anthropometric, birth, and socioeconomic characteristics by energy-adjusted tertiles of dietary insulin index, insulin load, GI, and GL at baseline (n¼ 262), DONALD Study,
Germany
Subjects
Dietary insulin index at baseline Dietary insulin load at baseline Dietary GI at baseline Dietary GL at baseline
n T1 T2 T3
P
valuea T1 T2 T3
P
valuea T1 T2 T3
P
valuea T1 T2 T3
P
valuea
Female (n (%)) 262 46 (53.5) 47 (53.4) 47 (53.4) 40.9 46 (53.5) 47 (53.4) 47 (53.4) 40.9 46 (53.5) 47 (53.4) 47 (53.4) 40.9 46 (53.5) 47 (53.4) 47 (53.4) 40.9
Age (years)b 262 9.8 9.9 9.3 0.7 9.8 9.9 9.3 0.6 9.9 9.5 9.2 0.7 9.8 9.8 9.6 40.9
Weight (kg)b 262 32.3 34.6 34.5 0.5 33.1 33.0 35.0 0.5 34.9 33.1 32.7 0.3 33.5 34.9 33.4 0.7
Height (m)b 262 139.7 142.1 142.2 0.6 139.9 141.3 142.5 0.8 142.0 140.0 142.1 0.2 141.0 142.1 141.1 0.7
BMI - SDS 262 -0.12 -0.02 0.06 0.4 -0.08 -0.10 0.10 0.3 0.10 -0.03 -0.15 0.2 0.06 -0.05 -0.09 0.5
BMI (kgm2)b 262 16.6 16.7 16.8 0.6 16.9 16.5 16.9 0.3 17.2 16.7 16.1 0.2 17.0 16.7 16.5 0.5
Overweight
(n (%))c
262 6 (7.0) 12 (13.6) 16 (18.2) 0.09 6 (7.0) 12 (13.6) 16 (18.2) 0.09 11 (12.8) 13 (14.8) 10 (11.4) 0.8 10 (11.6) 11 (12.5) 13 (14.8) 0.8
Body fatness
(%)b,d
262 15.1 16.3 17.4 0.1 15.1 16.3 17.5 0.09 15.4 16.4 16.0 0.9 16.3 15.9 16.0 0.7
Excess body fat
(n (%))e
262 11 (12.8) 15 (17.1) 19 (21.6) 0.3 12 (14.0) 14 (15.9) 19 (21.6) 0.4 14 (16.3) 15 (17.1) 16 (18.2) 0.9 15 (17.4) 12 (13.6) 18 (20.5) 0.5
Birth weight (g) 262 3443 3429 3542 0.2 3458 3423 3533 0.2 3506 3473 3436 0.6 3477 3481 3456 0.9
Birth length (cm)b 262 51.5 52.0 52.0 0.5 52.0 51.0 52.0 0.7 52.0 52.0 51.0 0.5 52.0 52.0 52.0 0.8
Pregnancy
duration (weeks)b
262 40.0 40.0 40.0 0.6 40.0 40.0 40.0 0.2 40.0 40.0 40.0 0.5 40.0 40.0 40.0 0.2
Breast feeding
(42weeks (n (%))f
262 58 (67.4) 66 (75.0) 61 (69.3) 0.5 56 (65.1) 69 (78.4) 60 (68.2) 0.1 62 (72.1) 56 (63.6) 67 (76.1) 0.2 60 (69.8) 61 (69.3) 64 (72.7) 0.9
Maternal
overweight
(n (%))g
262 22 (25.6) 31 (35.2) 31 (35.2) 0.3 22 (25.6) 31 (35.2) 31 (35.2) 0.3 24 (27.9) 27 (30.7) 33 (37.5) 0.4 23 (26.7) 30 (34.1) 31 (35.2) 0.4
Maternal
education (n (%))h
260 30 (35.3) 44 (50.0) 41 (47.1) 0.1 28 (32.9) 47 (54.0) 40 (45.5) 0.02 40 (46.5) 37 (42.5) 38 (43.7) 0.9 30 (35.3) 44 (50.6) 41 (46.6) 0.1
Smoking in the
household (n (%))
208 25 (34.7) 22 (31.9) 23 (34.3) 0.9 25 (34.2) 20 (28.6) 25 (37.3) 0.5 15 (22.7) 29 (40.3) 26 (37.1) 0.07 23 (31.9) 23 (32.4) 24 (36.9) 0.8
Abbreviations: BMI, body mass index; GI, glycemic index; GL, glycemic load; SDS, standard deviation scores; T, tertile. aSignificant differences between the tertiles were tested using analysis of variance for
normally distributed continuous variables, Kruskal - Wallis test for not normally distributed continuous variables and w2-test for categorical variables. Values are means unless indicated as mediansb or
otherwise. cDerived from the age- and sex-specific cut-points proposed by the International Obesity Task Force, which are linked to the adult cut-off point of a BMI of 25 kgm2.28 dCalculated according to
Slaughter et al.27 eDerived from age-specific cut-points proposed by McCarthy et al.,29 the 85th percentile of body fat was used as cut-off for excess of body fat. fBreast feeding categories:p2 weeks,42 weeks
of full breastfeeding. gMaternal BMI X25 kgm2. hSchool education for at least 12 years.
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and insulin load during puberty was associated with a higher %BF
in young adulthood, even after adjustment for early life,
socioeconomic and nutritional factors (model B for insulin index
and insulin load, both Pfor trend¼ 0.01). Additional consideration
of baseline %BF attenuated these relationships (model C,
Pfor trend¼ 0.1 for insulin index and Pfor trend¼ 0.08 for insulin
load). Model B did not include fiber as a covariate because it did
not affect the associations between dietary insulin index or insulin
load and body composition. Intakes of carbohydrate, protein or fat
were not considered because those macronutrients contribute to
the dietary insulin index and insulin load. However, as protein may
also conduce higher lean mass,39 we included this macronutrient
as a covariate in a further step (data not shown) and observed a
similar association between higher dietary insulin index and
insulin load during puberty, and higher %BF in young adulthood
(insulin index: Pfor trend¼ 0.0965; insulin load: Pfor trend¼ 0.07).
In an additional analysis we included carbohydrates and protein
to address the effect of qualitative changes in dietary insulin index
only, by holding the macronutrient intake constant, that is, the
effect of substituting carbohydrate- and protein-rich foods of a
high insulin demand for carbohydrate- and protein-rich foods with
a low insulin demand on %BF in young adulthood. Using this
qualitative approach, a higher dietary insulin index (Figure 2, Panel
A) and a higher dietary insulin load (Figure 2, Panel B) were both
related to a higher %BF in young adulthood even when
controlling for baseline %BF (Pfor trend¼ 0.04 and Pfor trend¼ 0.03,Ta
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Table 3. Relation of dietary insulin index, insulin load, GI, and GL at
baseline to body mass index (kgm2) in young adulthood (n¼ 262),
DONALD Study, Germany
T1 T2 T3 Pfor trend
Insulin index
Model A 22.5
(21.9, 23.2)
22.5
(21.8, 23.2)
22.8
(22.2, 23.5)
0.5
Model B 23.1
(22.3, 23.8)
23.0
(22.3, 23.7)
23.3
(22.6, 24.0)
0.5
Model C 23.0
(22.4, 23.6)
22.7
(22.2, 23.3)
22.9
(22.4, 23.5)
0.8
Insulin load
Model A 22.6
(21.9, 23.3)
22.3
(21.6, 22.9)
23.0
(22.3, 23.7)
0.5
Model B 23.1
(22.4, 23.8)
22.9
(22.2, 23.6)
23.4
(22.7, 24.1)
0.6
Model C 22.9
(22.3, 23.5)
22.7
(22.2, 23.3)
23.0
(22.4, 23.6)
0.9
GI
Model A 22.8
(22.1, 23.5)
22.5
(21.8, 23.2)
22.5
(21.8, 23.2)
0.8
Model B 23.0
(22.3, 23.7)
23.0
(22.3, 23.7)
23.3
(22.6, 24.0)
0.4
Model C 22.8
(22.2, 23.4)
22.8
(22.2, 23.3)
23.1
(22.5, 23.7)
0.4
GL
Model A 23.2
(22.5, 23.9)
22.6
(21.9, 23.3)
22.1
(21.4, 22.8)
0.3
Model B 23.3
(22.6, 24.1)
23.1
(22.5, 23.8)
22.8
(22.1, 23.5)
0.4
Model C 23.3
(22.7, 23.9)
22.9
(22.3, 23.5)
22.5
(21.9, 23.1)
0.6
Abbreviations: GI, glycemic index; GL, glycemic load; T, tertile. Values are
means and 95% confidence interval. Model A: adjusted for sex. Model B:
adjusted for sex, early life factors (breast feeding), socioeconomic factors
(maternal overweight) and nutritional factors (insulin index: energy; insulin
load: energy; GI: energy, fiber, protein; GL: energy, fiber, protein). Model C:
Model B + adjustment for baseline (body mass index).
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respectively). Similar results were obtained when adjusting for
intakes of carbohydrates and fat, or intakes of protein and fat
(data not shown).
Dietary insulin index, insulin load, GI and GL were not related to
waist circumference, which was, however, available for a
subsample of 196 participants only (data not shown).
We performed a number of additional analyses using
 the minimum number of two dietary records per subject
only, randomly selecting two records for those participants
who had provided more than two records (n¼ 262)
 the first anthropometric measurement in young adulthood as
an outcome (n¼ 262)
 anthropometric measurements at the age of 18 years as an
outcome (n¼ 218)
All approaches yielded similar results for the relationships of the
dietary insulin index or insulin load to %BF (data not shown).
DISCUSSION
To the best of our knowledge, the present study provides new
epidemiological evidence on a prospective relevance of dietary
insulin demand during puberty for %BF in young adulthood
among a healthy free-living population. Although our data are
purely observational and hence need to be interpreted cautiously,
our study suggests that postprandial rises in insulinemia rather
than glycemia may have adverse consequences for the develop-
ment of body composition in early adulthood.
Table 4. Relation of dietary insulin index, insulin load, GI, and GL at
baseline to percentage body fat in young adulthood (n¼ 262),
DONALD Study, Germany
T1 T2 T3 Pfor trend
Insulin index
Model A 22.3
(21.1, 23.4)
23.8
(22.7, 25.0)
24.2
(23.0, 25.3)
0.01
Model B 22.9
(21.6, 24.1)
24.5
(23.2, 25.7)
24.7
(23.5, 25.9)
0.01
Model C 23.2
(22.1, 24.3)
24.2
(23.1, 25.3)
24.2
(23.1, 25.3)
0.1
Insulin load
Model A 22.2
(21.1, 23.4)
23.7
(22.5, 24.9)
24.3
(23.2, 25.5)
0.007
Model B 22.8
(21.5, 24.0)
24.5
(23.2, 25.7)
24.8
(23.6, 26.0)
0.01
Model C 23.1
(22.0, 24.2)
24.2
(23.1, 25.3)
24.3
(23.3, 25.4)
0.08
GI
Model A 23.3
(22.1, 24.5)
23.5
(22.4, 24.7)
23.5
(22.3, 24.7)
0.9
Model B 23.5
(22.2, 24.9)
24.1
(22.9, 25.3)
24.4
(23.1, 25.6)
0.7
Model C 23.7
(22.5, 24.8)
24.0
(22.9, 25.1)
24.0
(22.9, 25.1)
40.9
GL
Model A 23.8
(22.6, 25.0)
23.6
(22.5, 24.8)
22.8
(21.7, 24.0)
0.8
Model B 24.3
(23.0, 25.6)
24.3
(23.1, 25.5)
23.5
(22.2, 24.8)
0.4
Model C 24.3
(23.1, 25.5)
24.2
(23.1, 25.3)
23.2
(22.1, 24.3)
40.9
Abbreviations: GI, glycemic index; GL, glycemic load; T, tertile. Values
are means and 95% confidence intervals. Model A: adjusted for sex.
Model B: adjusted for sex, early life factors (breast feeding), socioeconomic
factors (maternal overweight) and nutritional factors (insulin index: energy;
insulin load: energy; GI: energy, fiber, protein; GL: energy, fiber, protein).
Model C: Model B + adjustment for baseline (percentage body fat).
26a
b
Pfor trend=0.04
Pfor trend=0.03
T1
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T2 T3
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Figure 2. Percentage body fat in young adulthood by energy-
adjusted tertiles of dietary insulin index (II) (a) and insulin load (IL)
(b) during puberty (baseline) for 262 subjects. Data are means (95%
CI) adjusted for sex, early life factors (breast feeding), socioeconomic
factors (maternal overweight), nutritional factors (energy,
carbohydrates, protein) and percentage body fat at baseline. P for
trend refers to the P value obtained in linear regression models with
percentage body fat as continuous variable. T, tertile.
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The mechanistic role of high postprandial insulin levels for a
specific gain in %BF may be traced to the preferential direction of
nutrients away from oxidation in muscle and toward storage in
fat.40 In line with this, Chaput et al.41 reported that postprandial
hyperinsulinemia at 30min strongly predicted weight gain and
change in waist circumference over 6 years in adults, especially
among those consuming lower-fat diets. Furthermore, high insulin
and low plasma glucagon levels may restrain hepatic glucose
production and suppress lipolysis.42 Thus, over a longer term,
consistently high postprandial demand on the beta-cells may
eventually reduce insulin sensitivity14 and also promote the
development of higher %BF.43,44
Another plausible mechanism by which a high dietary insulin
index or insulin load (that is, insulin demand) may contribute to a
higher %BF may work through cross-stimulation of both insulin
and IGF-1 secretion.45 In vitro studies using cultures of adipocyte
precursor cells found a stimulatory effect of higher levels of
IGF-1 on the proliferation of preadipocytes, which may therefore
contribute to body-fat formation. Furthermore, IGF-1 stimulated
the cellular glucose uptake in preadipocytes and adipocytes,
increased lipogenesis and inhibited lipolysis in adipocytes.46
We speculate that the physiological insulin resistance and
the concurrent elevations of IGF-1 levels during puberty may
work together to increase the susceptibility to postprandial
insulinemic spikes and thus contribute to the development of
high body fat.
In our view, it is plausible that we did not observe an association
between dietary GI and body composition in our cohort of
relatively lean subjects with physiological insulin resistance
affecting peripheral tissues,47 as a higher dietary GI may be of
relevance primarily among persons who already respond with
exaggerated insulin responses.9 This may also explain why other
studies reported associations between dietary GI and body
composition mainly among overweight and less insulin-sensitive
persons.8,9 Conversely, we had expected to find at least a
tendency for a comparable relation between dietary GL and
body composition, as dietary GL has recently been identified as
the best indirect predictor of the postprandial insulin response.36
However, although the main contribution to the insulin responses
arises from carbohydrate-rich foods, Bao et al.36 reported dietary
GL to explain only 46% of the observed variability in insulin
responses, that is, foods with little or no carbohydrates and a
higher protein and fat content make additional important
contributions.
It could be argued that the association between dietary insulin
demand and unfavorable body composition may be primarily
attributable to one macronutrient only (for example, carbohy-
drates). However, our additional analysis adjusting for protein,
carbohydrates and energy suggests that in particular substitutions
of carbohydrate- and protein-rich foods with a higher insulin
demand for carbohydrate- and protein-rich foods with a lower
insulin demand are the relevant principle for the associations with
body fat. In addition, further adjustment for protein enhanced the
association between dietary insulin demand and body fat. This
may reflect a bi-directional relevance of dietary protein, which
may contribute to a higher lean body mass on the one hand39 and
a higher insulin secretion17 or lower insulin clearance on the other
hand.48
The relationship between a higher dietary insulin demand
during puberty and a higher %BF in young adulthood was
attenuated by the additional consideration of baseline %BF. While
this confirms the prevailing long-term relevance of %BF already in
childhood, we may have also corrected for earlier effects of dietary
insulin demand on body composition. It may be that the dietary
insulin demand has a more important role in adolescents who are
overweight or have a higher %BF. In our sample we did not find a
consistent interaction between overweight or excess body fat at
baseline and dietary insulin demand concerning %BF in young
adulthood, but this may be attributable to the fact that our sample
is comparatively healthy with lower prevalences of overweight or
excess body fat.
Our study has several limitations. First, we applied the FII
concept, developed to quantify the insulin response to foods --- to
estimate the dietary insulin demand. Hence, the limitations
debated for the estimations of dietary GI49 - 51 also apply to the
estimation of dietary insulin demand. As the FII assignment was
based only on 121 published FII values it must be considered
crude, yet allowing a classification of foods in FII groups.52 Second,
%BF was estimated from skinfold thickness measurements, which
are known to be more susceptible to measurement error than are
specialized research-based techniques. Other more accurate
methods to estimate %BF, such as hydrostatic weighing, may be
preferable to estimate body fat,53 but the skinfold equations of
Durnin and Womersley30 are feasible and agree, on average, very
well with results from hydrostatic weighing.53 Furthermore,
measurements were conducted by trained and quality-monitored
personnel, which has been shown to reduce intra- and inter-
observer variability considerably,54 as was the case in the present
study. Third, the DONALD population has a relatively high
socioeconomic status,55 as reflected by the parental educational
level. It is possible that the relative homogeneity of the healthy
DONALD sample means that extremes of diet or behavior are not
represented. However, non-representativeness is less relevant for
the present analysis and will likely result in underestimation rather
than overestimation of the true associations. On the other hand,
the homogeneity of our sample might have reduced our
vulnerability to residual confounding. Finally, we examined the
long-term relevance of the dietary insulin demand, GI and GL on
body composition at a single point in young adulthood only, as
presently only 141 participants had at least two anthropometric
measurements in both adolescence and young adulthood. In the
future, continued follow-up of our participants will also allow
analyses of growth trajectories.
A clear strength of our study is its prospective nature and the
carefully collected, repeated data on growth, the availability of
data on several possible confounders, such as parental character-
istics and repeated dietary data. Overall the analyses were based
on 1379 weighed 3-day dietary records, that is, on average each
subject had provided 5 dietary records during puberty (2 --7
records). A further advantage lies in the use of 3-day weighed
dietary records, which permitted a particularly detailed assign-
ment of dietary GI values for each carbohydrate-containing and
FII values for all foods.
In conclusion, our analysis indicates that postprandial increases
in insulinemia rather than glycemia are implicated in an
unfavorable development of body fat in the critical period of
puberty.
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Habitually Higher Dietary Glycemic
Index During Puberty Is Prospectively
Related to Increased RiskMarkers of
Type 2 Diabetes in Younger Adulthood
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OBJECTIVEdCarbohydrate nutrition during periods of physiological insulin resistance such
as puberty may affect future risk of type 2 diabetes. This study examined whether the amount or
the quality (dietary glycemic index [GI], glycemic load [GL], and added sugar, fiber, and whole-
grain intake) of carbohydrates during puberty is associated with riskmarkers of type 2 diabetes in
younger adulthood.
RESEARCH DESIGN AND METHODSdThe analysis was based on 226 participants
(121 girls and 105 boys) from the Dortmund Nutritional and Anthropometric Longitudinally
Designed Study (DONALD) with an average of five 3-day weighed dietary records (range 2–6)
during puberty (girls, age 9–14 years; boys, age 10–15 years) and fasting blood samples in
younger adulthood (age 18–36 years) (average duration of follow-up 12.6 years). Multivariable
linear regression was used to analyze the associations between carbohydrate nutrition and ho-
meostasis model assessment–insulin resistance (HOMA-IR) as well as the liver enzymes alanine ami-
notransferase (ALT) and g-glutamyltransferase (GGT) (n = 214).
RESULTSdA higher dietary GI was prospectively related to greater values of HOMA-IR
(Ptrend = 0.03), ALT (Ptrend = 0.02), and GGT (Ptrend = 0.04). After adjustment for sex, adult
age, baseline BMI, and early life and socioeconomic factors as well as protein and fiber intake,
predicted mean HOMA-IR values in energy-adjusted tertiles of GI were 2.37 (95% CI 2.16–
2.60), 2.47 (2.26–2.71), and 2.59 (2.35–2.85). The amount of carbohydrates, GL, and added
sugar, fiber, and whole-grain intake were not related to the analyzed markers.
CONCLUSIONSdOur data indicate that a habitually higher dietary GI during puberty may
adversely affect risk markers of type 2 diabetes in younger adulthood.
Diabetes Care 36:1870–1876, 2013
C
oncern has been raised that the
commonly advocated low-fat,
high-carbohydrate diet may be det-
rimental for the growing number of per-
sons with impaired glucose tolerance
even among youths, since it induces post-
prandial rises in glucose and insulin and
may thereby increase the risk the risk of
developing type 2 diabetes (1,2). Obser-
vational evidence suggests that dietary
glycemic index (GI) and glycemic load
(GL) are related to risk of type 2 diabetes
(3,4), yet it remains to be determined
whether the relevance of postprandial
rises in glucose and insulin extends to
pubertyda period characterized by a
physiological insulin resistance (5).
Chronic postprandial hyperglycemia
and hyperinsulinemia can also exacerbate
hepatic insulin resistance: enhanced glu-
cose uptake by the liver subsequently
leads to increased hepatic fat accumula-
tion through upregulated de novo lipo-
genesis. In fact, hepatic fat accumulation
is frequently observed in patients with
insulin resistance or type 2 diabetes (6).
The liver enzymes alanine aminotransfer-
ase (ALT) and g-glutamyltransferase
(GGT) are commonly used as surrogate
parameters for hepatic fat content and
are now recognized as risk markers for
type 2 diabetes (7,8). Furthermore, pre-
liminary evidence supports a role of car-
bohydrate nutrition for hepatic steatosis
and these indirect markers of liver fat (9).
This study addressed the hypothesis
that recurring postprandial glycemic ex-
cursions during puberty are of specific
relevance for later risk of type 2 diabetes.
Since calculated dietary GI is a valid
predictor of glycemic responses (10,11),
we postulate that dietary GI estimated
from 3-day dietary records repeatedly col-
lected during puberty is a better predictor
of type 2 diabetes risk in younger adult-
hood than intakes of dietary fiber, whole
grain, or added sugar. This hypothesis
was addressed using data from a cohort
of healthy young Germans. The homeo-
stasis model assessment–insulin resis-
tance (HOMA-IR) index and the liver
enzymes ALT and GGT was used as risk
markers of type 2 diabetes.
RESEARCH DESIGN AND
METHODSdThe present analysis is
based on data from the Dortmund Nutri-
tional and Anthropometric Longitudinally
Designed Study (DONALD), an ongoing
open cohort study conducted at the Re-
search Institute of Child Nutrition in Dort-
mund, Germany (12). This study has
previously been described in detail (12).
Briefly, since 1985, detailed data on diet,
growth, development, and metabolism
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have been collected from .1,300 healthy
children. Participants are recruited in the
city of Dortmund and surrounding com-
munities via personal contacts, maternity
wards, or pediatric practices. On average,
40 infants are newly recruited every year
and first examined at the age of 3 months.
Each child returns for three more visits
during the first year, two in the second,
and then annually until adulthood. Since
2005, participants over the age of 18 years
are invited for subsequent examinations
with fasting blood withdrawal. The study
was approved by the ethics committee of
the University of Bonn, and all examina-
tions are performed with written parental
and adult participants’ consent (12).
Because of the open cohort design,
many children had not yet reached youn-
ger adulthood, and among those who did
age varied from 18 to 36 years. At the time
of this analysis, one measurement of in-
sulin and glucose was available for 319
participants (mean age 22.7 years), who
were term (36–43 weeks’ gestation) sin-
gletons with a birth weight $2,500 g.
ALT and GGT values were available for
309 participants. Of these, 229 partici-
pants (for HOMA analysis) and 221 (for
ALT and GGT analysis), respectively, had
provided at least two plausible 3-day
weighed dietary records during the ado-
lescent baseline period (chronological
age: girls 9–14 years, boys 10–15 years),
allowing the estimation of habitual die-
tary intake. Participants who consistently
underreported their energy intake (i.e.,
they had provided more implausible
than plausible food records) were ex-
cluded from the study (n = 20) (13).
A 3-day weighed dietary record was con-
sidered plausible when the total recorded
energy intake was adequate in relation to
the basal metabolic rate (13). For inclu-
sion in the study sample, participants also
had to have anthropometric measures
taken in adolescence and adulthood as
well as information on relevant covariates.
This resulted in a final sample of 226 par-
ticipants for analysis of insulin or related
outcomes and of 214 for the liver enzymes.
Blood analysis
Venous blood samples were drawn after
an overnight fast, centrifuged within 15
min, and frozen at –808C in the Research
Institute. For the present analysis, blood
samples were transported to the technical
laboratory of the German Diabetes Center
to determine serum activities of ALT and
GGT using the COBAS C311 analyzer
(Roche, Mannheim, Germany). Serum in-
sulin concentrations were measured with
an immunoradiometric assay in the Lab-
oratory for Translational Hormone Analyt-
ics in Pediatric Endocrinology at the
University ofGiessen. Basedon these values,
HOMA-IR and secretion (HOMA of b-cell
function [HOMA-b]) were calculated (14).
Anthropometric measurements
From the age of 2 years onward, standing
height is measured to the nearest 0.1 cm
using a digital stadiometer (Harpenden,
Crymych, U.K.). Bodyweight is measured
to the nearest 100 g with an electronic
scale (Seca 753E; Seca Weighing and
Measuring Systems, Hamburg, Ger-
many). Measurements are taken at each
visit according to standard procedures.
Skinfold thicknesses are measured from
the age of 6 months onward at four
different sites (suprailiacal, subscapular,
biceps, and triceps) on the right side of the
body to the nearest 0.1 mm using a
Holtain caliper (Holtain, Crosswell, U.K.).
Table 1dDemographic, anthropometric, birth, and socioeconomic characteristics by
sex-specific tertiles of dietary glycemic index: DONALD, Germany
n
Dietary GI
T1
(n = 75)
T2
(n = 76)
T3
(n = 75) Pa
Female (%) 226 53.3 54.0 53.3 1.0
Early life factors
Birth yearb 226 1,986 1,987 1,987 0.3
Birth weight (g) 226 3,485 3,496 3,471 0.9
Birth length (cm) 226 51.7 51.8 51.6 0.8
Pregnancy duration (weeks)b 225 40 40 40 0.4
Breast-feeding (.2 weeks) (%)c 226 74.7 64.5 74.7 0.3
Data from puberty
Age (years)b 226 9.8 9.1 9.9 0.8
BMI SDs 226 0.16 0.03 20.08 0.2
BMI (kg/m2)b 226 17.5 16.6 16.4 0.2
Overweight (%)d 226 16.0 15.8 12.0 0.7
%BFb,e 226 16.3 16.0 16.2 0.7
Excess body fat (%)b,f 226 18.7 17.1 18.7 1.0
Socioeconomic factors (%)
Maternal overweightg 222 27.4 33.8 34.7 0.6
Maternal educationh 226 53.3 42.1 45.3 0.4
Maternal occupationi 226 50.7 51.3 50.7 1.0
Smoking in the household 221 20.8 42.7 39.2 0.01
Data from younger adulthood
Age (years)b 226 21.9 22.4 21.5 0.5
BMI (kg/m2)b 226 23.2 22.2 22.2 0.5
%BFb,j 226 26.9 27.5 26.1 1.0
Waist circumference (cm)b 226 76.7 76.1 75.1 0.8
ALT (units/L)b 214 14.9 15.6 17.7 0.02
GGT (units/L)b 214 13.7 14.7 16.3 0.07
TG (mmol/L)b 214 1.09 1.14 1.14 0.7
Glucose (mmol/L)b 226 5.11 5.11 5.22 0.4
Insulin (mU/L)b 226 76.8 81.5 81.2 0.2
HOMA-IRb 226 2.46 2.52 2.58 0.1
HDL (mmol/L)b 222 1.45 1.47 1.53 0.9
LDL (mmol/L)b 222 2.40 2.38 2.53 0.4
Data are means unless otherwise indicated. T, tertile. aSignificant differences between the tertiles were tested
using ANOVA for normally distributed continuous variables, Kruskal-Wallis test for non–normally dis-
tributed continuous variables, and x2 test for categorical variables. bValues are means unless indicated as
medians. cBreast-feeding categories:#2 vs..2 weeks of full breast-feeding. dDerived from the age- and sex-
specific cut points proposed by the International Obesity Task Force, which are linked to the adult cutoff point of
BMI 25 kg/m2 (Cole et al., 2000 [ref. 16]). eCalculated according to Slaughter et al. (1988 [ref. 17]). fDerived
from age-specific cut points proposed by McCarthy et al. (2006 [ref. 18]); the 85th percentile of body fat was
used as cutoff for excess of body fat. gMaternal BMI $25 kg/m2. hSchool education for at least 12 years.
iMaternal occupation (yes/no). jCalculated according to Durnin and Womersley (ref. 19).
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Waist circumference in younger adult-
hood was measured at the midpoint be-
tween the lower rip and the iliac crest to
the nearest 0.1 cm. Sex- and age-specific
SD scores (SDs) were calculated for the
adolescent BMI values using the German
BMI standards (15). For definition of over-
weight during puberty, values proposed
by the International Obesity Task Force
were used (16). Percentage body fat (%
BF) for pubescent children was derived
using the equations of Slaughter et al.
(17), and excess body fatness was defined
according to the %BF standard (18). For
estimation of %BF in adulthood, equa-
tions of Durnin and Womersley were
used (19).
Dietary assessment
During 3 days, the participants or their
parents weighed and recorded all foods
and beverages consumed as well as left-
overs to the nearest 1 g using electronic
food scales (initially, Soehnle Digita 8000;
Leifheit, Nassau, Germany; now, WEDO
digi 2000; Werner Dorsch, M€unster/
Dieburg, Germany). For this analysis, die-
tary variables were calculated as individ-
ual means of the 3-day weighed dietary
records using LEBTAB (20), the in-house
database. As we aimed to describe the ha-
bitual dietary intake, an individual aver-
age intake during puberty was calculated
from at least two records (average of 5
records per participant).
Each carbohydrate-containing food
recorded in the dietary records was
assigned a published GI value (21) (based
on glucose as a reference food) according
to a standardized procedure (22). The
carbohydrate content (in grams) of each
consumed food was then multiplied by
the food’s GI to obtain the respective
GL. The overall dietary GI is obtained by
dividing total daily GL by total daily car-
bohydrate intake.
The following foods were defined as
added sugars: white sugar, brown sugar,
raw sugar, corn syrup, corn syrup solids,
high-fructose corn syrup, malt syrup,
maple syrup, pancake syrup, fructose
sweetener, liquid fructose, honey, molas-
ses, anhydrous dextrose, and crystal dex-
trose (23). Fruit syrups commonly used
as sweeteners in Germany also were con-
sidered added sugars. Dietary fiber con-
tent was calculated using the LEBTAB
database.Whole-grain intakewas estimated
by assigning whole-grain content in grams
to each carbohydrate-containing food us-
ing the respective recipe and ingredient
information available at the time of record-
ing. The definition of whole grain fol-
lowed the whole-grain label statements
of the U.S. Food and Drug Administration
(24).
Statistical analysis
Baseline characteristics of the study pop-
ulation are presented by sex-specific ter-
tiles of dietary GI. Tests for differences
between these tertiles were performed
using ANOVA for normally distributed
continuous variables, Kruskal-Wallis test
for non–normally distributed continuous
variables, and x2 test for categorical vari-
ables.
For analysis of the prospective asso-
ciation between carbohydrate nutrition
during puberty and risk markers for type
2 diabetes in younger adulthood, multi-
variable linear regression models were
used. As the outcome variables were not
normally distributed, HOMA-IR was log
transformed prior to analysis, and liver
enzymes ALT and GGT were log trans-
formed twice to obtain normal distribu-
tion. All dietary variables except dietary
GI were energy adjusted using the re-
sidual method. To account for age-
dependent nutritional differences, we
standardized all variables by age-group
and sex (mean 6 SD 0 6 1).
Covariates considered as potentially
affecting the association between carbo-
hydrate nutrition and risk markers of type
2 diabetes were birth weight, gestational
age, breast-feeding for .2 weeks, first-
born child (yes/no), BMI SDs or %BF at
baseline, maternal overweight (BMI $25
kg/m2), high maternal educational status
($12 years of schooling), maternal occu-
pation (yes/no), smoking in the house-
hold, parental history of diabetes (yes/no
[questionnaire based]), physical activity
level (light, moderate, or high [question-
naire based]), and intakes of protein (to-
tal, animal, or vegetable) and fat (total and
saturated fat). Vice versa adjustment for
added sugar, fiber, and GI was also con-
sidered. Each potential confounder was
initially examined separately and in-
cluded only if it 1) substantially altered
the association of the principal dietary
variables with the outcome in the unad-
justed models (.10%), 2) significantly
predicted the outcome, or 3) improved
the coefficient of determination (.5%).
In the basic model (model A), sex and
age were included, since age at blood
Table 2dBaseline nutritional data by sex-specific tertiles of dietary glycemic index:
DONALD, Germany
Dietary GI
(n = 226 subjects)
PaT1 (n = 75) T2 (n = 76) T3 (n = 75)
Dietary GI 53.4 56.1 58.4 ,0.0001
Total energy (MJ/day)b 7.95 7.55 7.96 0.5
Fat (% energy) 35.4 36.5 35.4 0.2
Saturated fatty acid 15.8 16.2 15.4 0.08
Protein (% energy) 13.4 13.0 12.5 0.0007
Animal protein 8.69 8.10 7.62 0.0001
Vegetable protein 4.72 4.88 4.85 0.4
Carbohydrate (% energy) 51.1 50.5 52.1 0.08
Added sugar (% energy) 13.1 14.2 17.0 ,0.0001
From drinks 3.21 4.03 6.07 ,0.0001
From sweets 6.05 6.28 7.16 0.03
From other sources 3.81 3.92 3.73 0.8
Dietary GL (g)b 131.0 131.3 140.4 0.02
Fiber (g)b 20.6 18.9 17.3 0.0001
Fiber (g/MJ) 2.63 2.51 2.31 0.0005
From bread and cereals 1.30 1.30 1.30 1.0
From vegetables 0.55 0.50 0.48 0.06
From fruits 0.58 0.57 0.37 ,0.0001
Whole grain (g)b 29.1 19.2 16.3 0.0004
Whole grain (g/MJ) 4.43 3.36 2.9 0.003
Data are means unless otherwise indicated. aSignificant differences between the tertiles were tested using
ANOVA for normally distributed continuous variables, Kruskal-Wallis test for non–normally distributed
continuous variables, and x2 test for categorical variables. bValues are means unless indicated as medians.
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withdrawal in younger adulthood varied
considerably (18–35 years). In a second
model (model B), we further adjusted for
early life and socioeconomic as well as
other nutritional factors. Finally, we
ran a conditional model (additionally in-
cluding waist circumference in younger
adulthood) to assess whether the ob-
served associations are partly attributable
to effects of carbohydrate nutrition on
body composition. Verification of the lin-
ear regression modeling assumptions
showed that these were appropriate for
the analyzed longitudinal data.
As associations between carbohy-
drate nutrition and risk markers of type
2 diabetes did not differ by sex (P for in-
teraction .0.2), data were pooled for
analysis. The adjusted means are presen-
ted by tertiles with the corresponding
95% CIs. P values ,0.05 were consid-
ered statistically significant. All statistical
analyses were carried out using SAS
procedures (version 9.1.3; SAS Institute,
Cary, NC).
RESULTSdSubjects who were ex-
cluded from the study sample because of
missing information (dietary intake data
or covariates) (n = 93) did not differ from
those included (n = 226) with respect to
early life factors or anthropometric or
metabolic characteristics in younger
adulthood (data not shown).
Participants with a higher dietary GI
during adolescence were more likely to be
exposed to smoking in the household
(Table 1). There were no other differences
in anthropometric, early life, or socioeco-
nomic factors during puberty between the
dietary GI tertiles. Regarding data from
younger adulthood, participants with
a higher dietary GI during puberty had
higher ALT and GGT values (Table 1).
In terms of nutritional intake data during
puberty, those in the higher dietary GI
tertiles consumed less (animal) protein,
(fruit) fiber, and whole grain, as well as
more added sugar, especially from drinks
(Table 2).
The amount of carbohydrates, dietary
GL, added sugar, fiber, and whole-grain
intake during puberty was not associated
with HOMA-IR in younger adulthood
(Table 3). A higher dietary GI during pu-
berty was prospectively related to higher
values of HOMA-IR in multivariable anal-
ysis (P for trend = 0.03 [model A]). This
association was not explained by baseline
BMI, early life or socioeconomic factors,
or protein or fiber intake (P for trend =
0.03 [model B]). No prospective associa-
tions were observed between carbohy-
drate nutrition and HOMA-b (P for
trend $0.2) (data not shown).
A higher dietary GI was also indepen-
dently associated (adjustment for baseline
BMI and socioeconomic and nutritional
factors) with higher values of both ALT
Table 3dHOMA-IR in younger adulthood by tertiles of carbohydrate nutrition parameters during puberty
HOMA-IR (n = 226)
T1 T2 T3 Ptrend
Carbohydrate (energy %)
Model A 2.54 (2.31–2.78) 2.66 (2.42–2.91) 2.54 (2.32–2.78) 0.5
Model B 2.48 (2.24–2.75) 2.53 (2.31–2.77) 2.41 (2.18–2.65) 0.6
Conditional model 2.43 (2.20–2.67) 2.54 (2.33–2.77) 2.43 (2.21–2.67) 0.5
Glycemic Index
Model A 2.44 (2.23–2.67) 2.59 (2.37–2.83) 2.71 (2.47–2.96) 0.03
Model B 2.37 (2.16–2.60) 2.47 (2.26–2.71) 2.59 (2.35–2.85) 0.03
Conditional model 2.39 (2.19–2.61) 2.49 (2.28–2.72) 2.54 (2.32–2.79) 0.09
Glycemic load
Model A 2.58 (2.35–2.82) 2.52 (2.30–2.75) 2.64 (2.41–2.89) 0.6
Model B 2.46 (2.23–2.72) 2.38 (2.17–2.61) 2.57 (2.34–2.83) 0.4
Conditional model 2.44 (2.21–2.68) 2.39 (2.19–2.61) 2.58 (2.36–2.83) 0.6
Added sugar (energy %)
Model A 2.61 (2.39–2.86) 2.64 (2.41–2.89) 2.48 (2.26–2.71) 0.7
Model B 2.57 (2.32–2.86) 2.57 (2.34–2.82) 2.29 (2.07–2.54) 0.3
Conditional model 2.53 (2.29–2.80) 2.56 (2.35–2.80) 2.33 (2.11–2.57) 0.4
Added sugar from drinks (energy %)
Model A 2.71 (2.47–2.96) 2.52 (2.30–2.76) 2.51 (2.29–2.75) 0.8
Model B 2.64 (2.39–2.92) 2.45 (2.23–2.69) 2.35 (2.13–2.60) 0.5
Conditional model 2.60 (2.36–2.86) 2.43 (2.22–2.65) 2.40 (2.18–2.63) 0.8
Fiber (g/1,000 kcal)
Model A 2.67 (2.44–2.92) 2.65 (2.43–2.90) 2.41 (2.20–2.64) 0.3
Model B 2.51 (2.29–2.77) 2.56 (2.34–2.80) 2.36 (2.15–2.60) 0.4
Conditional model 2.50 (2.28–2.74) 2.53 (2.32–2.75) 2.40 (2.19–2.63) 0.6
Whole grain (g/1,000 kcal)
Model A 2.60 (2.38–2.85) 2.61 (2.38–2.85) 2.52 (2.30–2.76) 0.8
Model B 2.42 (2.20–2.66) 2.56 (2.34–2.80) 2.45 (2.23–2.69) 0.9
Conditional model 2.38 (2.17–2.60) 2.56 (2.35–2.79) 2.47 (2.26–2.71) 0.7
Values are means (95% CI) unless otherwise indicated. Model A, adjusted for sex, age (categorical:#19,.19,#25, and.25 years), and energy (residuals). Model B,
model A plus early life factors (firstborn), BMI SDs at baseline, socioeconomic factors (maternal education), and nutritional factors (carbohydrate, GI, GL, and sugar
adjusted for fiber and protein; fiber adjusted for GI and protein). Conditional model, additional inclusion of waist circumference in younger adulthood in model B.
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(P for trend = 0.02 [model B]) and GGT (P
for trend = 0.04 [model B]) (Fig. 1).
Amount of carbohydrates, dietary GL,
total added sugar, dietary fiber, and
whole-grain intake were not related to
liver enzymes. Higher intakes of added
sugar from drinks during puberty were
independently related to higher levels of
GGT in adulthood (P for trend = 0.04
[model B]) (data not shown).
We also examined the association
between carbohydrate nutrition and fast-
ing insulin levels; similarly, this analysis
revealed a prospective positive relation
for dietary GI only (P for trend = 0.045).
Further adjustment for breast-feeding sta-
tus, birth weight, physical activity level,
or parental history of type 2 diabetes did
not change any of the results.
The additional inclusion of waist
circumference in adulthood attenuated
the associations between dietary GI and
risk markers of type 2 diabetes toward a
trend (conditional model [Table 3]). The
corresponding mean predicted ALT and
GGT values in sex-specific tertiles of GI
were 16.7 units/L (95% CI 15.3–18.4),
16.3 units/L (15.0–17.8), and 18.0
units/L (16.4–19.9) (P for trend = 0.07)
and 14.1 units/L (12.7–15.7), 14.0 units/L
(12.6–15.5), and 16.6 units/L (14.8–18.7)
(P for trend = 0.09), respectively.
CONCLUSIONSdThis study pro-
vides new epidemiological evidence of a
detrimental role of postprandial glycemic
excursions during puberty for risk mark-
ers of type 2 diabetes in younger adult-
hood. Dietary GI was the only feature of
carbohydrate nutrition that was consis-
tently related to different diabetes risk
markers. As a low-GI diet is characterized
by an average of#45 (25), the dietary GI
in the present sample (56.06 2.4) can be
considered moderate.
The association between dietary GI
and diabetes risk seen in our study is in
accordance with observational evidence
in adulthood linking dietary GI to risk of
developing type 2 diabetes (3,4). Our
study is, however, the first to suggest
that this association emerges already dur-
ing puberty. In view of the relatively large
95% CIs, the observed associations have
to be interpreted cautiously. In our
study, a 5-unit increase of dietary GI
was accompanied by a 9% increase in
HOMA-IR and an 11% increase in ALT
values. This is in line with evidence
from large observational studies, where
moderate GI differences between extreme
quantiles were also associated with rela-
tively large differences in type 2 diabetes
risk (3). Importantly, there was no strong
correlation between HOMA-IR, ALT, and
GGT in our study (r,0.4), which argues
against the possibility of chance findings.
Of note, the relation between dietary
GI and diabetes risk markers appeared to
be partly attributable to body composition,
since associations were attenuated toward
a trend in the conditional model. None-
theless, a trend was maintained, suggest-
ing an additional mechanism independent
of body composition. In fact, a previous
analysis of ours did not reveal an inde-
pendent association between GI during
puberty and body composition in younger
adulthood (26). Another mechanism by
which dietary GI may affect diabetes risk
independently of body composition is
oxidative stress: Increased postpran-
dial glycemia can exert prooxidative
and proinflammatory effects (27).
Hyperglycemia-induced oxidative stress
could impair mitochondrial function
(28). In turn, impaired mitochondrial
function may cause both hepatocyte in-
jury and subsequently increased release
of ALT and GGT (28) and contribute to
insulin resistance independently of he-
patic lipid content (29). Moreover, exces-
sive postprandial glycemia increases the
strain on b-cell mass, which can be partic-
ularly detrimental in a phase of decreased
insulin sensitivity such as puberty (30).
Our data indicate a long-term relevance
of dietary GI for both systemic and hepatic
insulin resistance, as reflected by associa-
tions with HOMA-IR and insulin as well as
GGT and ALT. Moreover, in our healthy
sample, habitual dietary GI seems to be of
long-term relevance for insulin sensitivity
only, since GI was not prospectively
related to b-cell function (e.g., HOMA-b).
The results of our study dismiss the
relevance of total carbohydrate intake for
later insulin sensitivity and corroborate the
rising awareness that carbohydrate quality
ismore important for risk of type 2 diabetes
than carbohydrate quantitydat least for
healthy persons. We cannot, however,
exclude the possibility that lower carbohy-
drate intake may offer some benefits for
obese adolescents, since they cannot adapt
appropriately to high-carbohydrate diets
by increasing their insulin sensitivity and
may, hence, need to increase insulin secre-
tion further (31).
We observed no prospective associa-
tion between consumption of added
sugar from drinks or fiber intake and
adult type 2 diabetes risk markers except
for an association between added sugar
from drinks and GGT. Observational
studies in adults support a relation of
both consumption of sugar-sweetened
beverages (32) and cereal fiber (33) to
type 2 diabetes risk, while mechanistic
studies point to specific benefits of vis-
cous fiber on insulin sensitivity (34).
This discrepancy may to some degree
Figure 1dALT (units/L) (A) and GGT (units/L) (B) levels in younger adulthood by energy-
adjusted tertiles of dietary glycemic (GI) (mean dietary GI across tertiles [T]: tertile 1, 53.5; 2,
56.2; and 3, 58.5) during puberty (baseline) for 214 subjects. Data are geometric means (95%CI)
adjusted for sex, age (categorical #19, .19, #25, and .25 years), BMI SDs at baseline, so-
cioeconomic factors (maternal overweight), energy (residuals), and protein and fiber intake. See
the text for results from the conditional model additionally considering waist circumference in
younger adulthood. Note that the slight U-shape in A results from illustration of least square
means by GI tertiles, the association is linear, and all assumptions of linear regression modeling
are met. (See the STATISTICAL ANALYSIS.)
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result from residual confounding. In the
present analysis, confounding is less
likely because the DONALD population
is comparably homogeneous with a
higher socioeconomic status. In addition,
benefits of higher fiber intakes are partly
attributed to lower postprandial glyce-
mia. This response is, however, better de-
scribed by dietary GI: In a recent study
using 121 foods and 13 meals, postpran-
dial glycemia was related to GI and GL but
not fiber content (35). It is therefore pos-
sible that exposure to postprandial glyce-
mia during puberty (as estimated by
dietary GI) is of particular relevance for
diabetes risk in younger adulthood,
whereas other mechanisms linking fiber
intake to diabetes risk become more im-
portant in later adulthood.
The main strengths of our study are
its prospective design and the detailed
repeated measurements of dietary intake
during puberty. Assessment of dietary
intake during puberty is notoriously dif-
ficult, but the present analysis was based
on an average of five dietary records
during puberty (range 2–6 per partici-
pant), which allowed estimation of habit-
ual dietary intake. Comparisons of our
carbohydrate-intake data with other stud-
ies in adolescents showed similar intake
levels with respect to total carbohydrate,
added sugar (36,37), and dietary GI (38).
The availability of data on several poten-
tial confounders, such as parental charac-
teristics, including self-reported parental
history of type 2 diabetes, further
strengthens our analysis. However, we
cannot preclude residual confounding,
resulting from imprecisely measured or
unmeasured confounding factors. Impor-
tantly, only crude questionnaire-based data
were available for physical activity levels.
Our study also has several limitations.
First, risk markers of type 2 diabetes were
only measured once in younger adult-
hood. Second, the relatively elaborate
DONALD study design results in a socio-
economic status above average, and ex-
tremes of diet or behavior might not be
represented, which is likely to introduce
selection bias. Thirdly, estimation of the
dietary GI from the GI values of individual
foods is discussed controversially (10,39).
However, in contrast to most epidemiolog-
ical studies using food-frequency question-
naires, the GI estimates in this study stem
from direct assignment of GI values to all
carbohydrate-containing foods recorded
during 3 days (22).
Relating our results to those from
other studies, the lack of data on the
longer-term influence of adolescent nu-
trition on later health becomes very evi-
dent. Our study provides new evidence
for a long-term impact of postprandial
glycemic excursions during puberty on
later diabetes risk. The absence of such
associations for other measures of carbo-
hydrate quality suggests that advice fo-
cusing solely on dietary fiber and added
sugar intake is insufficient. Further large-
scale studies, preferably in at-risk popu-
lations (e.g., overweight or insulin-resistant
adolescents) are needed to support the
present findings and confirm their public
health relevance.
In conclusion, our data indicate that a
habitually higher dietary GI during pu-
berty may adversely affect risk markers of
type 2 diabetes in younger adulthood.
Advice for preferred selection of low-GI
carbohydrates during puberty may need
to be incorporated into preventive dietary
recommendations given to adolescents.
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Increased Intake of Carbohydrates from
Sources with a Higher Glycemic Index and
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Higher IL-6 Concentrations in Younger
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Abstract
Chronic low-grade inflammation represents a likely intermediary in the relation between carbohydrate nutrition and both type 2
diabetes and cardiovascular disease. This study assessed the prospective association between carbohydrate quantity and quality
[dietary glycemic index (GI), glycemic load (GL), and added sugar, fiber, and whole-grain intake] during puberty, a potentially critical
period for later disease, and low-grade inflammation in younger adulthood. The analysiswas based on 205 participants (113 girls and
92 boys) from the DONALD (Dortmund Nutritional and Anthropometric Longitudinally Designed) study with at least 2 3-d weighed
dietary records during puberty (girls: 9–14 y, boys: 10–15 y) and blood samples in younger adulthood (18–36 y). Multivariable linear
regressionmodelswere used to analyze the associations between carbohydrate nutrition and circulating concentrations of pro- and
anti-inflammatory immunemediators [high-sensitivity C-reactive protein (hs-CRP), interleukin (IL) 6, IL-18, and adiponectin]. A higher
intake of carbohydrates during puberty (P-trend=0.005), particularly fromhigher-GI food sources (P-trend=0.01),was prospectively
related to higher concentrations of IL-6 in younger adulthood, independently of baselineBMI and early life, socioeconomic, and other
nutritional factors. Furthermore, a higher dietary GL (P-trend = 0.002) and a lower intake of whole grains (P-trend = 0.01) were
independently associatedwith higher IL-6 concentrations in adults. Dietary GI and added sugar and fiber intakeswere not independently
associated with IL-6 (P-trend $ 0.09). Carbohydrate nutrition during puberty was not independently related to hs-CRP, IL-18, and
adiponectin concentrations (all P-trend > 0.1). During puberty, a higher intake of carbohydrates from higher-GI food sources and lower
whole-grain consumption prospectively predict greater IL-6 concentrations in young adulthood. These data support the hypothesis that
diet during puberty influences later inflammation and metabolic dysfunction. J. Nutr. doi: 10.3945/jn.114.193391.
Introduction
Carbohydrate quality plays a crucial role in the development of type
2 diabetes (T2D)11 and cardiovascular disease (CVD) (1). Observa-
tional evidence suggests that a high intake of whole-grain products
or dietary fiber, particularly from cereal sources, protects against
T2D and CVD (2,3). In addition, the glycemic potency of carbohy-
drates as measured by the dietary glycemic index (GI) and glycemic
load (GL) was linked to the risk of T2D (4,5) and CVD (6).
1 The results presented in this article are part of a project funded by the German
Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) through the
Federal Office for Agriculture and Food (BLE), grant 2810HS035. The DONALD study
is supported by the Ministry of Science and Research of North Rhine Westphalia,
Germany. The German Diabetes Center is funded by the German Federal Ministry of
Health, the State Ministry of School, Science and Research of the State of
North-Rhine-Westphalia, and in part by grants to the German Center for Diabetes
Research (DZD e.V.).
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C. Herder, no conflicts of interests.
3 Supplemental Tables 1 and 2 and Supplemental Figure 1 are available from the
"Online Supporting Material" link in the online posting of the article and from the
same link in the online table of contents at http://jn.nutrition.org.
11 Abbreviations used: CVD, cardiovascular disease; DONALD, Dortmund
Nutritional and Anthropometric Longitudinally Designed; GI, glycemic index; GL,
glycemic load; hs-CRP, high-sensitivity C-reactive protein; T2D, type 2 diabetes.
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Chronic low-grade inflammation is discussed as a main mech-
anism linking carbohydrate intake to the development of these
chronic diseases (7). Although the evidence on the impact of
total carbohydrate intake on inflammatory markers is inconclusive
(8), the majority of studies point to the relevance of carbohy-
drate quality: in a large intervention study, a diet characterized
by a lower GI led to a reduced inflammatory status (9) and pro-
spective studies observed an association between high dietary fiber
(10) and whole-grain intake (11) and decreased high-sensitivity
C-reactive protein (hs-CRP) and IL-6 concentrations.
Primary prevention of metabolic chronic diseases should start
early in life. The fact that puberty associates with physiologic
insulin resistance (12) suggests that insulin metabolism might
be particularly sensitive to carbohydrate nutrition during this
period. Indeed, we previously demonstrated a direct association
between a higher dietary GI during puberty and T2D riskmarkers
(HOMA-IR and liver enzymes) in younger adulthood (13). It
remains to be determined whether carbohydrate quantity and
quality during this period are also of prospective relevance for
chronic low-grade inflammation. Therefore, the present study
analyzes the prospective association between the amount (% of
total energy) and the quality (dietary GI, GL, and added sugar,
fiber, and whole-grain intakes) of habitual dietary carbohydrate
consumption during puberty and proinflammatory markers
(hs-CRP, IL-6, IL-18), as well as the anti-inflammatory adipose
tissue hormone adiponectin in younger adulthood in a cohort of
healthy young Germans. hs-CRP, IL-6, IL-18, and adiponectin
were selected because of their previously reported associations
with risk of T2D and/or CVD in large meta-analyses (14–16).
Participants and Methods
Study population. The present analysis is based on data from theDONALD
(Dortmund Nutritional and Anthropometric Longitudinally Designed Study)
study, an ongoing open cohort study conducted at the Research Institute of
Child Nutrition in Dortmund, Germany. Since 1985, detailed data on diet,
growth, development, and metabolism have been collected from >1500
apparently healthy children. On average, 40 infants are newly recruited
every year and first examined at the age of 3 mo. Each child returns for 3
more visits during the first year, 2 in the second year, and then annually until
adulthood (17). Since 2005, participants >18 y are invited for subsequent
examinations with fasting blood withdrawal. The study was approved by
the Ethics Committee of the University of Bonn, and all examinations are
performed with written parental and adult participants! consent.
Because of the open cohort design, many children have not yet reached
younger adulthood, and among those who did, age varies from 18 to 36
y. At the time of this analysis, 1 measurement of inflammatory markers
was available for 308 participants, who were term (36–43 wk gestation)
singletons with a birth weight $2500 g. Of these, 220 participants had
provided at least 2 plausible 3-d weighed dietary records during the
puberty baseline period (chronologic age: girls 9–14 y, boys 10–15 y),
allowing the estimation of habitual dietary intake. Participants whowere
identified to consistently under-report their energy intake (i.e., all food
records were implausible or they had provided more implausible than
plausible food records) were excluded from the study (n = 7). A 3-d
weighed dietary record was considered plausible when the total recorded
energy intake was adequate in relation to the basal metabolic rate
[estimated from the Schofield equations (18) by using modified cutoffs
from Goldberg et al. (19)]. For inclusion in the study sample, parti-
cipants also had to have anthropometric measures taken in puberty and
adulthood as well as information on relevant covariates such as early life
and socioeconomic factors. This resulted in a final sample of 205 par-
ticipants for analysis with an average follow-up duration between puberty
and younger adulthood of 12.7 y.
Blood analyses. In younger adulthood, venous blood samples were
drawn after an overnight fast, centrifuged within 15 min, and frozen at
–80!C in the Research Institute of Child Nutrition. For the present
analysis, serum and plasma samples were transported to the German
Diabetes Center. Concentrations of plasma hs-CRP were measured by
using the Roche/Hitachi Cobas c311 analyzer (Roche Diagnostics).
Plasma concentrations of IL-6 and total adiponectin were determined by
using the Human IL-6 Quantikine HS and the Human Total Adiponectin/
Acrp30 Quantikine ELISA kits, respectively, from R&D Systems. Serum
IL-18 was quantified with the ELISA kit from Medical and Biological
Laboratories. Intra-assay CVs for hs-CRP, IL-6, IL-18, and total adiponectin
were 1.0%, 7.2%, 3.7%, and 3.8%, respectively. Interassay CVs for hs-
CRP, IL-6, IL-18, and total adiponectin were 2.6%, 11.8%, 7.1%, and
8.0%, respectively.
Anthropometric measurements. From the age of 2 y onward, standing
height is measured to the nearest 0.1 cm by using a digital stadiometer
(Harpenden). Body weight is measured to the nearest 100 g with an
electronic scale (Seca 753E; Seca Weighing and Measuring Systems).
Measurements are taken at each visit according to standard procedures,
with the participants dressed in underwear only and barefoot. Skinfold
thicknesses are measured twice from the age of 6 mo onward at 4
different sites (suprailiacal, subscapular, biceps, triceps) on the right side
of the body to the nearest 0.1 mm by using a Holtain caliper. Sex- and
age-specific SD scores were calculated for the adolescent BMI values by
using the German BMI standards (20). To define overweight during
puberty, values proposed by the International Obesity Task Force were
used, which correspond to an adult BMI of 25 kg/m2. On the basis of
triceps and subscapular skinfold thicknesses, percentage of body fat for
pubescent children was derived by using the equations of Slaughter et al.
(21). Excess body fatness in puberty was defined according to body fat
reference curves by McCarthy et al. (22). For estimation of percentage
body fat in adulthood, equations of Durnin andWomersly (23) were used,
which are based on triceps, biceps, scapular, and iliac skinfold thicknesses.
Dietary assessment. Three-day weighed dietary records are used to
assess nutritional intake in the DONALD study. All foods and beverages
consumed by the participants as well as leftovers are weighed and recorded
to the nearest 1 g by using electronic food scales (initially Soehnle Digita
8000; Leifheit SG; now WEDO digi 2000; Werner Dorsch). Recording
household measures, such as number of spoons or scoops, is allowed
when weighing is not possible. Furthermore, recipes as well as packages
and labels are provided by the participants and their families for further
information on the foods consumed. For this analysis, dietary variables
were calculated as individual means of the 3-d weighed dietary records
by using LEBTAB, the in-house database (24). LEBTAB is based on the
German standard food tables and data obtained from commercial food
products and is continuously updated to include all recorded food items.
Because we aimed to describe the habitual dietary intake, an individual
average intake during puberty was calculated from at least 2 records (on
average, 5; range: 2–6). Each carbohydrate-containing food recorded
in the dietary records was assigned a published GI value (25) (based on
glucose as a reference food) according to a standardized procedure.
The carbohydrate content of the food was the principal consideration
when matching a particular food with one listed in the tables; additional
factors considered comprised food group, regional origin of the food,
mode of preparation, main ingredients, and sugar content. The assignment
process is updated on a regular basis to incorporate newly published GI
values. The value of carbohydrate content (in g) of each consumed food
was then multiplied by the respective GI to obtain the respective GL. The
overall dietary GI is obtained by dividing total daily GL by total daily
carbohydrate intake. To distinguish carbohydrate intake from higher and
low GI food sources, a GI of 55 was chosen as the cutoff. Foods with a GI
<55 are defined as low-GI foods (25).
The following foods were defined as added sugars: white sugar, brown
sugar, raw sugar, corn syrup, corn syrup solids, high-fructose corn syrup,
malt syrup, maple syrup, pancake syrup, fructose sweetener, liquid fructose,
honey,molasses, anhydrous dextrose, and crystal dextrose (26). Fruit syrups
commonly used as sweeteners in Germany also were considered added
sugars. Conversely, naturally occurring sugars such as lactose in milk or
fructose in fruits were not included.
Dietary fiber content was calculated by using the LEBTAB database.
Whole-grain intake was estimated by assigning whole-grain content in
2 of 8 Goletzke et al.
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grams to each carbohydrate-containing food using the respective recipe
and ingredient information available at the time of recording. The
definition of whole grain followed the Whole Grain Label Statements of
the US FDA: ‘‘Cereal grains that consist of the intact, ground, cracked or
flaked caryopsis, whose principal anatomical components—the starchy
endosperm, germ and bran—are present in the same relative proportions
as they exist in the intact caryopsis’’ (27).
Statistical analysis. Baseline characteristics of the study population are
presented for the total study population. To analyze the prospective as-
sociation between carbohydrate nutrition during puberty and low-grade
inflammation in younger adulthood, multivariable linear regression models
were used. Because the outcome variables were not normally distributed,
hs-CRP, IL-6, and IL-18 were log-transformed prior to analysis; and for
adiponectin, the square root was extracted to obtain normal distribu-
tion. All dietary variables except for dietary GI were energy-adjusted
by using the residual method. To account for age-dependent nutritional
differences, all variables were standardized by age group and sex (mean = 0,
SD = 1).
Covariates considered as potentially affecting the association between
carbohydrate nutrition and inflammatory markers were gestational weight
gain (kg), birth weight (continuous and < or $3000 g), gestational
age (wk), breastfeeding for >2 wk (yes or no), firstborn child (yes or no),
BMI SD score or % of body fat at baseline, maternal overweight (BMI
$25 kg/m2; yes or no), high maternal educational status ($12 y of
schooling; yes or no),maternal occupation (higher, other, or no), smoker in the
household (yes or no), parental history of diabetes (yes or no; questionnaire-
based), physical activity level (light, moderate, or high; questionnaire-
based), and intakes of protein (total, animal, or vegetable) or fat (total and
saturated fat). Vice versa adjustment for whole grain and GI was also
considered. Each potential confounder was initially examined separately
and included only if it 1) substantially altered the association of the
principal dietary variables with hs-CRP, IL-6, IL-18, or adiponectin in
the models (>10%); 2) significantly predicted the outcome variable; or
3) improved the coefficient of determination (>5%). In the basic model
(model A), sex and age (categorical:#19 or >19 y and#25 or >25 y) were
included, because age at blood withdrawal in younger adulthood varied
considerably (18–36 y). In a second model (model B), we further adjusted
for early life and socioeconomic factors as well as for other nutritional
factors. Finally, for significant findings we also conducted conditional
models (additionally including waist circumference in younger adult-
hood) to examine whether the observed associations were independent
of adult body composition.
Because other studies indicate sex differences regarding the associ-
ation between dietary GI or GL and both T2D and CVD (5,6,28,29) and
some inflammatory markers differ physiologically between women and
men, additional sex-stratified analyses were performed. However, tests
for interaction were not significant (all P- interaction > 0.3).
In addition to the slope of the regression, the adjusted means of the
respective inflammatory marker (i.e., least-squares means predicted by
the model when the other variables are held at their mean values) are
presented by tertiles of the carbohydrate nutrition parameters with the
corresponding 95%CIs. All P values presented in the tables or figures are
based on tests for trend over the entire respective samples by using the
continuous data. All models conform to the assumptions of linear regression
models (linearity, normality and homoscedasticity of residuals, absence of
multicollinearity). P values <0.05 were considered significant. All statis-
tical analyses were carried out by using SAS procedures (version 9.1.3;
SAS Institute).
Results
The participants who were excluded from the final study sample
because of missing dietary or covariable information (n = 103)
did not differ from those who were included (n = 205) with
regard to early life and adult anthropometric characteristics or
inflammatory markers (P-difference > 0.1).
Girls and boys did not differ with regard to early life or socio-
economic characteristics. Female participants were younger at
baseline and had a lower BMI but a higher percentage of body
fat. This persisted to younger adulthood, when women were
additionally less likely to be overweight and to have an increased
waist circumference. Also, women had higher concentrations of
hs-CRP and adiponectin (Table 1). With regard to nutritional
intake data during puberty, energy intake and dietary GL were
lower in girls because they consumed more fiber, particularly
from fruits, and had a higher magnesium intake compared with
boys (Table 2). Overall, the participants" diet during puberty can
be considered a high-carbohydrate diet with an energy percent-
age of >50%, mostly derived from foods with a GI >55, yet
relatively rich in fiber and whole grains (Table 2).
A higher intake of carbohydrates during puberty was pro-
spectively related to higher concentrations of the plasma IL-6 in
younger adulthood (P-trend = 0.009, model A). Separate con-
sideration of carbohydrates from higher- and low-GI food sources
indicated that only carbohydrate intake from higher-GI sources
was of relevance for later IL-6 concentrations (P-trend = 0.009,
model A). Additional consideration of body composition during
puberty and early life, parental socioeconomic, and other nutritional
factors did not affect these associations (model B). Furthermore,
a higher dietary GL (P-trend = 0.002, model B) and a lower
intake of whole grains (P-trend = 0.01, model B) during puberty
were independently associated with higher concentrations of
IL-6 in younger adulthood. No independent associations were
seen with dietary GI or added sugar or fiber intake (all P-trend$
0.09, model B) (Table 3).
The additional inclusion of waist circumference in adulthood
in a conditional model only slightly affected the associations ob-
served between aspects of pubertal carbohydrate nutrition and
adult IL-6 concentrations (total carbohydrates: P-trend = 0.006;
carbohydrates from higher-GI food sources: P-trend = 0.02;
dietary GI: P-trend = 0.12; dietary GL: P-trend = 0.003; whole
grains: P-trend = 0.02, conditional model) (Table 3).
None of the analyzed markers of carbohydrate nutrition
during puberty was independently related to hs-CRP (Table 4),
IL-18 (Supplemental Table 1), or adiponectin (Supplemental
Table 2) in younger adulthood (all P-trend > 0.1). Moreover,
added sugar consumption from drinks was not related to any of
the inflammatory markers (all P-trend > 0.3) (data not shown).
Sex-stratified analysis revealed similar findings for both male
and female participants: carbohydrate nutrition was unrelated
to hs-CRP, IL-18, or adiponectin (data not shown). In both
sexes, pubertal dietary GL and total carbohydrate intake were
related to adult IL-6 concentrations (women: P-trend = 0.02 and
0.05, respectively; men: P-trend = 0.049 and 0.06, respectively),
whereas carbohydrates from low-GI food sources and added
sugar and fiber intake were unrelated to later IL-6 concentra-
tions (data not shown). Of note, associations of carbohydrates
from higher-GI foods, dietary GI, and whole grains with adult
IL-6 concentrations were significant only among women (Sup-
plemental Fig. 1). However, these sex differences were not sig-
nificant in formal tests for interaction (all P > 0.3).
Further adjustment for breastfeeding status, pubertal physical
activity level, parental history of T2D, smokers in the household,
or smoking status in adulthood as well as the inclusion of interaction
terms for sex in the final models did not change any of the results
(data not shown). A subgroup analysis that included only those
participants aged 18–25 y showed similar results (data not shown).
Discussion
This study provides novel epidemiologic evidence for a sustained
adverse effect of a higher carbohydrate intake from higher-GI
Carbohydrate nutrition and inflammation 3 of 8
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food sources (GI >55) and a higher dietary GL during puberty on
adult IL-6 concentrations, although higher pubertal whole-grain
consumption appears to be beneficial.
Evidence on the relevance of carbohydrates and their glycemic
potency is inconsistent. Although low-carbohydrate diets per se
might be able to reduce inflammatory markers in intervention
studies (8), it remains questionable whether this effect is attrib-
utable to weight loss only (30). Cross-sectional observational
evidence for a role of GI and/or GL (31) was not confirmed by
the only 2 prospective studies in partly overweight adults (32) or
in those at risk of CVD (33). However, longer-term intervention
trials suggest benefits of reducing GL (34) or GI (9). In our study,
a 9% higher intake of carbohydrates was associated with a 4.8%
increase in plasma IL-6 concentrations during adulthood (values
calculated on the basis of differences between tertiles 1 and 3).
In line with this, a 26-g increase in dietary GL, which captures
carbohydrates adjusted for GI, was accompanied by a 4.4%
increase in plasma IL-6. Separate analyses of carbohydrates
from higher- and low-GI food sources did, however, reveal that
the relevance of overall carbohydrate intake was attributable to
those carbohydrates with a blood glucose–increasing effect only:
a 5% increase in these carbohydrates was related to an increase
of 5% in IL-6 concentrations.
Of note, the prospective associations between pubertal carbo-
hydrate nutrition and adult plasma IL-6 concentrations were
largely independent of adult body composition. The significant
relations of total carbohydrate intake, carbohydrates from high-
GI food sources, GL, and whole-grain intake to adult IL-6 con-
centrations were only slightly attenuated in conditional models
that additional accounted for adult waist circumference. This is
in line with our previous observation that pubertal GI and GL
were unrelated to adult body composition (35).
Oxidative stress in response to postprandial glycemic excur-
sions may be another main mechanism driving this association.
A possible compensation of oxidative stress by anti-inflammatory
effects of insulin in insulin-sensitive humans could be lost in
insulin-resistant individuals due to prolonged proinflammatory
conditions (36). Such a higher vulnerability to oxidative stress
may also extend to puberty, because exaggerated compensatory
insulin excursions in response to postprandial glycemia during
TABLE 1 Demographic, anthropometric, birth, and socioeco-
nomic characteristics for participants of the DONALD study1
Participants
F (n = 113) M (n = 92) P2
Early life factors
Birth year 1986 (1982, 1989) 1987 (1982, 1988) 0.8
Birth weight, g 3410 (3100, 3750) 3460 (3190, 3840) 0.2
Breast-fed .2 wk, n (%) 3 80 (70.8) 62 (68.1) 0.7
Data from puberty
Age, y 9.0 (9.0, 9.1) 10.0 (10.0, 10.1) ,0.0001
BMI SDS 20.03 (20.74, 0.63) 0.10 (20.62, 0.63) 0.7
BMI, kg/m2 16.4 (15.1, 18.0) 17.4 (15.7, 18.8) 0.02
Overweight,4 n (%) 17 (15.0) 11 (12.0) 0.5
Body fat,5 % 17.6 (14.4, 23.5) 13.6 (11.3, 20.0) ,0.0001
Excess body fat,6 n (%) 19 (16.8) 18 (19.6) 0.6
Socioeconomic factors, n (%)
Maternal overweight7 37 (32.7) 26 (28.3) 0.5
Maternal education8 50 (44.3) 45 (48.9) 0.5
Maternal occupation9 57 (50.4) 46 (50.0) 0.9
Smokers in household 37 (32.7) 30 (32.6) 1.0
Data from younger adulthood
Age, y 22.2 (18.1, 24.7) 21.9 (18.1, 23.8) 0.6
BMI, kg/m2 22.0 (20.6, 24.5) 23.2 (21.5, 25.8) 0.01
Overweight,7 n (%) 22 (19.5) 29 (31.5) 0.047
Body fatness,10 % 30.7 (27.8, 33.8) 17.7 (13.9, 22.9) ,0.0001
Waist circumference, cm 72.0 (68.0, 77.0) 80.3 (76.1, 87.5) ,0.0001
Plasma metabolites
hs-CRP, mg/dL 0.13 (0.06, 0.30) 0.05 (0.03, 0.11) ,0.0001
IL-6, pg/mL 0.68 (0.47, 1.01) 0.68 (0.48, 1.00) 0.7
Adiponectin, mg/mL 8.80 (6.82, 12.50) 3.89 (3.92, 9.29) ,0.0001
Serum IL-18, pg/mL 244 (209, 326) 244 (198, 300) 0.4
1 Values are medians (25th, 75th percentile) unless otherwise indicated. DONALD,
Dortmund Nutritional and Anthropometric Longitudinally Designed; hs-CRP, high-
sensitivity C-reactive protein, SDS, SD score.
2 Significant differences between female and male participants were tested by using
ANOVA for normally distributed continuous variables, Kruskal-Wallis test for non-
normally distributed continuous variables, and chi-square test for categorical variables.
3 Breastfeeding categories: #2 wk or .2 wk full breastfeeding; n = 91 for male
participants.
4 Derived from the age- and sex-specific cutoffs proposed by the International Obesity
Task Force, which are linked to the adult cutoff of a BMI of 25 kg/m2.
5 Calculated according to reference 21.
6 Derived from age-specific cutoffs proposed by McCarthy et al. (22); the 85th
percentile of body fat was used as the cutoff for excess of body fat.
7 BMI $25 kg/m2.
8 School education for at least 12 y.
9 Maternal occupation: yes or no.
10 Calculated according to reference 23.
TABLE 2 Baseline nutritional data during puberty for partici-
pants of the DONALD study1
Participants
Nutritional variables F (n = 113) M (n = 92) P2
Total energy, kJ/d 7166 (6532, 7952) 8921 (8025, 9935) ,0.0001
Fat, %en 36.3 (33.7, 38.3) 36.1 (33.1, 38.2) 0.6
SFAs 15.9 (14.3, 17.3) 15.7 (14.4, 17.0) 0.4
MUFAs 14.8 (13.5, 15.9) 14.8 (13.8, 15.7) 0.8
PUFAs 5.3 (4.7, 5.9) 5.1 (4.4, 5.7) 0.2
Protein, %en 12.6 (11.5, 14.0) 13.3 (12.1, 14.0) 0.2
Carbohydrate, %en 51.1 (48.5, 53.6) 51.1 (48.2, 53.8) 1.0
Higher-GI carbohydrate,3 %en 30.1 (26.3, 33.1) 30.3 (27.6, 32.9) 0.5
Low-GI carbohydrate,3 %en 21.1 (18.1, 23.7) 20.5 (17.5, 23.8) 0.4
$50% of carbohydrates from
higher-GI food sources, n (%)
95 (84.1) 83 (90.2)
Dietary GI 56.6 (54.9, 57.9) 57.0 (55.4, 58.1) 0.09
Dietary GL, g 124 (110, 136) 156 (136, 176) ,0.0001
Added sugar, %en 14.8 (11.2, 18.2) 14.8 (12.1, 18.8) 0.3
Fiber, g/1000 kJ 2.49 (2.19, 2.86) 2.29 (2.02, 2.68) 0.003
From cereals 1.24 (1.00, 1.57) 1.19 (1.03, 1.47) 0.9
From vegetables 0.54 (0.40, 0.68) 0.47 (0.36, 0.60) 0.08
From cereals 0.49 (0.37, 0.68) 0.38 (0.26, 0.53) 0.0006
Whole grain, g/1000 kJ 3.13 (1.67, 5.40) 2.60 (1.01, 4.83) 0.4
Magnesium, mg 242 (218, 276) 293 (252, 347) ,0.0001
Thiamin, mg 1.40 (1.10, 1.67) 1.68 (1.44, 1.97) ,0.0001
Riboflavin, mg 1.69 (1.43, 2.17) 2.18 (1.81, 2.46) ,0.0001
Vitamin B-6, mg 1.94 (1.58, 2.39) 2.24 (1.92, 2.75) ,0.0001
Folate, mg 339 (273, 437) 397 (341, 502) ,0.0001
Vitamin C, mg 148 (127, 200) 159 (127, 211) 0.5
1 Values are medians (25th, 75th percentile) unless otherwise indicated. Nutritional data
were averaged from 2–6 3-d weighed dietary records. DONALD, Dortmund Nutritional
and Anthropometric Longitudinally Designed; GI, glycemic index, GL, glycemic load;
%en, percentage of total energy intake.
2 Significant differences between girls and boys were tested by using ANOVA for
normally distributed continuous variables, Kruskal-Wallis test for non-normally distrib-
uted continuous variables, and chi-square test for categorical variables.
3 Distinction between carbohydrate intake from higher- and low-GI food sources with
GI of 55 as the cutoff.
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this period could increase the strain on b-cells, which are par-
ticularly sensitive to oxidative stress (37). Unfortunately, bio-
markers of oxidative stress are notoriously difficult to measure,
and the remaining serum and plasma samples from the DONALD
study did not allow these measurements because of low long-
term stability of markers of oxidative stress even during storage
at 280!C.
In rodents it has furthermore been shown that long-term
exposure to a high-GI diet leads to a delayed switch to both
carbohydrate and fat oxidation in the postprandial state. Of
interest, in a mouse model prone to obesity, FA oxidation was
impaired already 3 wk after the start of a high-GI diet, whereas
phenotypic markers were comparable in the low- and high-GI
groups, indicating that reduced metabolic flexibility might precede
changes and causally affect the development of an obese insulin-
resistant phenotype (38).
In our study we observed no independent effect of added
sugar intake or consumption of added sugar from drinks on later
inflammatory markers. Studies on the effect of a single glucose
challenge reported increased oxidative stress (36). Also, in a study
in healthy youngmen, a high consumption of soft drinks, sweetened
with glucose, fructose, or sucrose, over 3 wk led to increased
hs-CRP concentrations (39). In our cohort, added sugar mainly
comprised sucrose, and consumption amounts—in total and
from drinks—can be considered average, albeit not high (40).
Moreover, glycemic excursions in response to sucrose are mod-
erate rather than high as reflected by a GI of 65 (25). Hence, the
glycemic and, in turn, possibly proinflammatory potential of the
diet might be better described by dietary GI.
In contrast to whole-grain intake, which was inversely asso-
ciated with later IL-6 concentrations, dietary fiber was not of
independent relevance in our study. A recent cross-sectional
study in adolescents found an inverse association between fiber
intake and CRP concentrations (41). Among adults, most obser-
vational studies also reported reduced low-grade inflammation
among those consuming more whole grain and dietary fiber,
although the evidence is less consistent in intervention studies
(42,43). Dietary fiber may reduce chronic inflammation by benefi-
cially interactingwith gutmicroflora and decreasing lipid oxidation
(44), but whole grains possess several additional components
displaying diverse anti-inflammatory effects, such as free radical
scavenging or antioxidant enzyme activation (45). Our results
point to a relevance of whole grains, which may better represent
the combination of different anti-inflammatory effects.
Our study adds to the current discussion that a high carbohydrate
intake may have detrimental health effects if the carbohydrates
TABLE 3 Prospective associations of variables of carbohydrate quality at baseline with plasma IL-6 (pg/mL) in young adulthood1
T1 T2 T3 b (SE) P-trend
Carbohydrate
Model A 0.58 (0.49, 0.69) 0.67 (0.56, 0.79) 0.81 (0.68, 0.97) 0.190 (0.072) 0.009
Model B 0.58 (0.49, 0.69) 0.68 (0.57, 0.80) 0.83 (0.70, 0.98) 0.197 (0.069) 0.005
Conditional model 0.57 (0.48, 0.68) 0.68 (0.58, 0.81) 0.83 (0.70, 0.98) 0.193 (0.069) 0.006
Carbohydrate, higher GI2
Model A 0.61 (0.51, 0.73) 0.64 (0.54, 0.76) 0.80 (0.67, 0.95) 0.189 (0.072) 0.009
Model B 0.62 (0.52, 0.74) 0.64 (0.54, 0.76) 0.80 (0.68, 0.95) 0.183 (0.072) 0.01
Conditional model 0.63 (0.53, 0.75) 0.63 (0.53, 0.75) 0.80 (0.67, 0.95) 0.161 (0.073) 0.02
Carbohydrate, low GI2
Model A 0.73 (0.62, 0.88) 0.65 (0.54, 0.77) 0.66 (0.56, 0.79) 20.037 (0.074) 0.6
Model B 0.73 (0.61, 0.86) 0.65 (0.55, 0.77) 0.68 (0.57, 0.81) 20.013 (0.074) 0.9
Conditional model 0.72 (0.60, 0.85) 0.65 (0.55, 0.77) 0.69 (0.58, 0.82) 0.013 (0.074) 0.9
GI
Model A 0.58 (0.48, 0.69) 0.70 (0.59, 0.83) 0.78 (0.66, 0.93) 0.176 (0.078) 0.03
Model B 0.57 (0.47, 0.68) 0.68 (0.57, 0.81) 0.73 (0.61, 0.87) 0.136 (0.080) 0.09
Conditional model 0.57 (0.48, 0.69) 0.69 (0.58, 0.82) 0.72 (0.61, 0.86) 0.115 (0.080) 0.12
GL
Model A 0.57 (0.48, 0.67) 0.69 (0.58, 0.82) 0.82 (0.69, 0.97) 0.231 (0.073) 0.002
Model B 0.55 (0.46, 0.65) 0.66 (0.55, 0.79) 0.80 (0.67, 0.94) 0.226 (0.072) 0.002
Conditional model 0.55 (0.46, 0.65) 0.67 (0.56, 0.79) 0.80 (0.67, 0.94) 0.213 (0.072) 0.003
Added sugar
Model A 0.62 (0.52, 0.74) 0.63 (0.53, 0.75) 0.80 (0.67, 0.95) 0.158 (0.067) 0.02
Model B 0.62 (0.52, 0.75) 0.62 (0.51, 0.74) 0.74 (0.62, 0.88) 0.101 (0.072) 0.2
Conditional model 0.62 (0.52, 0.75) 0.62 (0.52, 0.74) 0.74 (0.62, 0.88) 0.101 (0.072) 0.2
Fiber
Model A 0.81 (0.68, 0.97) 0.68 (0.57, 0.81) 0.58 (0.49, 0.68) 20.148 (0.066) 0.03
Model B 0.77 (0.64, 0.92) 0.65 (0.55, 0.78) 0.59 (0.49, 0.71) 20.111 (0.069) 0.11
Conditional model 0.77 (0.64, 0.92) 0.65 (0.55, 0.77) 0.60 (0.50, 0.72) 20.105 (0.068) 0.12
Whole grain
Model A 0.84 (0.71, 1.00) 0.66 (0.56, 0.79) 0.56 (0.47, 0.67) 20.196 (0.067) 0.004
Model B 0.78 (0.65, 0.93) 0.66 (0.56, 0.79) 0.56 (0.46, 0.67) 20.177 (0.069) 0.01
Conditional model 0.77 (0.64, 0.91) 0.66 (0.57, 0.79) 0.56 (0.46, 0.67) 20.166 (0.069) 0.02
1 Values are means (95% CIs); nutritional variables are residuals; n = 205. Model A: adjusted for sex, age (categorical: #19 or .19 y and #25 or .25 y), and energy (residuals).
Model B: model A plus early life factors (gestational weight gain), socioeconomic factors (maternal overweight), BMI SD score at baseline, and nutritional factors (carbohydrates,
GI, GL, and added sugar: whole grain; fiber and whole grain: GI). Conditional model: model B plus adult waist circumference to investigate the possibility of a mediation of any
observed association by adult waist circumference. GI, glycemic index, GL, glycemic load; T, tertile.
2 Distinction between carbohydrate intake from higher- and low-GI food sources with a GI of 55 as the cutoff.
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stem from higher-GI food sources (46) and extends this observa-
tion to chronic low-grade inflammation. This is of public health
relevance because low-grade inflammation is linked to the devel-
opment of a range of chronic diseases including T2D, CVD,
depression, dementia, some types of cancers, frailty in old age,
and mortality (7) and because most free-living populations, such
as the DONALD adolescents, consume >50% of their calories as
carbohydrates (47,48). Of note, in the present study, 59% of the
carbohydrates and 76% of the whole grains came from foods
with a moderate or high GI. Hence, efforts to improve carbohy-
drate quality among adolescents should not focus solely on
encouraging a higher whole-grain intake but may need to be
complemented by specific advice for a preferred selection of low-
GI carbohydrates (e.g., pasta, legumes) and low-GI whole grains
(e.g., muesli, pumpernickel).
Although the associations between carbohydrate nutrition
and IL-6 in the present study can be considered robust, it is not
clear why these relations did not extend to other inflammatory
markers. Importantly, previous studies that reported associa-
tions between dietary components such as GL and inflammatory
biomarkers including CRP, IL-18, and adiponectin mainly focused
on individuals with T2D or at high cardiometabolic risk (31,32,
49,50) and who were not comparable to our study participants
with regard to age and overall health status. Furthermore, the
chemical complexity of foods summarized as whole grain or
determining GI and GL make it extremely difficult to identify
molecular pathways that may be responsible for the associations
observed for IL-6 in our study compared with the lack of effects
on hs-CRP, IL-18, and adiponectin.
Although our data do not allow us to explain why we ob-
served associations only for IL-6, we believe that our findings
may be of clinical relevance. We acknowledge that IL-6 is a com-
plex cytokine in the pathophysiology of T2D. On the one
hand, IL-6 is involved in the induction of obesity-associated
insulin resistance in liver and adipose tissue (51). On the other
hand, IL-6 is released from skeletal muscle after exercise with
potentially beneficial paracrine and endocrine effects (52).
Recent mouse studies indicated that IL-6 may be implicated in
the regulation of insulin secretion (53) and the limitation of
inflammatory processes (54). Despite the controversy that the
aforementioned studies indicate, it is important to emphasize
that IL-6 concentrations are consistently related to increased
T2D risk inmany epidemiologic studies (16). In addition,Mendelian
randomization analyses showed that IL-6 but not CRP is a
causal factor in the development of coronary heart disease
(55,56), underpinning the potential public health relevance of
TABLE 4 Prospective association of variables of carbohydrate quality at baseline with plasma hs-CRP (mg/dL) in young adulthood1
T1 T2 T3 b (SE) P-trend
Carbohydrate
Model A 0.10 (0.08, 0.13) 0.08 (0.06, 0.10) 0.08 (0.07, 0.11) 20.033 (0.106) 0.8
Model B 0.10 (0.08, 0.13) 0.08 (0.06, 0.10) 0.09 (0.07, 0.11) 20.021 (0.106) 0.8
Conditional model 0.10 (0.07, 0.13) 0.08 (0.06, 0.10) 0.08 (0.07, 0.11) 20.032 (0.104) 0.8
Carbohydrate, higher GI2
Model A 0.09 (0.07, 0.11) 0.09 (0.07, 0.11) 0.09 (0.07, 0.12) 0.027 (0.107) 0.8
Model B 0.09 (0.07, 0.11) 0.09 (0.07, 0.12) 0.09 (0.07, 0.12) 0.022 (0.109) 0.9
Conditional model 0.09 (0.07, 0.12) 0.08 (0.06, 0.11) 0.09 (0.07, 0.11) 20.044 (0.108) 0.7
Carbohydrate, low GI2
Model A 0.11 (0.08, 0.14) 0.07 (0.06, 0.10) 0.09 (0.07, 0.11) 20.073 (0.108) 0.5
Model B 0.11 (0.08, 0.14) 0.08 (0.06, 0.10) 0.09 (0.07, 0.12) 20.057 (0.110) 0.6
Conditional model 0.10 (0.08, 0.13) 0.08 (0.06, 0.10) 0.09 (0.07, 0.12) 0.002 (0.109) 1.0
GI
Model A 0.10 (0.08, 0.13) 0.07 (0.06, 0.09) 0.10 (0.08, 0.13) 20.013 (0.116) 0.9
Model B 0.10 (0.08, 0.13) 0.07 (0.06, 0.10) 0.10 (0.08, 0.13) 20.029 (0.120) 0.8
Conditional model 0.10 (0.07, 0.13) 0.07 (0.06, 0.10) 0.09 (0.07, 0.12) 20.087 (0.119) 0.5
GL
Model A 0.09 (0.07, 0.12) 0.09 (0.07, 0.11) 0.08 (0.06, 0.11) 20.053 (0.109) 0.6
Model B 0.09 (0.07, 0.12) 0.09 (0.07, 0.12) 0.09 (0.07, 0.11) 20.045 (0.110) 0.7
Conditional model 0.09 (0.07, 0.12) 0.09 (0.07, 0.12) 0.08 (0.06, 0.11) 20.080 (0.108) 0.5
Added sugar
Model A 0.09 (0.07, 0.11) 0.09 (0.07, 0.11) 0.09 (0.07, 0.12) 0.086 (0.098) 0.4
Model B 0.09 (0.06, 0.11) 0.09 (0.07, 0.12) 0.09 (0.07, 0.12) 0.080 (0.109) 0.5
Conditional model 0.08 (0.06, 0.11) 0.09 (0.07, 0.12) 0.09 (0.07, 0.12) 0.081 (0.106) 0.4
Fiber
Model A 0.09 (0.07, 0.11) 0.09 (0.07, 0.12) 0.09 (0.07, 0.11) 20.051 (0.097) 0.6
Model B 0.09 (0.07, 0.11) 0.09 (0.07, 0.12) 0.09 (0.07, 0.12) 20.041 (0.103) 0.6
Conditional model 0.08 (0.06, 0.11) 0.09 (0.07, 0.11) 0.09 (0.07, 0.11) 20.025 (0.100) 0.8
Whole grain
Model A 0.11 (0.08, 0.14) 0.08 (0.06, 0.10) 0.09 (0.07, 0.11) 20.063 (0.100) 0.5
Model B 0.11 (0.08, 0.14) 0.08 (0.06, 0.10) 0.09 (0.07, 0.12) 20.067 (0.104) 0.5
Conditional model 0.10 (0.08, 0.13) 0.08 (0.06, 0.10) 0.09 (0.07, 0.11) 20.038 (0.102) 0.7
1 Values are means (95% CIs); nutritional variables are residuals; n = 205. Model A: adjusted for sex, age (categorical: #19 or .19 y and #25 or .25 y), and energy (residuals).
Model B: model A plus early life factors (gestational weight gain), socioeconomic factors (maternal overweight), BMI SD score at baseline, and nutritional factors (carbohydrates,
GI, GL, and added sugar: whole grain; fiber and whole grain: GI). Conditional model: model B plus adult waist circumference to investigate the possibility of a mediation of any
observed association by adult waist circumference. GI, glycemic index, GL, glycemic load; hs-CRP, high-sensitivity C-reactive protein; T, tertile.
2 Distinction between carbohydrate intake from higher- and low-GI food sources with GI of 55 as the cutoff.
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our findings. Of interest, a cross-sectional study analyzing the
association between several inflammatory markers and insulin
resistance in adolescents observed the strongest association for
IL-6, whereas associations with IL-18 or adiponectin were not
significant after adjustment for confounders (57). Nonetheless,
further studies are needed to explore the potential vulnerability
of adolescents to carbohydrate-induced postprandial glycemia
and the potentially protective effects of whole grains during puberty
on inflammatory markers both in the short and the long term.
The main strengths of our study are its prospective design
and the detailed repeated assessments of dietary intake during
puberty. For the present analysis, an average of 5 dietary records
were available (range: 2–6 records per participant) from which
habitual dietary intake could be estimated. This repeated collec-
tion of dietary records further attenuates the risk of not capturing
seldom-consumed foods and also improves overall reliability.
Another strength is the availability of information on early life
and socioeconomic factors, which could potentially have con-
founded the examined associations. However, residual confounding,
resulting from imprecisely measured or unmeasured confounding
factors, cannot be precluded.
Our study also has several limitations. First, in contrast to the
repeatedly measured dietary intake data, inflammatory markers
were measured only once in younger adulthood. Second, because
of the relatively elaborate DONALD study design, the socioeco-
nomic status of the study population is above average and extremes
of diet or behavior might not be represented, which could introduce
selection bias yet reduces our vulnerability to residual confounding.
Third, the estimation of the dietary GI from the GI values of
individual foods is regarded controversial (58). However, although
most epidemiologic studies use FFQs, the GI estimates in this study
were directly assigned to all carbohydrate-containing foods recorded
during 3 d. Moreover, numerous factors exist influencing the
glycemic response to a food, such as heating or ripening (59).
Variability of glycemic response is, however, not only a problem
of GI but of other nutrients as well (25,60).
In conclusion, our study provides novel evidence that a higher
intake of carbohydrates from higher-GI food sources may be
detrimental and higher whole-grain consumptionmay be beneficial
for adult IL-6 concentrations. These data support the hypothesis
that diet during puberty influences later inflammation and
metabolic dysfunction.
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Association between carbohydrate quality and inflammatory markers:
systematic review of observational and interventional studies1–3
Anette E Buyken, Janina Goletzke, Gesa Joslowski, Anna Felbick, Guo Cheng, Christian Herder, and Jenny C Brand-Miller
ABSTRACT
Background: Chronic low-grade inflammation is a likely interme-
diary between quality of carbohydrate and chronic disease risk.
Objective: We conducted a systematic literature search to evaluate
the relevance of carbohydrate quality on inflammatory markers in
observational and intervention studies.
Design: MEDLINE, EMBASE, and the Cochrane Library were
searched for studies on associations between glycemic index (GI),
glycemic load (GL), dietary fiber or fiber supplements or whole
grain intake, and high-sensitivity C-reactive protein (hsCRP) or in-
terleukin 6 (IL-6). Included studies had to be conducted on adults
(healthy, overweight, with type 2 diabetes or metabolic syndrome
features, but without inflammatory disease) with $20 participants
and a 3-wk duration.
Results: In total, 22 of the 60 studies that met our inclusion criteria
examined GI/GL: 5 of 9 observational studies reported lower con-
centrations of hsCRP or IL-6 among persons with a lower dietary
GI/GL; 3 of 13 intervention studies showed significant antiinflam-
matory effects of a low-GI/GL diet, and 4 further studies suggested
beneficial effects (trends or effects in a subgroup). For fiber intake,
13 of 16 observational studies reported an inverse relation with
hsCRP or IL-6, but only 1 of 11 intervention studies showed a sig-
nificant antiinflammatory effect of fiber intake, and a further trial
reported a beneficial trend. For whole-grain intake, 6 of 7 observa-
tional studies observed an inverse association with inflammatory
markers, but only 1 of 7 intervention studies reported significant
antiinflammatory effects, 1 further study was suggestive (in a sub-
group) of such, and another study found an adverse effect (trend
only).
Conclusions: Evidence from intervention studies for antiinflammatory
benefits is less consistent for higher-fiber or whole-grain diets than for
low-GI/GL diets. Benefits of higher fiber and whole-grain intakes sug-
gested by observational studies may reflect confounding. Am J
Clin Nutr doi: 10.3945/ajcn.113.074252.
INTRODUCTION
Chronic, low-grade inflammation is now considered to be
intimately linked to the development of diabetes (1) and car-
diovascular disease (CVD)4 (2). In addition, subclinical activa-
tion of the immune system has been found to be associated with
a range of other diseases, such as dementia (3), depressive dis-
orders (4), and certain types of cancer (5). Finally, low-grade
inflammation is associated with a higher risk of all-cause mor-
tality in old age (6). Thus, modifiable risk factors that effectively
reduce chronic inflammation can be expected to contribute
substantially to the prevention of chronic disease.
In this context, different aspects characterizing carbo-
hydrate quality have recently received considerable interest.
Dietary fiber intake is considered to reduce chronic inflam-
mation by decreasing lipid oxidation (7) and beneficially
interacting with gut microflora via regulatory influences of
short-chain fatty acids produced from colonic fermentation of
fiber (8). Whole-grain foods are additionally rich in several
bioactive compounds with antiinflammatory properties, such
as free radical scavenging, antioxidant enzyme activation, or
modification of the redox status of tissues and cells (7). In
addition, viscous fiber from oats or barley may slow the rates
of glucose appearance in the blood (9). Postprandial glycemic
response to a food is best captured by the glycemic index (GI,
a ranking of carbohydrate foods by their glycemic potency)
(10) and the glycemic load (GL, defined as the mathematical
product of the GI and carbohydrate content) (11). Excessive
postprandial blood glucose excursions are considered to yield
nitric oxide generation, which in turn combines with super-
oxide to produce peroxynitrite—a potent long-lived pro-oxidant
molecule (12). Hence, consumption of high-GI foods may con-
tribute to oxidative stress and both acute and chronic low-grade
inflammation (13).
These potential effects of carbohydrate quality on chronic in-
flammation have recently been investigated in many observational
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and interventional studies. Comparative assessment of the
evidence from these 2 types of studies may be particularly
insightful because evidence appraisal on the relevance of car-
bohydrate quality for chronic diseases (eg, type 2 diabetes, CVD,
cancer) almost exclusively draws on observational studies. Thus,
the aim of the current systematic review was to evaluate the
evidence from currently published observational and interven-
tional studies conducted in adults who were either healthy, were
overweight, or had features of the metabolic syndrome or type 2
diabetes regarding the relevance of fiber intake, whole-grain
consumption, and dietary GI/GL for markers of chronic low-
grade inflammation. We selected high-sensitivity C-reactive pro-
tein (hsCRP) and IL-6 because they represent the most commonly
measured immune mediators in clinical and epidemiologic
studies. Currently, there is more evidence that IL-6 is causal for
the development of inflammation-related diseases such as CVD
(14, 15), whereas C-reactive protein (CRP) concentrations may
be a “bystander” rather than a true risk factor. However, CRP
has been frequently measured in studies with robust associ-
ations with many health outcomes and is therefore a useful
prognostic biomarker.
SUBJECTS AND METHODS
Study selection
We conducted a systematic literature search of the MEDLINE
(http://www.ncbi.nlm.nih.gov/pubmed/), EMBASE (http://www.
elsevier.com/online-tools/embase), and Cochrane Library [Co-
chrane Central Register of Controlled Trials (CENTRAL); http://
onlinelibrary.wiley.com/cochranelibrary/search/] databases from
January 1990 through September 2012 (updated June 2013). The
search was limited to this time frame because hsCRP assays
were first available in the early 1990s. The following terms were
used to identify all potentially relevant publications published as
conference abstracts or complete manuscripts in the English or
German language: glyc(a)emic index/load, whole grain(s), fiber/
fiber, carbohydrate quality together with (hs-) CRP, (high-
sensitivity) C-reactive protein, IL-6, and interleukin 6 (see “Sup-
plemental data” in the online issue). The search was restricted to
human studies carried out in adults ($18 y). Inclusion criteria
for epidemiologic studies (cross-sectional or prospective cohort
studies) were as follows: dietary GI, GL, whole grain or dietary
fiber intake as a predictor, hsCRP, or IL-6 among the outcomes
and information on the dietary assessment method. Inclusion
criteria for intervention studies were as follows: a randomized
controlled or a crossover design, information on adherence to
the intervention diets, and data on changes in BMI or body
weight.
Because we were interested in the specific effects of GI/GL,
whole grain, or fiber on low-grade inflammation, we excluded
studies that analyzed dietary patterns, treatment studies, or
studies on pregnant women. To this end, we excluded inter-
vention studies on participants with inflammatory diseases other
than type 2 diabetes or the metabolic syndrome at baseline, ie,
diseases such as arthritis, pneumonia, or Alzheimer disease for
which inflammation or oxidative stress represent relevant com-
ponents in their development and/or progression.
Furthermore, studies lasting ,3 wk or including ,20 partici-
pants (10 individuals per treatment group) were not considered to
provide sufficient information for the research questions under
investigation. The literature search was conducted independently
by 3 investigators (JG, GJ, and AF). The identification process is
illustrated in Figure 1. In addition, a manual search of references
cited by the published original studies and relevant review articles
was performed (cross-references). This systematic review was
conducted according to the Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses statement (16).
Data extraction
Two investigators (JG and AF) independently reviewed and
extracted relevant data from each report. Any disagreement
between reviewers was resolved by consensus and if necessary
referred to the senior researcher (AEB). Extracted data included
information on study design, duration, location, sample size,
participant characteristics (sex, age, BMI, health status), nutri-
tional assessment, type of intervention (eg, dietary counseling or
provision of foods) and weight maintenance or loss, GI, GL,
whole grain and/or fiber intakes, and adjustments for potentially
confounding factors (see Supplemental Tables 1–4 under
“Supplemental data” in the online issue). For studies that pro-
vided data on GL and carbohydrate intake only, the dietary GI
was calculated [GI = GL/carbohydrate (in g) 3 100]. GI values
referring to white bread as the reference food (= 100) (17–21)
were transformed to the glucose scale by dividing the respective
GI and GL values by 1.4286 (22). Data on hsCRP and IL-6 were
extracted as the inflammatory markers of interest. We extracted
data from baseline and change and/or endpoint of these outcome
measurements. Where available, results from intention-to treat
analyses are reported to reduce attrition bias.
RESULTS
The study selection process is shown in Figure 1. Of the 970
reports identified by the search, 864 were excluded based on title
and abstract. The remaining 106 reports were reviewed in full,
which led to the exclusion of a further 49 reports. The literature
update conducted in June 2013 revealed 3 more eligible studies.
Of the 60 studies included in the systematic review, 22 addressed
dietary GI or GL, 27 fiber, and 14 whole grain intake. Qi et al (23)
addressed all 3 aspects of carbohydrate quality considered in this
review, and Murakami et al (24) examined both dietary GI/GL
and dietary fiber intake.
Dietary GI and GL
Epidemiologic studies
Nine epidemiologic studies were identified that addressed
dietary GI and/or GL as a nutritional exposure variable (17–19,
23–28) (Table 1). Overall, the studies included 26,131 partici-
pants (range: 171–18,137) aged 20–67 y with a BMI (in kg/m2)
ranging from 21 to 30. Four of the studies included women only
(19, 23, 24, 27). Dietary GI ranged from 52 to 71 and dietary GL
from 96 to 179 g, mostly assessed by means of a food-frequency
questionnaire (FFQ) (n = 7 studies). Details on population, as-
sessment method, average baseline concentrations of exposures,
and covariates considered in the analysis and results are shown
elsewhere (see Supplemental Table 1 under “Supplemental data”
in the online issue).
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One cross-sectional study among 244 healthy US women
reported a strong association with hsCRP for both dietary GI and
GL (19). Similarly, in a subsample of 974 Dutch participants
drawn from 2 population-based cohorts, higher concentrations of
GI andGL tended to be related to higher concentrations of hsCRP (P
= 0.05 and P = 0.09, respectively) (26). Three cross-sectional
studies reported associations confined to either GI or GL: in
.18,000 postmenopausal US women (27) and a sample of 891 US
women with type 2 diabetes (23), a higher dietary GI, but not
a higher dietary GL, was related to increased hsCRP concentra-
tions. Conversely, in a subsample of 4366 Dutch participants drawn
from a population-based cohort, a direct association was seen for
dietary GL only (28). In two 1-y prospective studies among 511
Spanish participants at high CVD risk (25) and 582 healthy
Americans (17), indications of a cross-sectional association be-
tween GI and IL-6 (25) or GL and hsCRP (17) were not confirmed
in longitudinal analyses. Finally, 2 studies conducted in 136 over-
weight Americans (18), and 443 healthy young Japanese women
(24) found no associations between dietary GI or GL and hsCRP
(Table 1).
Intervention studies
Thirteen intervention studies met all the inclusion criteria (20,
21, 29–39) (Table 2). The included studies lasted 4–52 wk and
included a total of 2237 participants (range: 15–932) aged 30–66
ywith a BMI ranging from 28 to 36. Two studies included male
participants only (32, 37). The dietary GI (estimated from 10
studies) in the intervention (low-GI or GL) and control (high-GI or
GL) groups ranged from 33 to 57 and 58 to 86, respectively, and
the corresponding dietary GL ranges (estimated from 11 studies)
were 36–158 and 68–250 g, respectively. Three studies were de-
signed as weight-loss trials (21, 30, 36), and 2 additional studies
offered advice on weight loss if desired (20, 39), but weight
changes were similar in the intervention and control groups. Details
on participant characteristics, dietary interventions, primary end-
points, and the analysis and results are shown elsewhere (see
Supplemental Table 2 under “Supplemental data” in the online
issue).
Three GI/GL intervention studies reported that reductions in
hsCRP (21, 31) or IL-6 (34) in the low-GI/GL group were
significantly larger than changes in the control group. In the
Diet, Obesity and Genes study, conducted in 932 overweight
participants from 8 European countries, groups assigned to
a low-GI diet had notably larger reductions in hsCRP con-
centrations after the 26-wk weight-maintenance period than did
those assigned to a high-GI diet (31), whereas a higher protein
intake significantly increased hsCRP. Two smaller intervention
studies including obese persons reported larger reductions in
IL-6 in response to a low-GI diet (34) and larger reductions in
hsCRP in response to a low-GL diet (21) when compared with
changes under a high-GI or low-fat control diet, respectively.
In 4 further studies, overall changes were not significantly
FIGURE 1. Flowchart of the study selection process. The literature search was conducted during September 2012, was updated in June 2013, and included all
studies published from January 1990 onward. Note that 2 studies addressed more than one aspect of carbohydrate quality. MEDLINE: http://www.ncbi.nlm.nih.
gov/pubmed/; EMBASE: http://www.elsevier.com/online-tools/embase; CENTRAL: http://onlinelibrary.wiley.com/cochranelibrary/search/. GI, glycemic index;
GL, glycemic load.
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TABLE 1
Dietary GI/GL and hsCRP and IL-6: epidemiologic studies1
First author, year,
country
Study population,
characteristics, name
of study Follow-up
Exposure: assessment
method
Outcome: average
(baseline) concentration Results Association2
Bullo, 2011,
Spain (25)
511 participants with high
CVD risk, 56% female,
age 67.2 y*, BMI 29.2
kg/m2*, PREDIMED
trial
1 y FFQ Mean IL-6: 9.97 pg/mL · No prospective
associations between GI/
GL and IL-6 (P . 0.3)
· Trend for direct cross-
sectional association
between GI and IL-6
(P = 0.05)
GI/GLprosp w,
GIcross ([IL-6)
Du, 2008,
Netherlands (26)
786 participants (30% T2D,
23% IGT), 47% female,
age 65 y*, BMI 27.8
kg/m2*, CoDAM and
Hoorn Study
Cross FFQ Median hsCRP:
2.0 mg/dL
· Trend for direct
association between GI
and hsCRP (P = 0.05)
· Trend for direct
association between GL
and hsCRP (P = 0.09)
GI/GLcross ([CRP)
Griffith, 2008, USA
(17)
582 participants (64%
overweight or obese),
48% female, age 48 y*,
BMI 27.4 kg/m2*,
SEASONS
1 y 24-h dietary recall
(43)
Mean hsCRP: 1.8 mg/L · No longitudinal
associations between
GI/GL and hsCRP
(P . 0.16)
· Trend for direct cross-
sectional association
between GL and hsCRP
(P = 0.07)
· Direct cross-sectional
association between GL
and hsCRP among obese
participants (P = 0.04)
GI/GLprosp w,
GIcross ([CRP)
Huffman, 2007, USA
(18)
171 sedentary participants
with overweight to mild
obesity and dyslipidemia,
51% female, age 53 y*,
BMI 29.6 kg/m2*
Cross FFQ Geometric mean
hsCRP: 2.2 mg/L
· No association between
GI/GL and hsCRP
(P . 0.18)
GI/GLcross w
Levitan, 2008, USA
(27)
18,137 postmenopausal
women, age 54.8 y*,
BMI 25.7 kg/m2*,
Women’s Health Study
Cross FFQ Geometric mean
hsCRP3: 1.80 mg/L
· Higher hsCRP
concentrations among
persons with a higher
dietary GI (P , 0.001)
· No association between
GL and hsCRP (P = 0.2)
GIcross [CRP,
GLcross w
Liu, 2002, USA (19) 244 healthy women, age
59 y*, BMI 26 kg/m2*,
Women’s Health Study
Cross FFQ Median hsCRP:
2.8 mg/L
· Higher hsCRP concentra-
tions among persons
with a higher dietary GI
(P , 0.01) and higher
GL (P , 0.01)
GI/GLcross [CRP
Murakami, 2008,
Japan (24)
443 healthy women, age
19.5 y*, BMI 21.3
kg/m2*
Cross Diet-history
questionnaire
Mean hsCRP:
0.30 mg/L
· No association between
GL and hsCRP
(P . 0.3)
GI/GLcross w
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different between the treatment groups. However, results
suggested a treatment effect because the authors reported
a trend for a between-group difference of change (29) or
a treatment effect (35), a pronounced reduction in the low-GL
study arm only (36, 39), or a between-group difference of
change confined to participants with high body fat mass (35).
In 6 further studies, lasting 4–40 wk, low-GI/GL diets did not
result in larger reductions in hsCRP concentrations (20, 30,
32, 33, 37, 38) or IL-6 (37, 38) in comparison with reductions
observed under various control diets with a higher GI and GL
(Table 2).
Dietary fiber
Epidemiologic studies
In total, 16 epidemiologic studies were identified that reported
on the association between dietary fiber intake and hsCRP or IL-6
(23, 24, 40–53) (Table 3, top). Overall, these studies included
39,893 participants (range: 87–9895) aged 20–69 y (data from
12 studies) and a BMI of 21–31 (data from 12 studies). Three
studies included women only (23, 24, 51); one study was per-
formed in men only (53). Dietary fiber intake was assessed
through an FFQ (n = 8 studies), 24-h recalls (n = 5 studies), or
other methods (n = 3), and the studies varied notably in the
presentation of dietary fiber intake data (see Supplemental Table
3 under “Supplemental data” in the online issue).
Overall, 13 of these 16 studies reported an inverse association
between the intake of dietary fiber and concentrations of hsCRP
(23, 40–42, 45, 47–50, 53) or IL-6 (43, 46, 51, 53). Of note,
inverse associations with these markers were also seen in lon-
gitudinal analyses of 4 studies including healthy individuals
(51), persons with a metabolic syndrome (41), and CVD risk
factors or type 2 diabetes (45, 46), who were followed up after
3 mo (45) or 1 y (41, 46, 51). In 3 further cross-sectional studies
including ,2000 participants, dietary fiber intake was not re-
lated to hsCRP concentrations (24, 44, 52) (Table 3, top).
Intervention studies
Eleven intervention studies addressing the effect of dietary
fiber intake or fiber supplements on hsCRP and/or IL-6 were
identified (60–70) (Table 4, top). These studies lasted 3–16 wk
and included a total of 690 participants (12–166) aged 38–63 y
with a BMI range from 25 to 34 (data from 10 studies). One
study was performed in men only (70). In most of the studies,
fiber supplements were added to the habitual diet (61, 63, 66–
70), 2 used special fiber-enriched study foods (60, 62), and
1 study compared a high-fiber Dietary Approaches to Stop Hy-
pertension (DASH) diet and a fiber-supplemented diet (65). Four
studies reported the fiber dose of the administered supplements
only (63, 68–70). Overall, information on fiber intake differed
notably, precluding the calculation of mean intakes. Three of the
studies were designed as weight-loss trials (63, 69, 70), but
a trend toward a greater BMI reduction in the intervention group
was observed in one study only (63) (see Supplemental Table 4
under “Supplemental data” in the online issue).
In one crossover trial examining participants with mild hyper-
cholesterolemia, hsCRP but not IL-6 concentrations were reduced to
a larger extent in the 5-wk high-fiber periodwhen comparedwith the
low-fiber period (64). In a 3-wk randomized crossover study amongT
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TABLE 2
Dietary GI/GL and hsCRP and IL-6: intervention studies1
First author, year, country Participants’ characteristics
Study design, dietary
interventions
Outcome: baseline
concentrations Results2
Effect or no effect of
interventiont3
Ebbeling, 2012, USA (29) 21 participants with
overweight and obesity,
38% female, age 30.3 y*,
BMI 34.4 kg/m2*
Randomized, controlled,
crossover, 4-wk
duration, low-GI vs low-
fat vs very-low CHO diet
Mean hsCRP: 1.75 mg/L · hsCRP not significantly
different between test
diet periods (P = 0.13)
· P-linear trend from low-
fat to low-GI to very-low
CHO diet: 0.05
Low-GI/GL: (+CRP)
Fabricatore, 2011, USA (30) 79 participants with T2D,
64.9% female, age
52.5 y*, BMI
36.3 kg/m2*
Parallel-group study with
balanced randomization,
40-wk duration, low-GL
(n = 39) vs low-fat
(n = 40)
Mean hsCRP4: 7.7 mg/L · No between-group
difference for change in
hsCRP after 40 wk
(P = 0.8)
Low-GL: 2CRP
Go¨gebakan, 2011 (31)5 932 healthy participants,
65% female, age 41 y*,
BMI 34 kg/m2*,
DiOGenes study
RCT, 26-wk duration, low-
GI/low-protein (n = 150)
vs low-GI/high-protein
(n = 315) vs high-GI/
low-protein (n = 155) vs
high-GI/high-protein
diet (n = 155) vs control
group (n = 154)
Mean hsCRP: 2.78 mg/L · Decrease in hsCRP
significantly larger in
low-GI groups than
decrease in high-GI
groups (P , 0.001)
· Low-GI groups more
likely to achieve
a .15% hsCRP
reduction than high-GI
groups
(P = 0.007)
Low-GI: +CRP
Hartman, 2010, USA (32) 64 men at risk of colorectal
cancer, age 54 y*, BMI
28.7 kg/m2*
Randomized, crossover,
4-wk duration, legume-
rich/low-GI vs isocaloric
diet
Mean hsCRP: 1.28 mg/L · No between-group
difference for change in
hsCRP (P = 0.9)
Low-GI: 2CRP
Jebb, 2010, UK (33) 522 participants at risk of
metabolic syndrome,
58% female, age 51.5 y*,
BMI 28.5 kg/m2*
5-center parallel-design
RCT, 24-wk duration,
high-MUFA/LGI (n =
108) vs high-MUFA/
HGI (n = 107) vs low-
fat/LGI (n = 119) vs
low-fat/HGI (n = 109) vs
control high-SFA/HGI
(n = 79)
Mean hsCRP4: 0.53 mg/L · No between-group
difference for relative
change in hsCRP
(P = 0.9)
Low-GI: 2CRP
Jenkins, 2008, Canada (20) 210 participants with T2D,
39% female, age 60.5 y*,
BMI 30.9 kg/m2*
Parallel, randomized, 6-mo
duration, low-GI (n =
106) vs high-cereal fiber
(n = 104)
Mean hsCRP4: 4.61 mg/L · No between-group
difference for change in
hsCRP (P = 0.8)
Low-GI: 2CRP
(Continued)
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TABLE 2 (Continued )
First author, year, country Participants’ characteristics
Study design, dietary
interventions
Outcome: baseline
concentrations Results2
Effect or no effect of
interventiont3
Kelly, 2011, USA (34) 28 previously sedentary
participants with insulin
resistance and obesity,
46% female, age 66 y*,
BMI 34.2 kg/m2*
RCT, 12-wk duration, low-
GI (n = 13) vs high-GI
(n = 15)
No data · Reduction in IL-6
significantly larger in
low-GI than reduction in
high-GI diet group
(P = 0.01)
Low-GI: +IL-6
Neuhouser, 2012, USA (35) 80 participants with
overweight and obesity,
59% female, age 29.5 y*,
BMI 27.5 kg/m2*
Randomized, crossover,
28-d duration, low-GL vs
high-GL
Mean hsCRP: 2.13 mg/L,
mean IL-6: 1.79 pg/mL
· No treatment effect on
hsCRP, trend for higher
IL-6 after low-GL diet
period (P = 0.09)
· Treatment effect among
those with high baseline
body fat mass (n = 51):
low-GL diet period [0.7
(0.5–0.8)], high-GL diet
period [0.9 (0.7–1.1)
mg/L; P = 0.02)]
Low-GL
(+CRP subgroup)
Pereira, 2004,
USA (21)
39 participants with
overweight or obesity,
15% female, age 30.7 y*,
BMI $27 kg/m2
Parallel, randomized,
9–10-wk
duration, low-GL
(n = 22) vs
low-fat (n = 17)
Mean hsCRP5: 0.24 mg/dL · Relative reduction in
hsCRP significantly
larger in low-GL
diet group than
relative change in
low-fat diet group
(P = 0.03)
Low-GL: +CRP
Pittas, 2006, USA (36) 34 participants with
overweight, % female:
75.5%, age 34.6 y*, BMI
27.5 kg/m2*
RCT, 6-mo duration, low-
GL (n = 16) vs high-GL
(n = 1)
Mean hsCRP4: 2.7 mg/L · No between-group
difference for change in
hsCRP (P = 0.13)
· Mean hsCRP decreased
from baseline in low-GL
group (P , 0.01) but not
in high-GL group
Low-GL: (+CRP)
(Continued)
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TABLE 2 (Continued )
First author, year, country Participants’ characteristics
Study design, dietary
interventions
Outcome: baseline
concentrations Results2
Effect or no effect of
interventiont3
Shikany, 2009, USA (37) 24 men with overweight
and obesity, age 34.5 y*,
BMI 27.8 kg/m2*
Randomized, crossover, 4-
wk duration, low-GI/GL
vs high-GI/GL
Mean CRP4: 1.7 mg/L,
mean IL-64:2.9 ng/L
· Changes in CRP or IL-6
did not differ between
the 2 diet periods (P =
0.7 and P = 0.6,
respectively)
Low-GI/GL: –CRP,
2IL-6
Vrolix, 2010, Netherlands
(38)
15 participants with
overweight, 40%
female, age 52.5 y*,
BMI 31 kg/m2*
Randomized, double-blind,
crossover, 11-wk
duration, decreased GI
vs increased GI
No data · No treatment effect on
hsCRP or IL-6 (P = 0.3
and P = 0.9,
respectively).
Low-GI: –CRP,
2IL-6
Wolever, 2008, Canada (39) 162 persons with T2D, 54%
female, age 59.9 y*, BMI
30.9 kg/m2*
Multicenter, RCT, 1-y
duration, low-GI (n = 55)
vs high-GI (n = 48) vs
low-CHO (n = 53
Mean CRP4: 2.6 mg/L · CRP change tended to
differ between the diet
groups (P = 0.064) (low-
GI group: decrease;
high-GI group: increase;
low-CHO group:
intermediate)
· Proportion of participants
with CRP-concentration
$3 mg/L at 1 y
significantly different
between low-GI, high-
GI, and low-CHO
groups (33%, 80%, and
33%, respectively)
Low-GI: (+CRP)
1
See “Supplemental data” in the online issue for details on participant characteristics, dietary interventions, primary endpoints, analysis, and results. *Average value (mean or median as provided in the
original publication). CHO, carbohydrate; DiOGenes, Diet, Obesity and Genes; GI, glycemic index; GL, glycemic load; HGI, high glycemic index; hsCRP, high-sensitivity C-reactive protein; IL-6, interleukin
6; LGI, low glycemic index; RCT, randomized controlled trial; T2D, type 2 diabetes mellitus.
2
P values of between-group differences for changes in inflammatory markers are reported for RCTs; P values for treatment effects are reported for crossover trials.
3+: Effect of dietary intervention on hsCRP or IL-6; (1): trend for effect on hsCRP or IL-6; 2: no effect of dietary intervention on hsCRP or IL-6.
4Weighted mean value calculated from baseline concentrations for treatment groups. See “Supplemental data” in the online issue for baseline concentrations in the treatment groups.
5Denmark, the Netherlands, the United Kingdom, Greece (Crete), Germany, Spain, Bulgaria, and the Czech Republic.
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35 healthy, obese, or hypertensive participants, an hsCRP reduction
tended to be more pronounced under the high-fiber-supplemented
diet when compared with the high-fiber DASH diet (P-treatment
effect = 0.09) (59). In none of the other included intervention
studies did the fiber supplementation or the fiber-enriched study
foods result in greater reductions of hsCRP or IL-6 when compared
with changes under the control diets (60–63, 66–70) (Table 4, top).
Strictly speaking, the intervention by Jenkins et al (20) also con-
stitutes a fiber-intervention study. However, because fiber intake was
higher in the low-GI control diet group than in the high-cereal-fiber
diet group, this study was reviewed in the GI/GL section only.
Whole grain
Epidemiologic studies
Seven observational studies were identified reporting on the
association between whole grain intake and hsCRP and/or IL-6
(23, 54–59) (Table 3, bottom). The overall number of partici-
pants in these studies was 11,295 (259–5496); they were aged
27–62 y and had a BMI of 24–31. Two of the studies included
women only (23, 54). Definition and assessment of whole grain
intake, mostly by means of an FFQ (n = 6 studies), differed
notably across the studies (see Supplemental Table 3 under
“Supplemental data” in the online issue).
Five studies observed a significant association between a higher
whole-grain consumption and lower hsCRP or IL-6 concentrations
(23, 54, 56–59), and one study reported only a trend for the re-
lation between whole grain and hsCRP (56). In 2 further studies,
whole-grain intake was not related to hsCRP or IL-6 concentra-
tions (55). Of note, whole-grain intake appeared to be of specific
relevance for inflammatory markers among persons with type 2
diabetes (23, 57) (Table 3, bottom).
Intervention studies
Seven studies were identified that examined the effect of whole-
grain intake on hsCRP or IL-6 concentrations (71–77) (Table 4,
bottom). The duration of these intervention studies ranged from 3
to 16 wk. Studies included a total of 742 participants (15–266)
aged 46–60 y with a BMI range of 27 to 36. One study included
only women (76). Two studies were designed as weight-loss trials
(75, 76). Although weight loss did not differ between the groups,
one study observed a greater loss in percentage body fat in the
intervention group (whole-wheat group) (76). Definition and as-
sessment of whole-grain intake was again notably different be-
tween the studies (see Supplemental Table 4 under “Supplemental
data” in the online issue).
In one study (75) based on 50 obese individuals with the
metabolic syndrome, who were instructed to either avoid whole
grains or to consume all grains by means of whole grains, sig-
nificantly larger reductions in hsCRP were observed with the
whole-grain treatment. In a further study, significant improvements
in hsCRP in response to a whole-grain diet when compared with
changes under a control diet were confined to patients not using
statins (73). In addition, in a trial among 72 overweight post-
menopausal women, increases in IL-6 concentrations were more
pronounced in the whole-wheat group than in the refined-wheat
food group, whereas hsCRP concentrations were unaffected (76).
The remainder of 4 studies, in which whole-grain foods were
provided, did not observe a treatment effect on hsCRP or IL-6
concentrations (71, 72, 74, 77) (Table 4, bottom).
Qualitative comparison did not provide an indication that sex,
age, or health status of the study population influenced the results
of the 31 intervention studies identified in this systematic review.
DISCUSSION
The current systematic review identified 29 observational studies
that addressed the relevance of dietary GI/GL, fiber, and whole grain
to chronic low-grade inflammation as assessed by hsCRP or IL-6.
The observational studies addressing dietary fiber or whole-grain
intake almost unanimously suggest a benefit of a higher con-
sumption on low-grade inflammation, whereas evidence is less
consistent for a beneficial role of a lower GI or GL. However,
considering the evidence from 31 intervention studies, a different
picture emerges because most of the intervention studies do not
report a benefit of increasing fiber or whole-grain intake for low-
grade inflammation, whereas several intervention studies do support
a potential role of dietary GI or GL.
The current review shows considerable heterogeneity among
observational studies regarding associations between dietary GI/
GL and markers of chronic inflammation. This is in line with the
heterogeneity reported for observational studies linking GI/GL to
chronic disease outcomes such as type 2 diabetes (78, 79) and
CVD (80–83). A recent meta-analysis of the association between
dietary GL and the development of type 2 diabetes showed that
this heterogeneity was almost exclusively attributable to differ-
ences in the studies regarding sex, ethnicity, and the ability of
the FFQ to correctly measure carbohydrate consumption (79).
In the current review, 2 of the 4 studies reporting no associa-
tions had used an FFQ for which correlation coefficients with
dietary records were ,0.6 for total carbohydrate intake (24,
25) (see Supplemental Table 1 under “Supplemental data” in
the online issue). The calculation of dietary GL and GI is based
on data for total carbohydrate intake, which results in an in-
sufficient estimation of dietary GI and GL. Additional meth-
odologic limitations when estimating dietary GI and GL from
FFQs include entry of low and high-GI foods into the same
food grouping (eg, whole-kernel and whole-meal breads, re-
spectively), assignment of GI values available for similar
foods, and interresearcher variation in GI assignment (84). Of
note, epidemiologic studies on dietary GI/GL are, however, not
as amenable to residual confounding, because dietary GI/GL
does not strongly correlate with healthy lifestyle behaviors
given that most populations are still largely unaware of what
constitutes a low dietary GI (85).
In line with evidence from observational studies, intervention
studies provided some support for the relevance of the GI/GL
concept on chronic inflammation. Associations were most evident
in the largest (31) study, which used a low-GI diet rather than
a low-GL diet, ie, diets that modified the quality of the consumed
carbohydrates only. It is plausible that such a dietary approach
would be most effective regarding the reduction of chronic in-
flammation because the avoidance of glycemic spikes is consid-
ered to be of primary relevance for oxidative stress, and this is well
captured by the dietary GI in diets with at least a moderate to high
carbohydrate content (86). In contrast, a lower carbohydrate intake
may be associated with increased energy intake from protein and
saturated fat, which might in turn be expected to increase
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TABLE 3
Dietary fiber and whole grain intakes and hsCRP and IL-6: epidemiologic studies1
First author, year, country
Study population,
characteristics,
name of study Follow-up
Exposure: assessment
method
Outcome: average
(baseline) concentration Results Association2
Dietary fiber intake:
epidemiologic studies
Ajani, 2004, USA (40) 3920 participants, 52%
female, age 45.6 y*,
BMI 28.6 kg/m2*,
NHANES (1999–2000)
Cross 24-h dietary recall Mean CRP3: 4.3 mg/L · Lower CRP
concentrations
among persons with
higher dietary fiber
intakes (P = 0.045)
· Lower risk of CRP
.3 mg/L among
persons with higher
dietary fiber intakes
(P = 0.006)
Fibcross: YCRP
Bo, 2006, Italy (42) 1653 participants, 53%
female, age 54.6 y*,
BMI 26.5 kg/m2*,
representative sample
of Italian province
Cross Semiquantitative FFQ Mean % of participants
with hsCRP3
$3 mg/L: 25%
· Lower risk of hsCRP
$3 mg/L among
persons with higher
dietary fiber intakes
(P = 0.003)
Fibcross: YCRP
Bo, 2008, Italy (41) 335 participants with
metabolic syndrome,
58% female, age 55.7
y*, BMI 29.8 kg/m2*,
reanalysis of inter-
vention study
1 y Semiquantitive FFQ Mean hsCRP3:
3.3 mg/L
· Increases in fiber
intake associated with
decreases in hsCRP
concentrations
(P = 0.03)
Fibprosp: YCRP
Chuang, 2011, Italy (43) 87 participants free of
cancer, 39% female,
age 54.0 y*, BMI
25.7 kg/m2*,
sampled from the
EPIC-Italy cohort
Cross Center-specific FFQ Geometric mean IL-63:
57.0 pg/mL
· Trend for inverse
association between
dietary fiber intake
and IL-6 (P = 0.09)
Fibcross: (YIL-6)
Diaz, 2005, USA (44) 1567 participants with
overweight, 53%
female, age 38.1 y*,
BMI 30.6 kg/m2*,
NHANES (1999–2000)
Cross 24-h dietary recall No data · No association
between dietary fiber
intake and risk of
hsCRP $0.3 mg/dL
(NS)
Fibcross: w
Estruch, 2009, Spain
(45)
771 persons with
diabetes or .3 CHD
risk factors, 56%
female, age 68.8 y*,
BMI 29.9 kg/m2*,
reanalysis of
intervention study
3 mo FFQ No data · Increases in fiber
intake associated
with decreases in
hsCRP
concentrations
(P = 0.004)
Fibprosp: YCRP
(Continued)
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TABLE 3 (Continued )
First author, year, country
Study population,
characteristics,
name of study Follow-up
Exposure: assessment
method
Outcome: average
(baseline) concentration Results Association2
Herder, 2009, Finland
(46)
406 participants with
overweight or
obesity and IGT,
65.3% female, age
55.4 y*, BMI 31.2
kg/m2*, reanalysis of
the Finnish Diabetes
Prevention Study
1 y 3-d food record Median CRP3: 2.09
mg/L; median IL-64:
1.76 pg/mL
· Changes in fiber
(g/1000 kcal)
correlated with
changes in CRP
concentrations
(P = 0.015)
· Changes in fiber (g)
correlated with
changes in IL-6
(P = 0.008)
Fibprosp YCRP, YIL-6
Kantor, 2013, USA (47) 9895 participants,
mostly with
overweight or
obesity, 51.3%
female, NHANES
(1999–2000, 2001–
2002, 2003–2004
cycles)
Cross 24-h dietary recalls Geometric mean
hsCRP3: 1.82 mg/L
· Lower ratio of the
geometric mean
hsCRP among those
exposed to higher
fiber intakes
(P , 0.0001)
Fibcross: YCRP
King, 2003, USA (48) 4900 participants,
52.1% female, age
$18 y, BMI 27.9 kg/
m2*, NHANES
(1999–2000)
Cross Recollection of food
eaten the previous
day
Median hsCRP:
2.0 mg/L
· Lower hsCRP
concentrations among
persons with higher
dietary fiber intakes
(P , 0.05)
· Lower risk of hsCRP
.3 mg/L among
persons with higher
dietary fiber intakes
(P , 0.05)
Fibcross: YCRP
King, 2005, USA (49) 7891 persons with
diabetes,
hypertension or
obesity, NHANES
(1999–2002)
Cross 24-h dietary
recall
No data · Lower CRP
concentrations
among persons with
higher dietary fiber
intakes (P , 0.05)
· Lower risk of CRP
.3 mg/L among
persons with higher
dietary fiber intakes
(P , 0.05)
Fibcross: YCRP
(Continued)
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TABLE 3 (Continued )
First author, year, country
Study population,
characteristics,
name of study Follow-up
Exposure: assessment
method
Outcome: average
(baseline) concentration Results Association2
Ma, 2006, USA (50) 524 participants, 49%
female, age 48.3 y*,
BMI 27.2 kg/m2*
1 y 24-h dietary recalls
(43)
Geometric mean
(6SD) CRP: 1.78 6
1.66 mg/L
· Increases in fiber
intake associated
with decreases in
CRP concentrations
(P = 0.03)
· Lower risk of CRP
.3 mg/L among
persons with higher
dietary fiber intakes
(P = 0.01)
Fibprosp: YCRP
Ma, 2008, USA (51) 1958 postmenopausal
women, age 62.2 y*,
BMI 28.8 kg/m2*
Cross FFQ Geometric mean
hsCRP: 2.01 mg/L;
geometric mean IL-
6: 1.90 pg/mL
· Increases in fiber
intake associated
with decreases in IL-
6 concentrations
(P = 0.01)
· No association between
dietary fiber intake and
hsCRP (P = 0.4)
Fibcross: YIL-6, wCRP
Murakami, 2008, Japan
(24)
443 female students,
age 19.5 y*, BMI
21.3 kg/m2*
Cross Diet-history
questionnaire
Mean hsCRP:
0.30 mg/L
· No association
between dietary fiber
intake and risk of
hsCRP .1 mg/L)
(P . 0.3)
Fibcross: wCRP
Oliveira, 2009, Portugal
(52)
1060 participants, some
with overweight,
64% female, age 54
y*, BMI ,25 (n =
350) and $25 kg/m2
(n = 710)
Cross Semiquantitative FFQ Median hsCRP: 1.9 mg/
L (women), 1.4 mg/L
(men)
· No association
between dietary fiber
intake and risk of
increase in hsCRP
(NS)
Fibcross: wCRP
Qi, 2006, USA (23) 1055 women with T2D,
age 58.5 y*, BMI
29.8 kg/m2*
Cross Semiquantitative FFQ No data · Lower CRP
concentrations
among persons with
higher cereal fiber
intakes (P = 0.03)
· No association between
total fiber intake and
hsCRP (NS)
Fibcross: wCRP; cereal
fibcross: YCRP
Wannamethee,
2009, UK (53)
3428 men
with no prevalent
diabetes, age
60–79 y,
British Regional
Heart Study
Cross Detailed 7-d
recall, FFQ
Geometric mean
hsCRP4: 1.70 mg/L
· Lower hsCRP and
IL-6 concentrations
among persons with
higher dietary fiber
intakes (P , 0.0001)
Fibcross: YCRP,
YIL-6
(Continued)
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TABLE 3 (Continued )
First author, year, country
Study population,
characteristics,
name of study Follow-up
Exposure: assessment
method
Outcome: average
(baseline) concentration Results Association2
Whole-grain consumption:
epidemiologic studies
Gaskins,
2010, USA (54)
259 healthy women,
age 27.3 y*, BMI
24.1 kg/m2*
1 or 2
menstrualcycles
24-h dietary recall
(#43/cycle)
Mean hsCRP:
0.6 mg/L
· Lower hsCRP
concentrations
among
women with higher
whole-grain
consumption
(P = 0.04)
WGprosp: YCRP
Jensen, 2006, USA (55) 938 healthy participants,
50.1% female, age
(study 1: 60 y; study
2: 42.5 y)*, BMI
(study 1: 25.6 kg/m2;
study 2: 24.4 kg/m2)
*, study 1: Health
Professionals
Follow-Up Study;
study 2: Nurses’
Health Study II
Cross 131-item FFQ Mean CRP: 1.80 mg/L;
mean IL-6: 1.53 pg/
mL
· No association
between whole grain
intake and risk of
increase in CRP or
IL-6 (NS)
WGcross: wCRP, wIL-6
Lutsey, 2007, USA (56) 5496 healthy
participants,
52.8% female, age
61.9 y*,
BMI 27.9 kg/m2*
Cross Staff-assisted
127-item FFQ
Geometric mean
hsCRP3: 3.26 mg/L
· Trend for inverse
association between
whole grain intake
and hsCRP
(P = 0.08)
· No association between
whole grain intake and
IL-6 (P = 0.9)
WGcross: (YCRP),wIL-6
Masters, unpublished
data, USA (57)4
487 participants with
T2D, 53.9% female,
age 57.2 y*, BMI
31.4 kg/m2*
Cross FFQ Median hsCRP3:
4.62 mg/L
· Lower hsCRP
concentrations
among persons with
higher whole grain
intake (P = 0.017)
· Observed association
independent of
potential pathway
nutrients (dietary
fiber and magnesium
intake)
YCRP
(Continued)
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TABLE 3 (Continued )
First author, year, country
Study population,
characteristics,
name of study Follow-up
Exposure: assessment
method
Outcome: average
(baseline) concentration Results Association2
Masters, 2010, USA (58) 1015 healthy
participants, 56.4%
female, age 54.9 y*,
BMI 28.4 kg/m2*
Cross 114-item
semiquantitive FFQ
Median hsCRP3:
1.72 mg/L
· Lower hsCRP
concentrations
among persons with
higher whole grain
intake (P = 0.03)
· Inclusion of waist
circumference,
insulin sensitivity,
2-h glucose
attenuated the results
to nonsignificance
· No association
between refined
grain intake and
hsCRP (P = 0.6)
WGcross: YCRP
Montonen, 2012,
Germany (59)
2198 participants,
60.9% female, age
50.4 y*, BMI 26.1
kg/m2*, cohort from
EPIC-Potsdam
Cross 148-item FFQ Geometric mean
hsCRP3: 0.80 mg/L
· Lower hsCRP
concentrations
among persons with
higher whole-grain
bread intake
(P = 0.02)
· Observed association
independent of BMI
and waist
circumference
WGcross: YCRP
Qi, 2006, USA (23) 902 women with T2D,
age 58.5 y*, BMI
29.7 kg/m2*
Cross Semiquantitative FFQ Geometric mean
hsCRP3: 5.75 mg/L
· Lower hsCRP
concentrations
among persons with
higher whole-grain
bread intake
(P = 0.03)
WGcross: YCRP
1
See “Supplemental data” in the online issue for details on population, assessment method, average baseline concentrations of exposures, and covariates considered in the analysis and results. *Average
value (mean or median as provided in the original publication). Cross, cross-sectional; CHD, coronary heart disease; EPIC, European Prospective Investigation into Cancer and Nutrition; FFQ, food-frequency
questionnaire; fib, dietary fiber intake; hsCRP, high-sensitivity C-reactive protein; IGT, impaired glucose tolerance; T2D, type 2 diabetes mellitus; WG, whole grain.
2
[: Direct association with fiber or whole grains; ([): trend for association with fiber or whole grains; w: no association with fiber or whole grains;Y: inverse association with fiber or whole grains.
3Estimated from values given per quantiles or averaged from the intervention and control groups (in post hoc analyses).
4Unpublished data, provided by authors.
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TABLE 4
Fiber and whole grain and hsCRP and IL-6: intervention studies1
First author, year, country Participants’ characteristics
Study design, dietary
interventions
Outcome: baseline
concentration Results2
Effect or no effect of
intervention3
Fiber intake: intervention
studies
Bio¨rklund, 2008, Sweden (60) 43 participants with mildly
elevated serum
cholesterol
concentrations, 55.8%
female, age 58 y*, BMI
25.0 kg/m2*
Parallel, placebo-
controlled, 5-wk
duration, b-glucan
(n = 22) vs placebo
(n = 21)
Mean hsCRP4: 1.63 mg/L · No between-group
difference for change in
hsCRP (P . 0.05)
b-Glucan: 2CRP
Dall‘Alba, 2013, Brazil (61) 44 participants with T2D
and metabolic syndrome,
61.4% female, age 62 y*,
BMI 29.8 kg/m2*
RCT, 6-wk duration, guar
gum (n = 23) vs control
(n = 21)
Median hsCRP4: 2.37 mg/L · No data on between-
group difference for
change in hsCRP (ie, no
P value)
· No significant change
within each treatment
arm (P . 0.3)
Guar gum: 2CRP
Jenkins, 2002, Canada (62) 23 participants with T2D,
30% female, age 63 y*,
BMI 26.7 kg/m2*
Randomized crossover,
3-mo duration, wheat
bran vs control
Mean hsCRP: 4.49 mg/L · No between-group
difference for change in
hsCRP (P = 0.4)
Wheat bran: 2CRP
Jensen, 2012, Denmark (63) 80 participants with
obesity, 67.5% female,
age 42.9 y*, BMI 34.2
kg/m2*
Parallel, double-blind,
placebo-controlled,
12-wk duration,
alginate-fiber (n = 38)
vs placebo (n = 42)
Mean hsCRP4: 4.0 mg/L · No between-group
difference for change in
hsCRP (P = 0.3)
Alginate fiber: 2CRP
Johansson-Persson, 2013,
Sweden (64)
25 participants with mild
hypercholesterolemia,
52% female, age 58.6 y*,
BMI 26.6 kg/m2*
Randomized, single-blind,
crossover trial, 5-wk
duration, high-fiber vs
low-fiber
Mean CRP4: 1.7 mg/L;
median IL-64:
0.94 pg/mL
· Reduction in CRP
significantly larger in
high-fiber period than in
low-fiber period (P =
0.017)
· IL-6 not significantly
different between diet
periods (P = 0.2)
Dietary fiber: +CRP,2IL-6
King, 2007, USA (65) 35 participants (18 healthy
and 17 with obesity and
hypertension), 80%
female, age 38.3 y*, BMI
28.4 kg/m2*
Randomized, crossover,
3-wk duration, high-fiber
DASH diet vs psyllium
fiber
Mean hsCRP: 4.4 mg/L · Trend for greater hsCRP
reduction in fiber
supplementation period
(P = 0.09)
Psyllium fiber: (+CRP)
King, 2008, USA (66) 158 participants with
overweight or obesity,
72.8% female, age 50.5
y*, BMI 33.4 kg/m2*
RCT, 3-mo duration, high-
fiber (psyllium) (n = 48)
vs low-fiber (psyllium)
(n = 53) vs control
(n = 57)
Mean hsCRP4: 7.68 mg/L · No difference in change
between treatment
groups and control
group (P . 0.05)
Psyllium fiber 2CRP
(Continued)
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TABLE 4 (Continued )
First author, year, country Participants’ characteristics
Study design, dietary
interventions
Outcome: baseline
concentration Results2
Effect or no effect of
intervention3
Kohl, 2009, Germany (67) 12 participants with
overweight or obesity
and moderately
increased concentrations
of CRP (,5 mg/L), 67%
female, age 49.7 y*,
BMI 32.2 kg/m2*
Randomized, double-blind,
placebo-controlled
crossover, 4-wk
duration, b-glucan vs
placebo
Mean CRP: 5.7 mg/L; no
data for IL-6
· No treatment effect on
CRP (P = 0.4) and IL-6
(P = 0.9)
b-Glucan, –CRP, 2IL-6
Queenan, 2007, USA (68) 75 participants at
risk of CVD
(hypercholesterolemic),
67% female, age 44.9 y*,
BMI ,30 kg/m2
Randomized, double-blind,
parallel, 6-wk duration,
oat b-glucan (n = 35) vs
placebo (n = 40)
Mean CRP4: 0.37 mg/dL · No between-group
difference for change in
CRP (P = 0.3)
Oat b-glucan: 2CRP
Salas-Salvado, 2008, Spain (69) 166 participants with
overweight or obesity,
78.3% female, age
47.9 y*, BMI 31.2 kg/m2*
Parallel, double-blind,
randomized, placebo-
controlled, 16-wk
duration, supplemented
fiber twice a day (n = 53)
vs supplemented fiber 3
times/d (n = 58) vs
placebo (n = 55)
Mean hsCRP4: 0.77 mg/L · No difference in change
between treatment
groups and control
group (P = 0.5)
Fiber supplementation:
–CRP
Wood, 2006, USA (70) 29 men with overweight,
age 38.8 y*, BMI 29.7
kg/m2*
Parallel, placebo-controlled,
double-blind, 12-wk
duration, soluble fiber
(n = 14) vs placebo (n = 15)
Mean hsCRP4: 1.77 mg/L;
mean IL-64: 1.03 pg/mL
· No between-group
difference for change
in hsCRP and IL-6
(P . 0.05)
Soluble fiber
supplementation:
–CRP, 2IL-6
Whole-grain consumption:
intervention studies
Andersson, 2007, Sweden
(71)
30 healthy participants
(women were
postmenopausal), 73%
female, age 59 y*, BMI
28.3 kg/m2*
Randomized, nonblind,
crossover, 6-wk
duration, whole grain vs
refined grain
Mean hsCRP4: 2.45 mg/L;
mean IL-64: 15.4 ng/L
· No treatment effect on
hsCRP (P = 0.6) and IL-
6 (P = 0.8)
WG: –CRP, 2IL-6
Brownlee, 2010, UK (72) 266 participants with
overweight or obesity,
49.8% female, age 45.7
y*, BMI 30.1 kg/m2*
RCT, 16-wk duration, 60 g
whole grain/d (n = 85) vs
60 g whole grain/d in
first 8 wk, 120 g/d in last
8 wk (n = 81) vs control
(n = 100)
Median CRP4: 2.6 mg/L · No difference in change
between intervention
groups and control
group (P . 0.05)
(P . 0.05)
WG: 2CRP
(Continued)
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TABLE 4 (Continued )
First author, year, country Participants’ characteristics
Study design, dietary
interventions
Outcome: baseline
concentration Results2
Effect or no effect of
intervention3
de Mello, 2011, Finland (73) 103 participantswith impaired
glucose metabolism and
features of the metabolic
syndrome, 51% female,
age 59 y*, BMI 31.1
kg/m2*
Parallel design, RCT, 12-wk
duration, healthy diet
(n = 35) vs whole grain
(n = 34) vs control
(n = 34)
Median hsCRP4: 1.4 mg/L;
median IL-64: 1.4 ng/L
· No between-group
difference for change in
hsCRP (P = 0.3) and
IL-6 (P = 0.7)
· Significant improvements
in hsCRP on whole-
grain diet in comparison
with control among
patients not using statins
(P , 0.05) (n = 76)
WG: 2 IL-6,
(+CRP) subgroup
Giacco, 2010, Italy (74) 15 participants, some with
overweight or obesity,
20% female, age 54.4 y*,
BMI 27.4 kg/m2*
Randomized, sequential,
crossover, 3-wk
duration, whole-meal
wheat vs refined wheat
No data · No treatment effect on
hsCRP (P = 0.4)
Whole-meal wheat: 2CRP
Katcher, 2008, USA (75) 50 participants with obesity
and the metabolic
syndrome, 50% female,
age 46.6 y*, BMI
35.8 kg/m2*
Randomized, open-label,
parallel-arm, 12-wk
duration, whole grain
(n = 25) vs refined
grain (n = 25)
Mean hsCRP: 6.0 mg/L;
mean IL-6: 2.7 pg/mL
· Reduction in hsCRP
significantly larger in
whole-grain than in
refined-grain group
(P = 0.01)
· No between-group
difference of change in
IL-6 (NS)
WG: +CRP, 2IL-6
Kristensen, 2012, Denmark (76) 72 postmenopausal women
with overweight or
obesity, age 59.7 y*,
BMI 30.2 kg/m2*
Open-label, parallel, 12-wk
duration, whole wheat
(n = 38) vs refined wheat
(n = 34)
Mean hsCRP4: 0.97 mg/L;
mean IL-64: 2.10 ng/L
· No between-group
difference of change in
hsCRP (P = 0.95)
· Trend for greater IL-6
increase in whole-wheat
group as compared with
refined-wheat group
(P = 0.09)
Whole wheat –CRP,
(+IL-6 – adverse)
Tighe, 2010, Scotland (77) 206 healthy participants,
some with signs of
metabolic syndrome,
50% female, age 51.7 y*,
BMI 27.7 kg/m2*
Randomized, single-blind,
controlled, 12-wk
duration, whole wheat
(n = 73) vs wheat + oats
(n = 70) vs control
(n = 63)
Median hsCRP4: 1.9 mg/L;
median IL-64: 1.2 pg/L
· No between-group
difference of change in
hsCRP (P = 0.5) and
IL-6 (P = 0.3)
Whole wheat:
–CRP, 2IL-6
1 See “Supplemental data” in the online issue for details on participant characteristics, dietary interventions, primary endpoints, analysis, and results. *Average value (mean or median as provided in the
original publication). CVD, cardiovascular disease; DASH, Dietary Approaches to Stop Hypertension; hsCRP, high-sensitivity C-reactive protein; IL-6, interleukin 6; RCT, randomized controlled trial; T2D,
type 2 diabetes mellitus; WG, whole grain.
2
P values of between-group differences for changes in inflammatory markers are reported for RCTs; P values for treatment effects are reported for crossover trials.
3+: Effect of dietary intervention on hsCRP or IL-6; (1): trend for effect on hsCRP or IL-6; 2: no effect of dietary intervention on hsCRP or IL-6.
4Weighted mean value calculated from baseline concentrations for treatment groups. See “Supplemental data” in the online issue for baseline concentrations in the treatment groups.
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inflammation (31). In linewith this, the study by Ebbeling et al (29)
observed the lowest hsCRP concentrations in the low-GI diet arm
and higher hsCRP concentrations in the very low carbohydrate
arm.
The current review identified a substantial discrepancy between
observational and interventional studies with respect to the evidence
from these studies linking fiber or whole grain intake to chronic low-
grade inflammation. Similar discrepancies were previously reported
(87) and appear to extend also to the preventive potential of whole-
grain intake in the management of body weight (88). This may to
some extent reflect the fact that relative differences in fiber or whole-
grain intakes between the extreme quantiles in observational studies
notably exceed relative differences commonly realized between
treatment arms in intervention studies (see Supplemental Tables 3
and 4 under “Supplemental data” in the online issue). Alterna-
tively, this discrepancy may arise from considerable con-
founding or from substantial methodologic limitations of the
intervention studies.
It is well known that a higher fiber or whole-grain intake
correlates notably with other aspects characterizing a healthier
lifestyle (89), and it is very likely that observational studies only
partly account for residual confounding because the assessed
variables describing lifestyle may not reflect all relevant aspects
(unmeasured confounding). Hence, observational studies may
substantially overestimate the “true” beneficial effect of fiber or
whole-grain intakes on low-grade inflammation.
Similarly, residual confounding may operate in observational
studies linking higher fiber or whole-grain intakes to reduced
risks of type 2 diabetes and CVD (90–94), because these asso-
ciations are considered to be partly mediated by chronic low-
grade inflammation (95). Hence, effective increases in whole
grain or fiber intakes may not yield the health benefits currently
expected based on observational evidence only. The fact that
high-fiber diets were effectively used in landmark diabetes
prevention studies (96, 97) does not contradict this concern,
because the benefits observed in these studies stem from weight
loss via integrated lifestyle modifications and cannot be directly
attributed to the composition of the diet.
Concerning the intervention studies identified in this sys-
tematic review, note that most of them included ,100 partici-
pants and were not designed to address chronic low-grade
inflammation as a primary outcome (see Supplemental Tables 2–
4 under “Supplemental data” in the online issue). Because most
intervention studies may not have been sufficiently powered to
detect smaller effects with statistical significance, our evidence
appraisal also considered results suggestive of treatment effects
(ie, trends) and/or effects in subgroups only. In addition, it could
be argued that the included participants were too young or too
healthy or that the time period covered by the intervention
studies was too short for a beneficial effect on the inflamma-
tory markers to establish. However, to address this concern we
considered only studies lasting $3 wk, and qualitative com-
parisons did not suggest a link of effectiveness to age, health
status of the participants, or study duration. Although weight-
loss trials mostly observed comparable weight loss in both study
arms, minor between-group differences in energy intake and
hence minor differences in adiposity changes may nonetheless
have confounded the findings. Moreover, some studies did not
provide foods, but gave advice only. Generally, it is possible that
the foods provided or selected were foods rich in dietary fiber or
whole grain, yet had a high dietary GI because many whole-
grain foods or foods rich in dietary fiber are characterized by
a high dietary GI (eg, whole-meal breads or instant porridge
oats). Beneficial components of high-fiber or whole-grain foods
contributing to reduced chronic inflammation may have been
counteracted by the higher postprandial glycemic excursions
that these foods provoke. In this context, it is of interest that
approaches directed at lowering the dietary GI appear to entail
both a lower dietary GI and a higher dietary fiber intake, as
evident in the study by Jenkins et al (20). Therefore, larger in-
tervention studies using combinations of increases in whole-
grain and fiber intakes and reductions in dietary GI/GL are
needed to determine optimal dietary approaches to reduce
chronic inflammation. The magnitude of differences observed in
the studies reporting significant findings [with relative between-
group differences of change ranging from 16% (31) to w40%
(21, 64, 75)] supports the notion that such an approach can in-
deed yield clinically relevant findings.
Finally, CRP, although closely associated with the de-
velopment of chronic diseases, may not be a causal risk factor,
and the assays of both CRP and IL-6 are poorly standardized.
Considerable variation for average concentrations of CRP and IL-
6, which are most likely attributable to the type of assay, are
shown in Tables 1–4. Whereas this should, in principle, not
affect the effect sizes or estimates of intervention effects, it
cannot be excluded that some assays may have been more
precise than others [eg, interassay CVs ranged between 1.0%
(42) and 10.8% (18) for CRP and reached up to 30.7% for IL-6
(43)], which could have led to an underestimation of associa-
tions in epidemiologic studies and of effects in intervention
trials. We excluded studies that reported to be conducted in
participants who had inflammatory diseases at baseline, but re-
frained from excluding studies on the basis of initial CRP
concentrations alone because these may have depended more
strongly on the type of assay than the participants’ baseline
status of acute or chronic inflammation. However, note that the
diseases included in this review, such as diabetes or obesity, are
also characterized by a proinflammatory component, precluding
a strict exclusion of inflammatory diseases.
The strengths of this systematic review include its approach to
consider the totality of evidence currently available from both
observational and intervention studies for 3 major aspects of
carbohydrate quality. Mechanisms discussed to link these car-
bohydrate quality measures to chronic inflammation show only
some overlap, which justifies a separate consideration. Quanti-
fication of the observed associations would have been desirable;
however, in our view, the data are too heterogeneous to justify
a meta-analysis. In particular, the intervention studies differ
notably in their design: the degree to which foods were provided,
the use of supplements or dietary fiber, the definitions of whole-
grain foods, and the broad variety of diets used as control diets. In
view of this heterogeneity, the overall number of identified
studies covering 3 aspects of carbohydrate quality and 2 study
types is still considerably small. As larger intervention studies
and prospective observational studies become available, future
systematic reviews might be able to perform meta-analyses.
In conclusion, evidence from intervention studies for antiin-
flammatory benefits is less consistent for higher-fiber or whole-
grain diets than for low-GI/GL diets. Antiinflammatory benefits
of higher dietary fiber and whole grain intakes suggested by
18 of 21 BUYKEN ET AL
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observational studies are not supported by intervention studies,
which indicates that confounding is likely and/or that the sta-
tistical power in intervention studies may have been too low to
reveal small effects.
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Detailed search strategy systematic review 
 
1. "glycemic index" and CRP 
2. "glycaemic index" and CRP 
3. "glycemic load" and CRP 
4. "glycaemic load" and CRP 
5. "whole grain*" and CRP 
6. fiber and CRP 
7. fibre and CRP 
8. "carbohydrate quality" and CRP 
9. "glycemic index" and hs-CRP 
10. "glycaemic index" and hs-CRP 
11. "glycemic load" and hs-CRP 
12. "glycaemic load" and hs-CRP 
13. "whole grain*" and hs-CRP 
14. fiber and hs-CRP 
15. fibre and hs-CRP 
16. "carbohydrate quality" and hs-CRP 
17. "glycemic index" and "c-reactive protein" 
18. "glycaemic index" and "c-reactive protein" 
19. "glycemic load" and "c-reactive protein" 
20. "glycaemic load" and "c-reactive protein" 
21. "whole grain*" and "c-reactive protein" 
22. fiber and "c-reactive protein" 
23. fibre and "c-reactive protein" 
24. "carbohydrate quality" and "c-reactive protein" 
25. "glycemic index" and "high-sensitivity c-reactive protein" 
26. "glycaemic index" and "high- sensitivity c-reactive protein" 
27. "glycemic load" and "high-sensitivity c-reactive protein" 
28. "glycaemic load" and "high- sensitivity c-reactive protein" 
29. "whole grain*" and "high-sensitivity c-reactive protein" 
30. fiber and "high-sensitivity c-reactive protein“ 
31. fibre and "high-sensitivity c-reactive protein" 
32. "carbohydrate quality" and "high-sensitivity c-reactive protein" 
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33. "glycemic index" and IL-6 
34. "glycaemic index" and IL-6 
35. "glycemic load" and IL-6 
36. "glycaemic load" and IL-6 
37. "whole grain*" and IL-6 
38. fiber and IL-6 
39. fibre and IL-6 
40. "carbohydrate quality" and IL-6 
41. "glycemic index" and "interleukin 6" 
42. "glycaemic index" and "interleukin 6" 
43. "glycemic load" and "interleukin 6" 
44. "glycaemic load" and "interleukin 6" 
45. "whole grain*" and "interleukin 6" 
46. fiber and "interleukin 6" 
47. fibre and "interleukin 6" 
48. "carbohydrate quality" and "interleukin 6" 
 
We also worked with the NOT statement: e.g. for 2.  "glycaemic index" and CRP not #1
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Supplemental table 1: Dietary GI/GL and hsCRP/IL-6– epidemiological studies (detailed version)1 
First 
author, 
Year, 
Country 
Population, 
recruitment, Name 
of study 
Follow-
up 
Exposure : assessment 
method, average 
baseline values 
Outcome: 
average 
(baseline) level 
Covariates 
considered in 
analysis 
Results /∼/2 
Bullo, 2013,  
Spain (25) 
511 participants 
with high CVD risk 
 
PREDIMED trial 
 
% female: 56% 
Ø age: 67.2y 
Ø BMI: 29.2 
1 year FFQ, 
mean GI in GI quartiles: 
Q1: 61 
Q2: 69 
Q3: 74 
Q4: 80 
mean GL in GL quartiles: 
Q1: 110 
Q2: 150 
Q3: 190 
Q4: 264  
 
 
 
Correlation of 
carbohydrate intake from 
FFQ with food records: 
0.56 (energy adjusted) 
 
mean IL-6:  
9.97 pg/ml 
 
sex, age, changes in 
waist circumference, 
changes in BMI, 
intervention group, 
physical activity in 
leisure time, 
smoking, insulin use, 
presence of type 2 
diabetes, n-3 fatty 
acid intake, fiber 
 
Adjusted cross-sectional estimates:  
Baseline IL-6 (pg/ml) in GI 
quartiles (mean (95% CI)):  
Q1: 9.5 (8.2-10.9) 
Q2: 8.8 (7.7-10.1) 
Q3: 10.0 (8.7-11.5) 
Q4: 11.6 (10.1-13.4), pfor trend=0.05  
Baseline IL-6 (pg/ml) in GL 
quartiles (mean (95% CI)):  
Q1: 9.6 (8.2-11.2) 
Q2: 9.2 (8.0-10.6) 
Q3: 9.6 (8.4-11.1) 
Q4: 11.4 (9.8-13.3), pfor trend=0.2 
Adjusted longitudinal estimates: 
1y changes in IL-6 (pg/ml) in GI 
quartiles (mean (95% CI)):  
Q1: 0 
Q2: 1.5 (-1.8 - 4.7) 
Q3: -0.2 (-3.5 - 3.1) 
Q4: -1.1 (-4.4 - 2.1), pfor trend=0.3  
1y changes in IL-6 (pg/ml) in GL 
quartiles:  
Q1: 0 
Q2: -0.6 (-3.9 - 2.7) 
Q3: -1.8 (-5.1 - 1.5) 
Q4: 0.3 (-3.1 - 3.8), pfor trend=0.97  
GI/GLprosp. ∼ 
GIcross. (IL6) 
Du 2008, 
Netherlands 
(26) 
786 participants 
(30% T2D, 23% 
IGT)  
 
321 from CoDAM 
Study (high risk for 
CVD population), 
653 from Hoorn 
Study (general 
cross FFQ 
mean GI: 57 (SD: 4) 
mean GL: 130 (SD: 39) 
 
Correlation of 
carbohydrate intake from 
FFQ with food records: 
0.75 (energy adjusted and 
de-attenuated) 
median hsCRP: 
2.0 (Q1-Q4: 1.2-
3.6) mg/dl 
 
age, sex, current 
smoking status, 
physical activity, 
cohort, total energy, 
alcohol, fiber, 
cholesterol, animal-
and plant based 
protein, SFA. For GI 
additionally MUFA, 
Multiple regression of GI/GL with 
hsCRP  (mg/dl): 
hsCRP per 10-unit increase in GI  
ß=0.11 (SE:0.06); p=0.05 
hsCRP per 50-unit increase in GL  
ß=0.08 (SE:0.05); p=0.09 
GI/GLcross. (CRP) 
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First 
author, 
Year, 
Country 
Population, 
recruitment, Name 
of study 
Follow-
up 
Exposure : assessment 
method, average 
baseline values 
Outcome: 
average 
(baseline) level 
Covariates 
considered in 
analysis 
Results /∼/2 
population) 
 
Persons with CRP 
> 10 mg/l excluded  
 
% female: 47% 
Ø age: 65y 
Ø BMI: 27.8 
PUFA, 
polysaccharides, and 
mono-and 
disaccharides 
Griffith 
2008, 
USA (17) 
582 participants 
(64% overweight or 
obese)  
 
SEASON study 
 
% female: 48% 
Ø age: 48y 
Ø BMI: 27.4 
 
 
1 year, 
quarterly 
assessme
nts 
24h-dietary recall, 
quarterly 
mean GI: 593 
mean GL: 1393 
 
mean hsCRP: 
1.8 (min-max: 
0.03- 9.6) mg/l 
 
BMI, smoking status 
infection status 
Multiple regression of GI/GL with 
hsCRP  (mg/l): 
Adjusted cross-sectional estimates:  
hsCRP per GI unit:  
ß=0.002671 (SE=0.006269), p=0.7 
hsCRP per GL unit:  
ß=-0.00096 (SE=0.000528), 
p=0.07 
 
Adjusted longitudinal estimates: 
hsCRP changes associated with  
3-mo change in GI: 
ß=-0.00396 (SE=0.002832), 
p=0.16  
hsCRP changes associated with  
3-mo change in GL; 
ß=-0.00012 (SE=0.000331), p=0.7 
stratification by BMI category 
(18.5-24.9, 25.0-29.9, ≥30): cross-
sectional association between GL 
and hsCRP among obese 
participants, p=0.04 
GI/GLprosp. ∼  
Glcross. (CRP) 
Huffman 
2007, USA 
(18) 
171 sedentary 
participants with 
overweight to mild 
obesity and 
dyslipidemia 
 
35 with hsCRP 
≥10 mg/L excluded  
cross FFQ 
mean GI (SD): 53 (4)3 
mean GL: 109 (46)3 
Correlation of 
carbohydrate intake from 
FFQ with food records: 
0.60-0.70 in age and sex-
strata (energy adjusted) 
geometric mean 
hsCRP:  
2.2 (SD: 2.8) 
mg/l 
HDL, energy intake  Multiple regression of GI/GL with 
log-transformed hsCRP (mg/l): 
hsCRP per GI  unit: ß=0.003686, 
p=0.5 
hsCRP per GL unit: ß=0.001610, 
p=0.18; 
 
stratification by sex showed similar 
GI/GLcross. ∼ 
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First 
author, 
Year, 
Country 
Population, 
recruitment, Name 
of study 
Follow-
up 
Exposure : assessment 
method, average 
baseline values 
Outcome: 
average 
(baseline) level 
Covariates 
considered in 
analysis 
Results /∼/2 
 
% female: 51% 
Ø age: 53y 
Ø BMI: 29.6 
results 
Levitan 
2008, USA 
(27) 
18,137 
postmenopausal 
women  
 
Women`s Health 
Study 
 
Ø age: 54.8y 
Ø BMI: 25.7 
 
 
cross FFQ, 
median GI in quintiles: 
Q1:49 
Q2: 51 
Q3: 53 
Q4: 54 
Q5: 57  
median GL in quintiles: 
Q1: 92 
Q2: 107 
Q3: 117 
Q4: 127 
Q5: 143  
 
Correlation of 
carbohydrate intake from 
FFQ with food records: 
0.61 (energy adjusted) 
geometric mean 
hsCRP  
1.80 mg/l4 
 
age, BMI, strenuous 
exercise, history of 
hypertension, 
postmenopausal  
hormone use, 
smoking status, 
intake of protein, 
saturated fat, trans 
fat, polyunsaturated 
fat,alcohol, 
cholesterol, fiber, 
magnesium, folate, 
total energy 
Adjusted geometric mean CRP 
(mg/l) in quintiles of GI: 
Q1: 1.69 
Q2: 1.83 
Q3: 1.82 
Q4: 1.79 
Q5: 1.90; diff. Q5 - Q1: 1.12  
(95% CI: 1.06-1.18),  
p-trend≤0.001 
Adjusted geometric mean CRP 
(mg/l) in quintiles of GL: 
Q1: 1.78 
Q2: 1.77 
Q3: 1.80 
Q4: 1.81 
Q5: 1.86; diff. Q5 - Q1: 1.05  
(95% CI: 0.97-1.14),  
p-trend =0.2 
GIcross. CRP 
GLcross. ~ 
Liu 2002, 
USA (19) 
244 healthy women  
 
Women`s Health 
Study 
 
Ø age: 59y 
Ø BMI: 26 
 
cross FFQ, 
mean GI (SD): 53 (4)3 
mean GL (SD): 116 (22)2 
 
Correlation of 
carbohydrate intake from 
FFQ with food records: 
0.61 (energy adjusted) 
median hsCRP: 
2.8 (IQR: 1.1–
5.5) mg/l 
age, treatment status, 
smoking status, BMI, 
physical activity, 
parental history of 
myocardial 
infarction, history of 
hypertension, 
diabetes, high 
cholesterol, hormone 
replacement therapy, 
alcohol intake, 
intakes of dietary 
fiber, folate protein, 
cholesterol and total 
energy 
Adjusted geometric mean hsCRP 
(95% CI) (mg/l) in GI quintiles:  
Q1: 1.8 (1.3, 2.4) 
Q2: 2.5 (2.0; 3.2) 
Q3: 2.7 (2.0; 3.7) 
Q4: 2.5 (1.7; 3.3) 
Q5: 2.8 (2.0; 3.7);  p-trend<0.01 
Adjusted geometric mean hsCRP 
(95% CI) (mg/l) in GL quintiles:  
Q1: 1.4 (1.0; 2.0) 
Q2: 2.3 (1.8; 2.9) 
Q3: 2.9 (2.1; 4.1) 
Q4: 2.4 (1.7; 3.0) 
Q5: 3.8 (2.8; 5.2); p-trend<0.01 
GI/GLcross. CRP 
Murakami 443 healthy women  cross Self-administered, mean hsCRP: residential block Adjusted ORs (95% CI) for GI/GLcross ∼ 
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First 
author, 
Year, 
Country 
Population, 
recruitment, Name 
of study 
Follow-
up 
Exposure : assessment 
method, average 
baseline values 
Outcome: 
average 
(baseline) level 
Covariates 
considered in 
analysis 
Results /∼/2 
2008, Japan 
(24) 
 
Ø age: 19.5y 
Ø BMI: 21.3 
 
comprehensive diet 
history questionnaire, 
mean GI: 595 
mean GL/4184 kJ: 80 
(SD: 13); 
low GL: median: 71, high 
GL: median: 88 
 
Correlation of 
carbohydrate intake from 
FFQ with food records: 
0.48 (energy adjusted and 
de-attenuated) 
0.30 (SD: 0.73) 
mg/l 
 
(central or south 
Japan, size of 
residential area), 
current smoking, 
alcohol drinking, 
dietary supplement 
use, physical activity, 
BMI 
elevated hsCRP concentrations 
(>1mg/l) by low or high dietary 
GL (median split): 
low GL (n=221): REF 
high GL (n=222): 1.16 (0.50-
2.71), p>0.3 
Qi 2006, 
USA (23) 
891 women with 
T2D 
 
Nurses` Health 
Study 
 
Ø age: 58.5y 
Ø BMI: 29.7 
 
cross FFQ, 
median GI in quintiles:  
Q1: 49 
Q2: 51 
Q3: 53 
Q4: 54 
Q5: 56  
median GL in quintiles: 
Q1: 77 
Q2: 89 
Q3: 96 
Q4: 104 
Q5: 114  
 
Correlation of 
carbohydrate intake from 
FFQ with food records: 
0.61 (energy adjusted) 
geometric mean 
CRP: 5.75 mg/l4 
age, BMI, smoking, 
alcohol consumption, 
physical activity, 
aspirin use, HbA1C, 
history of 
hypertension or 
hyper-
cholesterolemia, 
postmenopausal 
hormone use, dietary 
fibers and 
magnesium 
 
Adjusted geometric mean CRP 
(mg/l) in quintiles of GI:   
Q1: 5.05 
Q2: 5.25 
Q3: 6.55  
Q4: 5.15  
Q5: 6.68, p-trend=0.04  
Adjusted geometric mean CRP 
(mg/l) in quintiles of GL:  
Q1: 5.02 
Q2: 6.20 
Q3: 5.57 
Q4: 5.84 
Q5: 6.15, p-trend=0.17 
GIcross. CRP 
GLcross. ~ 
Van 
Woudenber
gh 2011, 
Netherlands 
(28) 
4366 participants  
 
Rotterdam study 
 
% female: 60% 
Ø age: 67.3y 
Ø BMI: 26.2 
cross FFQ  
mean GI (SD): 59 (3) 
mean GL: 127 (22) 
 
Correlation of 
carbohydrate intake from 
FFQ with food records: 
0.79  
median hsCRP: 
1.65 mg/l  
age, sex,smoking, 
family history of 
diabetes, energy 
intake, protein, 
saturated fat, alcohol, 
fiber and BMI 
Multiple regression of GI/GL with 
log-transformed hsCRP (mg/l) 
hsCRP per 10-unit increase in GI  
ß=0.005 (SEE: 0.04), p: 0.9 
hsCRP per 50-unit increase in GL  
ß=0.11 (SEE: 0.04), p: 0.01 
GLcross. CRP 
GIcross. ~ 
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First 
author, 
Year, 
Country 
Population, 
recruitment, Name 
of study 
Follow-
up 
Exposure : assessment 
method, average 
baseline values 
Outcome: 
average 
(baseline) level 
Covariates 
considered in 
analysis 
Results /∼/2 
 
1 Abbreviations: cross, cross-sectional; CVD, cardiovascular disease; FFQ, food frequency questionaire; GI, glycemic index; GL, glycemic load; hsCRP, high-sensitivity C-
reactive protein; prosp, prospective; Q, Quantile; T2D, type 2 diabetes mellitus 
2 : direct association with GI or GL, (): trend for direct association with GI or GL, ∼: no association with GI or GL,: inverse association with GI or GL 
3 original values base on white bread reference and were converted to glucose reference by multiplying by 1.4286 (22) 
4 estimated from values given per quantiles 
5 calculated on the basis of carbohydrate intake and dietary GL 
Ø average value, mean or median as provided in the original publication. 
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Supplemental Table 2: Dietary GI/GL and hsCRP/IL-6 – intervention studies (detailed version)1 
First 
author,  
Year, 
Country 
Participants 
characteristic
s 
Study 
design Dietary Intervention 
Outcome: baseline levels and 
primary endpoint  Results
2 +/-3 
Ebbeling 
2012, USA 
(29) 
21 participants 
with 
overweight 
and obesity 
 
% female: 
38% 
Ø age: 30.3y 
Ø BMI: 34.4 
 
randomized 
controlled 
crossover, 
4 weeks 
duration 
 
low-GI: mean GI: 33 (SD: 3),  
GL: 51 (6) 
low-fat diet: mean GI: 68 (3), GL: 
185 (9) 
very low CHO diet: mean GI: 28 
(9), GL: 4 (2) 
 
weight maintenance, 
 
foods provided 
mean hsCRP: 1.75 (95% CI: 
0.44-4.61) mg/l 
 
Primary endpoint: change in 
resting energy expenditure 
hsCRP (95% CI) (mg/l) after intervention: 
low-fat: 0.78 (0.38-1.92) 
low-GI: 0.76 (0.50-2.20)  
very low CHO diet: 0.87 (0.57-2.69) 
p for difference between test diet periods: 0.13; 
p for linear trend from low fat to low GI to very 
low CHO diet: 0.05 
 
Repeated-measures analysis adjusted for sex, 
age, order of diets, baseline weight, and mean 
weight during each period 
Low 
GI/GL 
(+CRP)  
Fabricatore 
2011, USA 
(30) 
79 participants 
with T2D 
 
% female: 
64.9% 
Ø age: 52.5y 
Ø BMI: 36.3 
single-site 
parallel-
group study 
with 
balanced 
randomizati
on, 
40 weeks 
duration  
low-GL (n=39): mean GI: 57, 
mean GL: 89 
low-fat (n=40): mean GI: 65, 
mean GL: 121 
 
weight loss study, 
dietary advice based on “low-fat or 
low-GL pyramid”, sample eating 
plans and recipes provided 
mean hsCRP: 
low-GL: 8.0 (SE: 1.3) mg/l 
low-fat: 7.5 (1.8) mg/l 
 
Primary endpoint: weight 
change 
change in hsCRP (SE) (mg/l) after 40 weeks: 
low-GL: -2.6 (2.3)  
low-fat: -3.3 (2.2)  
no between-group difference for change (p=0.8) 
 
no between-group difference for 
weight loss (p=0.3) 
Low GL 
-CRP 
Gögebakan 
2011, 
Netherlands, 
Denmark, 
UK, Greece, 
Spain, 
Germany, 
Bulgaria, 
Czech 
Republic 
(31) 
932 healthy 
participants 
(some 
overweight)  
 
DiOGenes 
study 
 
% female: 
65% 
Ø age: 41y 
Ø BMI: 34 
 
RCT,  
26 weeks 
duration 
low-GI/low-protein (n=150) vs.  
low-GI/high-protein (n=315) vs. 
high-GI/low-protein (n=155) vs. 
high-GI/high-protein diet 
(n=155) vs. control group 
(n=154) 
 
target GI difference: 15 points 
 
weight maintenance, 
 
dietary instructions 
 
 
mean hsCRP before weight 
loss: 2.78 (SD: 2.63) mg/l,  
p=0.8 for difference between 
groups 
 
Primary endpoint: weight 
change 
Mean (95%CI) change in hsCRP (mg/l) (ITT): 
low-GI groups: -0.64 (-0.88 to –0.41)  
high-GI groups: -0.18 (0.41 to 0.05)  
low-GI vs. high GI groups: -0.46 (-0.79 to -
0.13) p<0.001;  
 
Similar results in sensitivity and completion 
analyses. 
 
low-GI groups more likely to achieve an >15% 
CRP reduction than high-GI groups: OR: 1.57 
(1.13-2.17), p=0.007   
 
Analysis compares low-GI to high-GI diets 
combining information from all four study arms. 
Low GI 
+CRP 
Hartman 
2010, USA 
64 men at risk 
for colorectal 
randomized 
crossover, 
legume-rich/low-GI: mean GI: 38 
(SD: 2), GL: 84 (4)  
mean  hsCRP: 
1.28 (SE: 1.24) 
Mean (SE) change in hsCRP (mg/l):  
legume diet: -0.26 (0.13)  
Low GI 
-CRP  
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First 
author,  
Year, 
Country 
Participants 
characteristic
s 
Study 
design Dietary Intervention 
Outcome: baseline levels and 
primary endpoint  Results
2 +/-3 
(32) cancer  
 
Ø age: 54y 
Ø BMI: 28.7 
 
4 weeks 
duration (~2 
weeks 
washout) 
 
isocaloric diet: mean GI: 69 (3), 
GL: 152 (8), 
 
weight maintenance, 
 
foods provided 
mg/l 
 
Primary endpoint: hsCRP, C-
peptide  
 
power calculations for hsCRP 
control diet: -0.23 (0.10)  
no between-group difference for change:  
-0.03 (0.17), p=0.9 
 
Similar results for stratification by IR status or 
adjustment for age, BMI, baseline biomarker 
status,period, and treatment order 
Jebb 2010, 
UK (33) 
522 
participants at 
risk for 
metabolic 
syndrome  
 
% female: 
58% 
Ø age 51.5y 
Ø BMI 28.5 
5-center 
parallel-
design RCT, 
24 weeks 
duration 
 
high-MUFA/LGI (n=108): mean 
GI: 55, mean GL %en: 24 (48) 
high-MUFA/HGI (n=107): mean 
GI: 63, mean GL %en: 28 (=55)    
(target GI difference: 11 points) 
low-fat/LGI (n=119): mean GI: 
56, mean GL: 29 %en (=50) 
low-fat/HGI (n=109): mean GI: 
64, mean GL: 33 %en (=61)       
(target GI difference: 13 points)   
high-SFA/HGI (n=79)(control):                
 
weight maintenance, 
 
key sources of fat and CHO 
provided, additional dietary 
information              
median hsCRP: 
high-MUFA/HGI:  0.54 (Q1, 
Q3: 0.20, 1.90) mg/l 
high-MUFA/LGI: 0.40 (0.14, 
1.10) mg/l 
low-fat/HGI: 0.50 (0.10, 1.95) 
mg/l  
low-fat/LGI: 0.57 (0.16, 1.90) 
mg/l 
high-SFA/HGI: 0.70 (0.16, 
2.30) mg/l 
 
Primary endpoint: change in 
insulin sensitivity  
% change (95% CI) in hsCRP:  
high-MUFA/HGI: +3.8 (-21.4, 35.6) 
high-MUFA/LGI: +36.3 (3.0, 78.2) 
low-fat/HGI: +22.4 (-7.6, 60.3) 
low-fat/LGI:  +8.0 (-13.5, 33.9), 
high-SFA/HGI: +21.3 (-5.8, 55.2) 
 
no between-group difference for change (p=0.9)  
 
Statistical test accounts for age, sex, center, 
ethnicity, baseline waist circumference, HDL 
cholesterol, and weight change 
Low GI 
-CRP 
Jenkins 
2008, 
Canada (20) 
210 
participants 
with T2D 
(treated with 
antihyperglyce
mic 
medications)  
 
% female 39% 
Ø age: 60.5y 
Ø BMI 30.9 
parallel 
randomized, 
6 months 
duration 
 
low-GI (n=106): mean GI: 48.7 
(95% CI: 47.4, 50.0)4, mean GL: 
90.2 (84.3, 96.1)4 
high-cereal fiber (n=104): mean 
GI (95% CI): 58.4 (57.7, 59.3)4, 
mean GL: 116.2 (108.8, 123.5)4 
 
no weight loss study  
(participants who wished to lose 
weight were given advice on 
portion sizes and fat intake),  
 
checklists with food options 
provided 
mean hsCRP:  
low-GI: 4.62 mg/l 
high-fiber: 4.59 mg/l 
 
Primary endpoint: change in 
HbA1c 
Mean change (95% CI) in hsCRP (mg/l) until 
week 24 (ITT):  
low-GI: -1.6 (-2.9, -0.3)  
high-fiber: -1.8 (-3.9, -0.4)  
no between-group difference for change  
(p= 0.8)  
 
change in body weight unrelated to hsCRP        
Low GI 
-CRP 
Kelly 2011, 28 previously RCT, low-GI (n=13): mean GI: 40.3 no data Change in IL-6 (ng/l) Low GI 
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First 
author,  
Year, 
Country 
Participants 
characteristic
s 
Study 
design Dietary Intervention 
Outcome: baseline levels and 
primary endpoint  Results
2 +/-3 
USA (34) sedentary 
participants 
with insulin-
resistance and 
obesity 
 
% female: 
46% 
Ø age: 66y 
Ø BMI: 34.2 
12 weeks 
duration 
(SEM: 0.4), mean GL: 102 (9)                            
high-GI (n=15): mean GI: 80.2 
(1.0), mean GL: 218 (24), 
diet and exercise intervention: 60 
minutes aerobic exercise 5d/week 
in both groups 
 
weight maintenance, 
 
foods provided 
 
reduction in IL-6 significantly larger in low-GI 
than reduction in high GI diet group p=0.01 
 
+CRP 
Neuhouser 
2012, USA 
(35) 
80 participants 
with 
overweight 
and obesity 
 
% female: 
59%  
Ø age 29.5y  
Ø BMI 27.5 
randomized, 
crossover,  
28 days 
duration (28 
days 
washout) 
low-GL: mean desired GL: 125 
high GL: mean desired GL: 250, 
 
no data on GI 
 
weight maintenance, 
 
foods provided 
mean hsCRP: 
2.1 mg/l 
 
mean IL-6: 
1.8 pg/ml 
 
Participants with hsCRP 
values >10 mg/l excluded 
prior to analysis 
 
Primary endpoint: biomarkers 
of inflammation and adiposity 
(among them: hsCRP and IL-
6) 
Mean (95% CI) hsCRP (mg/l): 
low-GL diet period: 0.6 (0.5-0.7) 
high-GL diet period: 0.6 (0.6-0.7)  
p for treatment effect=0.9  
 
Mean (95% CI) IL-6 (ng/l): 
low-GL diet period: 1.3 (1.2-1.5)  
high-GL diet period: 1.2 (1.1-1.3)  
p for treatment effect=0.09 
 
Treatment effect among those with high baseline 
body fat mass (n=51) (low-GL diet period: 0.7 
(0.5-0.8), high-GL diet period: 0.9 (0.7-1.1) 
mg/l, p=0.02) 
 
Linear mixed models adjusted for baseline 
concentrations, diet sequence, feeding period, 
age, sex, and BMI 
Low GL 
(+CRP) 
subgroup)  
Pereira 
2004, USA 
(21) 
39 participants 
with 
overweight or 
obesity  
 
% female: 
15% 
Ø age: 30.7y 
BMI: ≥ 27 
parallel, 
randomized, 
time until 
10% weight 
loss 
achievement 
(intervention 
group= 
mean 65 
days, control 
low-GL (n=22): mean GI: 35.04, 
mean GL: 57.44 
low-fat (n=17): mean GI: 57.44, 
mean GL: 143.54 
 
weight loss study, 
 
foods provided 
mean hsCRP: 
low-GL: 0.28 (SD: 0.06) 
mg/dl 
low-fat: 0.19 (0.06) mg/dl  
 
Primary endpoint: resting 
energy expenditure 
Post-treatment mean (SE) hsCRP(mg/dl):  
low-GL: 0.10 (0.03),  
%change (adjusted for baseline): -47.7 (11.9)  
low-fat: 0.13 (0.04),  
%change (adjusted for baseline): -5.1 (13.6)  
 
p between-group difference for change =0.03 
 
 
Low GL 
+CRP 
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First 
author,  
Year, 
Country 
Participants 
characteristic
s 
Study 
design Dietary Intervention 
Outcome: baseline levels and 
primary endpoint  Results
2 +/-3 
group=69da
ys) 
Pittas 2006, 
USA (36) 
34 participants 
with 
overweight 
 
% female: 
75.5% 
Ø age: 34.6y 
Ø BMI: 27.5 
RCT,  
6 months 
duration 
 
low-GL (n=16): mean GI: 53, 
mean GL: 88.55 
high-GL (n=16): mean GI: 86, 
mean GL: 228.15 
 
weight loss study (30% caloric 
restriction), 
 
foods provided 
mean hsCRP: 
low-GL: 3.1 (SEM: 0.7) mg/l 
high-GL: 2.2 (0.6) mg/l  
 
Primary endpoint: markers of 
glucose tolerance and hsCRP 
Mean (SEM) hsCRP (mg/l) change at 6 months: 
low-GL: -1.44 (0.44)  
high-GL: 0.41 (0.91)  
no between-group difference for change  
p=0.13   
 
mean hsCRP decreased from baseline by 35% in 
the low-GL group (p<0.01), and remained 
essentially unchanged in the high-GL group  
Low GL 
(+CRP) 
Shikany 
2009, USA 
(37) 
24 men with 
overweight 
and obesity  
 
Ø age: 34.5y 
Ø BMI: 27.8 
randomized, 
crossover, 
4 weeks 
duration (4 
weeks 
washout) 
low-GI/GL: mean GI: 49.5 (SD: 
3.3), mean GL: 158.3 (12.8), 
high-GI/GL: mean GI: 75.0 (4.2), 
mean GL: 245.5 (11.4), 
 
weight maintenance, 
 
foods provided 
mean CRP: 
low-GI/GL: 1.3 (SD: 1.2) mg/l 
high-GI/GL: 2.1 (1.8) mg/l,  
 
mean IL-6: 
low-GI/GL: 2.5 (SD: 1.9) ng/l  
high-GI/GL: 3.2 (2.8) ng/l 
 
Primary endpoint: glucose 
levels 
Mean (SD) CRP (mg/l) at 4 weeks: 
low-GI/GL diet period: 1.3 (1.2), change: 0.0 
(0.7)  
high-GI/GL diet period: 1.7 (1.9), change: -0.4 
(2.0) 
p for treatment differences: 0.7 
Mean (SD) IL-6 (ng/l) at 4 weeks: 
low-GI/GL diet period: 2.3 (1.7), change: -0.2 
(1.8)  
high-GI/GL diet period: 3.1 (3.4), change: -0.1 
(3.5) 
p for treatment differences: 0.6 
Low 
GI/GL 
-CRP, IL6 
Vrolix 
2010, 
Netherlands 
(38) 
15 participants 
with 
overweight 
 
%female: 40% 
Ø age: 52.5y 
Ø BMI: 31 
randomized, 
double-
blinded, 
crossover, 
11 weeks 
duration (≥2 
weeks 
washout) 
decreased GI: mean GL: 36 (11)  
increased GI:  mean GL: 68 (22)    
 
Data on GI not provided 
 
weight maintenance, 
 
replacement of regular foods 
(bread, fruit drink, cake, cookie for 
similar test foods with low GI 
baseline hsCRP and IL-6 data 
not provided.  
 
Primary endpoint: HDL 
cholesterol 
 
 
Mean (SD) hsCRP (mg/l) at 11 weeks: 
decreased GI diet period: 2.76 (1.85) 
increased GI diet period: 2.46 (1.71)  
Difference between diets: 
-0.30  (95%CI:-0.26, 0.86) mg/l, p=0.3 
Mean (SD) IL-6 (ng/ml)6 at 11 weeks: 
decreased GI diet period: 1.41 (0.64)  
increased GI diet period: 1.42 (0.72)  
Difference between diet periods: 
0.02 (-0.31, 0.72) ng/ml, p=0.9 
Low GI 
-CRP, IL6 
Wolever 
2008, 
Canada (39) 
162 persons 
with T2D  
 
% female: 
long-term 
multicenter, 
randomized, 
controlled, 
low-GI (n=55): GI: mean 55.1 
(SEM: 0.4), GL: 133 (2) 
high-GI (n=48): GI: 63.2 (0.4), 
GL: 135 (3) 
mean CRP:  
low-GI: 2.64 (95% CI: 1.89, 
3.72) mg/l,  
high-GI: 3.34 (2.56, 4.26) 
Mean (95% CI) CRP (mg/l) after intervention: 
low-GI: 1.95 (1.68, 2.27); 
high-GI: 2.75 (2.33, 3.24); 
low CHO: 2.35 (2.01, 2.75)  
Low GI 
(+CRP)  
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First 
author,  
Year, 
Country 
Participants 
characteristic
s 
Study 
design Dietary Intervention 
Outcome: baseline levels and 
primary endpoint  Results
2 +/-3 
54% 
Ø age: 59.9y 
Ø BMI: 30.9 
1year 
duration 
low CHO (n=53): GI: 59.4 (0.4), 
GL: 120 (2) 
 
no weight-loss study (500kcal/d 
subtracted, if weight loss desired), 
 
key foods to choose were provided  
mg/l  
low-CHO: 1.94 (1.48, 2.55) 
mg/l 
 
Primary endpoint: glycemic 
control (HbA1c) 
 
 
CRP change tended to differ between the diet 
groups (p=0.064) (low-GI group: decrease, high-
GI group: increase, low-CHO group: 
intermediate) 
Proportion of participants with CRP-level ≥3 
mg/L at 1 year signficantly different between 
low-GI, high-GI and low-CHO group (33%, 
80% and 33%, respectively). 
Linear mixed model regression analysis adjusted 
for BMI 
1 Abbreviations: %en, percentage of total energy; CHO, carbohydrate; GI, glycemic index; GL, glycemic load; hsCRP, high-sensitivity C-reactive protein; IR, insulin resistance;  
ITT, intention to treat; RCT, randomized controlled trial; T2D, type 2 diabetes mellitus 
2 p-values of between-group differences for changes in inflammatory markers are reported for randomized controlled trials, p-values for treatment effects are reported for cross-
over trials. 
3 +: effect of dietary intervention on hsCRP or IL-6, (+): trend for effect or effect in subgroup, -: no effect of dietary intervention on hsCRP or IL-6 
4 original values base on white bread reference and were converted to glucose reference by multiplying by 1.4286 (22) 
5 estimated from data on g/1000 kcal 
6 most likely pg/ml  
Ø average value, mean or median as provided in the original publication. 
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Supplemental Table 3: Dietary fiber/whole grain intake and hsCRP/IL-6 – epidemiological studies (detailed version)1 
First 
author, 
Year, 
Country 
Population, 
recruitment, Name 
of study 
Follow-
up 
Exposure : assessment 
method, average baseline 
values 
Outcome: 
average 
(baseline) 
level 
Covariates considered 
in analysis Results 
/∼/2 
Dietary fiber intake – epidemiological studies 
Ajani, 
2004, 
USA (40) 
 
3,920 participants 
 
NHANES (1999-
2000) 
 
% female : 52% 
Ø age: 45.6y 
Ø BMI: 28.6 
cross 24h dietary recall, 
mean fiber intake (g) in 
quintiles:                     
Q1: 5 
Q2: 10 
Q3: 14 
Q4: 18 
Q5: 32 
mean CRP:  
4.3 mg/l3  
Age, sex, race, 
education, smoking, 
physical activity, BMI, 
alcohol intake, fat 
intake, total energy 
Adjusted regression coefficients 
(SE) log-CRP (mg/l) by quintiles 
of fiber intake:                            
Q1: REF 
Q2: -0.19 (0.07) 
Q3: -0.19 (0.09) 
Q4: -0.12 (0.09) 
Q5: -0.31 (0.09); p-trend=0.045          
                     
Adjusted OR (95% CI) for CRP >3 
mg/l) Q5 vs.Q1: 
0.59 (0.41-0.85), p=0.006 
 
exclusion of participants with 
cardiovascular conditions, diabetes 
or cancer did not alter the results 
Fibcross. 
CRP 
 
Bo, 2006, 
Italy (42) 
1,653 participants 
 
representative sample 
of Italian province 
 
% female: 53% 
Ø age: 54.6y 
Ø BMI: 26.5 
cross Semi-quantitative FFQ (from 
the EPIC study) 
 
median fiber intake (g/d) in 
tertiles:              
T1: 13  
T2: 19 
T3: 28 
mean % of 
participants 
with hsCRP ≥ 
3 mg/l: 25%2 
Age, sex, BMI, 
smoking, alcohol 
intake, physical 
activity, total calories, 
%en fat, magnesium 
intake 
Adjusted OR of hsCRP≥3 mg/l by 
tertiles of fiber intake: 
T1: 1.83 (95% CI: 1.12-3.00)                                 
T2: 0.93 (0.63, 1.38) 
T3: REF 
p-trend=0.003         
 
fiber association independent of 
magnesium intake; similar results 
in subgroup analyses (those with 
normal BMI and no metabolic 
abnormality) 
Fibcross. 
CRP 
Bo, 2008, 
Italy (41) 
335 participants with 
metabolic syndrome  
 
Re-analysis of 
intervention study 
 
% female: 58% 
1 year Validated semi-quantitive 
FFQ, 
 
fiber intake (g/d): 19  
(intervention group (n=169): 
19 (SD 6), control group 
(n=166): 19 (8), p=0.8) 
hsCRP:  
3.3 mg/l 
(averaged 
from 
intervention 
and control 
group)     
Age, sex and current 
BMI 
Adjusted longitudinal estimates 
Log-transformed hsCRP changes 
(mg/l) associated with 1 year 
changes in fiber (g/day) 
ß: -0.01 (95%CI: -0.02 -0.002), 
p=0.03 
Fibprosp. 
CRP 
A
P
P
E
N
D
IX
 4
164
First 
author, 
Year, 
Country 
Population, 
recruitment, Name 
of study 
Follow-
up 
Exposure : assessment 
method, average baseline 
values 
Outcome: 
average 
(baseline) 
level 
Covariates considered 
in analysis Results 
/∼/2 
Ø age: 55.7y 
Ø BMI: 29.8 
 
lifestyle intervention (diet + 
exercise) 
Chuang, 
2011, 
Italy (43) 
87 participants free of 
cancer  
 
sampled within the 
EPIC-Italy cohort 
 
% female: 39% 
Ø age: 54.0y 
Ø BMI: 25.7 
Cross Centre-specific FFQ 
 
ranges of fiber intakes (g/d) in 
tertiles : 
T1: ≤17.52 
T2: 17.52-24.03 
T3: >24.03 
Geometric 
mean IL-6: 
57.0 pg/ml3 
Age at recruitment, sex, 
centres (categorical), 
education, smoking 
status, alcohol drinking 
at baseline, BMI, 
physical activity, total 
energy intake 
Adjusted geometric mean levels of 
IL-6 (95% CI) (pg/ml) according to 
tertiles of total fiber intake:                               
T1: 91.8 (45.6, 184.9)                          
T2: 45.2 (24.3, 83.1)           
T3: 34.1 (16.4, 71.5);  
p-trend=0.09             
 
Additional analysis for cereal fiber 
intake: p=0.3        
Fibcross. 
(IL6) 
Diaz, 
2005, 
USA (44) 
1,567 participants 
with overweight 
 
NHANES (1999-
2000) 
 
% female: 53% 
Ø age: 38.1y 
Ø BMI: 30.6 
cross 24h dietary recall 
 
mean fiber intake (g): 14.53 
(SD: 0.48) 
no data age, sex, BMI, smoking 
status, routine place of 
care, number of 
physician visits, 
exercise 
Adjusted OR (95% CI) for hsCRP 
≥ 0.3 mg/dl by fiber strata: 
<25 g/d fiber: REF 
≥ 25 g/d fiber: 0.77 (0.44-1.35) 
Fibcross. 
∼ 
Estruch, 
2009, 
Spain (45) 
771 persons with 
diabetes or more than 
3 CHD risk factors  
 
Re-analysis of 
intervention study 
 
% female: 56% 
Ø age: 68.8y 
Ø BMI: 29.9 
3 
months 
137 item FFQ 
 
mean fiber (g/d): 21.1 (SD: 
7.6) 
Intervention: low fat vs. two 
Mediterranean-style diets 
no data  age, sex, energy intake, 
intervention group, 
baseline 
3-months change in hsCRP (mg/l) 
by quintiles of change in dietary 
fiber intake:        
Q1: -0.02 
Q2: -0.03 
Q3: -0.18 
Q4: -0.21 
Q5: -1.01, p-trend=0.04                               
change Q5 versus Q1: 
-1.08 (-1.80, -0.48), p for 
difference=0.004 
Fibprosp. 
CRP 
Herder, 
2009, 
Finland 
(46) 
406 participants with 
overweight or obesity 
and IGT 
 
Re-analysis of the 
Finnish Diabetes 
1 year 3 day food record (pictures to 
estimate portion sizes) 
 
mean baseline fiber intake (g): 
intervention: 20.3 (SD: 7.3), 
control: 19.6 (SD: 7.9) 
median CRP: 
2.09  mg/l  
 
median IL-6:  
1.76 pg/ml  
 
age, sex, group, 
baseline BMI, change 
BMI 
Adjusted longitudinal estimates: 
Correlation of changes in CRP and 
fiber intake changes:  
fiber (g): r= -0.08 p=0.11  
fiber (g/1000 kcal): r=-0.122 
p=0.015 
Fibprosp. 
CRP, IL6 
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First 
author, 
Year, 
Country 
Population, 
recruitment, Name 
of study 
Follow-
up 
Exposure : assessment 
method, average baseline 
values 
Outcome: 
average 
(baseline) 
level 
Covariates considered 
in analysis Results 
/∼/2 
Prevention Study 
 
% female: 65.3% 
Ø age: 55.4y 
Ø BMI: 31.2 
 
Lifestyle intervention 
(including increase in fiber 
intake ≥15g/1000kcal) 
values 
averaged from 
intervention 
and control 
group 
 
 
Correlation of changes in IL-6 and 
fiber intake changes:  
fiber (g): r= -0.132, p=0.008  
fiber (g/1000 kcal):r= -0.052, p=0.3  
Kantor, 
2013, 
USA (47) 
9,895 participants, 
mostly with 
overweight or obesity  
 
NHANES (1999-
2000, 2001-2002, 
2003-2004 cycles) 
 
% female: 51.3% 
  
cross 24h dietary recalls (1 or 2 days 
included) 
 
fiber intake (g/d): 
<10: 27.1%,  
>10-20: 46.9%,  
>20-25: 12.1%,  
>25: 13.9%, 
geometric 
mean hsCRP: 
1.82 mg/l3 
 
age, sex, race, 
education, smoking, 
BMI, physical activity, 
vitamin E supplement 
use, dietary fiber intake, 
dietary SFA, total 
energy intake, aspirin 
use, NSAID use, statin 
use, diabetes, CHD, 
regular use of 
glucosamine, 
chondroitin, fish oil 
Adjusted association of dietary 
fiber (g/d) with hsCRP ratio4 
fiber <10: 1.00 (Ref),  
>10-20: 0.90 (0.83, 0.96), 
>20-25: 0.85 (0.76, 0.96) 
>25: 0.73 (0.66, 0.81), p<0.001 
Fibcross. 
CRP 
King, 
2003, 
USA (48) 
4,900 participants 
 
NHANES (1999-
2000) 
 
% female: 52.1% 
 age: ≥ 18 
Ø BMI: 27.9 
cross recollection of food eaten the 
previous day by the 
respondent 
 
fiber intake in quartiles (g/d):  
Q1: < 8.4 
Q2: 8.4-13.3 
Q3: 13.3-19.5 
Q4: >19.5 
median 
hsCRP level 
2.0 mg/l 
(64% of study 
population 
levels <3.0)  
age, race, sex, BMI, 
smoking status, alcohol 
consumption, exercise, 
medications, total 
caloric intake 
Adjusted OR (95% CI) of elevated 
hsCRP (>3,0 mg/l) by fiber 
quartiles:  
Q1: 1.0 (1.0) 
Q2: 0.75 (0.53-1.07) 
Q3: 0.64 (0.43-0.96) 
Q4: 0.58 (0.38-0.88), p<0.05                    
Median (95%CI) hsCRP (mg/l) for 
fiber quartiles: 
Q1: 2.3 (2.1-2.51) 
Q2: 2.04 (1.74-2.34) 
Q3: 1.89 (1.46-2.33) 
Q4: 1.76 (1.58-1.94), p<0.05      
Fibcross. 
CRP 
King, 
2005, 
USA (49) 
7,891 persons with 
diabetes, hypertension 
or obesity  
 
NHANES (1999-
cross 24h dietary recall 
 
fiber intake in quartiles (g/d): 
Q1: ≤8.8 
Q2: 8.9-13.5 
no data 
 
age, race, sex, smoking 
status, alcohol 
consumption, exercise, 
medications, history of 
heart disease, total 
Median (SE) hsCRP (mg/l) level 
by quartiles of dietary fiber:            
Q1: 2.39 (0.11) 
Q2: 2.23 (0.08) 
Q3: 2.05 (0.10) 
Fibcross. 
CRP 
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First 
author, 
Year, 
Country 
Population, 
recruitment, Name 
of study 
Follow-
up 
Exposure : assessment 
method, average baseline 
values 
Outcome: 
average 
(baseline) 
level 
Covariates considered 
in analysis Results 
/∼/2 
2002) 
 
 
Q3: 13.6-19.9 
Q4:≥ 20 
serum cholesterol, total 
caloric intake 
Q4: 1.52 (0.07), p<0.05   
OR (95%CI) of elevated hsCRP 
(>3,0 mg/l) by quartiles of fiber:              
Q1:1.53 (1.29-1.8) 
Q2:1.53(1.31-1.8) 
Q3:1.41(1.17-1.69) 
Q4: Ref, p<0.05  
 
Ma, 
2006, 
USA (50) 
524 participants 
 
% female: 49 
Ø age: 48.3y 
Ø BMI: 27.2 
1 year 24h-dietary recalls (telephone-
based) 
 
mean fiber intake (g/d): 16.1 
(SD: 5.89) 
 
data collected quarterly 
geometric 
mean CRP: 
1.78 (SD: 
1.66) mg/l 
BMI, smoking status, 
age, current infection 
status, season of year at 
CRP measurement 
Adjusted cross-sectional estimates 
Multiple regression of fiber with 
log CRP (mg/l): 
ß: -0.01 (SE 0.006), p=0.03  
 
OR (95% CI) for elevated CRP 
values (>3.0 mg/l) 
Q1: REF  
Q2: 1.13 (0.58, 2.19) 
Q3: 0.75 (0.37, 1.52) 
Q4: 0.37 (0.16, 0.87),  
p-trend=0.01 
 
Adjusted longitudinal estimates 
CRP changes associated with 3-mo 
change in dietary fiber 
ß:-0.008 (SE 0.004), p=0.03 
Fibprosp.. 
CRP 
Ma, 
2008, 
USA (51) 
1,958 postmenopausal 
women  
 
Ø age 62.2y 
Ø BMI: 28.8y 
cross FFQ 
 
mean fiber intake (g/d): 15 
(SD: 7)  
geometric 
mean hsCRP: 
2.01  (95% CI: 
1.91-2.10) 
mg/l 
 
geometric 
mean IL-6: 
1.90 (1.84-
1.97) pg/ml 
BMI, age, race, 
recreational physical 
activity, arthritis, 
smoking 
status, hormones 
therapy use in previous 
3 mo, alcohol intake, 
and energy intake  
Geometric mean (95% CI) hsCRP 
(mg/l):  
Q1: 2.31 (2.08-2.56) 
Q2: 1.85 (1.69-2.03)  
Q3: 1.87 (1.71-2.05) 
Q4: 2.04 (1.86-2.24) 
Q5: 1.98 (1.79-2.21), p-trend=0.4     
 
Geometric mean  IL-6 (pg/ml): 
Q1: 2.16 (1.99-2.35) 
Q2: 1.87 (1.74-2.02) 
Q3: 2.01 (1.87-2.16) 
Q4: 1.82 (1.69-1.96) 
 Q5: 1.68 (1.55-1.83), p-trend=0.01 
Fibcross. 
IL6, ~CRP 
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First 
author, 
Year, 
Country 
Population, 
recruitment, Name 
of study 
Follow-
up 
Exposure : assessment 
method, average baseline 
values 
Outcome: 
average 
(baseline) 
level 
Covariates considered 
in analysis Results 
/∼/2 
Muraka
mi, 2008, 
Japan 
(24) 
443 female students  
 
Ø age: 19.5y 
Ø BMI: 21.3 
cross self-administered 
comprehensive diet history 
questionnaire 
 
dietary fiber intake: 
7.1g/1000kcal (SD: 2.1)  
mean hsCRP: 
0.30 (SD: 
0.73) mg/l 
residential block 
(central or south Japan, 
size of residential area), 
current smoking, 
alcohol drinking, 
diaetary supplement 
use, physical activity, 
BMI 
OR (95%CI) for elevated hsCRP 
concentrations (>1mg/l) by  low or 
high dietary fiber (median split): 
low fiber: REF 
high fiber: 0.93 (0.41-2.12) p>0.3 
Fibcross. 
∼CRP 
Oliveira, 
2009, 
Portugal 
(52) 
1060 participants, 
some with overweight 
 
% female: 64% 
Ø age: 54y 
BMI: <25: n=350; 
≥25: n=710 
cross validated 82-item semi-
quantitative FFQ 
 
intake of fiber (g/d)  
women: 21.4 
men: 23.0 
(averaged from values given 
for hsCRP categories) 
median 
hsCRP:  
women. 1.9 
(25th –75th P: 
0.9-3.8) mg/l, 
men: 1.4 (0.7-
3.0) mg/l 
age, education, current 
smoking, regular 
exercise, total energy 
intake                             
OR (95% CI) for increase in 
hsCRP levels by one category ( 
<1.00; 1.00-3.00; >3.00 to <10) 
associated with each 10 g increase 
in dietary fiber 
Women: 
BMI <25: 1.07 (0.71-1.61), ns          
BMI >25: 0.93 (0.71-1.23) , ns           
Men:  
BMI <25: 0.85 (0.50-1.44), ns              
BMI >25: 0.53 (0.37-0.76),n s 
Fibcross. 
∼CRP 
Qi, 2006, 
USA (23) 
1055 women with 
T2D 
 
Ø age: 58.5y 
Ø BMI: 29.8 
cross semi-quantitative FFQ 
 
no data 
no data age, BMI, smoking, 
alcohol consumption, 
physical activity, 
aspirin use, A1C, 
history of hypertension 
or 
hypercholesterolemia, 
postmenopausal 
hormone use, dietary 
fibers, magnesium 
Increasing cereal fiber intake sig. 
associated with decreased hsCRP 
(p-trend=0.03) 
 
Intakes of total fiber, and fiber 
from other foods including fruits 
and vegetables were not associated 
with CRP (data not shown) 
Fibcross. 
∼CRP 
 
Cereal 
fibcross 
CRP 
Wannam
ethee, 
2009, UK 
(53) 
3428 men with no 
prevalent diabetes  
 
British Regional 
Heart Study 
 
age: 60-79y 
 
cross detailed 7-day recall FFQ 
 
mean fiber intake (g/d): 25.9 
(SD: 8.6); Q1: <20 
Q2: 20.1-24.9 
Q3: 25.0-30.9 
Q4: >31.0 
geometric 
mean hsCRP: 
1.70 mg/l3 
age, waist 
circumference, cigarette 
smoking, physical 
activity, social class, 
alcohol intake, 
preexisting myocardial 
infarction, stroke, use 
of statins, and total 
calorie intake 
Bivariate associations of dietary 
fiber with hsCRP (mg/l) 
(p<0.0001) and IL-6 (pg/ml) 
(p<0.0001) persisted after 
adjustments (data not shown). 
Fibcross. 
CRP, IL6 
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First 
author, 
Year, 
Country 
Population, 
recruitment, Name 
of study 
Follow-
up 
Exposure : assessment 
method, average baseline 
values 
Outcome: 
average 
(baseline) 
level 
Covariates considered 
in analysis Results 
/∼/2 
Whole grain consumption – epidemiological studies 
Gaskins 
2010, 
USA (65) 
259 healthy women 
 
Ø age 27.3y 
Ø BMI 24.1 
1 or 2 
menstru
ation 
cycles 
24h dietary recall (≤4x/cycle) 
whole grain intake servings/d 
(1 serving=16g of a 100% 
whole grain food): median 0.5 
(0.1, 1.3), 13.6 (6.0) g fiber/d                         
 
Whole grain: bread, cereals, 
rice, pasta 
mean hsCRP: 
0.6 (SD: 1.2) 
mg/l  
energy intake, age, race, 
BMI, illness during 7 d 
prior to visit, NSAID 
use the day before 
blood withdrawal  
Predicted mean hsCRP (mg/l), % 
change from REF 
nonconsumers (n=123): 
0.65, Ref.  
consumers <1 serving/d: (n=218): 
0.58, - 10.5%, p=0.04  
consumers ≥1 serving/d: (n=168):  
0.57, -12.1%?, p=0.04 
 
OR (95% CI) of increasing hsCRP 
levels from cycle 1 to cycle 2 by 
whole grain intake levels: 
OR for increase from low (<1 
mg/L) to elevated (>3mg/L) hsCRP 
level  
0 servings/d: REF 
0.01-0.99 servings/d: 0.49 (0.20, 
1.21)  
≥1 servings/d: 0.11 (0.03, 0.41) 
OR for increase from moderate 
(≥1-≤ 3mg/L) 
to elevated (>3 mg/L) CRP level:  
0 servings/d: REF 
0.01-0.99 servings/d: 0.86 (0.36, 
2.06)  
≥1 servings/d: 0.27 (0.08, 0.96) 
WGprosp. 
∼CRP  
Jensen 
2006, 
USA (66) 
938 healthy 
participants: 
Study 1: Health 
Professionals Follow-
Up Study, n=468; 
Study 2: Nurses 
Health Study II, 
n=470  
 
% female: 50.1% 
Ø age: study 1: 60y, 
cross 131-item FFQ, 
median whole grain intake : 
22.3 g/d, women: 21.9, men: 
23.4; 
median in quintiles:  
Q1: 8.2 
Q2: 15.9 
Q3: 22.3 
Q4: 29.6 
Q5: 43.8 
 
mean CRP: 
1.80 (SE: 0.12) 
mg/l 
 
mean IL-6: 
1.53 (SE: 0.07) 
pg/ml 
age, sex, total energy 
intake, alcohol intake, 
smoking, BMI, physical 
activity, 
hypercholesterolemia, 
fruit, vegetable, SFA, 
MUFA, PUFA intake                        
Geometric mean (SE) CRP (mg/l):  
Q1: 0.92 (1.107)  
Q2: 0.86 (1.07)             
Q3: 0.93 (1.07)            
Q4: 0.82 (1.07)              
Q5: 0.88 (1.07), p-trend=0.6  
%diff Q1 vs Q5: -4.3%       
 
Geometric mean (SE) IL-6 (pg/ml): 
Q1: 1.20 (1.04) 
Q2: 1.07 (1.04) 
WGcross. 
∼CRP, IL6 A
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First 
author, 
Year, 
Country 
Population, 
recruitment, Name 
of study 
Follow-
up 
Exposure : assessment 
method, average baseline 
values 
Outcome: 
average 
(baseline) 
level 
Covariates considered 
in analysis Results 
/∼/2 
study 2: 42.5y 
Ø BMI: study 1: 25.6 
study 2: 24.4 
Whole grain: whole 
wheat, whole-wheat flour, 
whole oats, whole-oat flour, 
whole cornmeal, corn flour, 
brown rice, brown rice flour, 
whole barley, whole rye, rye 
flour, bulgur, buckwheat, pop-
corn, amaranth, and psyllium 
Q3: 1.13 (1.05) 
Q4: 1.18 (1.05) 
Q5: 1.13 (1.05), p-trend=0.8  
%diff Q1 vs Q5: -5.8% 
Lutsey 
2007, 
USA (67) 
5,496 healthy 
participants  
 
% female: 52.8% 
Ø age: 61.9y 
Ø BMI: 27.9 
cross staff-assisted 127 item FFQ, 
mean whole grain intake: 0.54 
servings/d,  
median in quintiles: 
Q1: 0.02 
Q2: 0.15 
Q3: 0.39 
Q4: 0.72 
Q5: 1.39 
 
Whole grain: cold whole grain 
cereals, oatmeal, dark bread, 
bran muffins, brown or wild 
rice 
geometric 
mean hsCRP: 
3.26 mg/l3 
age, sex, race, 
education, survey 
centre, energy intake, 
current smoking, 
current alcohol use, 
dietary intake of fruit, 
vegetables, refined  
grains, dairy, fish and 
poultry, meat, leisure 
physical activity, 
sedentariness score, 
BMI, insulin 
Geometric mean hsCRP (mg/l):                                                                                
Q1: 3.43 
Q2: 3.23 
Q3: 3.20 
Q4: 3.24 
Q5: 3.17, p-trend=0.08 
 
Mean IL-6 (pg/ml): 
Q1: 1.54 
Q2: 1.47 
Q3: 1.45 
Q4: 1.51 
Q5: 1.51, p-trend=0.9 
WGcross. 
∼CRP  
(IL6) 
Masters 
2009, 
unpublish
ed data, 
USA3 
(68) 
487 participants with 
T2D  
 
% female: 53.9% 
Ø age: 57.2y 
Ø BMI: 31.4 
cross FFQ, 
median whole grain intake in 
tertiles (servings/day):  
T1: 0.15 (IQR: 0-0.43) 
T2: 0.72 (0.43-1.04)  
T3: 1.50 (1.04-4.15) 
 
whole grain: bread and cereals 
 
median 
hsCRP 4.62 
mg/l3 
 
age, sex, ethnicity, total 
caloric intake, smoking 
status, total estimated 
energy expenditure, 
alcohol consumption 
category, oral 
hyperglycemic 
medication use and 
lipid-lowering 
medication use, 
vegetable intake, fruit 
intake, % energy from 
fat intake 
Multiple regression of whole grain 
intake with hsCRP: 
ß: -0.151, SE: 0.063 p: 0.017 
 
The significant association 
remained after inclusion of 
potential pathway nutrients (dietary 
fiber and magnesium intake) in the 
model. 
WGcross. 
CRP 
Masters 
2010, 
USA (69) 
1,015 healthy 
participants  
 
% female: 56.4% 
cross 114 items semi-quantitive 
FFQ, 
median whole grain intake: 
0.81 (SD: 0.73) servings/d; 
median 
hsCRP 1.72 
mg/l3 
 
age, sex, ethnicity, total 
energy intake, smoking 
status, total energy 
expenditure, alcohol 
multiple regression analysis for 
whole grain intakes with hsCRP 
mg/l (log) (n=932):  
ß: -0.102 (SEM: 0.048), p=0.03, 
WGcross. 
CRP 
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First 
author, 
Year, 
Country 
Population, 
recruitment, Name 
of study 
Follow-
up 
Exposure : assessment 
method, average baseline 
values 
Outcome: 
average 
(baseline) 
level 
Covariates considered 
in analysis Results 
/∼/2 
Ø age: 54.9y 
Ø BMI: 28.4 
in quintiles:  
Q1: 0.04 
Q2: 0.32 
Q3: 0.65 
Q4: 1.04 
Q5: 2.00 
 
whole grain: bread and cereals 
consumption, refined 
grain, vegetable intake, 
fruit intake, percent 
energy from oleic acid, 
PUFA, SFA intake 
 
After inclusion of waist 
circumference, insulin sensitivity, 
2h glucose the results were no 
longer significant. 
 
No significant association between 
refined grain intake and hsCRP 
levels (p=0.6). 
Monto-
nen 
2012, 
Germany 
(70) 
2,198 participants  
 
cohort from EPIC-
Potsdam 
 
%female: 60.9% 
Ø age: 50.4y 
Ø BMI: 26.1 
cross 148 item FFQ; 
median whole grain bread 
servings (50g)/d:  
Q1: 0.02 servings  
Q3: 0.52 servings 
Q5: 2.68 servings 
 
Whole grain: bread 
geometric 
mean hsCRP: 
0.80 mg/l3 
age, sex, education, 
sport activity, 
occupational activity, 
smoking, alcohol 
intake, dietary variables 
(energy, red meat 
intake, coffee, and food 
items aggregating into 
the same pattern as 
whole gran bread (e.g. 
pasta, rice, pizza) 
Geometric mean (95% CI) hsCRP 
(mg/l) by quintiles of whole grain 
bread intake:  
Q1: 0.77 (0.65-0.92)  
Q2: 0.86 (0.71-1.03) 
Q3: 0.91 (0.76-1.09) 
Q4: 0.79 (0.66-0.95)  
Q5: 0.68 (0.56-0.82), p trend=0.02 
 
further adjustment for BMI and 
waist circumference did not change 
the results 
WGcross. 
CRP 
Qi 2006, 
USA (23) 
902 women with T2D  
 
Ø age 58.5y 
Ø BMI: 29.7 
cross semi quantitative FFQ, 
median whole grain intake in 
quintiles  
Q1: 4.75 
Q2: 9.82 
Q3: 15.3 
Q4: 22.8 
Q5: 35.4 
 
whole grain: whole 
wheat, whole-wheat flour, 
whole oats, whole-oat flour, 
whole cornmeal, corn flour, 
brown rice, brown rice flour, 
whole barley, whole rye, rye 
flour, bulgur, buckwheat, pop-
corn, amaranth, and psyllium 
geometric 
mean hsCRP: 
5.75 mg/l3 
age, BMI, smoking, 
alcohol consumption, 
physical activity, 
aspirin use, A1C, 
history of hypertension 
or 
hypercholesterolemia, 
postmenopausal 
hormon use, GI and 
magnesium 
Geometric mean hsCRP(mg/l) 
according to quintiles of whole-
grain:  
Q1: 6.60  
Q2: 5.28  
Q3: 5.76  
Q4: 5.59  
Q5: 5.52, p-trend= 0.03 
WGcross. 
CRP 
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1 Abbreviations: %en, percentage of total energy; cross, cross-sectional; CHD, coronary heart disease; fib, dietary fiber intake; FFQ, food frequency questionaire; hsCRP, high-
sensitivity C-reactive protein;  prosp, prospective; Q, Quantile; RC, regression coefficient; Ref, Reference; T2D, type 2 diabetes mellitus; WG, whole grain 
2 : direct association with dietary fiber or whole grains, ∼: no association with dietary fiber or whole grains, : inverse association with dietary fiber or whole grains, (): trend 
for inverse association with dietary fiber or whole grains 
3 estimated from values given per quantiles 
4 CRP ratio=ratio of the geometric mean hsCRP among those exposed to those unexposed 
Ø average value, mean or median as provided in the original publication. 
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Supplemental Table 4: Dietary fiber, fiber supplements and whole grain and hsCRP/IL-6 – intervention studies (detailed version)1 
First 
author,  
Year, 
Country 
Participants 
characteristics Study design Dietary Intervention 
Outcome: baseline levels 
and primary endpoint  Results
2 +/-3 
Dietary fiber and fiber supplements – intervention studies 
Biörk-
lund 
2008, 
Sweden 
(54) 
43 participants with 
mildly elevated 
serum cholesterol 
levels 
 
% female: 55.8% 
Ø age: 58y 
Ø BMI: 25.0 
parallel, placebo-
controlled, 
5 weeks duration (3 
wks run-in) 
ß-glucan enriched (n=22): mean 
fiber (g): 18.7 (SD: 5.7) 
control (n=21): mean fiber (g): 
17.4 (5.9) 
 
weight maintenance 
habitual diet plus study soup 
mean hsCRP:  
ß-glucan: 1.31 (SD: 0.97) 
mg/l 
control: 1.97 (1.83) mg/l    
 
primary endpoint: LDL-
cholesterol  
Relative difference (%) in hsCRP 
(week 7-8 minus week 2-3):  
ß-glucan: -19.1 
control: -30.8,  
no between group-difference for 
change p>0.05 
 
ß-glucan 
-CRP 
Dall` 
Alba 
2013, 
Brazil 
(55) 
44 participants with 
T2D and metabolic 
syndrome 
 
% female: 61.4% 
Ø age: 62y 
Ø BMI: 29.8 
randomized 
controlled trial, 
6 weeks duration (2 
weeks run-in) 
intervention: mean fiber (g): 24.3 
(SD: 5.4) 
control: mean fiber (g): 15.7 (6.3) 
 
weight maintenance, 
usual diet plus supplements in the 
intervention group (5g partially 
hydrolysed guar gum twice a 
day), white bread and soy bean oil 
supplied to avoid differences in 
carbohydrate and fat contents 
median hsCRP: 
intervention: 2.8 (IQR: 
1.1, 5.3) mg/l 
control: 1.9 (0.8, 5.2) mg/l 
 
primary outcome: 
metabolic syndrome 
components 
Median (IQR) hsCRP (mg/l) after 
intervention: 
intervention: 2.1 (0.8, 7.9), p for 
difference to baseline=0.3 
control: 1.5 (0.7, 4.0), p for 
difference to baseline=0.9 
 
no data on between-group difference 
for change 
 
Guar 
gum 
-CRP 
Jenkins 
2002, 
Canada 
(56) 
23 participants with 
T2D  
 
% female: 30% 
Ø age: 63y 
Ø BMI: 26.7 
randomized 
crossover, 
3 months (2 months 
wash-out) 
wheat bran: mean fiber (g): 37.1 
(SEM: 2.0), 21.3 g/1000kcal (0.8) 
control: mean fiber 21.0 (1.5), 
11.7 g/1000kcal (0.7) 
 
weight maintenance 
habitual diet, conformed to the 
National Cholesterol 
Education Program,  
 
bread and cereals provided 
mean hsCRP:  
wheat bran: 4.61 (SEM: 
1.93) mg/l,  
control: 4.37 (1.91) mg/l  
 
endpoints: lipid and non-
lipid CVD risk factors  
Mean (SEM) hsCRP (mg/l) after 
intervention:  
wheat bran: 3.79  (1.56) 
 control: 4.80 (2.01) 
 
no between-group difference for 
change in hsCRP  
-3.80 (-7.9%), p=0.4 
 
Analysis adjusts for sex, sequence 
and baseline values 
Wheat 
bran 
-CRP 
Jensen 
2012, 
Denmark 
(57) 
80 participants with 
obesity 
 
% female: 67.5% 
Ø age 42.9y 
parallel, double 
blind, placebo-
controlled, 
12 weeks duration 
alginate-fiber (n=38): 15g fiber 
supplement 
placebo (n=42): 0g fiber 
 
weight-loss study (-0.5 kg/ week) 
mean hsCRP:  
alginate fiber: 2.7 (SEE: 
0.4) mg/l  
control: 5.2 (1.0) mg/l 
 
Mean (SEE) hsCRP difference 
(mg/l) after intervention:  
alginate fiber :-1.0 (0.5) 
control: -0.4 (0.5),   
 
Alginate 
fib 
-CRP 
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First 
author,  
Year, 
Country 
Participants 
characteristics Study design Dietary Intervention 
Outcome: baseline levels 
and primary endpoint  Results
2 +/-3 
Ø BMI: 34.2  
free choice of food items plus 
supplements 
primary endpoint: weight 
change 
no between-group difference for 
change in hsCRP (p= 0.3) 
 
Analysis adjusts for baseline values 
of lean body mass, body weight, and 
sex 
Johans-
son-
Persson 
2013, 
Sweden 
(58) 
25 participants with 
mild 
hypercholesterolem
ia 
 
% female: 52% 
Ø age: 58.6y 
Ø BMI: 26.6 
 
for CRP analyses: 
subjects with levels 
>10mg/l excluded 
randomized, single-
blinded, crossover 
trial, 
5 weeks duration (3 
weeks washout) 
 
high-fiber diet period: mean 
fiber (g): 48.0 (SD: 6.8) 
low-fiber diet period: mean 
fiber: 30.2 (8.0) 
 
weight maintenance, 
usual diet plus study foods: one 
bread roll, one ready meal, two 
beverages, all with or without 
added fiber (rye bran, oat bran, 
sugar beet fiber) 
mean CRP: 
high-fiber (n=24): 1.9 
(SEM: 0.3) mg/l  
low-fiber (n=22): 1.5 (0.2) 
mg/l 
 
median IL-6: 
high-fiber (n=19): 0.73 
(IQR: 1.6) pg/ml  
low-fiber (n=17): 1.17 
(1.1) pg/ml 
 
primary endpoint: LDL-
cholesterol 
mean (SEM) CRP (mg/l) after 
intervention: 
high-fiber period (n=24): 1.5 (0.1)  
low-fiber period (n=22): 1.8 (0.3)l 
 
treatment difference (n=21): -0.71 
(0.4), p-trend=0.017 
 
median (IQR) IL-6 (pg/ml) after 
intervention: 
high-fiber period (n=19): 0.60 (1.4)  
low-fiber period (n=17): 0.99 (1.3), 
 
treatment difference (n=13): -0.14 
(0.8), p-trend=0.2 
Dietary 
fib 
+CRP 
-IL6 
 
King 
2007, 
USA (59) 
35 participants: 18 
healthy and 17 with 
obesity and 
hypertension  
 
%female: 80% 
Ø age: 38.3y 
Ø BMI: 28.4 
randomized, 
crossover, 
3 weeks duration (3 
wks run-in) 
high-fiber DASH-diet: mean 
fiber intake: 27.7g/d (SD: 0.06) 
psyllium fiber supplemented 
diet (supplemented to reach 
30g/d): mean fiber intake: 26.3 
(0.4) 
 
weight maintenance 
 
dietary instructions 
mean hsCRP: 
4.4 (SD: 1.0) mg/l  
 
primary endpoint: hsCRP    
Difference (%) in hsCRP after each 
diet period:  
DASH-diet:- 13.7 
supplemented diet: -18.1 
 
trend for difference between diet 
periods (0.051 (95% CI -0.008-
0.111) p=0.09; supplementation 
minus DASH diet) 
 
Psyllium 
fib 
(+CRP) 
 
King 
2008, 
USA (60) 
158 participants 
with overweight or 
obesity 
 
% female: 72.8% 
Ø age: 50.5y 
Ø BMI: 33.4 
 
RCT, 
3 months duration 
high fiber (n=48): mean fiber: 
14.5 g/d (SD: 3.9) 
low fiber (n=53): 13.5 (3.4)  
control (n=57): 14.1 (4.4) 
 
weight maintenance  
 
14, 7, or 0 g/d psyllium fiber 
Mean hsCRP:  
high-fiber: 7.61 (SD: 5.8) 
mg/l  
low-fiber: 7.62 (6.7) mg/l  
control: 7.79 (7.5) mg/l 
 
primary endpoint: hsCRP  
power calculations for 
Mean (SD) changes in hsCRP (mg/l) 
(ITT): 
high-fiber: 0.98 (4.57) 
low-fiber: -0.96 (4.45) 
control: 0.05 (7.87); 
 
no difference in change between 
treatment groups and control group 
Psyllium 
fib 
-CRP 
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First 
author,  
Year, 
Country 
Participants 
characteristics Study design Dietary Intervention 
Outcome: baseline levels 
and primary endpoint  Results
2 +/-3 
women needed to 
have CRP 
concentrations 
>3mg/l, and men 
>2mg/l 
supplement hsCRP (p>0.05) 
 
Kohl 
2009, 
Germany 
(61) 
12 participants with 
overweight or 
obesity and 
moderately 
increased levels of 
CRP (<5mg/l) 
 
% female: 67% 
Ø age 49.7y 
Ø BMI: 32.2 
randomized, 
double-blind, 
placebo-controlled 
crossover, 
4 weeks duration (3 
wks washout) 
intervention: 0.5g of ß-D-glucan, 
mean fiber 18.0 g/d  
control: nonfermentable waxy 
maize starch (placebo), mean 
fiber 18.8 
 
weight maintenance 
 
usual diet plus supplements 
mean CRP:  
5.7 (SEM: 0.6) mg/l 
 
primary endpoint: CRP 
power calculations for 
CRP 
 
no data for mean IL-6 
Mean (SEM) CRP (mg/l) after 4 
weeks: 
Intervention period: 5.3 (0.8) 
Control period: 6.1 (1.2)  
 
No treatment effect (p=0.4)  
     
IL-6:  
no data 
No treatment effect ( p=0.9, 
extracted from figure) 
ß-glucan 
-CRP 
Queenan 
2007, 
USA (62) 
75 participants at 
risk for CVD 
(hypercholesterole
mic)  
 
% female: 67% 
Ø age: 44.9y 
BMI <30 
randomized, 
double-blind 
parallel, 
6 weeks duration 
intervention (n=35): 6g/d 
concentrated oat ß-glucan,   
 
placebo (n=40): dextrose  
 
no data on baseline fiber intake 
 
weight maintenance, but in both 
groups reduction of energy intake 
(-340-520kJ/d) 
 
usual diet plus supplements 
mean CRP:  
intervention: 0.35 (SEM: 
0.08) mg/dl 
placebo: 0.38 (0.06) mg/dl 
 
endpoints: cardiovascular 
endpoints (including CRP) 
Mean (SEM) changes in CRP 
(mg/dl):  
intervention: -0.03 (0.06)  
placebo: 0.01 (0.04) 
no between-group difference for 
change in (p=0.5)  
 
Oat ß-
glucan 
-CRP 
Salas-
Salvado 
2008, 
Spain 
(63) 
166 participants 
with overweight or 
obesity 
 
% female: 78.3% 
Ø age: 47.9y 
Ø BMI: 31.2 
parallel, double-
blind, randomized, 
placebo-controlled, 
16 weeks duration 
fiber twice a day (2/d) (n=53) 
fiber three times a day (3/d) 
(n=58) 
placebo (n=55) 
mixed fiber dose: 3g Plantago 
ovata husk and 1 g glucomannan 
(placebo: 3g microcrystalline 
cellulose) 
 
weight loss study, (2.5MJ energy 
reduction) 
mean hsCRP:  
2/d: 0.75 (SD: 1.39) mg/l  
3/d: 0.86 (0.73) mg/l 
placebo: 0.70 (0.51) mg/l  
 
primary endpoint: weight 
change (no significant 
difference in weight 
change between groups)  
Mean (SD) change in hsCRP (mg/l): 
2/d: -0.10 (0.15) 
3/d: -0.08 (0.10) 
placebo: 0.02 (0.05) 
Mean differences to placebo: 
2/d: -0.12 (95% CI: -0.42, 0.18) 
3/d: -0.10 (95% CI: -0.32, 0.12) 
 
No difference in change between 
treatment groups and control group 
(p=0.3)  
Fib supp 
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First 
author,  
Year, 
Country 
Participants 
characteristics Study design Dietary Intervention 
Outcome: baseline levels 
and primary endpoint  Results
2 +/-3 
 
individual dietary advice plus 
supplements 
 
Analysis adjusts for baseline value 
and BMI stratum 
Wood 
2006, 
USA (64) 
29 men with 
overweight  
 
Ø age: 38.8y 
Ø BMI: 29.7 
parallel, placebo 
controlled, double 
blind, 
12 weeks 
intervention (n=14): 3 g/d 
soluble fiber supplement 
placebo (n=15): maltodextrin 
 
CHO-restricted diet (13% CHO, 
60% fat, 27% protein) 
 
weight loss study 
 
dietary instructions plus 
supplements 
mean hsCRP:  
intervention: 1.68 (SD: 
1.5) mg/l 
placebo: 1.86 (1.29) mg/l 
 
mean IL-6:  
intervention: 1.31 (SD: 
0.39) pg/ml 
control: 2.00 (1.62) pg/ml 
 
endpoints: cardiovascular 
risk factors (including 
hsCRP) 
Mean (SD) hsCRP (mg/l) week 12:  
intervention: 1.35 (0.95)                             
control: 1.55 (1.23) 
no between-group difference for 
change in (p>0.05)  
 
Mean (SD) IL-6 (pg/ml) week 12:  
intervention: 1.39 (0.50) 
control: 1.88 (1.07) 
no between-group difference for 
change in (p>0.05)  
 
changes in hsCRP were not 
correlated with change in body 
weight or fat mass  
Fib supp 
-CRP, IL6 
Whole grain consumption –  intervention studies 
Anders-
son 2007, 
Sweden 
(71) 
30 healthy 
participants 
(women were 
postmenopausal)  
 
% female: 73% 
Ø age: 59y 
Ø BMI: 28.3 
randomized, non-
blinded, crossover;  
6 weeks duration (6 
to 8 week wash out) 
whole grain: 30.0 (SD: 4.9) g 
fiber  
refined grain: 17.3 (5.5) g fiber 
 
weight maintenance,  
habitual daily diet plus fixed 
amount of whole or refined grain 
products  
 
foods provided 
 
whole grain products defined as 
containing a minimum of 50% 
whole grain per dry substance 
mean hsCRP: 
whole grain period: 2.03 
(SD:1.62) mg/l 
refined grain period: 2.86 
(2.96) mg/l  
 
mean IL-6:  
whole grain period: 14.8 
(SD: 32.2) ng/l 
refined grain period: 15.9 
(32.4) ng/l 
 
primary endpoint: insulin 
sensitivity 
mean hsCRP (mg/l) after 
intervention: 
whole grain period: 2.38 (2.29) 
refined grain period:2.34 (1.57) 
no treatment effect.(p=0.6)  
 
mean IL-6 (ng/l) after intervention: 
whole grain period:15.2 (33.2) 
refined grain period:15.8 (30.9); 
no treatment effect.(p=0.8)  
 
Analysis adjusts for sequence and 
BMI 
WG 
-CRP, IL6 
Brown-
lee 2010, 
UK (72) 
266 participants 
with overweight or 
obesity 
 
% female: 49.8%, 
randomized 
controlled; 
16 weeks duration 
intervention 1 (n=85): 60g whole 
grain/d (=3 servings/d) (mean: 74 
(SD: 28.5) g/d) 
intervention 2 (n=81): 60g whole 
grain/d in first 8 weeks, 120g/d in 
median CRP:  
intervention 1: 2.4 (SD: 
9.9) mg/l  
intervention 2: 3.2 (4.6) 
mg/l  
Median (SD) CRP (mg/l) at week 8: 
intervention 1: 2.6 (2.5) 
intervention 2: 3.5 (7.2)  
control: 2.7 (2.8) 
 
WG 
-CRP 
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First 
author,  
Year, 
Country 
Participants 
characteristics Study design Dietary Intervention 
Outcome: baseline levels 
and primary endpoint  Results
2 +/-3 
median age: 45.7y 
median BMI: 30.1 
 
inclusion criteria: 
habitual 
consumption ≤30g 
whole grain/d 
last 8 weeks (mean: 83 (31.1) g/d 
week 8, 115 (69.6) g/d week 16)  
control group (n=100): 
maintenance of current diet (mean 
19 (19.9) g whole grain/d) 
 
weight maintenance,  
 
substitution of whole grain with 
refined grain foods to a prescribed 
amount,  
foods provided on demand 
control: 2.4 (2.3) mg/l  
 
primary endpoint: LDL-
cholesterol 
 
 
Median CRP (mg/l) at week 16:  
intervention 1: 3.1 (4.3)  
intervention 2: 3.2 (5.9)  
control: 2.9 (3.5)  
 
No difference in change between 
intervention groups (average from 
two intervention groups) and control 
group  
-1.20 (-12.3-11.3), p>0.05  
de Mello 
2011, 
Finland 
(73) 
103 participants 
with impaired 
glucose metabolism 
and features of the 
metabolic 
syndrome  
 
% female: 51% 
Ø age: 59y, 
Ø BMI: 31.1 
parallel design, 
RCT; 
12 weeks 
healthy diet (n=35): baseline: 
29.3 g fiber/d (SD: 8.3), week 12: 
36.5 (6.0)  
whole grain (n=34): baseline: 
24.6 (7.0) g fiber/d, week12: 26.5 
(5.4) 
control (n=34): baseline: 22.2 
(6.9), week 12: 17.6 (4) 
 
weight maintenance, 
 
advice for replacement of usual 
cereal with at least 50% from 
whole grain source 
median hsCRP: healthy: 
1.4 (IQR: 0.7, 3.1) mg/l  
whole grain: 1.5 (0.7, 3.9) 
mg/l  
control: 1.4 (0.8, 2.3) mg/l 
 
median IL-6: healthy: 1.6 
(IQR: 1.0, 2.6) ng/l 
whole grain: 1.4 (1.0, 2.3) 
ng/l  
control: 1.3 (0.8, 2.0) ng/l 
 
primary endpoint: 
inflammatory markers 
(including hsCRP and IL-
6) 
median change (IQR) (%) of hsCRP 
after intervention: 
healthy diet: -10 (-37, 41) 
whole grain: -20 (-40, 11)  
control: -8 (-35, 49)  
no between-group difference for 
change in (p=0.2)  
 
median change (IQR) (%) of IL-6 
(ng/l) after intervention :  
healthy diet: -7 (-25, 13) 
whole grain: 3 (-15, 31)  
control: 3 (-11, 35) 
no between-group difference for 
change in (p=0.7)  
 
Significant improvements in hsCRP 
on whole grain diet in comparison to 
control among patients not using 
statins (p<0.05) (n=76) 
WG: 
(+CRP) 
subgroup 
Giacco 
2010, 
Italy (74) 
15 participants, 
some with 
overweight or 
obesity 
 
% female: 20% 
Ø age: 54.4y 
randomized 
sequential 
crossover, 
3 weeks duration (2 
wks run-in) 
Wholemeal wheat: mean 32g 
(SD: 4) fiber, 23.1g (2.3) cereal 
fiber 
refined wheat: 20g (4) fiber, 9.8g 
(1.7) cereal fiber 
 
weight maintenance,  
No data on baseline levels 
 
endpoints: metabolic 
markers (including 
hsCRP) 
Mean (SD) hsCRP (mg/dl) after 
intervention: 
wholemeal wheat period: 1.8 (SD: 
2.3) 
refined wheat period: 2.9 (4.1), 
no treatment effect (p=0.4)  
Wholem
eal 
wheat 
-CRP 
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First 
author,  
Year, 
Country 
Participants 
characteristics Study design Dietary Intervention 
Outcome: baseline levels 
and primary endpoint  Results
2 +/-3 
Ø BMI: 27.4 fixed amount of wholemeal or 
refined wheat products (wheat 
bread, pasta, rusks, and crackers), 
supplied by Barilla  
Katcher 
2008, 
USA (75) 
50 participants with 
obesity and the 
metabolic 
syndrome  
 
% female: 50% 
Ø age: 46.6y 
Ø BMI 35.8 
randomized, open-
label, parallel-arm, 
12 weeks duration 
diet composition at week 12: 
whole grain (n=25): mean 12.9 
(SD: 2.2) g fiber/1000kcal  
refined grain (n=25): 9.7 (3.5) g 
fiber/1000kcal 
 
weight loss study (-500 kcal) 
 
dietary advice (list of foods) 
mean hsCRP: whole 
grain: 6.0 (SD: 8.0) mg/l  
refined grain: 5.9 (6.0) 
mg/l 
 
mean IL-6: 
whole grain: 3.2 (6.3) 
pg/ml refined grain: 2.2 
(1.3) pg/ml 
 
primary endpoint: weight 
loss 
Mean (SD) change in hsCRP (mg/l) 
after intervention: 
whole grain: -2.4 (5.1) 
refined grain: 0.2 (2.9) 
significant between-group difference 
of change (p=0.01)  
 
Mean (SD) change in IL-6 (pg/ml) 
after intervention: 
whole grain: -0.9 (3.6) 
refined grain: -0.1 (0.4)  
no between-group difference of 
change (n.s.) 
 
Effects were independent of weight 
loss 
WG 
+CRP 
-IL6P 
Kristen-
sen 2012, 
Denmark 
(76) 
72 postmenopausal 
women with 
overweight or 
obesity 
 
Ø age: 59.7y 
Ø BMI: 30.2 
open-label parallel, 
12 weeks duration 
(2 weeks run-in) 
whole wheat (n=38): 105 g whole 
grains/d, 11.0 g fiber/d  
refined wheat (n=34): 0 g whole 
grains/d, 4.5 g fiber/d 
 
weight maintenance, 
 
intervention foods provided 
(bread, pasta, biscuits) 
 
whole-grain foods defined as 
containing a minimum of 50% of 
whole grain per dry matter, 
including the starchy endosperm, 
germ, and bran, in milled form 
. 
mean hsCRP: whole 
wheat: 0: 0.95 (95%CI: 
0.35, 1.55) mg/l 
refined wheat: 1.0 (0.42, 
1.58) mg/l 
 
mean IL-6: 
whole wheat: 2.45 
(95%CI: 2.13, 2.78) ng/l 
refined wheat: 1.70 (1.3, 
2.0) ng/l 
 
primary endpoint: body 
weight and composition 
mean (95%CI) hsCRP(mg/l): 
whole wheat: week 6: 0.98 
(0.36,1.60),  
week 12: 0.85 (0.25,1.45) 
refined wheat: week 6: 1.06 
(0.44,1.76), week 12: 1.07 
(0.49,1.65) 
no between-group difference of 
change (p= 0.95)  
 
mean (95% CI) IL-6 (ng/l) : 
whole wheat: week 6: 2.59 (2.16, 
3.02),  
week 12: 2.65 (2.15, 3.15)  
refined wheat: week 6: 1.84 (1.54, 
2.14), week 12: 1.83 (1.51, 2.15), 
trend for between-group difference 
of change (p= 0.09)  
 
Whole 
wheat 
-CRP 
(+IL6) 
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First 
author,  
Year, 
Country 
Participants 
characteristics Study design Dietary Intervention 
Outcome: baseline levels 
and primary endpoint  Results
2 +/-3 
Analysis refers to completers-only 
and adjusts for age, baseline levels, 
baseline BMI and change in body 
weight from baseline 
 
No sig. difference in weight loss but 
in percentage body fat reduction 
between groups 
Tighe 
2010, 
Scotland 
(77) 
206 healthy 
participants, some 
with signs of 
metabolic 
syndrome  
 
% female: 50% 
Ø age: 51.7y 
Ø BMI: 27.7 
randomized, single-
blind, controlled; 
12 weeks duration 
(4 wks run-in) 
whole wheat (n=73): nonstarch 
polysaccharides: 18.5g (SD 0.5),  
wheat+oats (n=70): nonstarch 
polysaccharides:16.8g (0.5)                           
control (n=63): nonstarch 
polysaccharides:11.3g (0.4) 
 
weight maintenance,  
 
refined cereal products substituted 
with 3 servings of whole wheat 
foods (bread, cereals) or 1 serving 
of whole wheat foods and 2 
servings of oats  - foods provided 
 
median hsCRP:  
control:1.4 (IQR: 0.7, 2.7) 
mg/l 
whole wheat: 3.3 (0.5, 
2.3) mg/l 
wheat+oat: 1.0 (0.4, 1.6) 
mg/l  
 
median IL-6:  
control:1.3 (IQR: 0.8, 2.3) 
pg/l 
whole wheat: 1.2 (0.9, 
1.9) pg/l wheat+oat: 1.1 
(0.8, 1.7) pg/l 
 
primary endpoints: total 
and LDL cholesterol 
median (IQR) hsCRP (mg/l) at week 
12:  
whole wheat: 0.9 (0.5, 1.9) 
wheat+oat:1.0 (0.6, 2.3),  
control: 1.1 (0.6, 3.0) 
no between-group difference of 
change (p=0.5)  
 
median (IQR) IL-6 (pg/l) 2 at week 
12: 
whole wheat: 1.4 (1.0, 1.9) 
wheat+oat: 1.1 (0.8, 1.6),  
control: 1.4 (1.0, 2.4) 
no between-group difference of 
change (p=0.3) 
Whole 
wheat 
-CRP, IL6 
1 Abbreviations: CHO, carbohydrate; CVD, cardiovascular disease; DASH, Dietary Approaches to Stop Hypertension, fib, dietary fiber intake; ITT, intention to treat; RCT, 
randomized controlled trial; supp, supplement; T2D, type 2 diabetes mellitus; WG: whole grain 
2 p-values of between-group differences for changes in inflammatory markers are reported for randomized controlled trials, p-values for treatment effects are reported for cross-
over trials 
3 +: effect of dietary intervention on hsCRP or IL-6, -: no effect of dietary intervention on hsCRP or IL-6 
Ø average value, mean or median as provided in the original publication. 
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Abstract
Non-alcoholic fatty liver disease (NAFLD) is closely associated with insulin resistance and obesity. Hence, carbohydrate quality could be of
relevance to the risk of NAFLD, but prospective data are lacking. The aim of the present study was to investigate longitudinal associations
between carbohydrate quality (including dietary glycaemic index (GI) and intakes of sugar, starch and fibre) and markers of liver function
in an older Australian population. The analysis was based on 866 participants ($49 years) of the Blue Mountains Eye Study with fasting
blood specimens and dietary intake data at baseline and 5-year follow-up. Multi-level mixed regression analysis was used to relate dietary
GI and sugar, starch and fibre intake to the liver enzymes alanine aminotransferase (ALT) and g-glutamyltransferase (GGT), as well as fast-
ing TAG and HDL-cholesterol (HDL-C). After adjustment for potential confounding factors, a lower fibre intake was cross-sectionally
related to higher GGT (P¼0·02) and fasting TAG (P¼0·002) levels, with fruit fibre being the most relevant fibre source (P¼0·095 for
GGT; P¼0·003 for TAG). A higher dietary GI was associated with lower HDL-C (P¼0·046). Changes in carbohydrate quality during
5 years were not related to changes in ALT, GGT, TAG or HDL-C (P$0·08). In conclusion, the absence of longitudinal associations between
carbohydrate quality and liver enzymes and serum lipids in this older population does not support a major role of carbohydrate nutrition
in liver function among the elderly.
Key words: Non-alcoholic fatty liver disease: Serum lipids: Glycaemic index: Dietary fibre
Non-alcoholic fatty liver disease (NAFLD) describes a condition
of fat accumulation in hepatocytes in the absence of other
causes of hepatic steatosis such as excess alcohol consumption.
Recently, NAFLD has been recognised as an important risk
factor for the development of both type 2 diabetes and CHD.
In this context, NAFLD has also been termed as the hepatic
manifestation of the metabolic syndrome, as it has been related
to all its constituting features(1).
The close relationship with obesity and insulin resistance
suggests a link to dietary factors associated with disturbances
in glucose and insulin metabolism. Indeed, several recent
cross-sectional(2,3) and case–control studies(4,5) have reported
associations between carbohydrate quality and NAFLD risk in
adults aged 50–60 years(2,3,5) as well as younger adults aged
30 years(4). Both higher dietary glycaemic index (GI)(2) (which
ranks carbohydrates according to their glycaemic potency)
and added sugars(4,5), particularly from soft drinks, were related
to increased NAFLD markers. By contrast, studies on the
relevance of dietary fibre for liver fat content have yielded
inconsistent results in middle-aged(6,7) and older adults(2).
Overall, evidence from prospective studies is lacking, but
would be of importance to shed light on the longitudinal
*Corresponding author: A. E. Buyken, fax þ49 231 71 15 81, email buyken@fke-do.de
Abbreviations: ALT, alanine aminotransferase; BMES, Blue Mountains Eye Study; GGT, g-glutamyltransferase; GI, glycaemic index; HDL-C, HDL-cholesterol;
NAFLD, non-alcoholic fatty liver disease.
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relevance of carbohydrate quality for NAFLD risk. As the
prevalence of NAFLD increases with age(1), investigating this
relationship in older cohorts is relevant.
The liver enzymes alanine aminotransferase (ALT) and
g-glutamyltransferase (GGT) are commonly used as non-
invasive estimates for hepatic fat accumulation, but in contrast
to ALT, GGT also serves as a marker for alcoholic fatty
liver(1,8–10). Serum lipids can be considered additionally as
risk markers, since NAFLD is closely related to dyslipidaemia
and the metabolic syndrome(11,12). Elevated hepatic lipogenesis
leads to an overproduction of TAG and subsequently VLDL;
hence, increased levels of fasting TAG may indicate metabolic
alterations in the liver(13). Low HDL-cholesterol (HDL-C)
values serve as a further marker for disturbances in lipid
metabolism, and, indeed, a study of non-obese, non-diabetic
subjects showed that, among others, hypertriacylglycerolaemia
and low levels of HDL-C were risk factors for NAFLD(14).
The present study aims to examine both the cross-sectional
and the 5-year concurrent associations between carbohydrate
quality (GI and intake of sugar, starch and fibre) and the pro-
posed markers of liver function (ALT, GGT, fasting TAG and
HDL-C) in an older population.
Materials and methods
Study population
The Blue Mountains Eye Study (BMES) is a population-based
cohort study of vision, common eye diseases and other health
outcomes in an urban, predominantly Caucasian Australian
population aged 49 years and older, which was initiated in
1992 with two 5-year follow-up examinations. A total of 3654
participants took part in the baseline examination (1992–4;
BMES-1)(15). The study was conducted in accordance with
the recommendations of the Helsinki Declaration and was
approved by the University of Sydney and the Sydney West
Area Health Service Human Research Ethics Committees.
Written informed consent was obtained from all participants.
Details on the study and covariate assessment have been
described elsewhere(15).
Study sample
We were interested to examine the cross-sectional and the
5-year concurrent associations of dietary carbohydrate quality
with liver enzymes, fasting TAG and HDL-C concentrations.
Liver enzymes were first analysed in the first follow-up
(BMES-2). Hence, in the present analysis, these data were
termed baseline and BMES-3 data (second re-examination) as
the respective 5-year follow-up. The analysis was restricted to
the participants who had provided a complete and plausible
FFQ, as well as a fasting blood specimen at both BMES-2 and -3.
Of the 2335 participants re-examined at BMES-2, 330
had to be excluded due to incomplete ($12 questions of
the FFQ missing, an entire page remaining blank) or implau-
sible dietary data (daily energy intakes were ,2500 or
.18 000 kJ(16)), and a further 195 because of missing blood
samples. Of the remaining 1810 participants, 388 died during
the 5-year follow-up period, 161 were lost to follow-up and
218 participated in BMES-3 but did not provide a plausible
FFQ and/or a blood sample. A total of 1043 participants had
dietary data and blood specimens at both BMES-2 and -3.
Another sixty-four participants were excluded because data
on BMI, use of lipid-lowering drugs, diabetes mellitus, CHD
or smoking status were missing. Moreover, to avoid any
confounding due to alcoholic fatty liver disease, we excluded
all BMES participants who consumed more than 20 g alcohol
per d at both baseline and follow-up (n 113), a cut-off point
which has commonly used(1,8). Therefore, the present examin-
ation included 866 participants for the analysis of ALT and GGT.
Furthermore, at BMES-3, some participants provided only non-
fasting blood specimens; hence, fasting TAG and HDL-C con-
centrations from both visits were available for 755 participants
only.
Dietary assessment
Dietary data were collected using a 145-item FFQ modified
for the Australian diet and vernacular from an early Willett
questionnaire(17). This FFQ was validated against 4 d weighed
food records collected on three occasions during 1 year
(n 79) and showed moderate-to-good agreement for ranking
individuals according to their GI, dietary fibre and total carbo-
hydrate intake(18).
Nutrient intakes were estimated using the Australian Tables
of Food Composition (NUTTAB95) and published GI values
with the glucose ¼ 100 scale(19). Additional GI data were
obtained from the Sydney University Glycaemic Index Research
Service online database (www.glycaemicindex.com). An over-
all GI value for each participant’s diet was calculated by
summing the weighted GI of individual foods in the diet with
the weighting proportional to the contribution of individual
foods to total carbohydrate intake. Additionally, data on total
fibre intake and fibre intakes from bread and cereals, vegetables
and fruits were extracted from the FFQ.
Liver enzymes and serum lipid levels
Fasting blood specimens were drawn, centrifuged on site and
then sent by courier within the same day to the Westmead
Hospital, Sydney, for haematological analysis and clinical bio-
chemistry assessment. Fasting serum TAG concentrations were
measured on a Reflotron reflectance photometric analyser
(Boehringer Mannheim Diagnostics; currently, Roche Diag-
nostics). CV for repeated measurements of plasma were
1·4% for TAG and 3·2% for HDL-C. ALT and GGT were deter-
mined using commercial kits performed on an automated
analyser (OCD Fusion 5.1; Ortho Clinical), and CV were
below 4% for ALT and below 2·8% for GGT.
Statistical methods
Statistical analyses were performed using SAS software
(version 9.1.3; SAS). Because some of the metabolic and
nutritional data were not normally distributed, all continuous
data are presented as medians (25th and 75th percentiles).
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Differences between baseline and the 5-year follow-up in
metabolic variables and nutritional intake data were analysed
using the Wilcoxon signed-rank test for continuous variables
and the Mantel–Haenszel x 2 test for categorical variables.
We used linear mixed-effect regression models (PROC
MIXED in SAS) to construct longitudinal models of trends in
ALT, GGT, fasting TAG and HDL-C between baseline and
the 5-year follow-up. Because the outcome variables were
not normally distributed, all of them were log-transformed
before the regression analysis.
In model 1, the following fixed effects were included: sex;
time (defined as 1 (baseline) and 2 (5-year follow-up)); the
respective dietary variable at baseline; the interaction of this
dietary variable with time; the change in the dietary variable,
calculated by subtracting baseline values of the respective
parameter from the one at follow-up. In this way, the analysis
yielded three regression coefficients representing the following:
(1) the cross-sectional estimate – an estimate for the regression
of carbohydrate quality at baseline on markers of hepatic fat
accumulation at baseline; (2) the prospective estimate – the
slope of the regression of carbohydrate quality at baseline on
the change in the outcomes over 5 years; (3) the concurrent
estimate – an estimate for the regression of the change in carbo-
hydrate quality between the 5 years on the concurrent change in
the outcomes. The parameters of carbohydrate quality (GI and
intake of sugar, starch and fibre; total fibre and fibre from
bread and cereals, vegetables and fruits) were energy-adjusted
using the multivariate energy density model(20), which required
the calculation of fibre densities (g/MJ).
For model 2, the fixed effects of age, diabetes mellitus, any
CHD, current or former smoking status, menopausal status,
hormone replacement therapy, post-secondary school qualifi-
cation, good self-rated health and use of cholesterol-lowering
as well as other potential influencing medications, e.g. anti-
diabetic drugs, at baseline were considered as potential
influencing factors. BMI and other metabolic and nutritional
variables (e.g. total or saturated fat) were additionally exam-
ined, including their level at baseline, interaction of baseline
level and time, or change in their level during the 5-year
period. Only those potential influencing factors that (1) sub-
stantially modified the association of the principal dietary
variables with ALT, GGT, TAG or HDL-C in the unadjusted
models, (2) significantly predicted the outcome variable or
(3) improved the fit statistic (Akaike’s information criterion)
were included in model 2. All analyses were performed with
a significance level at P,0·05.
Results
Among the 866 participants included in the present analysis,
more were women and individuals with a younger age,
a post-secondary school qualification, a good self-reported
health and overweight, but fewer suffered from CHD and
smoked compared with the 831 BMES participants who
had died or were lost to follow-up. Moreover, those included
had lower ALT and fasting glucose concentrations and had
consumed slightly more polyunsaturated fat, protein, carbo-
hydrates, sugar, starch and fibre, especially from bread and
cereals, and had a lower dietary GI at baseline (data not
shown).
Baseline characteristics of the 866 BMES participants
included in the present analysis are shown in Table 1. After
the 5-year follow-up, the participants’ BMI was lower and
serum concentrations of ALT, GGT, albumin and bilirubin
were higher, whereas concentrations of fasting TAG, glucose,
HDL-C and cholesterol improved significantly (Table 2).
Regarding 5-year changes in nutritional intake data, energy
intake as well as total fat, and saturated fat intake were
higher, whereas starch and fibre intake from bread and
cereals were lower (Table 2). All of the observed changes
were, however, very small.
Carbohydrates and liver enzymes
Carbohydrate quality was not independently associated with
ALT, neither in the cross-sectional nor in the concurrent anal-
ysis (Table 3, first and second main columns).
The cross-sectional analysis showed inverse associations
between fibre intake and GGT in model 1. These were attenu-
ated, but still significant, after adjustment for potentially con-
founding factors (P¼0·02, model 2; Table 3, third main
column). Among the fibre sources, fruit fibre seemed to
have the greatest relevance for GGT levels, with higher intakes
being related to lower GGT levels. However, this association
was attenuated towards a trend after adjustment for confound-
ing factors (P¼0·095, model 2; Table 3, third main column).
None of the other parameters of carbohydrate quality was
related to GGT – neither in the cross-sectional nor in the con-
current change analyses.
Carbohydrates and TAG and HDL-cholesterol
Higher levels of dietary GI were associated with higher fasting
TAG in the cross-sectional analysis, but this association was no
longer evident after adjustment for confounding factors. Con-
versely, associations between fibre intakes and fasting TAG
levels in the cross-sectional analysis were maintained
(P¼0·002, model 2; Table 4, first main column), with higher
Table 1. Baseline characteristics of the 866 Blue Mountains Eye Study
participants
(Percentages, or medians and 25th and 75th percentiles)
Total (n) Value (%)
Sex
Female 866 62·7
Age (years) 866
Median 67·0
25th percentile 62·0
75th percentile 73·0
Diabetes mellitus 866 9·8
Any CHD 866 16·3
Cholesterol-lowering medication 866 9·2
Menopause* 543 94·3
Hormone replacement therapy, ever* 543 38·7
Smoking 866 41·1
Post-secondary school qualification 835 64·2
Good self-reported health at baseline 866 84·2
*Percentage refers to women only.
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intakes of fibre from fruits being the relevant source (P¼0·003,
model 2; Table 4, first main column).
Regarding the associations between carbohydrate quality
and HDL-C, a higher dietary GI was cross-sectionally related
to lower HDL-C levels (P¼0·046, model 2; Table 4, third
column). A lower starch intake was also related to lower
HDL-C levels, but adjustment for confounding factors attenu-
ated this association (P¼0·05, model 2; Table 4, third column).
For none of the other aspects of carbohydrate nutrition,
a relationship to HDL-C could be observed – neither cross-
sectionally nor concurrently.
Sensitivity analyses
Additional adjustment for albumin or bilirubin, metabolic
variables sometimes also used to assess liver health, did not
alter the results. Furthermore, we repeated the analysis for
the entire study sample with data on BMES-2 and -3 including
also the 113 participants with a habitually high alcohol intake.
The results were comparable with those presented for ALT,
TAG and HDL-C, with the observed associations being more
pronounced. For GGT, both cross-sectional and 5-year
concurrent associations were observed with dietary GI and
fibre intake (particularly from fruit sources) in the
entire study sample (data not shown). To assess any effect
modification by liver marker status (e.g. normal or elevated
values), we performed stratified analysis which did, however,
yield comparable results (data not shown).
Discussion
To the best of our knowledge, the present study is the first
investigating the prospective association of carbohydrate qual-
ity with liver enzymes in an older population. The present
study confirms previously reported associations between diet-
ary GI and fibre intake with TAG and HDL-C, but suggests that
these are not of prospective relevance. Overall, the effect sizes
for all observed associations were small. Hence, the present
analysis does not support a major role of carbohydrate quality
in relation to markers of liver function among the elderly.
Added sugars, particularly from soft drinks, are proposed
to be relevant in NAFLD pathophysiology: Kechagias et al.(21)
found a positive correlation between the intake of simple
sugars and the levels of ALT, and case–control studies have
indicated a positive association of NAFLD risk and severity
with soft drink consumption(4,5). We did not observe relation-
ships of sugar with any of the analysed markers. This could
be due to the fact that soft drinks were rarely consumed
by this elderly population. In this context, concern has
been expressed that high intakes of fructose primarily derived
Table 2. Comparison of the metabolic variables and nutritional intake of the 866 Blue Mountains Eye Study participants at baseline and 5-year
follow-up
(Median values and 25th and 75th percentiles)
Baseline 5-year follow-up
n Median 25th percentile 75th percentile Median 25th percentile 75th percentile P *
Metabolic variables
BMI (kg/m2) 866 26·8 24·4 29·9 26·6 24·1 29·8 ,0·0001
ALT (U/l)† 866 19 15 26 22 18 28 ,0·0001
GGT (U/l)† 866 20 15 29 23 17 32 ,0·0001
Albumin (%) 866 42 40 44 43 41 44 ,0·0001
Bilirubin, total (mmol/l) 865 10 8 12 11 8 14 ,0·0001
Fasting glucose (mmol/l) 737 5·0 4·7 5·5 4·9 4·6 5·3 ,0·0001
Fasting TAG (mmol/l) 755 1·34 0·98 1·83 1·28 0·93 1·75 0·0001
Fasting cholesterol (mmol/l) 866 6·0 5·3 6·6 5·4 4·8 6·1 ,0·0001
Fasting HDL (mmol/l) 755 1·4 1·2 1·7 1·6 1·3 1·9 ,0·0001
Daily nutritional intakes
Energy (kJ) 866 8201 6869 9750 8360 6890 10 112 0·004
Fat (%) 866 31·6 27·8 35·6 32·5 28·4 36·6 ,0·0001
SFA (%) 866 12·1 10·1 14·2 12·5 10·4 14·5 0·02
MUFA (%) 866 11·3 9·9 12·8 11·9 10·2 13·4 ,0·0001
PUFA (%) 866 4·9 3·9 6·1 5·1 4·0 6·2 0·05
Protein (%) 866 17·6 15·7 19·6 17·7 15·8 19·7 0·2
Carbohydrates (%) 866 47·8 43·5 52·4 47·1 42·8 51·4 0·002
Sugar (%) 866 25·2 21·2 29·2 25·6 21·6 29·4 0·1
Starch (%) 866 21·7 18·7 24·9 20·5 17·4 23·2 ,0·0001
GI 866 56·1 53·2 58·6 56·1 53·4 58·6 0·6
GL 866 132·0 106·1 158·3 132·6 106·1 160·5 0·5
Fibre (g/1000 kJ) 866 3·28 2·71 3·98 3·22 2·65 3·87 0·01
From vegetables (g/1000 kJ) 866 1·14 0·90 1·47 1·17 0·93 1·51 0·05
From fruits (g/1000 kJ) 866 0·78 0·49 1·13 0·83 0·52 1·18 0·02
From bread and cereals
(g/1000 kJ)
866 0·83 0·54 1·17 0·69 0·43 0·96 ,0·0001
Alcohol (g) 866 1·62 0·21 9·58 1·67 0·17 9·51 0·2
ALT, alanine aminotransferase; GGT, g-glutamyltransferase; GI, glycaemic index; GL, glycaemic load.
*Wilcoxon signed-rank test.
† To convert U/l to mkat/l, multiply by 0·017.
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from high-fructose maize syrup could adversely affect liver
function(22). In contrast to the USA, sucrose is the most
commonly used sweetener in Australia, which, however, has
been proposed to yield effects comparable with those of
high-fructose maize syrup(22). Unfortunately, additional data
that would have allowed separate appraisal of intrinsic and
added sugar or fructose intake were not available in the
present study.
Dietary fibre, particularly viscous fibre, may exert bene-
ficial effects on blood lipids and inflammatory markers(23).
Indeed, oxidative stress is increasingly recognised as an
important parameter in NAFLD pathophysiology and is
another possible mechanism linking carbohydrate quality to
hepatic steatosis(24,25). While Valtuena et al.(2) did not observe
a relationship between total fibre intake and liver steatosis,
we saw a favourable association of dietary fibre with GGT
and fasting TAG, in particular for fibre from fruit sources.
In contrast to single nutrients such as fructose or fibre, diet-
ary GI gives an estimate of repeated postprandial glycaemic
excursions, i.e. it allows us to address the relevance of one
particular metabolic response to carbohydrate nutrition. The
assumption that a higher dietary GI could be related to
NAFLD stems from the observation that a hyperenergetic
intake of carbohydrate-rich foods leading to increased
postprandial glucose elevations enhances hepatic lipogen-
esis(26–28). Valtuena et al.(2) showed an association between
dietary GI and the degree of hepatic steatosis measured by
liver echography. However, in a stratified analysis, they
observed a significant impact of dietary GI only for parti-
cipants, who were insulin-resistant (n 60, 24·9%). They
concluded that the combination of hyperglycaemia and
hyperinsulinaemia may lead to increased hepatic fat accumu-
lation through elevated lipogenesis, on the one hand, and
suppressed b-oxidation, on the other hand(2). By contrast,
we did not observe an interaction with diabetes/impaired fast-
ing glucose status; however, this could reflect insufficient
power as the number of participants with these conditions
was small (n 85, 9·8%) (data not shown). In the present anal-
ysis, dietary GI was not related to liver enzymes. Instead, we
observed cross-sectional associations of dietary GI with TAG
and HDL-C levels – the latter one also mirrored by a relation-
ship to starch intake, a dietary factor closely related to dietary
Table 3. Mixed models* of the cross-sectional and the 5-year concurrent relationships of markers of carbohydrate quality to log transformed serum
alanine aminotransferase (ALT) and g-glutamyltransferase (GGT) levels (U/l) in the 866 Blue Mountains Eye Study (BMES) participants
(b Coefficients and standard errors)
ALT (n 866) GGT (n 866)
Cross-sectional
estimate
5-year concurrent
change estimate
Cross-sectional
estimate
5-year concurrent
change estimate
b SE P b SE P b SE P b SE P
GI
Model 1† 0·0018 0·0039 0·6 0·0055 0·0032 0·09 0·0068 0·0045 0·1 0·0063 0·0035 0·07
Model 2‡ 0·0007 0·0041 0·9 0·0043 0·0033 0·2 0·0004 0·0048 0·9 0·0053 0·0037 0·2
Sugar intake (%)
Model 1† 0·0001 0·0025 1·0 0·0025 0·0020 0·2 0·0046 0·0029 0·1 0·0002 0·0022 0·9
Model 2§ 0·0016 0·0031 0·6 0·0017 0·0025 0·5 0·0018 0·0036 0·6 0·0014 0·0028 0·6
Starch intake (%)
Model 1† 0·0039 0·0032 0·2 0·0021 0·0024 0·4 0·0060 0·0037 0·1 0·0028 0·0027 0·3
Model 2‡ 0·0008 0·0033 0·8 0·0041 0·0026 0·1 0·0046 0·0038 0·2 0·0033 0·0029 0·3
Fibre intake (g/1000 kJ)
Model 1† 0·0032 0·0039 0·4 0·0048 0·0034 0·2 0·0149 0·0045 0·0009 0·0034 0·0037 0·4
Model 2k 0·0004 0·0046 0·9 0·0020 0·0038 0·6 0·0128 0·0054 0·02 0·0020 0·0043 0·6
Fibre intake from bread
and cereals (g/1000 kJ)
Model 1† 0·0042 0·0069 0·5 0·0115 0·0059 0·049 0·0149 0·0080 0·06 0·0042 0·0066 0·5
Model 2k 0·0020 0·0069 0·8 0·0084 0·0060 0·2 0·0098 0·0080 0·2 0·0052 0·0068 0·4
Fibre intake from vegetables
(g/1000 kJ)
Model 1† 0·0062 0·0078 0·4 0·0052 0·0058 0·4 0·0118 0·0091 0·2 0·0038 0·0065 0·6
Model 2k 0·0043 0·0076 0·6 0·0032 0·0058 0·6 0·0055 0·0089 0·5 0·0066 0·0066 0·3
Fibre intake from fruits
(g/1000 kJ)
Model 1† 0·0032 0·0064 0·6 0·0035 0·0055 0·5 0·0189 0·0074 0·01 0·0079 0·0060 0·2
Model 2k 0·0049 0·0081 0·5 0·0039 0·0065 0·6 0·0158 0·0095 0·095 0·0070 0·0073 0·3
GI, glycaemic index.
*Models contain a random statement with an unstructured covariance structure.
†Model 1 contains time defined as 1 (BMES-2) and 2 (BMES-3) and the predictor variable (e.g. dietary GI (per 10 units/d)) as terms at baseline, baseline£ time and concurrent
change, adjustment for sex and energy (use of the multivariate energy density model).
‡Model 1 additionally adjusted for BMI as terms at baseline and baseline £ time, age, diabetes at baseline, smoking (past and/or concurrent), alcohol consumption (categorical)
as terms at baseline, baseline £ time and concurrent change, the use of cholesterol-lowering medication and dietary fat (percentage of energy, en%) and fibre intake (g/MJ)
as terms at baseline, baseline £ time and concurrent change.
§Same as ‡, but adjustment for fibre intake from fruits (g/MJ) as terms at baseline, baseline £ time and concurrent change instead of total fibre intake.
kModel 1 additionally adjusted for BMI as terms at baseline and baseline £ time, age, diabetes at baseline, smoking (past and/or concurrent), alcohol consumption (categorical)
as terms at baseline, baseline £ time and concurrent change, the use of cholesterol-lowering medication and dietary fat intake (en%) and dietary GI as terms at baseline,
baseline £ time and concurrent change.
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GI values(29). The present findings are in line with other cross-
sectional observational studies(30–36); however, the absence of
a longitudinal relationship questions the clinical relevance of
these associations in this age group. Furthermore, evidence
from meta-analyses of intervention studies does not support
an effect of dietary GI on TAG or HDL-C(37,38).
The main strengths of the present analysis were the pro-
spective study design with repeated measurements of liver
enzymes, fasting TAG and HDL-C, as well as dietary intake
data in a contemporary sample of older men and women.
We could control for repeatedly measured key confounding
factors such as BMI, medications taken or health status.
However, we cannot preclude residual confounding, resulting
from imprecisely measured or unmeasured confounding fac-
tors. Additionally, due to the large number of tests, chance
findings are a possibility.
Regarding the markers for NAFLD, it has to be considered
that raised liver enzymes can only reveal an increased risk,
yet no quantitative conclusions about the extent of hepatic
fat accumulation can be drawn. Moreover, NAFLD can be
present without any elevations in liver enzymes. However,
these markers are commonly used as minimally invasive par-
ameters(1,8), and were readily available for the present study
sample. Despite the fact that we employed a validated FFQ,
misclassification bias can still exist. This may apply to fibre
sources in particular, since the FFQ was neither designed
nor validated for fibre source-specific analyses. At the 5-year
follow-up, participants may have had a greater recall of certain
food groups increasingly considered healthy such as fruits and
vegetables. However, such a recall bias would have rather
translated into an underestimation for the concurrent changes
in markers of liver function. Selection bias resulting from the
limited number of persons eligible for the longitudinal analysis
is a particular concern and may hamper the extent to which
the present results can be generalised. Similar characteristics
among those lost to follow-up suggest that attrition bias intro-
duced by loss to follow-up was low. However, attrition due to
higher natural mortality limits the generalisability of the pre-
sent findings. Also, selective survival may have occurred
because those included in the analysis were healthier at base-
line regarding some but not all clinical parameters than those
who died during the follow-up.
Table 4. Mixed models* of the cross-sectional and the 5-year concurrent relationships of markers of carbohydrate quality to log-transformed serum
fasting TAG (mmol/l) and HDL-cholesterol levels (mmol/l) in the 755 Blue Mountains Eye Study (BMES) participants
(b Coefficients and standard errors)
TAG (n 755) HDL (n 755)
Cross-sectional estimate
5-year concurrent change
estimate
Cross-sectional
estimate
5-year concurrent change
estimate
b SE P b SE P b SE P b SE P
GI
Model 1† 0·0123 0·0043 0·005 0·0014 0·0035 0·7 0·0053 0·0023 0·02 0·0009 0·0016 0·6
Model 2‡ 0·0066 0·0045 0·1 0·0022 0·0037 0·6 0·0048 0·0024 0·046 0·0021 0·0017 0·2
Sugar intake (%)
Model 1† 0·0005 0·0028 0·9 0·0008 0·0022 0·7 0·0011 0·0015 0·5 0·0001 0·0010 0·9
Model 2§ 0·0028 0·0034 0·4 0·0022 0·0028 0·4 0·0002 0·0018 0·9 0·0011 0·0013 0·4
Starch intake (%)
Model 1† 0·0045 0·0036 0·2 0·0007 0·0027 0·8 0·0046 0·0019 0·02 0·0020 0·0013 0·1
Model 2‡ 0·0044 0·0037 0·2 0·0002 0·0029 0·9 0·0038 0·0019 0·05 0·0020 0·0014 0·1
Fibre intake (g/1000 kJ)
Model 1† 0·0135 0·0043 0·002 0·0030 0·0038 0·4 0·0027 0·0023 0·2 0·0028 0·0018 0·1
Model 2k 0·0161 0·0051 0·002 0·0038 0·0044 0·4 0·0037 0·0027 0·2 0·0036 0·0020 0·08
Fibre intake from bread
and cereals (g/1000 kJ)
Model 1† 0·0108 0·0076 0·2 0·0103 0·0066 0·1 0·0039 0·0040 0·3 0·0030 0·0031 0·3
Model 2k 0·0108 0·0076 0·2 0·0117 0·0068 0·09 0·0047 0·0040 0·2 0·0034 0·0032 0·3
Fibre intake from vegetables
(g/1000 kJ)
Model 1† 0·0095 0·0087 0·3 0·0057 0·0066 0·4 0·0023 0·0046 0·6 0·0017 0·0031 0·6
Model 2k 0·0087 0·0084 0·3 0·0059 0·0066 0·4 0·0033 0·0044 0·5 0·0008 0·0031 0·8
Fibre intake from fruits
(g/1000 kJ)
Model 1† 0·0225 0·0070 0·001 0·0068 0·0061 0·3 0·0043 0·0037 0·3 0·0041 0·0028 0·1
Model 2k 0·0269 0·0089 0·003 0·0102 0·0072 0·2 0·0046 0·0047 0·3 0·0058 0·0034 0·09
GI, glycaemic index.
*Models contain a random statement with an unstructured covariance structure.
†Model 1 contains time defined as 1 (BMES-2) and 2 (BMES-3) and the predictor variable (e.g. dietary GI per 10 units/d) as terms at baseline, baseline£ time and concurrent
change, adjustment for sex and energy (use of the multivariate energy density model).
‡Model 1 additionally adjusted for BMI as terms at baseline and baseline £ time, age, diabetes at baseline, smoking (past and/or concurrent), alcohol consumption (categorical)
as terms at baseline, baseline £ time and concurrent change, the use of cholesterol-lowering medication and dietary fat (percentage of energy, en%) and fibre intake (g/MJ)
as terms at baseline, baseline £ time and concurrent change.
§Same as ‡, but adjustment for fibre intake from fruits (g/MJ) as terms at baseline, baseline £ time and concurrent change instead of total fibre intake.
kModel 1 additionally adjusted for BMI as terms at baseline and baseline £ time, age, diabetes at baseline, smoking (past and/or concurrent), alcohol consumption (categorical)
as terms at baseline, baseline £ time and concurrent change, the use of cholesterol-lowering medication and dietary fat intake (en%) and dietary GI as terms at baseline,
baseline £ time and concurrent change.
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In conclusion, the absence of longitudinal associations
between carbohydrate quality and liver enzymes or serum
lipids in this older Australian population does not support
a major role of carbohydrate nutrition in liver function
among the elderly. A potential impact of carbohydrate
nutrition in populations with more adverse dietary habits
deserves further investigation, ideally using direct measures
of NAFLD status.
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